Full text of "Control of ovulation; proceedings of the conference held at Endicott House, Dedham, Massachusetts, 1960"

See other formats

Marine Biological Laboratory Library

Woods Hole, Mass.

Presented by

Dr. Claude A. Villee
June 22, 1961

CONTROL OF OVULATION

1,I2.L
V 'fl

CONTROL
OF OVULATION

Proceedings of the Conference held at
Endicott House, Dedham, Massachusetts, i960

Edited by
CLAUDE A. VILLEE

HARVARD MEDICAL SCHOOL
BOSTON, MASSACHUSETTS

SYMPOSIUM PUBLICATIONS DIVISION

PERGAMON PRESS

NEW YORK • OXFORD • LONDON • PARIS
1961

PERGAMON PRESS INC.

122 East 55th Street, New York 22, N. Y.
S la tier Center 640, 900 Wilshire Boulevard, Los Angeles 17, California

PERGAMON PRESS LTD.

Headington Hill Hall, Oxford

4 and 5 Fitzroy Square, London, W.l

PERGAMON PRESS S.A.R.L.

24 Rue des Ecoles, Paris V

PERGAMON PRESS G.m.b.H.

Kaiserstrasse 75, Frankfurt am Main

Library of Congress Card No. 60-14946

Printed in Great Britain by John Wright and Sons Ltd., at The Stonehridge Press, Bristol

PREFACE

Although recent years have seen major advances in all aspects of endo-
crinology, some of the most exciting ones have been in our understanding of
the mechanisms controlling ovulation. In addition to a clarification of the
roles of steroid hormones and the pituitary gonadotropins in this process,
evidence has accrued that certain regions in the hypothalamus, and perhaps
in other regions of the central nervous system, have a primary function in
controlling ovulation, probably by way of the pituitary. On February 26-28,
1960, a group of investigators met at Endicott House, Dedham,
Massachusetts, under the sponsorship of Harvard University and the
Association for the Aid of Crippled Children, New York City, to review
and evaluate the experimental evidence upon which the current concepts
of the mechanisms controlling ovulation are based. The results of some
current attempts to inhibit or prevent ovulation by the administration of
analogs of the steroid hormones were also discussed in detail.

Some thirty endocrinologists, biochemists, physiologists, neurologists,
anatomists, obstetricians and gynecologists from the United States, England,
and the Continent were invited to participate in this conference. The twelve
papers given at the conference have been published with the minimum of
scientific editing necessary to bring them into a consistent form. The
discussion following each paper was recorded by a stenotypist and edited by
each discussant. The task of the editor was greatly facilitated by the generous
co-operation of the authors and discussants in returning their corrected
manuscripts promptly.

The conference was planned by a committee composed of Drs. Roy O.
Greep, Duncan E. Reid, and Claude A. Villee of Harvard University with
Mr. Leonard W. Mayo and Mrs. William F. FitzGerald of the Association
for the Aid of Crippled Children as consultants. Funds to underwrite the
costs of the conference were provided by a grant from the Association which
is interested in conferences of this type as part of its program in medical and
social research related to the prevention of disabling diseases and conditions
of children and youth.

Claude A. Villee

Boston, Massachusetts

CONTENTS

List of Contributors

The Role of the Pituitary Gonadotropins in Induction of Ovulation
in the Hypopliysectomized Rat 1

Frances Carter, Marion C. Woods and Miriam E. Simpson

Discussion by Knobil

Follicular Development, Ovular Maturation and Ovulation in
Ovarian Tissue Transplanted to the Eye 24

R. W. Noyes, T. H. Clewe and A. M. Yamate

Discussion by Hammond

The Role of Steroids in the Control of Mammalian Ovulation 37

Gregory Pincus and Anne P. Merrill

Discussion by Barraclough, Breneman, Chang, Folley, Creep,
Hisaw, Knobil, McArthur, Meyer, Nalbandov, Nelson, Noyes,
Pincus, Segal, Simpson and Sturgis

The Pituitary Stalk and Ovulation 56

Geoffrey W. Harris

Discussion by Critchlow

Interactions between the Central Nervous System and Hormones

Influencing Ovulation 79

Charles H. Sawyer and M. Kawakami

Discussion by Hansel

The Preoptic Region of the Brain and its Relation to Ovulation 101

John W. Everett

Discussion by Barraclough, Folley, Hansel, Harris and Segal

Mechanisms Controlling Ovulation of Avian and Mammalian

FolUcles 122

Andrew V. Nalbandov

Discussion by Hisaw, Meyer and Nalbandov

Ovulation in the Domestic Fowl 133

Richard M. Fraps

78^06

viii Contents

PAGE

Hormonal Augmentation of Fertility in Sheep and Cattle 163

John Hammond, Jr.
Discussion by Breneman, Chang, Folley, Ganong, Creep, Hammond,
Harris, Hisaw, Knobil, Meyer, Nalbandov and Pincus

The Induction of Ovulation in the Human by Human Pituitary

Gonadotropin 192

Carl A. GemzcU
Discussion by McArthur, Reid, Segal and Villee

Factors Influencing Ovulation and Atresia of Ovarian Follicles 213

Somcrs H. Sturgis
Discussion by Gemzell, Creep, Hertz, McArthur and Pincus

Inhibition of Ovulation in the Human 222

John Rock
Discussion by Hisaw and Nelson

Subject Index 245

LIST OF CONTRIBUTORS

Edward B. Astwood, Department of Medicine, New England Center Hospital,
Boston, Massachusetts

Charles A. Barraclough, Department of Anatomy, University of California
Medical Center, Los Angeles, California

W. R. Breneman, Department of Zoology, Indiana University, Bloomington,
Indiana

MiN Chueh Chang, Worcester Institute for Experimental Biology, Shrewsbury,

Massachusetts

Vaughn Critchlow, Department of Anatomy, Baylor University, Houston, Texas

John W. Everett, Department of Anatomy, Duke University, Durham, North
Carolina

Mrs. William FitzGerald, Consultant, Association for the Aid of Crippled
Children, New York

S. John Folley, The National Institute for Research in Dairying, Shinfield,
Reading, England

Richard M. Fraps, Agricultural Research Service, Beltsville, Maryland

William F. Ganong, Department of Physiology, University of California Medical
Center, San Francisco, California

Carl Gemzell, Department of Obstetrics and Gynecology, Karolinska Institute,

Stockholm, Sweden
Roy O. Greep, Harvard School of Dental Medicine, Boston, Massachusetts

Dwain D. Hagerman, Department of Biological Chemistry, Harvard Medical
School, Boston, Massachusetts

John Hammond, Jr., School of Agriculture, Cambridge University, Cambridge,

England
Willl\m Hansel, New York State College of Agriculture, Ithaca, New York

Geoffrey W. Harris, Department of Neuroendocrinology, The Maudsley Hospital,

London, England
Roy Hertz, Endocrinology Department, National Institutes of Health, Bethesda,

Maryland
Frederick Hisaw, Biology Laboratories, Harvard University, Cambridge,

Massachusetts

Ernest Knobil, Department of Physiology, Harvard Medical School, Boston,
Massachusetts

Charles W. Lloyd, Department of Obstetrics and Gynecology, Upstate Medical
Center, Syracuse, New York

Janet McArthur, Department of Obstetrics and Gynecology, Harvard Medical
School and Massachusetts General Hospital, Boston, Massachusetts

X List of Contributors

Roland K. Meyer, Department of Zoology, University of Wisconsin, Madison,
Wisconsin

Andrew V. Nalbandov, Department of Animal Science, University of Illinois,

Urbana, Illinois
Warren O. Nelson, The Population Council, Inc., The Rockefeller Institute,

New York

Robert W. Noyes, Department of Obstetrics and Gynecology, Stanford University
School of Medicine, Palo Alto, California

Gregory Pincus, Worcester Institute for Experimental Biology, Shrewsbury,
Massachusetts

Duncan E. Reid, Department of Obstetrics and Gynecology, Harvard Medical
School, and Boston Lying-in Hospital, Boston, Massachusetts

John Rock, Rock Reproductive Study Center, Brookline, Massachusetts

Charles H. Sawyer, Department of Anatomy, University of California Medical
Center, Los Angeles, California

Sheldon Segal, The Population Council, Inc., The Rockefeller Institute, New York

Miriam E. Simpson, Institute of Experimental Biology, University of California,
Berkeley, California

Somers H. Sturgis, Department of Obstetrics and Gynecology, Harvard Medical
School, and Peter Bent Brigham Hospital, Boston, Massachusetts

Claude A. Villee, Department of Biological Chemistry, Harvard Medical School,
Boston, Massachusetts

THE ROLE OF THE PITUITARY GONADOTROPINS

IN INDUCTION OF OVULATION IN THE

HYPOPHYSECTOMIZED RAT*

Frances Carter, Marion C. Woods and Miriam E. Simpson

Institute of Experimental Biology and Departments of Anatomy

University of California

Berkeley and San Francisco

The experimental induction of ovarian follicular development constitutes no
problem. Growth of follicles has been induced in many species by homologous
and heterologous gonadotropins. Luteinization of follicles can also be
accomphsiied with relative ease, but ova are too often enclosed.

Monkey

This was our experience (van Wagenen and Simpson, 22, 26, 27) in efforts
made to induce ovulation in the primate (Macaca mulattd). Immediate
success was attained in causing follicular growth but the conditions for
induction of ovulation were more difficult to determine. Once conditions of
timing and dosage were mastered, ovulation was induced after administration
of follicle-stimulating hormone (FSH) and interstitial cell-stimulating
hormone (ICSH) derived from sheep pituitaries, as well as by monkey
pituitary extracts. Ovulation resulted more consistently after administration
of preparations from monkey pituitaries, either with or without supplementa-
tion by human chorionic gonadotropin (HCG). Both immature and adult
females ovulated after injection of appropriate dosage for 7 to 9 days. Adults
were injected during the first half of the cycle (from day 5 to 15). Ovulations
were multiple in all adults but not in all prepuberal animals. Whether this
constitutes a significant difference in the response of the immature monkeys
is not yet certain. These observations in the monkey have been adequately
documented in the literature.

Similar procedures have been followed by Gemzell et ah (8, 8a) and by
Rosemberg et al. (18) with success in the human female, and recently by
Knobil et al. (12) in the hypophysectomized monkey. However, these studies

* Aided by grants A-800 and RG-4339 from the United States Public Health Service, and
by a grant from the Committee on Research, Council of Pharmacy and Chemistry,
American Medical Association, and from the Population Council, Inc., New York City.

2 Frances Carter, Marion C. Woods and Miriam E. Simpson

in primates share the defects common to all efforts which have been made in
the last 30 years to obtain an understanding of the pituitary factors necessary
for ovulation (9, 10, 19, 20, 29). The presence of a pituitary in the recipients
complicates the response of normal animals to any gonadotropin adminis-
tered. All efforts have been handicapped by the lack of pure gonadotropins.
In the studies of van Wagenen and Simpson, to which reference has just been
made, neither hypophysectomized monkeys nor single pure gonadotropins
were available. The products from sheep pituitaries which were injected were
prepared by repeated ammonium sulfate fractionation of 40% ethanol extracts
of whole glands. The preparations from monkey pituitaries were lyophilized
40% ethanol extracts of anterior lobes. No further purification could be
undertaken at the time due to the scarcity of material. It was therefore evident
that we were not ready for sufficiently exacting experiments in the primate.

Hypophysectomized Rat

Meanwhile studies were in progress in which hypophysectomized rats
were being used as the experimental animal (2). These animals were available
in adequate numbers, and their use avoided the confusion introduced into
interpretation of the results by contributions from the recipient's pituitary.
These studies, like those in the primate, were subject to the criticism that
no completely pure pituitary gonadotropins were available, so that the
proportion of the two pituitary gonadotropins, FSH and ICSH, tentatively
regarded as essential for ovulation, could not be precisely determined. An
attempt will be made, however, to define the status of our knowledge
regarding the pituitary factors necessary for ovulation in the rat as determined
with the purest sheep pituitary FSH and ICSH now available.

In the rat, as in other species investigated, there was no difficulty in develop-
ing follicles, or in luteinizing them, but conditions necessary to cause release
of ova were more exacting. When these conditions were determined for the
hypophysectomized rat, it was found that superovulation was typical, a
characteristic observed repeatedly in experimental induction of ovulation
with exogenous gonadotropins in normal animals of many species. The
shedding of a number of ova greater than that characteristic for the species
is in itself an abnormal phenomenon, and the question must be raised
eventually as to the significance of the number of ova shed, though no
attempt will be made here to evaluate this matter.

In order to analyze which pituitary hormones are needed, and in what
proportion they must be present, it was necessary first to determine a set of
conditions under which ovulation might reliably be obtained in the hypo-
physectomized rat. These standard conditions were determined by the use
of a follicle-stimulating preparation from sheep pituitaries which was obtained
by repeated refractionation of an 0.8 saturated ammonium sulfate (AS)
fraction from which a number of fractions had already been removed at

The Role of the Pituitary Gonadotropins 3

lower AS concentrations (Table 1). Such preparations are commonly called
"FSH", because instigation of follicular growth is their predominant
biological characteristic. No corpora lutea are produced until many multiples

Table 1. Ammonium Sulfate Method for Fractionation of Gonadotropins from
40 % Ethanol Extract of Dried Whole Sheep Pituitaries

830 g dried whole sheep pituitaries

40% Ethanol pdr. 43 g
extr. 1.25LH20pH4RT

insol. 19.4g soluble 15 g (organic)

Add solid ammonium sulfate (AS)

ppt. 0.2 SAS: reppt.

0.5 SAS ppt.

0.8 SAS ppt.

0.2 SAS

0.5 SAS ppt. /
\ /

re-extr. 50 cm* H2O pH 4

re-extr. 400 cm^ H2O pH 4, adj. pH 5

0.2 SAS ppt.

0.5 SAS ppt.

0.2 SAS ppt. 0.5 SAS ppt.

0.8 SAS ppt.

wash 0.5 SAS: dial, ppt. dry 1.7 g
re-extr. 100 cm^ HoO pH 4

0.1 SAS ppt.

3rd 0.5 SAS ppt.
SVI 11 B 0.75 g
ICSH MED 15 ^g

dial, dry 2.7 g ext. 0.4 SAS pH 4

0.4 SAS insol.

sol.; to 0.8 SAS

3rd 0.8 SAS ppt.
SVI 3 B 0.8 g
FSH MED 25 /xg

of the minimal effective dose are given. Since microscopic evidence of repair
of the interstitial tissue was found on injection of this preparation at 10-fold
the dose giving follicular development it was characterized as containing
10% ICSH.

In experimental induction of ovulation in the hypophysectomized rat, both
dosage and timing of administration of the hormones are of utmost im-
portance. Rats hypophysectomized at 26 to 29 days of age were used in
experimentation 7 days after the operation, which allowed time to determine
completeness of hypophysectomy on a body weight basis, to insure ehmina-
tion of circulating endogenous hormones, and to establish a reasonably
uniform degree of atrophy of the reproductive tract. Table 2 shows the
standard conditions adopted for induction of ovulation. Adequate follicular
development had to be induced, and for this, subcutaneous injection of FSH

4 Frances Carter, Marion C. Wcxjds and Miriam E. Simpson

once daily for 4 days was found to be satisfactory; during this period a total
of 4 RU FSH (4 times the minimally effective dose) was injected. Many
healthy medium to medium large, or fully developed (large) follicles were
then present. The interstitial tissue was deficient, as only 4 RU FSH had
been given, and it would be necessary to inject 10 RU or more of this FSH
preparation before interstitial cells would be repaired. Ovulation did not

Table 2. Standard Conditions for Induction of Ovulation
IN Hypophysectomized Rats

Total dose, subcutaneous

No.

rats

Number
ovulating

Ova in
oviducts

Ovaries

Preparatory
days 1-4

Supplement
late day 4

Wt.

Histology

—

mg
39

mml F

IT deficient

28
82%

11
(3-65)

IT partial repair

young CL

follow this preparatory treatment without supplementary hormonal adminis-
tration. However, it could readily be induced by giving an injection of twice
the total preparatory dose (8 RU, likewise subcutaneously) late on the day
of the 4th injection (6 hr after the last preparatory dose). Observations of the
ovaries and oviducts to determine the incidence of ovulation were made
24 hr after this supplementary injection. Under these circumstances young
corpora lutea were present in the ovaries in 82 % of the 34 rats so treated.
Multiple ova were shed, and an average of 27 were present in the oviduct.

Figure 1 shows the multiplicity of corpora lutea, interspersed with some
follicles which did not rupture. The large number of ova shed is indicated by
the clumps of granulosa cells in the loop of oviduct shown. Figure 2 shows
a group of ova in a distended loop of oviduct. Figure 3 shows that ova some-
times still lingered in the bursa at time of autopsy.

The corpora lutea present 24 hr after the last injection were still not
completely formed, the predominating cell, the granulosa lutein cell, not
having developed much cytoplasm (Fig. 4). Rupture points were seen
occasionally but these close quickly in the rat (Fig. 5).

The treatment almost always developed multiple follicles. The proportion
of follicles releasing ova, together with the proportion of rats in the group
which ovulated were used as a measure of the efficacy of treatment. With the
particular FSH preparation shown in Table 2 the number of ova released

The Role of the Pituitary Gonadotropins 5

varied from 3 to 65, the average being high (27) so this was considered an
effective treatment. (At least a few of the multiple follicles stimulated always
enclosed ova with luteinization of their walls. Therefore a higher proportion
of follicles releasing their ova was evaluated as a better response, although,
as pointed out previously, the normality of superovulation may itself be
questioned.) Figure 6 shows some apparently normal follicles which did not
ovulate within 24 hours. It had been determined previously, however, that
the differences in number of ova shed between 18 and 24 hours was no greater
than the variation between animals, and that a longer period before autopsy
(28, 32, 40 hours) merely resulted in greater maturity of the corpora lutea,
and enclosure of the remaining ova in luteinized bodies.

When the corpora lutea were allowed to complete their development under
the influence of lactogenic hormone, they could be shown to be functional.
The corpora lutea after administration of 2 lU daily of lactogenic hormone*
for 10 days were large and compact (Fig. 7) and the uteri of such animals
were able to produce placentomata around threads inserted through the
endometrium (Table 3).

Table 3. Functional Capacity of Corpora Lutea Induced in Hypophysectomized

Immature Rats by FSH or by FSH + HCG and Maintained for 10 days by Lactogenic

Hormone. Placentoma Reaction

' Ovulatory
treatment
(4 days)*

No.
of
rats

Placentoma

Ovarian
weight

FSH 4 RU

+
FSH 8 RU day 4

100%

FSH 4 RU
HCG 1 RU

+
FSH 8 RU day 4

100%

122

Followed by lactogenic hormone: 2 lU daily 10 days, threads in endometrium 5th day.

As the FSH preparation used initially in determining the standard
conditions for induction of ovulation contained ICSH, it was important to
determine the significance of each of the two gonadotropins present. Attention
was first directed to the adequacy of FSH unsupported to induce ovulation,
for which purpose FSH preparations of increasing purity and potency were
compared in regard to this capacity. The FSH preparations used were

* The lactogenic hormone (prolactin) used in these studies was a gift from the Endo-
crinology Study Section, National Institutes of Health.

6 Frances Carter, Marion C. Woods and Miriam E. Simpson

assayed carefully in hypophysectomized immature rats. The end point, or
RU, in the assay was the minimal dose which would cause resumption of
follicular growth (Table 4).

Table 4. Assay for Pituitary Follicle-stimulating Hormone (FSH)
IN Hypophysectomized Female Rats (after Simpson, 21)

Strain, Long-Evans. H 26-28 days, 7 days PO.

Inject SQ, 1 x day, 3 days Autopsy 72 hr.

RU: Minimal total dose, in a graded series of doses, giving microscopic
evidence in two-thirds of the animals of growth of follicles from
control size (< 375 n) to beginning antrum formation (450-500 n).

The purified FSH preparations were made from sheep pituitaries by 40%
ethanol extraction of whole glands followed by fractional ammonium sulfate
precipitation, anion-exchange chromatography on DEAE-cellulose and
further ammonium sulfate fractionation.

The best preparations had minimal effective doses (RU) for FSH ranging
from 4.0 down to 1.7 /xg, when given subcutaneously over a 3-day-period,
and did not show contamination with ICSH by interstitial cell repair until
25 to 70 times this dose was injected by the intraperitoneal route (IP),
likewise for 3 days. As can be seen (Table 5), the process of purification

Table 5. Purification of Sheep FSH (after Simpson, 21)

Yield

MED

Multiple

Procedure

mg/kg

FSH

wet gl

/^g

repair

Frozen pituitary Acetone-

dried

250x103

ca. 2500

0.4 X

40%EtOH, pH7, 25°C

8000

250

AS Fractionation

300-400

DEAE-cellulose

30^0

2.9

35 X

AS 0.6-0.7 sat

12-15

1.7

70 X

reduced the MED for FSH from 2.5 mg in the original glands to 1.7 ^g in
the final product. Whereas the original glands gave interstitial repair at 0.4
the MED for FSH the final product could be given at 70-fold the MED
before evidence of presence of ICSH was obtained.

The favorable comparison with potency of other purified sheep FSH
preparations is shown in Table 6 (3-5, 11, 15, 17, 25, 30, 31). To be noted
particularly is the relative potency for FSH, and the contamination with ICSH
present in the NIH-FSH-Sl standard. By the assay method used here this
preparation had an MED of >50 jug and showed contamination with ICSH
at 5-fold this dose. It may be noted that Velardo in the recent report on
induction of ovulation in hypophysectomized rats (28) used this standard, a

The Role of the Pituitary Gonadotropins 7

preparation which is less potent and more contaminated with ICSH than
the gonadotropin used in estabhshing the standard conditions described here.
The FSH used in determining standard conditions was made in 1939 and is
comparable in method and preparation and potency to that listed as the
first item in Table 6.

Table 6. Comparison of Follicle-stimulating Hormone (FSH) Preparations from
Sheep Pituitary made in Different Laboratories (after Simpson, 21)

Preparation

Unitage

Multiple giving

Author + year

Method

MED fig

FinH

Multiple of
Armour std.

Repair

ITinH

VP 100%
inH
SQ

Jensen, Simpson,
Tolksdorf, Evans

1939

40%EtOH; AS

Conrat, Simpson,
Evans 1940

40% EtOH; AS

2.5-3

Li, Simpson 1949

aq. ext.; AS

^100

ca. 1.4

>20

Raacke, Lostroh, Li
1958

Electrophoresis

Ellis 1958

NIH-Sl AS
DEAE-C

Electrophoresis

>50

4(g)

2.7
20 (40)

Steelman, Segaloff

1957

EtOH; DEAE-C

ca. 4

Woods, Simpson

1959

40% EtOH; AS
DEAE-C; AS

1.7

5
70

18
85

Table 7. Effect of Further Purification of FSH on Its Ability to Induce Ovulation
in Hypophysectomized Rats, under Standard Conditions of Dosage and Timing

Total dose,
subcutaneous

MED and % ICSH contamination of
FSH preparation used

days 1^

day 4

25 Mg

5°/

-' /o

4 Mg 4%

1.7 Mg

1.5%

RU
FSH 4

Ovaries
mg
33

Ova

0/8

Ovaries
mg
35

Ova

0/8

Ovaries
mg
30

Ova
0/9

FSH 4

FSH 8

4/9

12/34

10
10/19

8 Frances Carter, Marion C. Woods and Miriam E. Simpson

The sheep FSH from DEAE-ccllulosc columns, given at the same total
unitage, and under the same time relationships used in determining standard
conditions, resulted in ovulation less reliably than did the original preparation
containing 10% ICSH. Pilot experiments (Table 7) show the ovulatory
response from three FSH preparations of increasing purity, as indicated by
lower MED (25 /Mg down to 1.7 ^g) and decreasing percentage of ICSH
contamination (5%, 4% and 1.5%, respectively). The results from use of
these purified fractions did not equal that obtained from the original less
purified preparation; in fact, only about one-third to one-half of the rats
ovulated.

Several possible explanations for the discrepancy between these and earlier
results can be offered. In the first place, the rate of absorption and excretion
of the more purified preparations may differ from that of cruder ones. Several
means for obtaining prolonged action were tried, such as multiple injections
and injection of FSH in solutions containing gelatin or serum albumin, but
no clear evidence was obtained that this was an important factor. The
possibility that pituitary tropic hormones other than gonadotropins may be
involved in induction of ovulation also must be considered. This seems
improbable, however, as the only important biologically active contaminant
of FSH preparations is ICSH. Even the starting material for all preparations,
the 40% ethanol extract of whole sheep pituitaries which had an MED for
follicle development of 0.250 mg, contained less than 0.1 % growth, thyro-
tropic and adrenocorticotropic hormones. It did contain a small amount of
lactogenic hormone (0.075 lU/mg) but lactogenic hormone has been tested
as an ovulatory supplement in rats (as well as monkeys) and no effect in
inducing ovulation has been demonstrated. Purified preparations of FSH
with potency of 25 /xg down to 1.7 /Mg contained less than 0.1 % of all the
other tropic hormones: growth, thyrotropic, adrenocorticotropic and
lactogenic hormones.

The most obvious explanation of the reduced eflRcacy of more highly
purified FSH preparations was that the ICSH content had been depleted too
far. Attention was therefore turned to whether the ovulatory stimulus from
purified FSH was improved by addition of ICSH. Reconstitution of the
fraction of ICSH found in the original preparation, by addition of 10% by
unitage of ICSH, was the first approach.

As the ICSH added was a highly purified product a word should be said
regarding its chemical fractionation and assay. These preparations were all
standardized in hypophysectomized immature rats by determining the
minimal dose (RU) which would repair the deficient interstitial cells (Table 8).

The ICSH was prepared by methods similar to those used in purifying
FSH from a starting material of 40% ethanol extract from whole sheep
pituitary. The steps in the procedure, the potency of the preparation, and
the multiple of the MED which showed evidence of FSH contamination are

Ovaries of rats hypophysectomized at 26-29 days of age and treated one week later, for
4 days, with gonadotropins to induce ovulation. H and E stain. (Magnifications x ^)

Fig. 1. Whole ovary, in bursa, showing multiple corpora lutea of ovulation, residual large
follicles, some with luteinized walls enclosing their ova. A few ova, still surrounded by
granulosa cells, may be seen free in the bursa or within a distended loop of oviduct, x 27.

^3^^

.•:>*- *i

.. ^^-'X

«^^\

Fig. 2. Fimbriated end of oviduct and distended loop of oviduct, with ova. x91,

.'^Cili^;*??*

Fig. 3. Ova surrounded by granulosa cells, still free in the bursa and approaching the
fimbriated end of the oviduct, 24 hr after injection of the ovulatory supplement, x 125.

^i4^l^

Fig. 4. Numerous young ccipora luica of o\ Liiaiinii, surrounded by capillaries which have
not yet penetrated very deeply into the granulosal walls, x 125.

Fig. 5. Young corpus uteum showing rupture point, x 125.

■■■• ■ -C^M

Fig. 6. Young corpus luteum, with residual large follicles, x 125.

Fig. 7. Corpora lutea maintained for 10 days by 2 lU lactogenic hormone daily, following

induction of ovulation by 4 RU FSH in 4 days with a supplementary injection of 8 RU FSH

late on the 4th dav. Frozen section. H and E. x 27.

The Role of the Pituitary Gonadotropins 9

given in Table 9. Judged by the assay procedure described the best prepara-
tions had an MED of 1 /^g and did not lead to resumption of follicular
development at 6000-fold this dose. No other pituitary tropic hormones
were present in significant amounts in these ICSH preparations.

Table 8. Assay for Pituitary Interstitial Cell-stimulating Hormone (ICSH) in
Hypophysectomized Female Rats (after Simpson, 21)

Strain, Long-Evans. H 26-28 days, 7 days PO.

Inject IP 1 X day, 3 days Autopsy 72 hr.

RU: Minimal total dose, in a graded series of doses, giving microscopic
evidence in two-thirds of the animals of repair of "deficient"
interstitial cells : increased nuclear size, loss of pyknosis ; reappear-
ance of rim of eosinophilic cytoplasm.

Table 9. PuRincATioN of Sheep ICSH (after Simpson, 21)

Procedure

Yield
mg/kg
wet gl.

MED ICSH

Multiple
of MED

F devel.f

Frozen pituitary
Acetone-dried
40%EtOH, pH 7, 25°C
AS 0.4-0.45 sat.
DEAE-cellulose

250x10^
8000
50-75
10-12

ca. 1000
100

5-7.5
1

2.5 X
2.5 X
75 X
>6000x

* IP. t S.Q.

The purity of these preparations can be judged by comparing them with
those from sheep pituitaries made elsewhere, shown in Table 10 (13, 14, 23,
24, 30).

The comparison of potency of ICSH with different standard preparations
(NIH and Armour) by two different assay methods is given in Table 1 1 . The
best preparation was 4 times as potent as the Armour "LH" standard,
judged by the repair of interstitial tissue of hypophysectomized female rats,
and 5 times as potent by the ventral prostate test in hypophysectomized male
rats (21).

Table 12 shows a preliminary effort to determine whether the efficacy of
more purified FSH preparations is increased by reinstating the ICSH content
to 10%. The two FSH preparations used, with MED's of 5 and 1.67 /xg
respectively, did not cause ovulation during the preparatory stimulation of
follicular growth when given in doses of 4 RU combined with 10% ICSH.
When this preparatory treatment was supplemented as before by FSH alone,
given at twice the total dose used in the preparatory treatment (or 8 RU FSH),
ovulation occurred in most rats and large numbers of ova were shed. A
supplement of the combination (FSH + 10% ICSH) gave comparable

Frances Carter, Marion C. Woods and Miriam E. Simpson

Table 10. Comparison of Interstitial Cell-stimulating Hormone (ICSH) Preparations
FROM Sheep Pituitary, made in Different Laboratories (after Simpson, 21)

Preparation

Unitage (/ig)

Multiple of
Armour std.

Multiple

H MED

given SQ

F dev.

Author -1- Year

repair
H?IP

100%

rep.

Li, Simpson, Evans 1940

40%EtOH;AS

500

Squire, Li 1958-9

aq.ext.;IRC-50

< 2

2.5

>1000

Ellis 1958

aq.ext.;IRC-50

ca. 5

150

Leonora, McShan, Meyer

1958

IR-4B; IRC-50

<60

>20

Woods, Simpson 1959

aq. ext. ; AS
DEAE-C

1.7

>1200

IRC-50; AS

(from above)

2.5

40% EtOH
AS, DEAE-C

>6000

Table 11. Comparison of Potency of ICSH Preparations Made in Different

Laboratories, by Ventral Prostate Weight Increase or by Interstitial Cell

Repair, in Hypophysectomized Rats (after Simpson, 21)

Preparation

Ventral prostate
100% increase*

Interstitial

cell repair

MED rats

Armour std. (sheep)
LH 227-80

15t (S-D strain)
13 (L-E)

5 (L-E strain)

Ellis (sheep)
LH XIII-25-2

5 (S-D)

>5 < 10 (L-E)

WDI 40C (sheep)
WDIII 58A (sheep)

15 (L-E)

2.2 (L-E)

15 (L-E)
1.3 (L-E)

* 21-22 days at H, onset injection 2 days PO; injections given 1 x day, 4 days, autopsy
96 hr; injection SQ; Creep, PSEBM 46: 644, 1941.

t Potency reported by Ellis,/. Biol. Chem. 233, 63, 1958, for assay in Sprague-Dawley rats.
Steelman and Pohley, Endocrinology Si, 604, 1953 (15 /xg, V.P.), for Sprague-Dawley rats.

ovulation, judged both by the proportion of rats ovulating and the average
number of ova shed. However, this combined supplement did not appear to
be so effective after FSH alone was used in preparation of the follicles; fewer

The Role of the Pituitary Gonadotropins

ova were released. From this we proceeded on the assumption that the
presence of ICSH is of more importance during preparation of the follicles
than it is in the ovulatory supplement.

Table 12. Pilot Experiment. Recombination of Two Purified FSH Preparations
WITH 10% ICSH, IN Different Phases of the Ovulatory Treatment

Total dose, subcutaneous

MED of FSH preparation used

days \-A

day 4

5 Mg

1.67 Mg

FSH 4
ICSH 0.4

Ovaries
mg

Ovaries

FSH 4
ICSH 0.4

FSH 8

Ova: 58

3 of 3

Ova: 15

2 of 3

FSH 4

FSH 8
ICSH 0.8

Ova: 6

3 of 3

Ova: 5

2 of 2

FSH 4
ICSH 0.4

FSH 8
ICSH 0.8

Ova: 31
3 of 3

Ova: 17
3 of 3

Table 13 shows a more careful analysis, which confirms the importance of
the presence of 10% ICSH during preparation of follicles. Six FSH prepara-
tions were tested; for preparation of the follicles each was injected alone in
4 RU total dose, and after addition of 10% ICSH. The respective FSH under
examination was given alone as the supplement to all groups. Neither the
purified FSH preparations given alone nor those to which 10% ICSH was
added caused ovulation without supplementation. FSH alone followed by
the respective FSH as supplement on the 4th day gave variable results; some
FSH preparations caused all rats to ovulate whereas others resulted in
ovulation in as few as 30%. The same FSH preparations, upon the addition
of 10% ICSH during the preparatory period caused ovulation in most
groups when supplemented by the respective FSH. Both the number of rats
ovulating and the numbers of ova shed were in most instances greater than
when the follicles had been prepared by FSH without the addition of 10%
ICSH. The number of purified FSH preparations used and the size of the
groups tested seem adequate to establish that more ICSH is needed during
follicular growth than is provided by the purest FSH preparations.

It should not be concluded from the data presented that the proportion
of ICSH used (10%) was that most favorable for ovulation. The proportion
of FSH and ICSH occurring naturally differs in the pituitaries of various
species. The rat pituitary is high in ICSH, certainly far higher than the
purified FSH preparations from sheep pituitary. In turning to an analysis

Frances Carter, Marion C. Woods and Miriam E. Simpson

(/5

ril

O
H
<
OS
<

CL.

^*x

OS ^

fco

2 P
<^

> 1 <^

On " o
o — °^

m
^

o\ o

'S 5Po

U-)

r~_

g Em

r-~

rt "^

Tf J^ =

ITi

— o -

■*

6 1 a-

^s^

c
.9

"C 60 rr,

■*

5 E^

r<^

a
a
X

5 1 21
O ' o

-t

ON^

Froo

'5 ??o

« E<N

«N

> 1 °°

c
o

O 1 o

:^;^

■*

^H OS

c/l

.Si

5 2P"^

5 E^
O

■*

> 1 °°
O ' o

v^ OS o\

OS 5

•C 6prn

g E^

>/^

> 1 "^

'"'

•g 60o

IT)

5 E's-

3
O

^ 1

M-

</i

Tl-

Qi '^

■* d

CO on

U.U

•■^

The Role of the Pituitary Gonadotropins

of the efficacy of rat pituitary preparations it was also kept in mind that
species specificity of the pituitary proteins might constitute an important
factor in the abihty of the protein hormones to induce ovulation. Saline
suspensions of pooled rat anterior pituitaries were tested for ovulatory
response in hypophysectomized rats and found to be effective when given
even at lower unitage than the sheep preparations (provided, of course,
that they were given under the conditions of timing described above which
were rigidly maintained in this and all subsequent experiments).

Table 14. Induction of Ovulation by Saline Suspensions of Rat Anterior Pituitary,
UNDER Standard Conditions of Timing

Total dose, subcutaneous
(RU by assay)

Ovarian
weight

Ova in

days 1-4

day 4

FSH 4
ICSH 16

FSH 4

ICSH 16

mg
99

63
(30-98)

3/3

FSH 2
ICSH 8

FSH 4
ICSH 16

113

3/3

FSH 2
ICSH 8

3/3

FSH 1
ICSH 4

FSH 4
ICSH 16

*
3/3

FSH 2
ICSH 8

*
3/3

* Distended oviducts indicating ovulation.

The 40% ethanol extracts of rat pituitary were likewise effective. The
unitage administered was, however, of critical importance in determining
whether ovulation resulted. When a dose containing 4 x the minimum dose
for follicular stimulation was administered, a dose most nearly comparable
therefore to the 4 RU dose of sheep FSH though containing 16 times the
minimal dose necessary for interstitial cell stimulation, it proved to be too
high for ovulation (Table 15). This dose sometimes caused luteinization of
the follicle wall with enclosure of ova even before the supplement of twice
the total preparatory dose of the same material was given. When a half or a
fourth this preparatory dose was given, containing the equivalent of 2 RU
FSH + 8RUICSH or 1 RU FSH + 4 RU ICSH, normal, large follicles
developed which ovulated when supplemented as before.

Frances Carter, Marion C. Woods and Miriam E. Simpson

In order to determine whether these results were pecuHar to rat pituitary
gonadotropins, an clTort was made to reconstitute the proportion in rat
pituitary ethanol extracts by use of sheep pituitary gonadotropins. Purified
sheep FSH and ICSH preparations were therefore combined in the proportion
1 : 4, and were given at unitages corresponding to those of the rat pituitary
preparations (Table 15). Sheep gonadotropins in doses of 4 RU FSH+ 16 RU

Table 15. Induction of Ovulation by a 40% Ethanol Extract of Rat PrrurrARY, or
BY Sheep FSH and ICSH combined in the Same Proportion

Total dose, su
(RU by

bcutaneous
assay)

Rat pit. 40% EtOHextr.
MED: Fstim. 75 ^g
IT repair 20 /xg

Sheep pituitary

FSH: MED 4 ^g

ICSH: MED 1 ^lg

days 1-4

day 4

FSH 4
ICSH 16

Ovaries
mg
110

End.

Ova

3/3

Ovaries
mg
53
End.

Ova

0/3

FSH 8
ICSH 32

128

End.

3/3

76
End.

3/3

FSH 2
ICSH 8

—

1/3

36
IF

7
1/12

FSH 8
ICSH 32

117

3/3

60
CL

35
12/12

FSH 1
ICSH 4

—

0/3

10
mF

0/3

FSH 8
ICSH 32

3/3

18
mF

0/2

ICSH caused luteinization of follicles with enclosure of ova, even before
supplementation. Half these unitages, 2 RU FSH + 8 RU ICSH, caused
follicular development, but even without supplementation occasionally
caused ovulation, as had the rat pituitary extract at this level; optimal
conditions for ovulation were attained only when the usual supplement was
administered. Mixtures of 1 RU FSH + 4 RU ICSH did not give adequate
follicular growth in the first phase of treatment and the supplementary dose
was therefore ineffective, so that such mixtures were slightly inferior to the
rat pituitary preparations.

Several purified FSH preparations were combined with ICSH in this ratio
(1 : 4) and when given at the optimal dose level, 2 RU FSH and 8 RU ICSH,
were equally effective in promoting follicular development. When this was

The Role of the Pituitary Gonadotropins

followed by the usual supplementary dose of the combination excellent
ovulation ensued (Table 16).

Table 16. Supplementary Treatments Effective in Inducing Ovulation, after

Follicular Development by Purified Sheep FSH and ICSH* Preparations combined

IN THE Proportion Present in a Rat Pituitary Extract

Total dose,
subcutaneous

MED and % ICSH contamination of FSH

injected

days 1^

day 4

25 Mg 10%

4/^g 4%

2.5 /xg

2.5%

1.7 Mg

1.5%

Ovaries

Ova

Ovaries

Ova

Ovaries

Ova

Ovaries

Ova

FSH 2

mg
36

mg
12

mg
36

ICSH 8

0/3

1/12

0/3

FSH 8

ICSH 32

3/3

12/12

3/3

2/3

FSH 8

3/3

2/3

5/6

ICSH 32

3/3

28
18/18

0/3

2/3

ICSH MED 12.5 /^g used with the 25 /xg FSH; MED 1 /^g with all others.

In order more specifically to define the requirements for the supplement,
experiments were conducted to determine whether this proportion and dose
of FSH and ICSH (8 RU + 32 RU) was optimal. Each component of the
mixture was therefore examined separately, at the dose level contained in
the mixture just described (Table 16). It was found that FSH alone at the
8 RU level was effective as a supplement under the conditions of this
experiment. ICSH was then tried by itself at the same dose at which it had
been present in the combined supplement (32 RU) and it too caused ovulation.
In some instances, however, the number of animals ovulating and the number
of ova shed were less than after the combination or after FSH alone; in fact
there was one experiment in which not a single animal ovulated when ICSH
only was used as a supplement at the 32 RU level.

Subsequently the efficacy of ICSH as an ovulatory supplement, following
preparation of follicles by 2 RU FSH + 8 RU ICSH, was analyzed more
thoroughly at dose levels ranging from 2 to 40 RU. It was found that doses
of 16 to 40 RU resulted in ovulation (Table 17). However, when the follicles
were prepared by 4 RU of the same purified FSH given alone, and therefore
containing only 4 % intrinsic ICSH, even the highest supplementary dose of
ICSH (32 RU) was not entirely effective (only 2 of 4 rats ovulated). When

Frances Carter, Marion C. Woods and Miriam E. Simpson

the FSH preparation used to develop the follicles contained 10% intrinsic
ICSH, ovulation occurred following ICSH as a supplement at all levels:
8, 16 or 32 RU.

Table 17. Graded Doses of ICSH as the Ovulatory Supplement, after Follicular
Development by Different Treatments

Preparatory
total dose, subcu-
taneous, days 1-4

Supplementary dose ICSH (MED I ^g), day 4

subcutaneous, RU

16-20

Ov.

Ova

Ov.

Ova

Ov.

Ova

Ov.

Ova

Ov.

Ova

FSH 2

MED 4 Mg

4% ICSH

ICSH 8

1/12

2/7

10/10

8/8

MED 1 Mg

FSH 4

—

MED 4 fig

4% ICSH

0/8

0/4

2/4

FSH 4

MED 25 Mg

10% ICSH

0/10

2/4

3/4

4/4

* Not counted; distended oviducts.

Table 18. Graded Doses of Chorionic Gonadotropin (HCG) as the Ovulatory
Supplement, after Follicle Development by Different Treatments

Preparatory

Supplementary dose HCG, day A

[, subcutaneous

, lU

total dose, subcu-
taneous, days 1-4

Ov.

Ova

Ov.

Ova

Ov.

Ova

Ov.

Ova

Ov.

Ova

FSH 2

—

MED 4 /xg

4% ICSH

ICSH 8

1/12

0/1

5/6

4/4

MED 1 /xg

FSH 4

—

. —

MED 4 fig

4% ICSH

0/8

0/4

3/4

FSH 4

100

MED 25 fig

10% ICSH

0/10

1/7

4/4

* Not counted; distended oviducts.

The Role of the Pituitary Gonadotropins

Another luteinizing substance, human chorionic gonadotropin (HCG), was
tested as a supplement at levels from 2 to 32 lU (Table 18, RU = HJ). Doses
of 8 or more lU HCG were found to be effective as ovulatory supplements
following combinations of 2 RU FSH + 8 RU ICSH. The results were the
same when 10% intrinsic ICSH was present in the FSH preparation, but
following FSH containing 4% ICSH higher doses of HCG were required,
32 lU being optimal (Table 18).

The importance of the presence of more than4 % ICSH with the FSH during
stimulation of follicular growth was exemplified further by experiments

Table 19. Graded Doses of ICSH as the Ovulatory Supplement, after Follicular
Development by Purified FSH, with or without the ADomoN of 10% ICSH

Preparatory

Supplementary dose ICSH (MED 1 /xg),day 4, subcutaneous, RU

total dose, sub-
cutaneous, days 1-4

Ov.

Ova

Ov.

Ova

Ov.

Ova

Ov.

Ova

FSH 4

—

MED 4 fig

4% ICSH

0/8

0/4

5/10

FSH 4

MED 4 ng

4% ICSH

ICSH 0.4

0/12

4/6

6/6

MED 1 fig

Not counted ; distended oviducts.

Table 20. Graded Doses of HCG as the Ovulatory Supplement, after Follicular
Development by Purified FSH, with or without the Addition of 10% ICSH

Preparatory
total dose, sub-
cutaneous, days 1-4

Supplementary dose HCG, day 4, subcutaneous, lU

FSH 4

MED 4 Mg
4% ICSH

Ov.

mg
35

Ova

0/8

Ov.

Ova
0/4

Ov.

Ova

3/4

Ov.

mg
60

Ova

3/4

FSH 4

MED 4 Mg
4% ICSH
ICSH 0.4
MED 1 Mg

0/12

*
6/6

* Not counted; distended oviducts.

Frances Carter, Marion C. Woods and Miriam E. Simpson

in which 10",, ICSH was added to the purified FSH during the
preparatory treatment. ICSH was then elTective as the ovulatory supplement
in a greater number of animals, and at lower dose levels, than when following
the FSH alone (Table 19). These results were confirmed with HCG (Table 20).
FSH was similarly evaluated as an ovulatory supplement at different dose
levels, following different preparatory treatments. FSH had previously been
shown to be effective as a supplement at the 8 RU level following follicular
development by 2 RU FSH + 8 RU ICSH. This held true for several FSH
preparations of increasing purity (Table 16). As shown in Table 21, 4 RU of

Table 21. Graded Doses of FSH as the Ovulatory Supplement, after
Follicular Development by Different Treatments

Preparatory
total dose, sub-

Supplementary dose of the respective FSH, day 4,
subcutaneous, RU

FSH 2
MED 4 Mg
4% ICSH

ICSH 8
MED 1 Mg

Ovaries
mg
36

Ova

1/12

Ovaries
mg
46

Ova

2/3

Ovaries
mg
54

Ova

15/15

FSH 4
MED 4 ^lg
4% ICSH

0/8

12/34

FSH 4
MED 25 Mg
10% ICSH

0/10

*
6/6

27
28/34

* Not counted; distended oviducts.

purified FSH (MED 4 jug, 4% ICSH contamination) was still effective as a
supplement after preparation of follicles by 2 RU FSH + 8 RU ICSH.
However, 8 RU FSH was less effective as a supplement when the follicles
had been prepared by 4 RU of this FSH alone. The preparation used in
determining the standard conditions, containing 10% intrinsic ICSH, was
equally effective as an ovulatory supplement at 4 RU or at 8 RU, following
follicular development by 4 RU of this preparation.

This apparent non-specificity of the gonadotropic supplementary stimulus
to ovulation leaves several questions unanswered. That time is not the factor
has been shown by failure of ovulation after the preparatory treatment alone,
even though the rats were autopsied simultaneously with those which had
received a supplementary injection in the interim. The occasional release of

The Role of the Pituitary Gonadotropins 1 9

a few ova, reported here upon preparatory treatment by high unitages of
FSH and ICSH, was accompanied by excessive luteinization of the majority
of the follicles with enclosure of their ova. Sporadic instances of ovulation
without supplementary treatment have also been observed during routine
assay of gonadotropins, especially those of human pituitary origin, and here
again the answer may lie in the high proportion of ICSH present. Ovulation
in hypophysectomized rats after injection for four days of human pituitary
has been reported by Bahn et a/. (1) and by Velardo with sheep FSH and
ICSH (28).

That the injection per se is not the stimulus has been shown by the inade-
quacy of lower doses of FSH, ICSH or HCG than those illustrated in the
tables. A common factor might be sought in the possible contamination of
all these products by minute amounts of substances such as posterior lobe
hormones.* The existence of a separate "ovulatory hormone" has also been
postulated (5). It is difficult, though not impossible, to conceive that another
factor of sufficient biological potency could accompany FSH and ICSH in
their present state of purification.

SUMMARY AND CONCLUSIONS

What has been learned thus far in experimental induction of ovulation in
rat and monkey may be summarized as follows. Ovulation has been induced
in normal immature and adult Macaca mulatta with sheep pituitary fractions
high in FSH, and by 40% ethanol extracts of monkey anterior pituitary, with
and without supplements of sheep ICSH or of HCG. Although the sheep
preparations which caused ovulation in the monkey were designated as "FSH"
and were prepared by methods which yielded potent FSH, which by physico-
chemical criteria consisted of homogeneous protein, they were nevertheless
not homogeneous biologically, and still contained small amounts of ICSH.

These experiments were also subject to the criticism that normal recipients
were used and the pituitary undoubtedly contributed to the response. This
criticism has been obviated in the studies conducted in hypophysectomized
rats. Sheep FSH prepared similarly to that used in monkeys, as well as
further purified FSH preparations of greater potency, in which ICSH contami-
nation had been further reduced, have been examined carefully for their
adequacy in induction of ovulation in the hypophysectomized rat. FSH
preparations of potency comparable to those used in the monkey, with MED
25 jxg and containing 10% ICSH were effective both in promoting growth of
follicles and, terminally at higher doses, in giving the final impetus to
ovulation. FSH preparations of greater potency, MED 4 to 1.7 /xg, which

* Subsequent experiments have indicated that neither Pitressin, in doses of 0.5 or 0.05
dog pressor units, nor Pitocin, in doses of 0.5 or 0.05 guinea-pig uterine units, is effective
as an ovulatory supplement after follicular development by the FSH preparation used in
establishing standard conditions for ovulation. (The two products were supplied by Parke,
Davis & Co.)

20 Frances Carter, Marion C. Woods and Miriam E. Simpson

contained 4 to 1.5% ICSH contamination, were more variable in promoting
ovulation and were improved by an increase of ICSH content to 10% during
the preparatory phase of follicular growth.

A much higher content of ICSH than 10% did not interfere with the
effectiveness of the FSH preparations either during the preparatory or
supplementary phases. Combinations of FSH with 4-fold as much ICSH
were active, optimally at doses of 2 RU FSH + 8 RU ICSH. After stimulation
of follicles by such combinations ovulation could be induced not only by the
combination but also by either component given alone as the supplement.
Purified FSH was somewhat more effective as a supplement and could be
used at lower doses than ICSH (or HCG). It was clear, however, that FSH,
though effective as a supplement, was sufficiently purified to require additional
ICSH, more than 4%, during preparation of follicles.

It should be noted that the sheep preparations, at stages of purification
after the 40% ethanol starting material, contained negligible amounts of
other pituitary tropic hormones (growth, thyrotropic, adrenocorticotropic and
lactogenic hormones) so that it appears improbable that the other pituitary
tropic hormones are involved in either the preparatory or the supplementary
impetus to ovulation. Perhaps it will be impossible to clarify further the
proportion of the pituitary gonadotropic factors necessary for ovulation
until FSH and ICSH have been prepared in pure form.

REFERENCES

1. Bahn, R. C, N. Lorenz, W. A. Bennett and A. Albert, Gonadotropins of the

pituitary gland and urine of the adult human male, Proc. Soc. Exptl. Biol, and Med.
82, 111-1%2, 1953.

2. Carter, F., M. E. Simpson and H. M. Evans, Conditions necessary for the induction

of ovulation in hypophysectomized rats, Anat. Record {Proceedings) 130, 283, 1958.

3. Ellis, S., A scheme for the separation of pituitary proteins, J. Biol. Chem. 233, 63-68,

1958.

4. Evans, H. M., M. E. Simpson, S. Tolksdorf and H. Jensen, Biological studies of the

gonadotropic principles in sheep pituitary substance, Endocrinology 25, 529-546, 1939.

5. Everett, J. W., The time of release of ovulating hormone from the rat hypophysis,

Endocrinology 59, 580-585, 1956.

6. Fraenkel-Conrat, H. L., M. E. Simpson and H. M. Evans, Purification of follicle-

stimulating hormone (FSH) of the anterior pituitary, Proc. Soc. Exptl. Biol, and Med.
45, 627-630, 1940.

7. Fraenkel-Conrat, H. L., M. E. Simpson and H. M. Evans, Purification of follicle-

stimulating hormone of the anterior pituitary, Anales de la Facultad de Medicina,
Montevideo 25, 159-168, 1940.

8. Gemzell, C. a., E. Diczfalusy and K. G. Tillinger, Clinical effect of human pituitary

follicle-stimulatinghormone(FSH),y.C/m.£'«f/ocr/«o/.o«JMc/a6. 18, 1333-1348, 1958.
8a. Gemzell, C. A., E. Diczfalusy and K. G. Tillinger, Ciba Foundation Colloquium
on Human Pituitary Hormones, Buenos Aires, Argentina, Aug. 6-8, 1959.

9. Hammond, J., Jr., Induced ovulation and heat in anoestrous sheep, /. Endocrinol. 4,

169-180, 1945.
10. HiSAw, F. L., Development of the Graafian follicle and ovulation, Physiol. Rev. 27,
95-119, 1947.

The Role of the Pituitary Gonadotropins 2 1

11. Jensen, H., M. E. Simpson, S. ToLKSDORFand H. M. Evans, Chemical fractionation of

the gonadotropic factors present in sheep pituitary, Emhcrinology 25, 57-62, 1939.

12. Knobil, E., J. L. KosTYO and R. O. Greep, Production of ovulation in the hypo-

physectomized Rhesus monkey, Endocrinology 65, 487^93, 1959.

13. Leonora, J., W. H. McShan and R. K. Meyer, Separation of LH fractions from

sheep pituitary glands by use of ion exchange resins. Endocrinology 63, 867, 1958.

14. Li, C. H., M. E. Simpson and H. M. Evans, Interstitial cell-stimulating hormone. II.

Method of preparation and some physico-chemical studies, Endocrinology 27,
803-808, 1940.

15. Li, C. H., M. E. Simpson and H. M. Evans, Isolation of pituitary follicle-stimulating

hormone (FSH), Science 109, 445-446, 1949.

16. Meyer, R. K. et al.. Conference on Human Pituitary Gonadotropins (Sponsored by

the Endocrinology Study Section, National Institutes of Health) Gatlinburg,
Tennessee, December 3-5, 1959.

17. Raacke, I. D., A. J. LosTROH and C. H. Li, Zone electrophoresis on starch of pre-

parations of follicle-stimulating hormone from sheep pituitary glands, Arch. Bio-
chem. Biophys. 11, 138-146, 1953.

18. Rosemberg, E. et al.. Conference on Human Pituitary Gonadotrophins (Sponsored by

the Endocrinology Study Sections, National Institutes of Health) Gatlinburg,
Tennessee, December 3-5, 1959.

19. Rowlands, I. W. and P. C. Williams, Comparative activity of the gonadotrophin in

horse pituitary glands and in pregnant mare's serum, /. Endocrinol. 2, 380-394, 1941.

20. Rowlands, I. W. and P. C. Williams, Production of ovulation in hypophysectomized

rats, /. Endocrinol. 3, 310-315, 1943.

21. Simpson, M. E. et al.. Conference on Human Pituitary Gonadotrophins (Sponsored by

the Endocrinology Study Section, National Institutes of Health) Gatlinburg,
Tennessee, December 3-5, 1959.

22. Simpson, M. E. and G. van Wagenen, Experimental induction of ovulation in the

macaque monkey. Fertility and Sterility 9, 386-399, 1958.

23. Squire, P. G. and C. H. Li, Purification and properties of an interstitial cell-stimulating

hormone from sheep pituitaries. Science 127, 32, 1958.

24. Squire, P. G. and C. H. Li, Purification and properties of interstitial cell-stimulating

hormone from sheep pituitary glands, /. Biol. Chem. 234, 520-525, 1959.

25. Steelman, S. L. and A. Segaloff, Abstracts, The Endocrine Society, 39th meeting.

New York, May 1957, p. 158.

26. VAN Wagenen, G. and M. E. Simpson, Induction of multiple ovulation in the Rhesus

monkey (Macaco midatta). Endocrinology 61, 316-318, 1957.

27. VAN Wagenen, G. and M. E. Simpson, Experimentally induced ovulation in the

Rhesus monkey (Macaca midatta). Revue Suisse de Zoologie 64, 807-819, 1957.

28. Velardo, J. T., Induction of ovulation in immature hypophysectomized rats. Science

131, 357-359, 1960.

29. Williams, P. C, Studies of the biological action of serum gonadotrophin. 2. Ovarian

response after hypophysectomy and oestrogen treatment, /. Endocrinol. 4, 131-136,
1945.

30. Woods, M. C. and M. E. Simpson, Chromatography of sheep pituitary gonadotropins

on DEAE-cellulose, Federation Proc. 18, 687, 1959.

31. Woods, M. C. and M. E. Simpson, Purification of sheep pituitary follicle-stimulating

hormone (FSH) by ion exchange chromatography on diethylaminoethyl (DEAE)-
cellulose, Endocrinology 66, 575-584, 1960.

DISCUSSION

Dr. Ernest Knobil: I would much prefer to stand in mute admiration of Dr. Simpson's
impressive studies, but since siie has mentioned some of our work dealing with ovulation
in the hypophyscctomized rhesus monkey, I will accept this opportunity to take the
floor.

As Dr. Simpson indicated, we were able to induce ovulation in hypophyscctomized
monkeys by the subcutaneous administration of porcine FSH followed by the simul-
taneous administration of this FSH preparation and HCG (Etulocrinolugy 65, 487,
1959). We most certainly concur with Dr. Simpson that non-primate FSH preparations
are highly active in the monkey and that their administration, in small quantities, all
too easily leads to the production of cystic follicles.

Our few attempts to induce ovulation in hypophyscctomized monkeys with LH
preparations other than HCG (non-primate pituitary LH) were uniformly unsuccessful.
These findings, the difficulties encountered by other workers in the induction of
ovulation in normal monkeys with non-primate pituitary LH preparations, coupled
with our experiences with the species specificity of growth hormone, prompted us to
determine whether a similar specificity could account for the apparent ineffectiveness
of non-primate LH preparations in primates.

Because of the complexities in the ovulatory mechanism and other matters described
by Dr. Simpson we decided to test the effects of these LH preparations in the male
hypophyscctomized monkey rather than in the female. We estimated their stimulatory
effect on androgen secretion by the interstitial cells of Leydig by measuring the
secondary effects on the epithelium of the seminal vesicles and on the seminiferous
tubules of the testes.

It was also felt that considerations of species specificity would be equally applicable
to both sexes. With the apologia for the interjection of the testis into an ovarian
conference I should like to summarize some of our experiments.

Male monkeys which had been hypophyscctomized for 2 months to 3^ years were
used. Testicular and seminal vesicle biopsies were performed approximately two weeks
before the treatment period. The tissues were stained with hematoxylin and eosin.
In addition, frozen sections of a portion of the testicular biopsy material were prepared
and stained with Sudan black B. The various hormone preparations were administered
twice daily by subcutaneous injection in 1 ml of 12% gelatin. This regimen was
continued for 14 days in all instances. On the day following the last injection the
contralateral testis and seminal vesicle were biopsied and the tissues prepared as
before. The hormone preparations used with their daily doses were as follows:
HCG (500 Units), Equine LH-Armour (10 mg equivalent of Armour standard).
Ovine LH-NIH (10 mg equivalent of Armour standard), and a human pituitary
gonadotropin concentrate kindly provided by Dr. S. L. Steelman. The latter was given
at a dose of 10 mg per day but its relative potency has not been established.

All of these treatments resulted, within a few days, in edema and pigmentation of
the scrotum as well as variable degrees of testicular descent. The biopsies revealed
distinct stimulation of the secretoi"y epithelium of the seminal vesicle and enlargement
of the seminiferous tubules. The equine and human preparations which contained
large quantities of FSH as determined by rat assay occasioned, in addition, marked
mitotic activity in the spermatogcnic elements of the tubules.

Gonadotropin treatment, while producing but modest and inconsistent hypertrophy
and hyperplasia of Leydig cells, resulted in a most striking sudanophilia of the
interstitial tissue. Figures 8 and 9 illustrate the response of a hypophyscctomized
monkey to ovine LH.

Fig. 8. Monkey 182 (4 kg BW). Hypophysectomized 2 months previously. A, Control
testis; B, Control seminal vesicle; C, Appearance of testis following treatment with ovine
LH (10 mg per day for 14 days); D, Seminal vesicle following treatment. Note increase
in cell height and accumulation of cytoplasm characteristic of androgen stimulation.

H and E.

Fig. 9. Frozen sections of icsiiculai i issue stained with Sudan black B. A, Hypophysecto-
mized control; B, Following treatment as in Fig. 8 (monkey 182).

Discussion 23

We conclude from these observations that LH preparations of non-primate origin
are capable of stimulating the interstitial cells of the hypophyscctomized male monkey
with resultant increases in androgen secretion. While preliminary evidence indicates
that quantitative differences may exist in the potencies of various LH preparations in
the monkey, an absolute species specificity analogous to that described for growth
hormone cannot be attributed to FSH and LH, at least as far as the monkey is con-
cerned. The difficulties encountered in experimental ovulation in primates must
reside, as Dr. Simpson has so clearly indicated, in problems concerned with the
dosages and ratios of the hormones used as well as the timing of their administration.

FOLLICULAR DEVELOPMENT, OVULAR

MATURATION AND OVULATION IN OVARIAN

TISSUE TRANSPLANTED TO THE EYE

R. W. NoYEs, T. H. Clewe and A. M. Yamate

Department of Obstetrics and Gynecology

Stanford University School of Medicine, Palo Alto, California

Previous studies on ovarian tissue transplanted into the anterior chamber of
the eye have been mainly concerned with the ovary as an endocrine organ.
Although both ovulation and follicular hemorrhage have been reported (7, 1 3),
little attention has been paid to the maturation of ova in the anterior chamber
of the eye. Our interest has been to obtain mature fertile ova from primordial
follicles after the ovary has been removed from the body. Similar attempts,
using tissue culture methods (4, 8, 14) have failed, and ova removed from the
ovarian follicles do not mature normally in vivo (9) or in vitro (11), though
certain nuclear changes simulate meiosis (2).

Follicles are maturing and undergoing atresia concomitantly in the
mammalian ovary, and there is no way to distinguish a growing from an
atretic follicle by inspecting the ovary at any particular time of the cycle.
In order to correlate the growth rate of a follicle with the maturity of its
contained ovum, it is essential that the follicle be observed continuously. We
have taken advantage of the remarkable tolerance of the anterior chamber
of the eye for both interspecies and intraspecies transplants to study follicular
growth and ovulation.

MATERIALS AND METHODS

Whole fetal ovaries, halves of immature ovaries and fractions of adult
ovaries without corpora lutea were transplanted, using Goodman's technique
(5), to the anterior chamber of the eyes of 1296 albino rats of the Sprague-
Dawley strain. In most cases the donor animals were 25 days old, since it
was found that about that period of time was required for the ovaries of
newborn rats to develop a degree of follicle growth sufficient to insure
adequate response to the gonadotropic hormones. The host animals included
males and females, also 25 days old, both intact and gonadectomized.

In a typical experiment, half an ovary from a black pigmented donor rat
was placed in the anterior chamber of the eye of an albino male recipient rat,

Follicular Development, Ovular Maturation, Ovulation in Ovarian Tissue 25

and the graft was observed daily with the aid of an 18-power dissecting
microscope equipped with an eyepiece micrometer. On the fourth day after
the operation the host was castrated and injected with 15 I.U. of pregnant
mare's serum gonadotropin (PMS). Fifty-six hours later, 25 I.U. of human
chorionic gonadotropin (HCG) was injected, this sequence having been
found to cause superovulation in immature rats (12).

The maturity of ova from the above transplants was evaluated histologically
and biologically. The ovarian grafts were recovered by killing the host and
dissecting the ovarian tissue away from the iris. The follicles were pierced
with a sharp blade and the ova were extruded into saline. Some of the ova
were fixed and stained whole under a covershp, others were transferred into
the ovarian bursas of recently mated adult female rats of the Sprague-Dawley
strain. If such transferred ova were mature they became fertilized, implanted
and developed into normal young in the foster mother. Since the donor ova
came from a strain of black rats, the donor had black iris pigment, whereas
the young native to the foster mother had no iris pigment.

In some experiments the ovarian grafts were fixed and serially sectioned,
and the volume of the larger follicles was calculated. Two diameters were
measured at right angles to each other with the eyepiece micrometer and the
third diameter was estimated from the number of sections in which the
follicle appeared {V= \/6v(P).

In a few instances, donor ovarian tissue was taken from rabbits, or from
other rodent species {Microtus calif ornicus (1), Per omy sens maniculatus, Mus
musculus), and from young adult women at the time of operation. Ten
guinea-pigs and 6 rabbits were used as recipients, and cortisone, x-ray, and
desensitization of embryos with cellular suspensions from future donor
species, all were tried in order to reduce recipient antigenicity (10).

MORPHOLOGIC OBSERVATIONS

Of 1296 transplants of rat ovarian tissue into the eyes of rats, 1084 (84%)
became vascularized within 4 days of the time of transfer. Ovulation did not
occur spontaneously, but was observed in about 6% of grafts following
gonadotropin injections. Ovulation usually occurred 14 to 18 hr after the
second injection, and was more common in the eyes of castrated males than of
ovariectomized females. Although usually 6 to 8 large follicles developed,
no more than 2 ova were ovulated at one time. Ovulation occurred as early
as the seventh day after transplantation and could be induced again eleven
days later, but the critical intervals were not determined. In some cases the
ovulated ova were grossly and microscopically indistinguishable from normal
ova, but in others the cumulus cells were densely packed (as around an im-
mature ovum) and the vitellus showed degenerative changes suggesting atresia.

The initial growth and maturation of follicular ova in ovarian tissue
transplanted from black donor rats to albino hosts was indistinguishable

26 R. W. NoYES, T. H. Clewe and A. M. Yamate

from that observed in albino-to-albino transfers. However, after fourteen days
the tissue from the blacks became unresponsive to gonadotropins and began
to degenerate. The albino-to-albino transplants lasted indefinitely; several
animals being observed for as long as one hundred and eighty days without
regression of the transplants.

The interspecific transplants often became vascularized, and one crop
of follicles sometimes developed. However, neither ovulation nor ovum
maturation was observed. The average period of viability of such grafts was
10 days. The details of these interspecific experiments are recorded elsewhere
(3, 10).

Figures 1 and 2 are low and high power photomicrographs of ovarian
tissue from a 25-day-old rat. After four days in the eye, all of the original
antrum-containing follicles degenerated, and the few surviving primordial
follicles were located along the interface between the ovary and the iris
(Fig. 3). The earliest of the new antrum-containing follicles appeared on the
fourth day (Fig. 4). Fifty-six hours after castration and gonadotropin
injection of the host, the new follicles had enlarged greatly (Fig. 5) and the
ova had begun to separate from the mural granulosa. The nuclei in most of
the ova remained in the immature or germinal vesicle stage (see Fig. 2),
although occasional ova formed the first meiotic spindle (Fig. 6). Fourteen
hours following the injection of HCG, the follicles enlarged still further, and
an occasional follicle ovulated (Fig. 7). Ova in the maturing follicles usually
completed meiosis by this time and they were separated completely from the
mural granulosa. Mitotic activity in the cumulus cells was abundant (Fig. 8).

Corpora lutea were formed 22 hr after the administration of HCG (Fig. 9),
and ova that had not been ovulated were found compressed among the
lutein cells (Fig. 10). The relationship of the transplant to the iris and to the
cornea is shown in Fig. 9. In this particular section the connection between
the iris and the ovary is narrow, but usually the transplant was attached to a
wide area of the iris.

Figure 1 1 is a photograph of a transplant taken through the cornea at the
same magnification that was routinely used with the dissecting microscope.
A freshly ovulated ovum, still surrounded by cumulus oophorus, is visible.

Plate I

Fig. 1. Ovary from a 25-day-old rat. (x 20)
Fig. 2. An early antrum follicle from Fig. 1. Volume = 65 x 10® ^^ (x 90)

Fig. 3. Half an ovary from a 25-day-old donor rat, 4 days after transfer to the anterior
chamber of the eye of a 25-day-old recipient rat of a different strain. ( x 20)

Fig. 4. An early antrum follicle from Fig. 3. Volume = 4.6 x 10" ix^. ( x 90)

Fig. 5. Rat ovarian transplant 56 hr after injection of the recipient rat with
15 I.U. pregnant mare's serum gonadotropin, (x 20)

Fig. 6. Developing follicle from Fig. 5. Volume 110 x 10® fj.^. The ovum is
unusual in that it has formed the first meiotic spindle, (x 90)

.--■^^wj^^^'

ii^i#^^

Plate I

%»

*•!. •

■■:■■:. '

Follicular Development, Ovular Maturation, Ovulation in Ovarian Tissue 27

Figure 12 shows a mature follicular ovum that has been stained in toto under
a coverslip. The crescentic first polar body has recently been abstricted from
the horseshoe-shaped telophase spindle.

THE RATE OF FORMATION OF MATURING FOLLICLES

Daily sketches were made of 36 ovarian transplants between the fourth and
seventh days following transplantation. The host animals to 30 of these
transplants were subjected to PMS and HCG injections, and 6 were untreated
controls. The rate of appearance of the follicles growing in treated animals
did not differ from the controls. This suggests that the intrinsic pituitary
gonadotropin level of the immature castrate male recipient is high enough
to stimulate all follicles that are mature enough to respond.

Sixty-five follicles appeared (diameter 0.25 mm) in the 36 transplants on
the fourth, 60 on the fifth, 32 on the sixth, and 28 on the seventh postoperative
day. The number of follicles that appear each day diminishes rapidly after
the first 2 days, and this cannot be prevented by supplementary gonadotropin
injections. These direct observations are in agreement with the theory that
the original stimulus for follicular maturation is independent of gonadotropic
hormone stimulation.

In order to compare the performance of transplants with that of ovaries
in situ, 25-day-old female rats were injected with gonadotropin on the same
schedule that has been outlined above. Serial sections of these normal control
ovaries showed that the average number of follicles that "appear" each day
is five times that observed in the transplants. Probably the smaller original
size of the transplant, plus the massive follicular degeneration that occurs
before its new blood supply develops is sufficient to account for this difference.
It is not likely that antigenic influences would be manifest so soon after
transplantation.

Plate II

Fig. 7. A developing follicle from an ovarian transplant 70 hr after injecting the recipient
with PMS and 14 hr following the injection of 30 international units of human chorionic
gonadotropin. Volume = 90 x 10^ /x^. The opening in the follicle is possibly the

point of ovulation. ( x 90)

Fig. 8. An ovum 14 hr following HCG injection, showing the first polar body.
Mitosis of a cumulus cell can be seen to the upper right. ( x 370)

Fig. 9. An ovarian transplant 78 hr following PMS and 22 hr following HCG,

showing early corpora lutea. The cornea is on the left and the attachment of the iris to

the graft is shown to the right. ( x 20)

Fig. 10. An early corpus luteum from Fig. 9, showing a squeezed atretic ovum to the

right. ( X 20)

Fig. 1L An ovarian transplant as seen through the dissecting microscope, 14 hr
following HCG, and showing, to the left, an ovulated ovum in front of the iris. ( x 20)

Fig. 12. A follicular rat ovum that has been fixed and stained in toto under a coverslip.
The first polar body is being abstricted from the horseshoe-shaped late telophase

spindle, (x 1300)

R. W. NoYES, T. H. Clewe and A. M. Yamate

VOLUME CHANGES IN MATURING FOLLICLES

The diameter of a given follicle, as measured in the anterior chamber of the
eye using an eyepiece micrometer, was estimated to be accurate to within
about ± 0.25 mm. Tlic volumes of 1 57 follicles in 36 transplants were recorded
daily from the fourth through the seventh postoperative days. In 24 of the
transplants, both PMS and HCG were given to the recipient animal; in 6,

10X10-

PMS

No treatment.
Pregnant mare's serum.
♦_Chorionic Gonadotrophin.

Lhcc

DAY AFTER TRANSPLANTATION TO EYE

Fig. 13. Growth of ovarian follicles in the anterior chamber of the eye as affected by
pregnant mare's serum and human chorionic gonadotropin injections. Each point represents
the average volume of all of the grossly visible follicles in many transplants. The measure-
ments were made on living follicles. The points that pertain to a group of follicles that
first appeared on the same day are connected by lines. The time of injection and dosage
of PMS and HCG are given in the text.

only PMS was given; and in 6 no gonadotropin was given. The average
volume for each group of follicles that appeared on a given day in each of
the three groups of animals was plotted against time (Fig. 13). The average
volume of 65 follicles that appeared on the fourth day was 40xlOV^
and one day later, following castration and PMS administration, the average
volume had increased to 1 65 x 1 O*' /x^. When the recipients were castrated,
but no PMS was given, the average volume was slightly less, 120 x lO'^/x^
and although they continued to grow, the follicles in uninjected animals grew
more slowly than those in the treated animals.

Follicular Development, Ovular Maturation, Ovulation in Ovarian Tissue 29

When HCG is given there is a further increase in the follicular growth rate.
The curve of growth is very similar for each group of follicles irrespective of
the day on which they appeared. In the group of animals treated with PMS,
the average volume of follicles that first appeared on the sixth day is much
larger than that in the preceding groups. This artifact is caused by the sudden
emergence into view of older follicles that had been growing deeply on the

t.oooxio-

I
I

100X(0-

^Prtgnant mam's serum, Ovary in situ. _
£i " " " , Ovary in eye.

♦ Chorionic Gonadotrophin, Ovary in situ.
0 " " , Ovary In eye.
X Ovary in Si+0, Adulf rat (Boling,ef:a/.)'

• No treatment, Ovary in situ. ■
o " " , Ovary in cyg-

10X10-

7 DAY AFTER
TRANSFER TO EVE

AGE OF RAT
(days)

Fig. 14. The effect of gonadotropin injections on the volumes of ovarian follicles in eye
transplants and in noimal immature ovaries in situ. Each point represents the average
volume of many follicles from different ovaries. The measurements were made on fixed,
sectioned tissue. The time of injection and dosage of PMS and HCG are given in the text.

interface between the iris and the ovary. Although they appear on the sixth
day many of these follicles are actually older, and thus larger, than the more
superficial follicles. These observations vv'ere not continued long enough to
include the dechning growth of follicles as they become atretic, or the curves
for those that formed corpora lutea.

Similar data were plotted from the average volumes of the larger follicles
in the serially sectioned transplants (Fig. 14). Again, three groups of trans-
plants were studied (castration only, PMS only, and PMS plus HCG), and
a parallel series of three groups of normal immature rat ovaries in situ was
studied for comparison.

30 R. W. NoYES, T. H. Clewe and A. M. Yamate

The average follicular volume in the normal untreated ovary does not
increase between the twenty-ninth and the thirty-second day of age, but there
is a steady rise in the follicular volume each day the ovarian transplant
remains in the eye of the castrate male recipient. None of the follicles in
untreated animals matures completely, although there is a tendency for ova
in some atretic follicles to undergo early meiotic nuclear activity. The volume
of both //; situ and transplanted ovaries increases rapidly following PMS
treatment, and injection of HCG causes still further growth after a short lag
period. In the /// situ ovaries, ovulation and regression follow the final
dramatic growth spurt.

Follicles in the eye transplants grow more slowly, and do not attain the
large preovulatory volumes that follicles in normal ovaries do. However,
the rate of nuclear maturation of the ova appears to be the same whether the
ovary is in the eye or in its normal location.

The curve of follicular growth obtained in the normal ovary of adult female
rats by Doling et al. (1) is very similar to the curve for superovulated ovaries
in situ although the time sequences cannot be directly compared. No doubt
the lack of a final growth spurt in transplanted ovarian follicles is related in
some way to their low rate of ovulation. At these early stages there is no
evidence that intraocular pressure is increased, or that moderate increases in
extrinsic pressure would interfere with follicular growth or ovulation. In the
sectioned transplants blood vessels are smaller and less numerous than in the
normal immature ovary. Perhaps the failure of preovulatory growth and
ovulation can be explained on the basis of inadequate blood supply.

Shrinkage resulting from fixation of the tissue accounts for the smaller
over-all follicular volumes in the sectioned material compared with the living
transplants, but other than this, the data from the two series are quite
comparable. More than 100 ova were stained in toto to correlate the growth-
rate of the follicle with the maturation of the contained ovum. The results
were exactly the same as those for the serially sectioned ova. In each
group of ova recovered from ovarian transplants, however, a few immature
vesicular ova from the smaller follicles of an earlier generation were seen.
Although these unripe ova were obviously unlike the maturing ova when
they were fixed and stained, they were not easy to distinguish in the living
state.

THE FERTILITY OF FOLLICULAR OVA FROM
OVARIAN TRANSPLANTS

From 470 transplants, 1154 ova were obtained by lancing large follicles
under saline, an average of 2.5 ova per transplant. More than twice this
number of large follicles was counted under the dissecting microscope and
in the sectioned material, so it is obvious that our recovery technic was
imperfect.

Fig. 15. Method for transferring follicular ova into the ovarian bursa. The tip of the pipet
(see arrow) is visible behind the bursal membrane.

Follicular Development, Ovular Maturation, Ovulation in Ovarian Tissue 31

Approximately 6 follicular ova were pipetted into each of 184 ovarian
bursas of previously mated albino recipient animals. The method for injecting
ova is illustrated in Fig. 15.

In a previous experiment (1), when 130 developing follicular ova were
removed from the ovaries of normal adult animals six hours or less before
the expected time of ovulation, and were then transferred into the bursas of
19 recipient animals, 44 (34%) of the ova were fertilized and developed to
term embryos.

"JT"

® No. Q\ia in iQcb transfap
El No. all OvQ +rans-fcrr4d

6 6 10 12 H 15 16 17 18 19 20 Zl 22 27 24

NO. HM. ELAPSED FOLLOWING CHORIONIC GONADOTROPHIN INJECTION

Fig. 16. The fertility of follicular rat ova taken from ovaries transplanted to the eyes of
recipient rats of a different strain. The data are from Table I . The figures within the circles
are the numbers of ova in each transfer in which one or more of the transferred ova
developed to term. The figures in the squares represent the number of all ova transferred
into recipient bursas at a given hour following chorionic gonadotropin injection.

Our present experience with the fertility of follicular ova obtained from eye
transplants is not nearly this encouraging (Table 1). When 809 maturing ova
from eye transplants were transferred to 131 bursas, only 36 (4.5 %) developed
into term embryos.

The optimal stage of folHcular development was between the fourteenth
and sixteenth hours following the administration of HCG (Fig. 16), but even
at this time only 10% of transferred ova survived. The results of individual
experiments were quite variable, and the apparent high fertility of ova
occurring 24 hr after HCG was probably a chance occurrence. This was a
very rigorous test for fertility, with many chances for ova to be lost and for
inadequate conditions for fertilization to be present. However, the conditions
in these eye transplant experiments were similar to those with normal
follicular ova, yet only one-tenth as many of the ova from the eye transplants
were fertile as compared with the preovulatory ova from ovarian follicles
in situ.

R. W. NoYES, T. H. Clewe and A. M. Yamate

>r)

»— •

■«

U-)

«N

rs|

IT)

1/1

v-t

»s

f<^

«N

«M

■V

<*)

»N

S£>

'"'

»S

r«

'"'

■^

•o

>«

tri

'5.
o

■T)

'—

U-1

V~i

-a

«s

trt

«s

Tl-

*— «

1— 1

»— '

l-H

—

•*

•<r

«s

IT)

„

>rt

„^

-o

1/^

_C3

U-1

«s

■*

r»-i

•o

U-)

■^

«N

v~,

IT)

■*

■t

u-i

«s

•^

u~,

:S^-2 5

en
1

:Se-S5

Transfers in which
the recipient was
pregnant, but no
embryo survived
in the experimen-
tal uterine horn

Transfers

Ova

.•51 S?

Transfers in wh
follicular ova s
vived to term
the experimen
uterine horn

Transfers

Ova

3
>

Transfers in wh
only control e
bryos survived
the experimer
uterine horn

Transfers

Ova

"«
o

3
(/3

Transfers in wh
the recipient fai
to continue pr
nancy

Transfers

Ova

Totals
Transfers
Ova
Ova survivin

Follicular Development, Ovular Maturation, Ovulation in Ovarian Tissue 33
SUMMARY AND CONCLUSIONS

Transfers of immature rat ovarian tissue to tlie anterior chamber of the eyes
of immature male recipient rats of a different strain produced vascularized,
growing grafts in 84 % of trials. Most of the antrum-containing follicles of
these grafts degenerate, but new ones grow from surviving primordial
follicles within 4 days following transplantation. One to 4 new follicles begin
to grow each day, and an average of 6 mature within 4 days. The number of
follicles that appear is independent of extrinsic gonadotropin injections, but
is dependent on the intrinsic rise of gonadotropin level following castration
of the host animal.

When treated with pregnant mare's serum gonadotropin, the follicles
increase in volume at about the same rate that has been reported for follicles
in the mature ovary in situ, while in untreated grafts, follicular growth lags.
Following the injection of human chorionic gonadotropin, the follicles in
transplants do not grow so rapidly or become so large as those developing
in ovaries in situ, and ovulation is rare. However, meiotic changes in the
ovum's nucleus, and cumulus maturation of these ova, seem to progress at
the normal rate despite their smaller volume. Only 4.5% of ova removed
from follicles that seemed to be maturing proved to be fertile. This is only
one-tenth the fertility rate expected from previous experiments on follicular
ova obtained from mature ovaries in situ. Ovulation occurred in 6 % of the
grafted ovaries.

Interspecies transplants of ovarian tissue from rabbit to rat, from rat to
rabbit, and from human to rat, rabbit or guinea pig, all failed to produce
normal ova despite extensive and varied treatments aimed at reducing the
antigenic response of the host.

From an immunologic point of view it is interesting that in these acute
experiments, ova can be brought to maturity despite the fact that these
intraspecies grafts invariably degenerate a short time later. It is felt that
inadequate blood supply, rather than antigenicity, may be the cause for the
failure of rapid growth following the injection of chorionic gonadotropin.
Slow growth may in turn be responsible for the failure of ovulation, and still
more remotely may decrease the fertility of these ova. Further advances in
solving this problem will depend on better immunologic control in the
recipient host, so that transplants may grow long enough to attain a normal
blood supply before ovum maturation is attempted.

Acknowledgments — This investigation was supported in part by PHS
Research Grant RG 4470 from the National Institutes of Health, Public
Health Service, and in part by the generosity of Mrs. Lilian Howell.

34 R. W. NoYES, T. H. Clewe and A. M. Yamate

REFERENCES

1. BoLiNG, J. L. ct al.. Growth of the Graafian follicle and the time of ovulation in the

albino rat, Anat. Rec. 79, 313, 1941.

2. Chang, M. C, Maturation of rabbit oocytes in culture and their maturation, activation,

fertilization and subsequent development in fallopian tubes, /. Exper. Zool. 82, 85,
1939.

3. Clewe, T. H., A. M. Yamate and R. W. Noyes, Maturation of ova in mammalian

ovaries in the anterior chamber of the eye. Internal. J. Fertil. 3, 187, 1958.

4. Gaillard, p. J., Growth and difTerentiation of explanted tissues. Internat. Rev. Cytol.

2, 331, 1953.

5. Goodman, L., Observations on transplanted immature ovaries in the eyes of adult

male and female rats, Anat. Rec. 59, 223, 1934.

6. Greene, H. S. N., Use of mouse eye in transplantation experiments. Cancer Research

7,491, 1947.

7. Lane, C. E. and J. E. Markee, Response of ovarian intra-ocular transplants to gonado-

trophins. Growth 5, 61, 1941.

8. Martinovitch, P. N., Effect of subnormal temperature on differentiation and survival

of cultivated //; vitro embryonic and infantile rat and mouse ovaries, Proc. Roy. Soc.
London BUS, 138, 1939.

9. Noyes, R. W., Fertilization of follicular ova, Fertil. & Steril. 3, 1, 1952.

10. Noyes, R. W., A. M. Yamate and T. H. Clewe, Ovarian transplants to the anterior

chamber of the eye, Fertil. & Steril. 9, 99, 1958.
ll.PiNCUS, G., Comparative behavior of mammalian eggs in vivo and in vitro. IV.

Development of fertilized and artificially activated rabbit eggs, J. Exper. Zool. 82, 85,

1939.

12. Rowlands, I. W., Production of ovulation in the immature rat, J. Endocrinol. 3, 384,

1944.

13. Ward, J. E., J. L. Gardner and B. L. Newton, Anterior ocular ovarian grafts in the

rabbit. Am. J. Obst. & Gynec. 66, 1200, 1953.

14. Wolff, E., Sur la differenciation sexuelle des gonades de souris explantees in vitro,

Compt. Rend. Ii4, 1712, 1952.

DISCUSSION

Chairman : Roy O. Creep

Dr. John Hammond, Jr. : I have one idea that I should like to put to you because it follows
what was said about ovulation.

Dr. Noyes seems to disregard the effect of the intra-ocular pressure, and it seems to
me that that might be of some considerable importance. Ovulation depends upon the
formation of the ovulation cone and that cone formation, I suppose, depends upon
the occlusion of the vessels. And that point, that occlusion, depends upon the pressure
gradient across the wall of the follicle.

Now, I have heard the follicle picturesquely described as a blister on the surface of
the ovary, and I think that is more than a figure of speech. We think of the liquor as
secretion of the cells. It is in part, particularly in the early stages when you have a lot
of cells and cement substance around the oocyte, a viscous sort of fluid; but, in the
later stages of the follicle, you get rapid accumulation of fluid, of tertiary liquor.

Some Italians (R. Catavaglios and R. Cilotti, /. Endocrinol 15, 273, 1957) analyzed
the liquor and showed that it contains most of the blood proteins; the largest molecules
are present in reduced amounts, but it seems more or less to be a transudate from the
thecal vessels, and yet collecting amongst the epithelium of the granulosa. This is
very much like the foitnation of a blister. You burn yourself, and a fluid is liberated
from the blood vessels of the dermis, yet in like manner, the fluid accumulates in the
epithelium of the epidermis. If the liquor is a transudate, its formation depends upon
the hydrostatic pressure in the blood vessels.

The intra-ocular pressure in the human eye is about 30 mm of mercury, and the
ordinary capillary hydrostatic pressure is of the order of 30 mm of mercury. I don't
know what it is in the ovary but it does not seem to be surprising that when you inject
pregnancy urine, the follicle doesn't grow so rapidly as it does in its normal position
because there is obviously much greater pressure opposing the filtration of the liquor.

Dr. Noyes also said that the two phenomena of the maturation of the eggs and of
ovulation were not necessarily due to the same causes. But I wonder if the stimulus
to ovulate which the follicle gets may not produce the maturation of the oocyte and
liberate it from the follicle wall, and induce the secretion of the tertiary-liquor, all
by the same mechanism. Whether, in fact, the stimulus to ovulate may produce an
incipient process of degeneration in the granulosa cells, and that this, on the one
hand, liberates the ovum from the wall of the follicle, and at the same time it may also,
perhaps, free the ovum from an inhibition of cleavage and allow it to go through the
reduction division. Perhaps the degenerating cells release a substance which increases
the permeability of the thecal vessel walls, and this results in the sudden increase
in pressure and accumulation of fluid, inside the follicle.

I think one might, perhaps, understand the way in which the pituitary works in
inducing ovulation, if one could reconstruct the way in which the process has evolved.
For that, I can see two main clues, and perhaps there are many others. One is this : It
seems very improbable that FSH and LH should have appeared simultaneously as
hormones regulating the process of ovulation. Secondly, one has the probability that
the steroid hormones started as gonadal organizer substances. Working from this,
I would like to put forward an idea. Initially, I suppose that the ovary was regulated
purely by nutrition. I suppose the gonad was a late-developing part of the body.
It only developed fully when feeding conditions and nutritive conditions were good.
When it did, the germ cells developed and were surrounded by the satellite cells; and
when the oocytes were full-grown they went automatically, as cells have a habit of

36 Discussion

doing, through the next stage, which is that of cell division. In this case, of course,
this is the reduction division.

Then there came the necessity of restricting the season of reproduction. Food is
plentiful in autumn, but it is a poor time for young animals to have to start their
development. I suppose this seasonal restriction was imposed, first of all, by the
granulosa cells, inhibiting the germinal meiosis, and secondly, that the granulosa came
under the influence of the pituitary through the regulation of the thecal-organizing
substance.

I imagine that the first gonadotropin was something like PMS, with both FSH and
LH activities, and that the response of the thecal cell depended on its maturity. I here
partly follow, with modification, the ideas of Gadrenstroom and de Jongh (Research
in Holland. Elsevier, Amsterdam, 1946). When the thecal cell was young it responded
to the FSH part of the molecule, and the FSH caused thecal estrogen secretion which
maintained the granulosa cells. As the thecal cell became older it responded to the
LH part of the molecule, and secreted androgen that produced the effect of destroying
the granulosa, thus removing the inhibition to meiosis and at the same time freeing
the egg.

When estrogen becomes a hormone as well as an organizer, its output has to increase
as the follicle ripens — when one supposes the theca becomes reactive to LH. One may
imagine, then, the evolution of LH as a separate hormone, synergizing with FSH for
estrogen secretion; and also the evolution of interstitial cells, derived from the theca
and stimulated by LH, in which estrogen can be produced at a site remote from the
follicle — and so can act as a hormone without also having an effect on the follicle
where it might antagonize the presumed thecal androgen production, which organizes
ovulation by destroying the granulosa. Later still, the granulosa will not be destroyed,
but stimulated to luteinize when vascularized.

Finally, a question I would like to put to Dr. Noyes. How do you know that the
follicles haven't been stimulated and maturation changes initiated by discharge from
the host pituitary before you give chorionic gonadotropin?

THE ROLE OF STEROIDS IN THE CONTROL
OF MAMMALIAN OVULATION*

Gregory Pincus and Anne P. Merrill

The Worcester Foundation for Experimental Biology

Shrewsbury, Massachusetts

We have previously described methods for determining the effects of various
compounds on copulation-induced ovulation in the rabbit (1,2,3). Our
standard procedure is to administer the test substance to a post-partum
female rabbit and then mate her to a male of knovv'n fertility 1 8 to 24 hr later.
On the day following the mating the occurrence of ovulation is ascertained
by examining the ovaries for rupture points at laparotomy. The occurrence of
pregnancy in such mated rabbits may easily be determined by palpation of
uteri for implantations at the tenth to fourteenth day after mating. In order to
obtain a preliminary idea of the effectiveness of any given compound, our
usual procedure is to administer a dose of 10 mg per animal to each of five
post-partum females. In view of the fact that approximately 90% of untreated
post-partum rabbits ovulate under these conditions, the absence of ovulation
in all of the five test animals is highly significant; if one out of five ovulates
the effect is considered marginally significant.

In Figs. 1 through 12 are presented the structural formulae of those steroids
which have given some indication of acting as ovulation inhibitors when
administered to groups of five post-partum rabbits. At the dosage underlined
with a soHd line, all animals failed to ovulate; at the dosages underlined with
a broken line, marginally significant frequency of inhibition occurred.

Among the estrogens (ring A unsaturated) and their derivatives, nine
compounds gave indication of activity (Figs. 1 and 2). Consistent evidence of
inhibition following subcutaneous injection at various dosages is given by
estrone (IV, Fig. 1) and I7a-ethyl-I7/3-estradiol (II, Fig. 1). Estradiol (I,
Fig. 1) itself, which we expected to be quite a potent inhibitor and which was
thus tested at relatively low dosages, gave a marginally significant effect at
0.1 mg per rabbit by mouth but not at 0.5 mg per rabbit. All of the other
compounds listed in Figs. 1 and 2 appear to be of rather low potency.

* Investigations described in this paper have been conducted with grants-in-aid from
G. D. Searle & Company and the Population Council, Inc.

Gregory Pincus and Anne P. Merrill

)H OH

CHtO

H0-" "^-^ ^^^ n

SO-10,2,0.4

SQ-10,2

SQ- 10,2, 0.4

OOCCH,

CH.COO

CH,COO

SQ~I0,2
Fig. 1. Estrogens and derivatives. (Dosage in milligrams. SQ = subcutaneous injection;

O = by gavage.)

SQ-jO ,I0,5J

CH3O'

CH,0

SQ-iO SQ-10,2

Fig. 2. Estrogens and derivatives. (Dosage in milligrams. SQ = subcutaneous injection;

O = by gavage.)

The Role of Steroids in the Control of Mammalian Ovulation

Seven compounds classifiable as androgens and their derivatives (Fig. 3)
are clearly of low or marginal potency.

Among a large number of progesterone derivatives and analogs tested, we
list in Fig. 4 two epoxides (XVII and XVIII) which gave marginal indications
of activity, two 16-substituted compounds of which one (XX) is clearly of

CH,COQ

CHXOO

0'/ ^^ ^^ SK

SQHq,2,0.4,0.08

,-CH,

Fig. 3. Androgens and derivatives. (Dosage in milligrams. SQ = subcutaneous injection;

O = by gavage.)

low potency and the other (XIX) is inconsistently active by injection and
of low potency by mouth, and Il-keto-A«-progesterone (XXI) which is of
moderate potency by injection. In Fig. 5, among the 21 -substituted pro-
gesterone derivatives only 21-fluoroprogesterone (XXVI) shows consistent
activity to a dosage as low as 0.4 mg per rabbit. Among a group classified as
miscellaneous progesterone derivatives (Fig. 6) only one, XXIX, is con-
sistently inhibitory by the subcutaneous route. It appears to be inactive on
oral administration.

The reported high progestational activity of certain derivatives of 17-
hydroxyprogesterone (4, 5) led us to test a number of them (Figs. 7 and 8).

Gregory Pincus and Anne P. Merrill

77?^ Role of Steroids in the Control of Mammalian Ovulation

Previously we had found 17-hydroxyprogesterone itself to be inactive as an
ovulation inhibitor in the rabbit (1) and, as can be seen in Fig. 7, four
compounds with a free 17a-hydroxyl group proved to be marginally active
(numbers XXXII to XXXV). Acetylation of the 17a-hydroxyl alone (XXXVI)
confers consistent and rather high inhibitory activity by the subcutaneous

0=0

Q-^ ^^ \^ XXM
SQ-I0,5,I

c=s

so !p,5,l
0-10

CH,

c=o

0^ "^-^ \^^ XXYT
. so -10,2, 0.4

Fig. 6. Miscellaneous progesterone derivatives. (Dosage in milligrams. SQ = subcutaneous

injection ; O = by gavage.)

route. This parallels the emergence of progestational activity with 17-
esterification (6). It should be noted that oral activity is not pronounced.
Various derivatives of 17-acetoxyprogesterone are listed in Fig. 8. Two
(XXXVII and XXXVIII) give evidence of minimal activity, and the two most
thoroughly tested (XL and XLI) are highly potent by the subcutaneous route
and somewhat less active when administered orally.

In Figs. 9 through 12 are listed active compounds classified as 19-nor-
steroids. These are basically derivatives of 19-nortestosterone. The potent

Gregory Pincus and Anne P. Merrill

SQ-IO

:-0H

SQ-2.0.4. 0.08 .0.016
0-10,2

Fig. 7. Derivatives of 1 7-hydroxyprogesterone. (Dosage in milligrams. SQ = subcutaneous

injection ; O = by gavage.)

^-OAc

SQ-IO ,04 ,008 ,0.016 SQ-2. 0.4.0.08 .0.016

0 2 , 04 , 0.08 O-jO ,2 , 0.4 , 0016

Fig. 8. Derivatives of 17-hydroxyprogesterone. (Dosage in milligrams. SQ = subcutaneous

injection; O = by gavage.)

The Role of Steroids in the Control of Mammalian Ovulation 43

SQ-IO

OAc

CjH,

SQ-iO.,2

SQ-Q5,0.I

0-0.5,0.3,02 9^^^

— - ',..C=CH

AcO

C=CH

XLOT
SQ— 5 , 2, 0.4,0.08

XLvni

5Q-I0

Fig. 9. 17a-Methyl, ethyl and ethinyl derivatives of 19-nortestosterone. (Dosage in milli-
grams. SQ = subcutaneous injection; O = by gavage.)

,/C— CH2OH
OH

Q^f^-^i^-^.^ XLIX
SQ-IO.2,0.4

CH2CH2OH

CH2CH2^Cn2

^-CH2CH2 CH CHj

LH
SQ-2. 0.2. 0.04, 0.008

50-05,01,002
,0-5,1,0.5

C^CCgHg

SQ-20,O4,0.08
0-1.0,2

Fig. 10. Higher 17a-derivatives of 19-nortestosterone. (Dosage in milligrams. SQ = sub-
cutaneous injections; 0 = by gavage.)

Gregory Pincus and Anne P. Merrill

oral progestational activity of 17a-ctliinyl-19-nortcstostcrone (XLVI) was
first reported by Hertz et al. (7). We reported in extenso (2, 3, 4) on the
progestational, ovulation-inhibiting, deciduomagenic and other properties
of four 17a-alkyl-19-norsteroids (XLVI, XLII, XLIII and LXII), as well as
on their effects on ovulation and various menstrual cycle phenomena in
women (2, 8, 9, 10). Of the compounds listed in Fig. 9, all save XLIV are
potent ovulation inhibitors. Among the higher alkyl derivatives of 19-
nortestosterone (Fig. 10), significant ovulation inhibition at fairly low
dosages is exhibited on subcutaneous injection, but all the compounds of
high potency by this route are much less active by the oral route (cf. LI, LIII,

SQ -10,2,0.4

AcC ^OAc
SQ~I0,2

HCCH,

SQ-IO

C,H,

SQ-10,2

Fig. II. Miscellaneous 19-norsteroids. (Dosage in milligrams. SQ = subcutaneous injection;

O = by gavage.)

LIV and LV). Certain miscellaneous 19-norsteroids listed in Fig. 11 are
either marginally active or of low potency. Finally, the shifting of the ring A
double bond from the 4, 5 to the 5, 10 position may reduce the ovulation-
inhibiting activity by subcutaneous administration (cf. LXII and XLVI;
LXIII and XLIII; LXIV and LII), but highly potent activity is exhibited by
the one compound (LXII) tested orally.

We have presented in the foregoing figures a list of sixty-four steroid
compounds indicated as ovulation inhibitors in the rabbit. One hundred and
twenty-three additional steroid compounds have been submitted to this test,
with negative results. In Table 1 we list the numbers tested in various classi-
fications and the percentages of active compounds. It is clear that the largest
proportion of active compounds is in the group of 19-norsteroids, with the
1 7-hydroxyprogesterone derivatives ranking next. These percentage figures

The Role of Steroids in the Control of Mammalian Ovulation

probably represent in part the deliberate selection of potentially active
substances, but it should be noted that in those groups where the proportion
of active compounds is lowest the potency of those deemed active is relatively
low.

HO- -/ -- LXI
SQ-10,2,0.4

C=CH

CpHc

SO-!0,l
0-JO,5,I,0,5jPJjO.I
?H

C3H7

SQ-!0,2,0.4

S0-ip,2

Fig. 12. A^'^''-19-Norsteroids. (Dosage in milligrams. SQ = subcutaneous injections;

O = by gavage.)

Table 1 . The Numbers in Various Classes of Steroid Compounds
Tested as Ovulation Inhibitors

Type of compound

Number

demonstrating

activity

Number
inactive

%
active

Estrogens and derivatives
Androgens and derivatives
Progesterone derivatives
17-OH-progesterone derivatives
19-Norsteroids

34
28
42
9
10

21
20

52
70

One feature of our findings which requires further remark is the discrepancy
between activity by mouth and by injection exhibited particularly by some of
the more potent substances. This is illustrated in Table 2 where we present
the calculated minimal effective doses of five compounds which have been
sufficiently tested by both routes both as ovulation inhibitors and as
progestins. The data on oral : subcutaneous progestational potency ratios
are from the paper by Miyake and Pincus (4). The parallelism in relative oral
effectiveness is evident. The fact that XLVI is somewhat and LXII very much
more potent by mouth suggests that these may be transformed to more

Gregory Pincus and Anne P. Merrill

potent ovulation inhibitors following oral ingestion. In this connection it
should be noted that, in addition to finding them more potent as oral than as
parenteral progestins, Saunders and Drill (11) were unable to find evidence

Table 2. The Relative Effecttveness of Certain Steroids by Parenteral and Oral
Routes as Ovulation Inhibitors and as Progestins

Minimal efTective

Oral/subcutaneous

Compound

ovulation-inhibiting dose

ratio

number

as progestinst

SQ*

XXXVI

0.05

0.01

0.1

XLI

0.05

0.4

0.13

0.2

XLIII

0.2

0.10

0.6

XLVI

0.3

0.25

1.2

1.4

LXII

0.2

5.4

* SQ = by subcutaneous injection; O = by gavage.
t From Miyake and Pincus (4).

of direct effect on the endometrium with intrauterine implants. Their trans-
formation to active progestins somewhere outside the uterus is indicated by
this evidence as well as by our data on the oral : subcutaneous ratio.

If this in vivo conversion to a potent progestin be accepted, then it may be
asked if the unknown conversion product is also responsible for the ovulation
inhibition. The fact is that a number of highly potent progestins are also
rather potent ovulation inhibitors on injection (e.g. LIII, XLI and related
compounds). Presumably their reduced activity by mouth is due to some
inactivation process in the gut or in the liver. We have considered the
possibility that norethynodrel (LXII) and norethindrone (XLVI) are con-
verted to estrogenic compounds which in turn are the active ovulation
inhibitors. The rather unremarkable record of the estrogens as ovulation
inhibitors in our tests (see Fig. 1) has led us to discount this possibility. We
have, in fact, tested the 3-methyl ether of ethinyl estradiol subcutaneously at
dosages of 10, 5, 1 and 0.1 mg and have had no significant inhibition of
ovulation. However, 17a-ethinyl estradiol itself is the probable estrogenic
metabolite, and we have not as yet tested this compound as an ovulation
inhibitor in the rabbit.

Before concluding this presentation, I should like to exhibit data which we
have obtained on the ovaries of rats receiving norethynodrel. These are
presented in Tables 3 and 4, in which the numbers of corpora lutea, of various
folhcle types, and of primordial ova per unit area are given for control and
for norethynodrel-injected rats. The rats were injected daily for fourteen days
and sacrificed at the fifteenth day. In both groups of animals there was con-
sistent reduction over the control values only in the number of corpora lutea.

The Role of Steroids in the Control of Mammalian Ovulation

The significantly lower number of normal follicles without antra in the 30-day-
old rat series is certainly not seen in the 90-day-old rat series. The reduction in
corpus luteum number may be due to a reduction in the number of follicles
ovulating or to a facilitation of corpus luteum resorption, or, indeed, to a

Table 3. The State of the Ovaries in Thirty-day-old Rats Receiving Norethynodrel
BY Daily Injection rw a Fifteen-day Period

Total

dosage

(mg)

No. of
animals

Number per unit area

Treatment

Corpora
lutea

Follicles
with antra

Follicles
without antra

Primordial
ova

Atretic

Normal

Atretic

Normal

None

Norethynodrel

2.8
14.0

20
18
17

2.0 ±0.30
0.7±0.31
0.2 ±0.14

5.1+0.93
4.9 ±0.67
6.2±0.71

1.4 ±0.40
1.4±0.33
0.6 ±0.26

8.7+1.42
7.5 ±1.39
11.5±1.52

7.1 + 1.13
7.5 ±0.96
2.7 ±0.63

8.8 ±1.45

12.5±2.17

9.5±1.39

Underlined values differ significantly from control values.

Table 4. The State of the Ovaries in Ninety-day-old Rats Receiving Norethynodrel
BY Daily Injection in a Fifteen-day Period

Total

dosage

(mg)

No. of
animals

Number per unit area

Treatment

Corpora
lutea

Follicles
with antra

Follicles
without antra

Primordial
ova

Atretic

Normal

Atretic

Normal

None
Norethynodrel

2.8
14.0

20
18
16

6.6 ±0.46
4.4 ±0.69

6.0 + 0.84
5.6±0.44
5.6 ±1.00

0.6 + 0.21
0.2 ±0.35
0.8 ±0.35

8.4 ±1.25
8.7±1.12
7.9 ±0.75

2.2 + 0.48
2.1 ±0.57
2.7 ±0.57

5.7 + 0.97
12.1 ±3.71

Norethynodrel

3.9 ±0.49

7.7 ±1.27

Underlined values differ significantly from control values.

retention of corpora lutea present at the tim^ the injections were begun. A
direct examination of the oviducts for ova could perhaps resolve these
possibilities.

In conclusion, I should like to summarize as follows: (a) a good number
of steroid substances give evidence of acting as ovulation inhibitors in the
rabbit; (b) except, however, for certain progestational steroids, most of these
substances are of low or dubious activity; (c) among the compounds of
relatively high potency by subcutaneous injection, there are several in which
activity by mouth is apparently absent (e.g. XXIX, LIV) or much less than
by the parenteral route (e.g. XLI, LV); (cl) one compound, norethynodrel.

48 Discussions

is highly active on oral administration (in fact it is the most active ovulation
inhibitor) but of quite low potency by injection; norethindronc is similarly
somewhat more active by mouth than by injection. It is interesting to note
that thus far the most consistent oral ovulation inhibitors in women are
these two compounds, whereas others (e.g. XLI and LIV) are by themselves
not very effective oral agents in women (12, 13).

REFERENCES

1. PiNCUS, G. and M. C. Chang, Acta Physiol. Latino-americana 3, 177, 1953.

2. PiNCUs, G., Proc. 5th Internat. Conf. Planned Parenthood, p. 176, 1955.

3. PiNCUS, G., M. C. Chang, M. X. Zarrow, E. S. E. Hafez and A. Merrill, Endo-

crinology 59, 695, 1956.

4. MiYAKE, T. and G. Pincus, Endocrinology 63, 816, 1958.

5. Saunders, F. J. and R. L. Elton, in Endocrinology of Reproduction (Edited by C. W.

Lloyd), p. 227. Academic Press, New York, 1959.

6. JuNKMANN, K., Arch. Exptl. Pathol. Pharmakol. 223, 244, 1954.

7. Hertz, R., W. Tullner and E. Raffelt, Endocrinology 54, 228, 1954.

8. Rock, J., G. Pincus and C. R. Garcia, Science 124, 891, 1956.

9. Rock, J., C. R. Garcia and G. Pincus, Recent Progress in Hormone Research 13,

323, 1957.

10. Garcia, C. R., G. Pincus and J. Rock, Am. J. Obstet. & Gynec. 75, 82, 1958.

11. Saunders, F. J. and V. A. Drill, Ann. N.Y. Acad. Sci. 71, 516. 1958.

12. Pincus, G., Vitamins and Hormones 17, 307, 1959.

13. Rock, J. and C. R. Garcia (this volume).

DISCUSSIONS

Chairman: Dr. Roy O. Greep

Dr. Frederick L. Hisaw: The experiments reported by Dr. Simpson on the induction of
ovulation in monkeys (Macaca mulatta) and rats deal with two mammalian species
that differ widely in sensitivity to exogenous pituitary gonadotropins, and particularly
in responsiveness to the luteinizing hormone (LH). An unfractionated pituitary
extract that contains both FSH and LH, when given subcutaneously to monkeys in
moderate doses, produces primary growth of follicles, most of which may be cystic and
show little or no luteinization of the granulosa. If, following follicular development,
the same preparation is injected intravenously, luteinization usually occurs and
occasionally a follicle may rupture, but when this happens it always involves a follicle
of approximately normal size that has not become cystic. In contrast with this, a
similar preparation invariably causes luteinization in rats when administered sub-
cutaneously in effective doses for a period longer than 3 or 4 days.

Therefore, as Dr. Simpson has emphasized, an analysis of follicular development
and ovulation as induced by pituitary gonadotropins must depend in large measure
on the purity of FSH and LH preparations, the length of treatment, the relation of
the two hormones in the reactions, and the responsiveness of the experimental animal.
It seems that LH can be obtained free of FSH but it is disappointing that so far no
one has succeeded in isolating FSH in sufficient purity that it will not produce
luteinization when given in large doses. This, of course, could mean an incomplete
separation of the two hormones but the possibility should be considered that the
weak luteinizing action of purified FSH may be due to an amino-acid sequence held
in common with LH as has been found for the melanophore-stimulating hormone
(MSH) and adrenocorticotropin (ACTH).

Discussions 49

It may not be an unimportant observation that the conditions most favorable for
folhcLilar development when induced by gonadotropins are also at the same time most
favorable for stimulating estrogen secretion. Both FSH and LH are notoriously
ineffective when given alone in dosages that are very effective when the two hormones
act concurrently. A notable difference between the two situations is that in the former
estrogen is not secreted and in the latter it is. The follicular growth produced by large
doses of FSH is probably facilitated by the weak LH action that is invariably present,
and also estrogen is secreted.

The association of estrogen secretion with follicular growth seems to apply equally
well to ovarian responses induced by the chorionic luteotropin, HCG. This hormone is
capable of causing the secretion of both estrogen and progesterone provided follicles
and corpora lutea (particularly the latter) are present when it is administered. It
also can substitute for LH when FSH is given. However, it cannot promote follicular
growth, at reasonable dosage, in the involuted ovaries of hypophysectomized rats or
in the ovaries of juvenile monkeys, and in neither instance is estrogen secreted.
The probable importance of estrogen is suggested by the fact that the ovaries of
hypophysectomized rats will respond to HCG when the treatment is preceded by a
series of injections of estrogen. Also, estrogen will facilitate the action of FSH.

Another placental hormone, PMS, is of interest in this connection in that it can mimic
both FSH and LH, particularly the former, and, of course, estrogen secretion is associ-
ated with its effects. It is an excellent hormone for producing follicular growth and is
useful in experimental ovulation. However, both it and HCG are, in reality, hormones
of gestation that are designed for the specific physiological needs of the species
in which they are found and are useful in studies of ovulation only in so far as
their pharmacological actions assist in the elucidation of the physiology of FSH
and LH.

It may not be of direct practical importance for the problem in hand, but I do think
it adds interest to keep in mind that the interactions of pituitary and ovarian hormones
in the regulation of follicular development and ovulation, as found in vertebrate
animals, represent the culmination in the evolution of a long series of adaptations.
The present evidence indicates that in the vertebrates the hormonal situation is
basically the same in all reproductive cycles up to and including ovulation. The
principal hormones seem to be FSH, LH and estrogen. This means of course that
the cycle in all vertebrates is physiologically homologous with the follicular phase
of a mammalian estrous cycle. Also, it seems quite possible that the steroid hormone of
the Graafian follicle in all instances is estradiol-17p. This is supported by the isolation
of estradiol-17p from ovaries of such distantly related vertebrates as the mammal,
bird, lung fish and dogfish. It is also of added interest that estradiol- 17 [3 has been found
in the ovaries of certain invertebrates, i.e. a starfish, sea urchin and pecten. It is also
a possibility that progesterone is an ubiquitous steroid. A steroidal substance has been
obtained from the ovaries of invertebrates, by using methods applicable to mammalian
tissues, which has been tentatively identified as progesterone on the basis of column
chromatography, paper chromatography and positive Hooker-Forbes reactions.

The general presence of these steroids raises the question of their importance and
function in the physiology of the follicle itself. When reduced to its simplest form,
it is conceivable that estrogens and progesterone along with various other steroids
and sterols were deposited in the ovum by the surrounding nurse cells or granulosa,
with which ova are commonly associated, long before they assumed hormonal functions.
It is not even necessary to assume that these compounds were synthesized and secreted
by the nurse cells. There is some evidence that they are present in plants and con-
sequently might have been obtained ready formed as is true of most vitamins. However,
regardless of origin, the most important point is the probability that the nurse cells
of the follicle from the inception of the practice of passing materials along to the ovum
were metabolically acquainted with steroid compounds and also it is a further
assumption that the initial endocrine functions were concerned only with physiological
processes in the follicle. The acquisition of the status of bodily hormones was probably
a specialization that came later.

50 Discussions

The only endocrine features that seem to be common throughout the life of a
follicle in both vertebrates and invertebrates are the presence of steroid hormones
and the fact that the follicle normally ruptures. Therefore, the solution of the problem
of ovulation may be found by investigating the basic physiological processes that go
on in the follicle. There have been very few analytical efforts in this direction. Most
research has been concerned with the regulatory mechanisms that affect follicular
physiology. Those factors which originate outside the ovary are for the most part
timing devices to guarantee that ovulation occurs at the most favorable moment and
season for fertilization and survival of the embryo. It is of course a familiar fact that
environmental factors such as light, temperature, humidity, food, etc., can influence
the secretion of gonadotropins by the pituitary and it is now quite evident that these
effects are mediated by the nervous system.

It is of course a familiar and interesting observation that ovarian development and
ovulation generally is attuned to environmental influences such as light, temperature,
humidity and food. These influences in vertebrates are mediated by the pituitary but
it is obvious that ovulation was a well-established phenomenon long before a pituitary
was invented. Therefore, the physiology of the follicle itself should hold the solution
of the problem and steroid action may be the answer.

The research reported by Dr. Pincus deals with the most important practical problem
that confronts the human race today. The destiny of mankind most certainly depends
more on control of the world's population than it does on the curious international
competition now raging over such comparatively trivial things as who is to enjoy the
dubious distinction of being the first to get a peek at the sea's bottom or the moon's
backside. Even so, finding a method for the inhibition of ovulation is in reality a
problem in endocrine engineering which relies on basic information rather than
contributing to it. However, these studies have raised many important questions
regarding essential molecular morphology of an effective steroid inhibitor and the
nature of the inhibitory process.

Chairman Creep: Dr. Folley, would you like to comment on any of these three papers?

Dr. S. John Folley: At this rather early stage of the proceedings I do not think
that any comment of an all-embracing nature has occurred to me, except for one point
in connection with what Dr. Hammond has just said about the follicular fluid. We
know that, in addition to the proteins, salts and so forth mentioned by him, follicular
fluid also contains other substances, in particular at least two mucopolysaccharides.
I have often wondered if there is some connection between the fact that the gonado-
tropins are glycoproteins and the fact that the cells lining the follicles, at least some
of them, are cells which secrete mucopolysaccharides. I am afraid I cannot offer any
more specific suggestions about this at the present time, but it would seem to me to
be a point which is worth some consideration. More pertinent, perhaps, is the fact
that these mucopolysaccharides undergo depolymerization just before ovulation, with
a concomitant rise in the colloid osmotic pressure of the follicular fluid (Zacharias and
Jensen, Acta Endocrinol. 27, 343, 356, 1958), and one cannot help wondering whether
estrogen produced by the follicular cells plays any role in this as it seems to do in the
liquefaction of the cervical mucus at estrus. I throw this out to the meeting as something
which might be thought about and perhaps we might have some ideas about it.

Chairman Creep: Is there any one who would like to comment, or is there any one who
would like to pose a question to any of our speakers of the afternoon ?

Dr. Warren O. Nelson: I wonder, Cregory, harking back to your remarks about
inhibition of ovulation in the rat whether it would not be appropriate to take into
account the fact that the 19 nor-compounds behave very much, under some circum-
stances, as estrogens do. If they are given to adult rats corpora lutea are maintained.
Your objective was, of course, to examine the inhibitory activity of these compounds
which, indeed, are very effective gonadotropin inhibitors, but I wonder if the presence
of corpora lutea in animals, treated for fifteen days, would not reflect the fact that
corpora lutea were present at the time treatment was begun and were caused to persist
by treatment.

Discussions 51

Dr. Gregory Pincus: That is a probable explanation in the 90-day-olds, and perhaps in
the 30-day-old animals, although you would know, perhaps, better than I, whether
you would get ovulation in a 30-day-rat.

There is one possibility that we are examining and that is the possibility that there
is in the young rat perhaps some initial stimulation by steroid; I don't think it is true,
though, because the ovaries, as you well know, even after two weeks' treatment, are
smaller than those of the controls and though there are corpora lutea, they are less
in number.

Also we have run the animals for a longer period of time, and eventually we see no
corpora lutea. So I was merely being over-conservative in saying that there may have
been an ovulation. Actually, we have no proof.

In the mouse, we have looked for ova, and it is quite clear that the ova are not
produced. Maybe I should have made that remark in my presentation. Otherwise, I quite
agree with you that these are just as potent gonadotropin inhibitors in the rat and
mouse, by the standards that we have been able to set up, as they are in the rabbit and
the human.

Dr. Ernest Knobil : May I ask Dr. Hisaw whether he has failed to find estrogen in any
of these invertebrate animals he has investigated ?

Dr. Frederick L. Hisaw: So far we have studied ovarian material from only three species
of invertebrates: a starfish {Pisaster ochraceous), a sea-urchin {Strongylocentrotus
franciscamis) and a pecten {Pecten hericins). Estradiol-17p and progesterone were
present in all three, as determined by techniques commonly employed in the isolation
and identification of these steroids in mammalian tissue. Lots of 10 to 14 kg of ripe
ovaries were extracted. The amounts of these steroids on a tissue-weight basis were
very small and we were interested primarily at this time in identification rather than
quantitation. However, the estrogen content in pecten ovaries was found to be much
greater than in the ovaries of either the starfish or sea-urchin.

Dr. Janet McArthur : I would like to ask Dr. Simpson what sort of extrapolation she
would make from these studies to her applied work on the FSH and ICSH content
of the monkey pituitary during diff"erent stages of the menstrual cycle.

Dr. Miriam E. Simpson : I do not think we are in a position to answer your question. I made
the point for the rat, that we have not so far been able to show a relationship between
the pituitary hormone content at different stages of the cycle and the ability to induce
ovulation. The preparations of rat pituitary used were crude preparations.

Such studies have not been conducted with monkey pituitaries removed at different
stages of the menstrual cycle.

Dr. Janet McArthur: In your monkey studies, the FSH went up as well as the LH in
the cycle ?

Dr. Miriam E. Simpson : There are several things that would indicate that the presence of
ICSH is necessary for ovulation. The stimulation from FSH preparation may in part
be attributable to a masked ICSH in FSH preparations. ICSH cannot be recognized
at as low doses in the presence of FSH as when given alone.

When very high doses of ICSH were injected during preparation of follicles prema-
ture thecal luteinization with enclosure of eggs occurred.

Chairman Creep: The ovulatory process may really start with the growth of the follicle.
Perhaps the processes producing ovulation have to follow a given sequence right
from the very beginning. Do you see what I am driving at ?

Dr. Miriam E. Simpson : They have to go on in a normal sequence.

Chairman Creep: This, we haven't unravelled as yet, but your data indicate to me that if
you had a pure FSH, you might not be able to ovulate the follicle when it was fully
grown, because certain of the processes had lagged behind, and could not then catch up.

52 Discussions

Dr. Miriam E. Simpson: Although it is commonly assumed that some ICSH must be
present with FSH before full maturity of the follicles and estrous response can be
elicited, nevertheless the exact amount of ICSH needed is not known accurately. I
think we arc agreed that a follicle needs a vascular envelopment for development, and
this is supplied by the theca.

Chairman Creep: It seems that the importance of balance is not just at the time of
ovulation, but long before that. You have to have the proper preparation all the way
along, in order to get really effective ovulation.

Dr. Somers H. Sturgis: I would like to ask Dr. Pincus a question. I gather that the
steroids were given just after mating so that you had 10 hr in which they had to work,
presumably to prevent ovulation. This would seem to me to be a very short time for
these compounds to work, particularly those that were given by the oral route. It
suggests some mode of action other than through pituitary inhibition. What about
the possibility of some direct action on the follicles themselves? We don't know very
much about the activity of an ovarian steroid as estrogen or progesterone on the
ovary itself, yet in the hypophysectomized rat, estrogen certainly does maintain and
perhaps even stimulate the growth of follicles and granulosa. Last fall, Vasicka
reported at the American College of Surgeons some evidence for the direct action of
Enovid on human ovaries. In ovarian biopsies, he felt that he could show an increase
in follicle atresia following Enovid medication.

In this regard, do you want to say something about the possibility of some direct
action of these steroids on the ovarian follicles, or do you believe that the effect that
you have shown us on inhibition of ovulation can and must take place through the
pituitary, even when giving oral preparations after mating with only ten hours for
effective action before ovulation will occur?

Dr. Gregory Pincus: Dr. Chang and I originally found that with progesterone, we could
practically invariably ovulate the animal receiving an inhibiting dose, by giving
gonadotropins intravenously. Whether this would be true of all the compounds we
have tested, I don't know. I know it is true in some cases. As to the possibility of a
direct influence on the ovary, this ties in with Dr. Hisaw's and Dr. Hammond's
discussion; it is something that fascinates me very much.

If we had been lucky enough to find a steroid which causes ovulation, the course of
reproductive physiology might have changed markedly. I think that there may be
such a substance.

If there is something which can stimulate ovulation, there are certainly plenty of
things you should be able to do to reverse such stimulation. We know that steroids can
act as antagonists to each other in many situations. We have tried to find some
evidence for direct action of steroids upon the ovaries in studies with the mouse.
What we did was to use PMS and HCG to ovulate the mice, administer the steroid,
and then see if ova were produced.

The most potent ovulation inhibitors proved to be reserpin and chlorpromazine.
So we probably weren't by-passing the pituitary of the animals but affecting an endo-
genous factor that acts with the administered gonadotropins. Certain of the steroids
also were active in inhibiting ovulation.

The last point I want to make is in reference to Dr. Hisaw's remarks. As far as the
genesis of hormonal steroids is concerned, in every species of mammals studied so far,
the process is identical. The major precursor is cholesterol; this is transformed to
A^-pregnenolone, which is the parent of all the steroid hormones.

One of the possibilities very much overlooked is that some of these steroids are
mitosis-stimulating and others mitosis-inhibiting. What relationship this would have
to egg development and maturation has never been studied. With modern techniques,
one ought to be able to isolate and grow eggs to see whether there are inhibiting and
stimulating steroids.

Chairman Creep: Is there a biologist in the house? I would like to have someone comment
on the work of Witschi and Chang.

Discussions 53

Dr. Sheldon Segal: I am reminded of three recent studies that bear on today's discussion.
The first is by Meyer and Bradbury {Endocrinology 66, 121-128, 1960), demonstrating
a direct effect of estrogen on growing ovaries. Using both immature and hypophy-
sectomized rats, they found that estrogen priming (stiibestrol) enhanced the ovarian
response to gonadotropin. This principle may be of significance with respect to some
aspects of the work reported by Dr. Noyes and Dr. Simpson. In each case, the failure
of the ovary to respond to stimulation could be correlated with an absence of estrogen.
In the experiments of Dr. Noyes, the ovarian implants were made in castrate hosts.
Would the addition of estrogen improve the performance of the ovarian implants?
Dr. Simpson reports that FSH preparations most purified and free of ICSH contamina-
tion (<4%) are least effective as a supplement in causing ovulation. Do these results
correlate with the effect of the preparations on causing ovarian estrogen production?
The two other studies I would like to mention deal with in vitro ovulation using
frog ovaries. Witschi and Chang {Endocrinology 61, 514—519, 1957) found that exposure
of primed segments of frog ovaries to cortisone in vitro favored egg-release. Bergers
and Li {Endocrinology 66, 255-259, 1960) reported that in vitro ovulation by this test
is induced by progesterone. ICSH and GH, from mammalian sources, induced
ovulation also under the conditions of the experiment. Neither study included a report
of the activity of estrogen in this in vitro test. It would be of interest to learn about this
in view of the evidence for the direct effect of estrogen on the mammalian ovary.

Dr. Villee: I would like to ask Dr. Simpson whether she had tried to add estrogens in
the course of the preparation of the follicles.

Dr. Miriam E. Simpson: Estrogens have not been injected. Furthermore, there was not
sufficient time to present the estrogenic properties of each of the follicle-stimulating
preparations injected. The purified follicle-stimulating preparations were very different
in regard to their ovulating capacity and eventually we will present the correlation
between the capacity of FSH preparations to induce ovulation and to cause estrous
uterine response.

Dr. Robert W. Noyes: It always appeared to me that a follicle may make enough estrogen
to prepare the endometrium on its own. Occasionally, in post-menopausal women, a
pregnancy may occur two or three years after the last period, and you wonder if a
single follicle was able to make enough estrogen and progesterone to support
implantation and pregnancy.

Nalbandov: In connection with Bradbury's work, it seems significant to me that the
doses of estrogen or stiibestrol required to produce these effects on the ovary are
extremely high. I believe that a minimum of 1 mg of the steroid per day must be given.
This fact suggests that this is not a physiological mechanism and raises the question
whether the effect is produced by the hormone itself or by a metabolite of these
substances.

Dr. Sheldon Segal: One can't decide that issue until he does a subsequent step of making
local implantations of estrogen crystals or small pieces of estrogen in one ovary, in
relation to the next step. We will have to wait for those results before deciding whether
it is a physiological thing or not.

Dr. Gregory Pincus: I would like to say one thing in regard to that. He may not be
using the right estrogen.

Maybe it is natural. If you study ovarian vein blood and study the estrogens in
there, you would be surprised. They are not the usual estrogens, but they may be of
importance physiologically.

Dr. W. R. Breneman: Perhaps I should let Dr. Segal speak on the following point since
I believe that the non-mammalian vertebrates provide information relative to the
effect of steroid hormones on the gonads. For example, in the amphibia distinct
primary and secondary cords usually are present in both testes and ovaries and
Burns demonstrated in the 1930's that sex hormones were able to regulate the

54 Discussions

development of the cords. Genetic males could be transformed into females with
estrone. Unfortunately, this result does not follow in all amphibia as Witschi demon-
strated in frogs.

The experiments of Burns provide evidence for the direct effect of sex hormones on
the development of the primary and secondary cords of the developing gonad.

Changes in the nature of the follicular contents have been referred to in the discussion.
It is interesting that Van Oordt and his co-workers have observed comparable changes
with the seminiferous tubules. The administration of anterior pituitary hormones
transforms the viscous contents of the tubules to a watery consistency and there is a
simultaneous disappearance of mucopolysaccharide. However, 1 suppose caution
should be exercised in considering this to be homologous with changes in the ovarian
follicle.

Finally, it may be of interest to report in connection with Dr. Simpson's results
some observations of Dr. R. R. Humphrey on axolotls. He tried to ovulate these
animals with Armour LH with which we provided him. This experiment was unsuc-
cessful. Armour FSH, on the other hand, did a beautiful job in ovulating the axolotls.

Dr. M. C. Chang: I should like to comment here about Dr. Noyes' paper in connection
with the point raised by Dr. Pincus, whether the presence of estrogen in the follicle
would inhibit or facilitate maturation of the egg. In 1955 (J. Exp. Zool. 128, 379;
Science 121, 867) I did some work on the cultivation and transplantation of follicular
eggs in the rabbit. It was found that eggs recovered from follicles of the unmated
rabbit could mature, that is, there was disappearance of the nuclear membrane,
formation of the first maturation spindle, extrusion of the first polar body and formation
of the second maturation spindle, either in culture or in the fallopian tubes. It seems
to me that there is perhaps a factor in the follicle which inhibits the maturation of the
egg. Whether it is estrogen, I do not know. Some of these eggs can be fertilized, but
most of them failed to develop into normal young after fertilization. It seems to me
that whether an egg with second maturation spindle observed outside the follicle is
really matured in the follicle or matured in vitro is uncertain and whether or not they
are really normal is also difficult to say. By application of potassium fluoride, Nadamitsu
(/. Sci. Hiroshima Univ. 17, 47, 1957) observed the ovulation of rat ovaries in vitro
and claimed that the eggs are normal because of the presence of the second maturation
chromosomes. I wonder whether these eggs ovulated in vitro or in the anterior chamber
of eye are really normal.

Dr. Gregory Pfncus: The experimenter has done more than that. He has actually taken
eggs and added gonadotropin in vitro, and decided that unless the gonadotropin is
present, the eggs do not go through the first maturation division. Unfortunately, I
don't think that he is statistically minded, so we cannot find out more details.

All you need to do with rabbit eggs is take them out of the follicles, put them in
culture, and it can be a variety of types of cultures, and they will go through the first
maturation division.

The second division doesn't occur, ordinarily, unless the egg is fertilized or partheno-
genetically activated.

It is the first maturation division which occurs in the ovaries in practically all
species.

Dr. Robert W. Noyes: These early follicular eggs cannot be fertilized because of the
immaturity of the cumulus, corona and probably zona pellucida. Although certain
features of nuclear maturation and meiosis take place in such ova removed to in vitro
conditions, the cumulus and corona do not mature, and spermatozoa do not penetrate
these coats if the cultured ova are transferred into a recipient oviduct.

Chairman Greep: Does any one know about the hyperemia test?

Dr. Charles A. Barraclough: Would the development beyond the secondary follicle
occur with a smaller amount of FSH, given to the estrogen-primed animal ?

Discussions

Dr. MnuAM Simpson: As estrogens will cause follicular growth in hypophysectomized rats
I think it is quite possible the follicular growth resulting from the combination of
FSH and estrogen might be greater than that which results from either alone.

Dr. FrederickL.Hisaw: I should like to suggest that probably the frog's ovary could be used
to test certain ideas that have been mentioned regarding ovulation. One advantage
offered is that ovarian fragments can be induced to ovulate quite easily in vitro. Also,
sufficient material for a rather large series of experiments can be obtained from a
single ovary. Several investigators have reported results of experiments of this sort
and the chief difficulty encountered seems to be variability in responsiveness of ovaries
from different animals. This is at least partly due to such things as the time of year
the frogs are collected and the conditions under which they are kept. Best results can
be expected when the animals are taken directly from hibernation under natural
conditions. Also, the responsiveness of the ovaries can be greatly increased by admini-
stering a subovulatory dose of frog pituitary tissue or by hypophysectomizing the
animal a day or so before the ovaries are removed. It may also be added that physio-
logical solutions used should be low or even lacking in calcium.

THE PITUITARY STALK AND OVULATION

G. W. Harris

Department of Neiiroendocrinology, Institute of Psychiatry
Mauds ley Hospital, London S.E.5, England

The ripening of an ovarian follicle and its rupture, with discharge of an ovum,
is dependent on the secretion of the anterior pituitary gland. Administration
of purified follicle-stimulating hormone (FSH) results in follicular enlarge-
ment, but such follicles are unable to reach full size or secrete estrogen unless
some luteinizing hormone (LH) is also present (39). Ovulation is most
effectively produced by administration of FSH with a small amount of LH
(ratio about 10 : 1).

FOLLICULAR GROWTH

Until recently the central neural factors responsible for regulating the
pituitary secretion of FSH had received little attention. Studies of such factors
require the use of animals with quiescent ovaries; either immature animals
or adult animals with a well-marked anestrous period.

(i) The Hypothalamus and Development of Puberty

It was at first thought that the onset of puberty was due to an ageing or
maturation process in the endocrine glands concerned. However, Foa (34)
showed that ageing of ovarian tissue could not be concerned since the ovaries
of immature animals transplanted to mature animals show changes typical
of the adult organ; likewise ovaries from a mature animal transplanted to
the prepubertal become quiescent and undergo atrophy. After it was realized
that the anterior pituitary gland was responsible for ovarian activity, it was
found that this gland contained active gonadotropic hormone before the onset
of maturity and that the implantation of anterior lobes of immature animals
into other immature animals might induce gonadal activity. Further, Harris
and Jacobsohn (48) found that pituitary tissue obtained from new-born rats
grafted under the hypothalamus of hypophysectomized adult female rats
became vascularized by the hypophysial portal vessels, and was capable of
supporting full adult reproductive functions. Thus the functional activity
of the ovary and anterior pituitary gland in the immature animal does
not depend on an intrinsic property of the tissue but on the "environment"
in which it is situated.

The Pituitary Stalk and Ovulation 57

In considering the sequence of events underlying the onset of puberty,
account must be taken of the endocrine status of the immature animal. It is
likely that the adenohypophysis and gonads are active, secreting glands in
prepubertal forms. The data for this statement have been reviewed in detail
by Donovan and Harris (20) and may be summarized as follows:
{a) The immature gonad secretes sex hormones, since prepubertal castra-
tion in the rat results in regression of the seminal vesicles and penis
(15), an increase in pituitary content of gonadotropin (52) and the
development of castration cells in the pituitary gland (17).
{b) The immature pituitary gland secretes gonadotropic hormones since
hypophysectomy in infantile rats results in regression of both ovarian
(84) and testicular (83) development,
(c) A feed-back action of gonadal hormones on pituitary function is
indicated by the fact that castration of one of a pair of infantile rats
united in parabiosis leads to precocious puberty in the other (61, 62);
this can be prevented by the administration of low doses of gonadal
hormone to the castrate partner (13). It is probable that a temporary
fall in blood concentration of ovarian hormones, resulting in increased
gonadotropin secretion, underiies the precocious puberty seen to
follow auto-transplantation of infantile ovaries (74, 40).
It seems then that before puberty the anterior pituitary gland and gonads
are functionally active but, although capable of maintaining adult repro-
ductive function at this time, their activity is restricted to a low level. The
fact that a feed-back mechanism of gonadal hormones is present in the
immature form implies the existence of some control mechanism regulating
gonadal activity at this level.

In 1956 Donovan and van der Werff ten Bosch (21) reported that vaginal
canalization in the rat, which serves as an index of ovarian maturation,
occurred significantly earlier in animals with lesions in the anterior hypo-
thalamus than in control animals. In a recent report (23) these workers give
an account of a study based on over 200 animals divided into the following
groups — normals, blank-operated and those with various hypothalamic or
preoptic lesions. It was found that lesions placed in the anterior region of the
hypothalamus in animals 10-15 days of age will, on the average, advance
puberty by 5-7 days. In one experiment 34 blank-operated animals had a
mean pubertal age of 43.3 days, whilst 13 rats with hypothalamic lesions had
a mean pubertal age of 38.1 days. Lesions in the preoptic region did not
hasten the onset of puberty. It is of interest that some of the sexually
precocious rats displayed cycles of prolonged estrus, and their ovaries
contained no corpora lutea, though others had normal vaginal cycles and
were fertile. The effective lesions were found to be situated basally in the
hypothalamus immediately behind the optic chiasma. Such lesions did not
result in hyperphagia and obesity and did not significantly affect the weight

58 G. W. Harris

of the adrenal glands. Bogdanove and Schoen (9) have recently obtained
confirmatory results to the above in the rat. In attempting an explanation of
these findings Donovan and van der Werff ten Bosch (23) suggest that
anterior hypothalamic lesions damage or destroy some neural mechanism
sensitive to the feed-back action of gonadal hormones. It seems clear in adult
animals that this feed-back action is exerted on the hypothalamus, and that
this structure in turn exerts a restraining influence over gonadotropin secretion
by the pituitary gland. A reduced sensitivity of the hypothalamus to gonadal
hormone may be one of the changes occurring in the development of sexual
maturity, since Hohlweg and Dohrn (57) found that in infantile rats the
cytological changes in the pituitary after gonadectomy could be prevented
by gonadal hormone in doses approximately one-hundredth of that required
in the adult.

In comparing the experimental findings with the clinical data on cases in
which hypothalamic lesions have been found associated with precocious
puberty in children (85, 3), two facts are outstanding. Firstly, various lesions
(especially hamartomata — a type of congenital abnormality) may result in a
greater advancement of puberty in the human than the experimental lesions
do in the rat. It is possible, however, that lesions placed in the hypothalamus
of fetal rats might yield results more equivalent to those seen in the human
in this respect. Secondly, the site of the hypothalamic lesions in clinical cases
of pubertas praecox may be well circumscribed and localized, and are often
found to be in the posterior part of the tuber cinereum or in the region of the
mammillary bodies. Ganong (37) has recently mentioned the results of
unpublished experiments by Gellert and Ganong in which lesions just in
front of the mammillary bodies of rats have been found to be the most
effective in accelerating the onset of puberty. He states that "Lesions in the
thalamus and the cerebral cortex also accelerate the onset of vaginal opening
to a slight degree, suggesting a non-specific 'stress' effect. . . . However, it
should be emphasized that this acceleration is slight when compared to the
marked acceleration produced by posterior hypothalamic lesions."

It is possible that the central nervous system exerts a restraining influence
on prepubertal gonadal activity in a wide variety of biological forms. Wells
and Wells (86) have found, in the octopus, that blinding by optic nerve
section or optic lobe removal, that lesions placed in the subpedunculate/
dorsal basal region of the posterior part of the supraesophageal lobes of the
brain, or that interference with the nerve supply to the optic glands, all
result in enlargement of the optic glands and gonads. The ovary may enlarge
from 1 /500th to as much as l/5th of the total body weight, and may visibly
distort the body of the operated animal. Such females may lay viable eggs
and brood in a normal manner. Wells and Wells suggest that a neural reflex
arc, consisting of the optic nerves-optic lobes-supraesophageal lobes of
the brain-and the nerve supply to the optic glands, normally exerts an

The Pituitary Stalk and Ovulation 59

inhibitory influence on the secretory activity of the optic glands. Lesions in
the reflex arc thus allow a release effect on the optic glands, the secretory
product of which in turn stimulates the gonads. They compare this suggested
mechanism with that in insects in which, after the last moult, the corpus
allatum becomes a source of gonadotropic hormone under the control of an
inhibitory center in the supraesophageal ganghon and an opposing excitatory
center in the subesophageal ganglion.

(ii) The Hypothalamus and Follicular Ripening following Anestrus

The physiological factors responsible for regulating FSH secretion at the
beginning of the breeding season have received little attention. It is well known
that various environmental factors, such as conditions of hghting, are of
major importance in determining the onset of reproductive activity following
a period of sexual quiescence. Rowan (78) was the first to demonstrate that
artificial illumination during the hours of darkness in winter causes enlarge-
ment of the gonads and sperm production in the junco finch. These findings
were extended to mammals by Baker and Ranson (field mouse, 2) and
Bissonnette (ferret, 7). Other mammals whose reproductive rhythm has
been found sensitive to changes in light exposure include the rat, hedgehog,
cat, mink, goat and sheep.

The ferret shows a well-marked breeding season from March to July or
August and in the estrous state exhibits a prodigious vulval swelling. On
account of these facts it has been used in experimental work to analyze the
light-estrus reflex. The following facts have been established:

{a) Extra illumination with light of wave lengths 6500-3650 A (red-
near ultra-violet) accelerates the onset of estrus in winter (68).

{b) The acceleration of estrus may be correlated with the intensity of the
extra illumination (67).

(<?) Long periods of light alternating with short periods of darkness are
more effective than continuous illumination (42).

{d) Hypophysectomized ferrets do not respond to extra illumination (55).

(e) Section of the optic nerves or blinding by other means (8, 16, 79) frees
the onset of estrus from photic influence.

It thus seems clear that the influence of light is mediated through the retina
and optic nerves to stimulate the release of FSH from the adenohypophysis.
The anatomical pathway intervening between the optic nerve fibers and
anterior pituitary cells is not clear. Data adduced by Clark, McKeown and
Zuckerman (16) and Jefferson (58) indicated that the pathway does not
involve the optic tracts in the region of the lateral geniculate body. In order
to see whether the central nervous pathway involved the pituitary stalk,
Donovan and Harris (18) cut the stalk in a series of female ferrets. They found
that animals in which regeneration of the blood vessels of the stalk (the
hypophysial portal vessels) had been prevented by placement of a waxed

G. W. Harris

Nov. Dec.

Jan.

Feb.

Mar. Apr.

16 23 30 7 U 21 28 * 11 18 "25 1 8 IS 22 29 7 M 2' 26 •« 11 1g
-I ' 1 1 1 1 1 1 1 1— I 1 1 I ■ ■ ■ ■ ■ ■ ■ ■ I

Lesion in

ant.

hypothalamus

287
263
24129o|

Lesion in

ant.

hypothalamus

299 292 314

Blank

318 316
315 310
1305 302 300
1312 303 296 297 3071

Lesion in

ant.

hypothalamus

|329|

13321

333

|331 336 328

^ Lesion in

post,
hypothalamus
and thalamus

[344
[337340

330339 3431

Lesion in

327

amygdala

326

323

325 324

322320I 1

Blank

342

341

J334 335

Fig. 1. Diagram to illustrate the eflFect of various operations on the brain on the onset of
estrus in the ferret. In this figure the height of the block indicates the number of anini.iis
which began to show vulval swelling each week. The numerals within the block identify
individual animals. The animals marked by an asterisk possessed lesions confined to the
thalamus. The solid vertical bars indicate the time of operation. (From Dono\an and

van der Werff ten Bosch, 24.)

Fig. 2. View of ventral surface of brain of ferret. Note the dark damaged area posterior
to the optic chiasma and extending forward over the left optic tract. (From Donovan and

\an der Werff ten Bosch, 24.)

Fig. 3. Transverse section through the anterior hypothalamus of the brain shown in Fig. 2,

showing the region in the midline destroyed by the lesion. (Loyez stain, 25 fi.) From

Donovan and van der Werff ten Bosch, 24.)

Fk;. 5. Photomicrographs of midline sagittal sections through the hypothalamus, pituitary
gland and base of skull of three rabbits, (a) Normal animal. Note the portal vessels passing
from the median eminence to the pars distalis. (h) Stalk-sectioned animal. Regeneration
has occurred across the site of stalk section. The neural lobe is atrophic, (c) Stalk-sectioned
animal with waxed paper plate placed to intervene between the hypothalamus and pituitary
gland. Neural lobe atrophic. In all cases the vascular system was perfused with India ink
after death. (From Fortier, Harris and McDonald, 35.)

The Pituitary Stalk and Ovulation 61

paper plate between the cut ends of the stalk, remained anestrus. Ferrets in
which the stalk had been cut, but in which vascular regeneration had occurred
across the site of the injury, became estrus on exposure to prolonged
illumination. The results of their study indicate that the final connecting link
from brain to pituitary gland involves the hypophysial portal vessels
[Thomson and Zuckerman (80) have drawn different conclusions].

To investigate the possibility that reflex nerve tracts between the chiasmal
region of the optic pathway and the upper end of the pituitary stalk (median
eminence of the tuber cinereum) were involved in the increased secretion of
FSH occurring in the spring, Donovan and van der Werff ten Bosch (22, 24)
placed lesions in this part of the hypothalamus of the female ferret during
winter. Electrolytic lesions were placed with the aid of a stereotaxic machine,
with the animals anesthetized with Nembutal (pentobarbitone sodium).
Since the plan of the experiment was to see whether such lesions delayed or
prevented the onset of the breeding season in the spring it was surprising to
find that about 75% of the animals with anterior hypothalamic lesions
became estrous early; that is, at a time of the year when normal animals,
blank-operated animals and those with lesions in the posterior hypothalamus
and thalamus, or amygdala, were still in the winter anestrum (Fig. 1). Many
of the animals that showed early estrus were placed with males, and produced
litters which they reared successfully. Serial sections through the brains
showed that the effective lesions were situated basally in the anterior part
of the hypothalamus, between the optic chiasma and pituitary stalk, extending
upward to the level of the paraventricular nuclei (Figs. 2 and 3). The optic
chiasma, suprachiasmatic nuclei and fornices were usually involved. In only
one animal was the pituitary stalk partly damaged. Ineffective lesions involved
the mammillary bodies, medial nuclei of the thalamus and habenular complex,
and amygdaloid area. In view of the fact that the hypothalamic lesions might
have exerted a stimulating effect by pressure on surrounding structures,
Donovan and van der Werff ten Bosch (24) electrically stimulated various
regions in the anterior hypothalamus. These experiments were carried out
with implanted electrodes and stimulation continued for periods of weeks
or months during winter. There was no indication of any release of gonado-
tropin by stimulation.

The specificity of the above results has been questioned by Herbert and
Zuckerman (53, 54) who claim that estrus in ferrets is advanced by lesions
placed in the thalamus or adjacent areas and by blank operations. The reason
for this discrepancy is, at the moment, not clear.

General Conclusions

The most hkely explanation of the finding that hypothalamic lesions
result in FSH secretion, follicular ripening and estrus, in both the immature,
or the mature anestrous, animal, is to be found in terms of a neural mechanism

62 G. W. Harris

situated in the anterior hypothalamus which exerts a tonic inhibitory effect
over the release of FSH. Such a mechanism may be supposed to be sensitive

. Gonadal
hormone

Excitatory

Exteroceptive
factors-light

Fig. 4. Diagram to illustrate the influence of the hypothalamus on FSH secretion. Since
pituitary stalk section may result in atrophy of the reproductive organs, whereas anterior
hypothalamic lesions lead to premature release of FSH and block the feed-back action
of ovarian steroids, it is necessary to postulate both excitatory and inhibitory neural effects.

to the effects of both environmental stimuli (light) and the blood concentra-
tion of gonadal hormones (Fig. 4). The present evidence may be summarized:

(1) Light. Increased illumination hastens the onset of puberty in infantile
rats (63, 30, 59). The onset of puberty varies in many forms with the
time of year of birth. An increasing or decreasing day length, or period
of artificial illumination, is a potent factor in determining the onset of
the breeding season in many forms.

(2) Ovarian Hormones. The immature animal appears especially sensitive
to the feed-back action of ovarian hormones (57). The work of Flerko
has been important in establishing the paraventricular region of the
hypothalamus as an important site of action for the feed-back mechan-
ism in adult animals. Flerko (31) found that lesions in the region of
the hypothalamic paraventricular nuclei prevented the gonadal atrophy
induced by estrogen administration, and Flerko and lUei (32) found
that similar lesions interfere with the inhibition of gonadotropin
secretion produced by testosterone propionate. By autotransplanting
small fragments of ovarian tissue into the hypothalamus Flerko and

The Pituitary Stalk and Ovulation 63

Szentagothai (33) demonstrated that the hormones released from the
graft depressed gonadotropin secretion if in the region of the
paraventricular nuclei.
(3) Anterior Hypothalamic Lesions. Such lesions result in a discharge of
FSH that would not occur in the immature or mature anestrous female
(see above). Since pituitary stalk section results in atrophy of the
reproductive organs it is necessary to suppose that the inhibitory
action of the anterior hypothalamus over FSH release is normally in
balance with an excitatory effect exerted by some other hypothalamic
area, both acting through the "final common path" of the hypophysial
stalk.

FOLLICULAR RUPTURE — OVULATION

Non-spontaneous Ovulation

Ovulation occurs spontaneously in most mammals, but in some forms
requires the sensory stimuli normally supplied by the presence of a male and
coitus for its occurrence. These latter forms include many birds, the rabbit,
ferret, cat, ground squirrel, short tailed shrew and mink, and possibly (see
Eckstein and Zuckerman, 25) the hare, weasel, Asiatic vole {Microtus
guentheri), certain marsupials (i.e. Didelphus azarae) and a tropical fruitbat
(Pteropus giganteus). Marshall (66) and Heape (51) first reported that ovulation
follows copulation in the ferret and rabbit, respectively. Early studies showed
that ovulation in the rabbit was not due (1) to absorption of semen from the
female reproductive tract, (2) to release of a hormone from the vaginal wall,
(3) to a direct nervous reflex acting on the ovaries [ovulation occurred in
transplanted ovaries — Asdell (1), Friedman (36)], and the idea became
current that a neuro-humoral reflex arc was involved: that sensory nerve
pathways caused activation of the anterior pituitary gland and the released
gonadotropic hormone brought about follicular rupture. This view received
support when it was found that hypophysectomy within one hour of coitus
prevented ovulation from occurring some nine hours later, though hypo-
physectomy later than this was followed by ovulation (28).

Sensory Stimuli

The sensory stimuli involved appear to be varied. Since artificial stimulation
of the vulva or vagina may result in ovulation, the sensory receptors in these
regions would seem of importance. However, local anesthesia of the vulva
and vagina (29), or denervation of these structures by removal of the sacral
region of the spinal cord (even when supplemented by complete abdominal
sympathectomy, hysterectomy and extirpation of the proximal half of the
vagina (11)) does not prevent ovulation following coitus. Brooks (11) also
studied the effect of bilateral destruction of the labyrinths and auditory
apparatus, enucleation of the eyes and the olfactory lobes, and removal of

64 G. W. Harris

the cerebral cortex. He found that none of these structures was essential for
post-coital ovulation in the rabbit, and concludes ". . . that ovulation occurs
as a result of intense sexual or emotional excitement rather than as a result of
a reflex initiated by stimulation of any specific group of sensory endings".
It seems likely, then, that under normal conditions of coitus afferent impulses
from many dilTerent receptors converge in the diencephalon and in some way
excite anterior pituitary activity.

Electrical Stimulation of Central Nervous System

The first positive evidence that reflex nerve tracts do activate LH release
came from the experiments of Marshall and Verney (69). These workers
showed that electrical stimuli applied through the lumbar spinal cord or
through the head of rabbits resulted in ovulation and pseudopregnancy in
a large proportion of animals. The stimulation used was strong and diffuse,
resulting in generalized convulsions, so that no localization was possible. It
seemed likely, hovv'ever, that the site of action was some region in the central
nervous system. The results of experiments in which localized stimuli were
applied to different sites in the diencephalon were soon forthcoming. Harris
(43), using a stereotaxic machine, stimulated the hypothalamus or pituitary
gland of ether-anesthetized rabbits. It was found that stimulation of the
tuber cinereum, posterior hypothalamus or pituitary gland directly might
result in ovulation or the formation of cystic or hemorrhagic follicles.
Similar results were reported by Haterius and Derbyshire (50) who found
that electrical stimuli applied to the preoptic region evoked ovulation. Some
ten years after these reports two groups of workers observed that electrical
stimuli, too weak to excite LH discharge and ovulation if applied directly to
the pituitary gland, might be fully effective if applied to the tuber cinereum.
Markee, Sawyer and Hollinshead (65) anesthetized rabbits with ether and
stimulated the pituitary at operation by a pharyngeal or temporal route,
and the hypothalamus via the superior orbital fissure. It was found that
stimulation of the pituitary did not result in ovulation unless there were signs
of spread of the stimulus, whereas stimulation of the hypothalamus at a
lower voltage resulted in ovulation in three out of four animals. Harris (44)
used the remote control method of stimulation which permits the use of
unanesthetized animals and the repetition of an experiment in any one
animal. The method consisted essentially of implanting a coil of wire (about
2000 turns) beneath the scalp. The ends of the coil were connected to
electrodes, one of which was inserted through a trephine hole in the skull so
that the stimulating tip was placed in some part of the hypothalamus or
pituitary gland. After recovery from the operation, electrical stimulation was
applied by placing the animal in an electro-magnetic field. Forty-two experi-
ments on seventeen rabbits showed that stimuli applied to various regions of
the tuber cinereum might elicit a full ovulatory response, even when applied

The Pituitary Stalk and Ovulation 65

for as short a time as three minutes, whereas stimuli appHed to the pituitary
stalk (below the level of the median eminence) or to the pars distalis of the
gland, for periods of up to 1\ hours, were not followed by any ovarian
response. Both Markee, Sawyer and Hollinshead (65) and Harris (44)
suggested that the failure of the anterior pituitary to respond to electrical
stimulation might be due to the fact that the hypothalamus normally regulates
the activity of this gland by a humoral mechanism rather than by a direct
nerve supply. Such a suggestion had been tentatively put forward by various
workers previously (56, 43, 1 2) in an attempt to explain the absence of a well-
marked nerve supply to the pars distalis.

Anatomical Pathway from Hypothalamus to Pituitary

The anatomical pathway by which the hypothalamus influences the adeno-
hypophysis has been discussed many times (for recent and detailed reviews,
see 46, 5, 20). Data relating to the various suggested pathways may be
summarized, for the present purpose, as follows :

(1) Direct nerve supply

{a) Cervical sympathetic supply carried to the gland via the carotid plexus.
But, ovulation still follows sterile coitus in the partially or completely
sympathectomized rabbit (49, 10).

{b) Parasympathetic supply carried to the gland via the greater superficial
petrosal nerves. However, ovulation still follows coitus after bilateral
avulsion of the facial nerve and geniculate ganglion, or after destruction of
the petrosal nerves at the geniculate ganglion (41, 82).

(c) A nerve supply passing to the gland via the pituitary stalk. However,
prolonged electrical stimulation of the pituitary stalk at a level below the
median eminence does not evoke ovulation (44). Section of the pituitary
stalk in the rabbit (35) may be followed by a normal ovulation reflex if
vascular regeneration has occurred across the cut. All available evidence
indicates that hypothalamic nerve fibers do not regenerate across the site of
pituitary stalk section.

Histological studies, although unable to prove a negative finding, give very
strong indication that the pars distalis of the anterior pituitary receives a
very scanty nerve supply, if any at all (77, 38, 87).

(2) Vascular path

{a) General systemic circulation. There are no data that the hypothalamus
regulates the anterior pituitary release of FSH or LH through the general
circulation. Unlike the ovary, testis, adrenal cortex and thyroid, the pituitary
gland does not maintain normal internal secretory activity if transplanted to
a distant site in the body. General ovarian and folHcular atrophy have been
repeatedly observed in well-controlled studies of pituitary transplants.

{b) Hypophysial portal circulation. This system of vessels, first described
by Popa and Fielding (75, 76) in man, has now been extensively studied.

66 G. W. Harris

A primary plexus of vessels, formed by a multitude of capillary loops or
twisted skeins of capillaries, is situated in the median eminence of the tuber
cinercum. This plexus drains into wide vascular trunks which pass down the
pituitary stalk and break up to distribute blood into the sinusoids of the
anterior pituitary. The system is supplied with blood by small arterial twigs,
from the internal carotid arteries or Circle of Willis, which penetrate the
pars tuberalis and median eminence. The portal vessels form a constant link
between the median eminence and anterior pituitary in all vertebrates
investigated from amphibians to man. Analogous vessels are found in cyclo-
stomes and fishes. Microscopic examination in living amphibians, rats, dogs
and mice has established the direction of blood flow as being from the tuber
cinereum to the pituitary. From the anatomical point of view these vessels
form the only direct and constant system linking the central nervous system
and adenohypophysis.

Experimental data confirm the importance of the hypophysial portal
vessels for normal anterior pituitary function :

(a) As mentioned above, Markee, Sawyer and Hollinshead (65) and Harris
(44) found electrical stimulation of the tuber cinereum effective in evoking
ovulation in the rabbit, though similar stimuli applied to the pituitary gland
did not cause ovulation. These data are compatible with the view that the
hypothalamus controls the adenohypophysis by humoral means.

(b) Pituitary stalk section is followed by very varied results so far as anterior
pituitary activity is concerned. The extensive literature on this topic has been
recently reviewed (20). It was found first in rats (45) and later in other forms —
the duck (4), ferret (18), rabbit (35) and Triturus cristatus (71) — that the return
of normal, or near normal, levels of anterior pituitary function after operation
occurs in those animals in which regeneration of the hypophysial portal
vessels takes place across the site of stalk section. If regeneration is prevented
by the placement of a barrier between the hypothalamus and pituitary, FSH
and LH secretion ceases. The results of Fortier, Harris and McDonald (35)
may be taken as an example. These workers cut the pituitary stalk in thirty-
two rabbits. In twenty-two the stalk was severed and a paper plate left in situ
between the cut ends. These animals all showed atrophic reproductive organs
when killed. In ten rabbits the stalk was cut, a paper plate inserted between
the cut ends but immediately removed (Fig. 5). Six of these animals showed
marked portal vessel regeneration and had ovarian weights not significantly
different from the normal (two of them accepted the male and ovulated in
the normal way).

(c) Transplantation of the anterior pituitary gland to a site in the body
remote from the sella turcica results in a marked loss of anterior pituitary
function, though if the tissue is placed in the subarachnoid space beneath
the median eminence it becomes vascularized by the hypophysial portal
vessels and apparently normal anterior pituitary function returns (48, 73, 81).

The Pituitary Stalk and Ovulation 67

It is clear then that a normal level of function of the anterior pituitary
depends on its vascularization by the hypophysial portal vessels and that the
central nervous system through the hypothalamus exerts an influence over
the gland through the mediation of this vascular system. It is probable that
nerve fibers from the hypothalamus liberate some humoral substance(s) into
the capillaries of the primary plexus in the median eminence and that this
substance is carried by the portal vessels to excite or inhibit the cells of the
adenohypophysis.

Many important investigations have now been undertaken in an attempt to
identify such humoral agents. Most of this work has however been concerned
with the regulation of secretion of the adrenocorticotropic hormone (ACTH);
a fact which has added to the difficulties of the problem, since the discharge of
ACTH is evoked so easily by so many and varied stimuli. The identification
of any particular substance as a physiological humoral agent involved in
anterior pituitary control, and indeed the neurohumoral view as a whole,
will only be established if it is possible to ". . . firstly identify a particular
substance which exerts a direct action on anterior pituitary cells ; secondly,
to show this substance is present in the blood in the hypophysial portal vessels
in greater amount than in systemic blood; thirdly, to show that the concen-
tration of this substance in the blood of the hypophysial portal vessels varies
according to electrical or reflex activation of hypothalamic nerve tracts ; and
fourthly, to demonstrate that the activity of the adenohypophysis is correlated
with this varying concentration". (Harris, 47.) Data such as this are not yet
available for any of the substances postulated for the role of a transmitter
agent. Various reports have suggested that the substance involved in gonaiio-
tropin release may be (a) adrenergic in nature (64, see, however, 19), {b)
intermedin (60), (c) oxytocic hormone (6, 72), {d) posterior pituitary poly-
peptides (70).

Work at the Institute of Psychiatry, London, has recently been undertaken
to see the effect of infusing various brain extracts into the adenohypophysis
of rabbits on the release of thyrotropic hormone (TSH) and LH (H. J.
Campbell, G. Feuer, J. Garcia and G. W. Harris, unpublished). Careful
consideration was first paid to two points — the anatomical limits of the
region which might be expected to contain active material and the methods
to be used for applying this material with minimal concurrent trauma to
anterior pituitary tissue.

The median eminence of the tuber cinereum is the region of the infundi-
bulum which contains the primary plexus of the portal vessels, surrounded by
a wealth of nerve fibers (Fig. 6). Extracts of the median eminence might then
be expected to contain a greater concentration of any humoral transmitter
agent than surrounding structures. In the brain of the freshly-killed animal
the median eminence may be identified from adjacent hypothalamic tissue
as the pink and bulbous upper end of the pituitary stalk. If the brain is

68 G. W. Harris

forcibly removed from the skull the median eminence often tears away from
the hypothalamus and remains attached by the stalk to the sella turcica and
its contents. After hypophyscctomy or pituitary stalk section the portal
vessels thrombose and the median eminence is clearly defined as a hard

Hypothalamus

Nerve
tracts

Mediam

Portal
vessels

Neural

lobe

Fig. 6. To show the region — the median eminence — probably involved in the transfer of
humoral agents from hypothalamic nerve tracts to the hypophysial portal vessels.

plum-colored nodule whose vessels have undergone retrograde thrombosis
(Fig. 7). Since the median eminence is structurally part of the neurohypo-
physis (and forms about 12% of total neurohypophysial tissue — see Campbell
and Harris, 14), many workers have investigated the effect of posterior
pituitary extracts on anterior pituitary activity. A priori there would appear
to be little to support this procedure, since — firstly, the median eminence :
anterior pituitary complex is evolutionarily the basic unit, with the neural
lobe arising as a secondary outgrowth from the median eminence in terrestrial
forms (38); secondly, the median eminence in all probability contains nerve
tracts with their fiber terminations and chemical constituents that are not
present in the neural lobe; and thirdly, although the median eminence is
constantly connected to the adenohypophysis by a rich vascular unit, the
neural lobe is connected by scanty capillaries at most. Some authors have
laid emphasis on the existence of these capillaries, but there is little data that
they possess much functional significance and, indeed, in some mammals
(whale, porpoise, sea-cow, armadillo, Indian elephant) and birds the two
lobes of the pituitary are separated by an intervening fibrous septum. Thus
although there is much data that the median eminence of the neurohypophysis
is directly related to anterior pituitary function there are few reasons for
believing the neural lobe of the neurohypophysis is so related.

Some reports in the literature have dealt with the effects of extracts of the
hypothalamus (presumably including the median eminence) on anterior

Wf^^

Fig. 7. To illustrate the anatomical extent of the median eminence as seen on the base of
the rabbit brain, (a) Base of brain of normal rabbit; (b) base of brain of rabbit hypophy-
sectomized 6 hr before death. Hypophysectomy severs the hypophysial portal vessels.
The primary plexus of these vessels in the median eminence therefore undergoes retrograde
thrombosis and the median eminence may then be clearly seen as a hardened, plum-colored
nodule. Anterior to the median eminence is the optic chiasma, and posterior is the
mammillary body, the posterior perforated substance and the emergence of the oculomotor
nerves from the midbrain. Scale in mm.

—

^ E

o =

(■

MM MM
20

1 m

c^ -

o -

Fig. 8. Photograph of the cannula with inserted stilette (seen as bent wire protruding from
upper end) and protective screw cap. Scale in mm.

.#'#

Fig. 9. X-ray photograph of cannula in situ in head of rabbit. The stainless steel, anchoring

screws may be seen in the vault of the skull, though the mound of dental cement fixing the

cannula to these screws is invisible by X-ray photography.

Fig. 10. Photograph of rabbit after recovery from the operation of cannula implantation.
For infusion of extracts into the pituitary gland, the stainless steel screw cap and the
stilette in the cannula are removed, and the upper end of the cannula connected by fine
polythene tubing to a syringe operated by a Palmer slow injection apparatus, by which
means infusion is made at a constant rate.

The Pituitary Stalk and Ovulation 69

pituitary activity. If, for the reasons given above, the median eminence
contains the greatest concentration of any agent, then this would be greatly
diluted by taking a relatively large mass of surrounding hypothalamic
tissue.

In the present work eight extracts of median eminence tissue have been
studied. The first six of these were obtained from rabbits and the last two from
cattle (steers). For each extract made from rabbit tissue four normal adult
female rabbits, that had been isolated for several weeks, were anesthetized
with ether, the skin of the head reflected and the head sawn through in the
transverse plane so that the cut severed the midbrain. The forebrain in the
front end of the skull was quickly removed from the bone, care being taken
to cut the pituitary stalk with fine scissors so that no fragment of pars distalis
tissue was removed with the stalk. The median eminence, the hypothalamus
and samples of cerebral cortex were dissected and immediately frozen. The
cattle material was obtained from a slaughter house, but in this case the
animals (castrated) had been killed (by bleeding) |-2 hr previously. The same
tissues were taken from each brain ; material from about twelve brains being
pooled for each cattle extract. Again the tissues were immediately frozen after
dissection. The extracts were prepared by homogenizing the pooled samples
in 0.5 % acetic acid and centrifuging. The solutions were then neutralized and
made isotonic by addition of appropriate amounts of sohd sodium bi-
carbonate and sodium chloride, centrifuged for 15 min at 10,000 r.p.m. at
0°C, and the supernatant distributed into sealed ampoules and kept in the
frozen state. The volume of the final extracts of the different brain samples
was equivalent on the basis of wet tissue weight.

The technique finally chosen for infusing the extracts directly into the
anterior pituitary in the conscious animal was a modification of that used by
von Euler and Holmgren (26). In a preUminary operation cannulae consisting
of fine platinum tubing (SWG 25) are inserted through a small trephine hole
in the vault of the skull so that the tip of the cannula is located in the pars
distalis of the pituitary. This is easily and simply performed with the use of a
stereotaxic machine and X-ray control. A flange attached to the upper end
of the tubing is then fixed to stainless steel screws inserted in the skull with
dental cement, a fine wire stilette inserted in the cannula, the skin sutured
around the cannula mounting and a protective cap screwed to the mounting
(see Figs. 8, 9, 10).

In early experiments attention was paid to the spread of infused dye, or
radioactive P^\ when different rates of administration were used. An infusion
rate of 0.06-0.07 ml/hr, for a 2-hr period, was finally chosen.

Since the majority of the animals in this work were being used to see
the eff"ect of the various infusions on both TSH and LH release, the experi-
mental procedure was usually as follows. After recovery from the operation
of implanting the cannula, the animals received 100 /xc P^^ subcutaneously.

70 G. W. Harris

Four days later half-hourly blood samples (0.5 ml each) were taken from
the marginal vein of the ear for 6-8 hr, during which time the infusion of the
various extracts or solutions was made either into the pituitary (at the above
rate) or intravenously (at a rate of 2.1 ml/hr) for 2 hr. Two days later the
animals were killed and the ovaries inspected under a binocular microscope.
If any sign of follicular activation was observed, serial sections were made of
the ovaries and histological studies carried out.

Since ovulation is said to occur "spontaneously" in the occasional female
rabbit, it is necessary to know the frequency with which this happens in any
particular colony. In thirty-one normal, isolated Chinchilla rabbits from the
present stock, killed for various reasons, corpora lutea of various ages were
found in the ovaries of three. In a previous study, in which various adrenalin
and noradrenalin solutions were infused under ether anesthesia into the
anterior pituitary gland, Donovan and Harris (19) found three out of thirty-
eight isolated Chinchilla rabbits had ovulated. For control purposes then,
one out of about eleven rabbits could be expected to show corpora lutea in
the ovaries. But since freshly ruptured follicles are distinguishable from
mature corpora lutea the experimental error would be less than indicated
by these figures.

Infusion of median eminence extract in various doses into the pituitary
gland resulted in ovulation in nine out of sixteen rabbits. In three cases,
fresh cystic and hemorrhagic follicles were found in the ovaries, though no
ruptured follicles were present.

Following infusion of extracts of the cerebral cortex, hypothalamus or
solvent only, into the pituitary gland only one animal out of thirteen rabbits
was found to have ovulated.

Infusion of median eminence extract intravenously, in doses greater than
those given (ranging up to x 20) in the pituitary resulted, in ovulation in
three out of seventeen rabbits.

The following conclusions may be tentatively put forward:

(1) Infusion of extracts of median eminence tissue directly into the anterior
pituitary gland results in an increased blood level of LH, and so
ovulation.

(2) It is unlikely that this result can be explained in terms of damage to
anterior pituitary tissue, since control infusions of hypothalamic
extract, cerebral cortical extract or solvent only did not produce a
similar result.

(3) It is unlikely that the effect is due to gonadotropic material in the
median eminence extract, since intravenous infusion did not evoke
comparable results.

(4) It is probable that there is some substance in extracts of the median
eminence which is active in causing discharge of LH from anterior
pituitary cells.

The Pituitary Stalk and Ovulation

Infusion of Median Eminence Extracts into Rats

Concurrently with the above study, Dr. M. Nikitovitch-Winer, working
in this department, has been investigating the effect of intrapituitary infusions
of median eminence, and other extracts in rats in which spontaneous
ovulation has been blocked with nembutal. The procedure used is as follows.

Adult female rats (Wistar strain), whose vaginal cycles had been found to be
regular for at least two weeks, were anesthetized early in the day of proestrus
and a fine platinum or platinum-iridium cannula (SWG 27) was inserted in
the right half of the pars distalis with a stereotaxic machine. In general
principle the technique used was similar to that described above for the rabbit.
Later on the same day, the spontaneous release of LH, and subsequent
ovulation, was blocked by intraperitoneal injections of 30 mg/kg body weight
"nembutal" (pentobarbitone sodium) at 1 1.00 a.m. and 2.00 p.m. (see Everett
and Sawyer, 27). In the afternoon, usually between one and three o'clock, the
brain extracts (from cattle) were infused either into the pituitary gland
directly (at a rate of 0.005-0.006 ml/hr or 0.008-0.009 ml/hr for one to two
hours) or intravenously (0.016-0.019 ml/hr) for the same period. The
following morning, the animals were anesthetized, the pituitary glands
infused with a dye solution at the same rate and for the same period as
perfused on the previous day, and the ovaries and Fallopian tubes removed.

Table 1. Induction of Ovulation by Direct Intra-pituitary Infusion of Median
Eminence Extracts into "Nembutal-blocked" Proestrous Female Rats

No. of
animals

Ovulation

Dose

mg wet wt.

Yes

Nembutal intra-pituitary infusion median eminence
extract

0.88-2.3

Nembutal intra-pituitary infusion cortical extract

1.9-2.4

Nembutal intravenous infusion median eminence
extract

2.2-5.4

Nembutal + cannula

—

Nembutal

—

* 0.44 mg infusion.

t Fast infusion over a period of 1 min.

After kiUing the animal, the cranium was opened and the position of the tip
of the cannula and the spread of the dye was observed. The ovaries were
examined for fresh rupture points, and the ampullae of the oviducts searched
for ova. The results obtained are shown in Table 1 . It may be seen that median
6

72 G. W. Harris

eminence extracts infused in the pituitary were efTective in evoking ovulation
(except in the case of the two animals that received the smallest dose),
whereas control infusions of the cerebral cortex in the pituitary failed to
excite the same response. Intravenous infusion of median eminence extract
was likewise ineffective in causing ovulation except in one animal that was
exceptional in that it was injected with the maximal dose (5.4 mg of extract)
over a period oi\)ne minute. Thirteen animals in which no infusion was given
failed to ovulate after nembutal treatment.

The preliminary results presented above dealing with the infusion of
median eminence extracts into the pituitary glands of rabbits and rats are
suggestive, but further work is necessary before any definite conclusions
can be drawn.

Acknowledgments — The original work reported in this paper (by H. J.
Campbell, G. Feuer, J. Garcia and G. W. Harris) was performed with the
assistance of a grant from the United States Air Force (Contract No. AF61
(514)-953) and (by M. Nikitovitch- Winer) a postdoctoral Fellowship Award
from United States National Institutes of Health (AF-8155-CI).

REFERENCES

1. AsDELL, S. A., Studies in the physiology of lactation, Dissertation, Cambridge

University, England, 1926.

2. Baker, J. R. and R. M. Ranson, Proc. Roy. Soc. S 110, 313, 1932.

3. Bauer, H. G., /. din. Endocrinol. 14, 13, 1954.

4. Benoit, J. and I. Assenmacher, Arch. Anat. micr. 42, 334, 1953.

5. Benoit, J. and I. Assenmacher, /. Physiol. (Paris) 47, 427, 1955.

6. Benson, G. K. and S. J. Folley, J. Endocrinol. 16, 189, 1957.

7. Bissonnette, T. H., Proc. Roy. Soc. B 110, 322, 1932.

8. Bissonnette, T. H., Res. Publ. Ass. nerv. ment. Dis. 17, 361, 1938.

9. Bogdanove, E. M. and H. C. Schgen, Proc. Soc. exp. Biol., N.Y. 100, 664, 1959.

10. Brooks, C. McC, Amer. J. Physiol. 113, 18 P, 1935.

11. Brooks, C. McC, Amer. J. Physiol. 120, 544, 1937.

12. Brooks, C. McC, Amer. J. Physiol. 121, 157, 1938.

13. Byrnes, W. W. and R. K. Meyer, Endocrinology 48, 133, 1951.

14. Campbell, H. J. and G. W. Harris, /. Physiol. 136, 333, 1957.

15. Clark, H. M., Anat. Rec. 61, 175, 1935.

16. Clark, W. E. Le Gros, T. McKeown and S. Zuckerman, Proc. Roy. Soc. B 126,

449, 1939.

17. DoHRN M. and W. Hohlweg, Proc. 11 Int. Congr., Sex Res., pp. 436^442, London, 1931.

18. Donovan, B. T. and G. W. Harris, /. Phvsiol. 131, 102, 1956.

19. Donovan, B. T. and G. W. Harris, J. Physiol. 132, 577, 1956.

20. Donovan, B. T. and G. W. Harris, in Marshall's Physiology of Reproduction, Vol. I,

Part 2 (Edited by A. S. Parkes) (in press). Longmans, Green & Co., London, 1960.

21. Donovan, B. T. and J. J. van der Werff ten Bosch, Nature, Lond. 178, 745, 1956.

22. Donovan, B. T. and J. J. van der Werff ten Bosch, J. Physiol. 132, 57P, 1956.

23. Donovan, B. T. and J. J. van der Werff ten Bosch, J. Physiol. 147, 78, 1959.

24. Donovan, B. T. and J. J. van der Werff ten Bosch, J. Physiol. 147, 93, 1959.

25. Eckstein, P. and S. Zuckerman, in Marshall's Physiology of Reproduction, 3rd Ed.,

Vol. I, Part 1 (Edited by A. S. Parkes), p. 257, Longmans, Green &. Co., London, 1956.

The Pituitary Stalk and Ovulation 73

26. VON EuLER, C. and B. Holmgren, J. Physiol. 131, 125, 1956.

27. Everett, J. W. and C. H. Sawyer, Endocrinology 47, 198, 1950.

28. Fee, A. R. and A. S. Parkes, J. Physiol. 67, 383, 1929.

29. Fee, A. R. and A. S. Parkes, /. Physiol. 70, 385, 1930.

30. Fiske, V. M., Endocrinology 29, 187, 1941.

31. Flerko, B., Acta Morphol. Hung. 4, 475, 1954.

32. Flerko, B. and G. Illei, Endokrinologie 35, 123, 1957.

33. Flerko, B. and J. Szentagothai, Acta endocr., Copenhagen 26, 121, 1957.

34. FoA, C, Arch. ital. biol. 34, 43, 1900. (Quoted from Parkes, A. S., The Internal

Secretions of the Ovary, Longmans, Green & Co., London, 1929.)

35. FoRTiER, C, G. W. Harris and L R. McDonald, /. Physiol. 136, 344, 1957.

36. Friedman, M. H., Amer. J. Physiol. 89, 438, 1929.

37. Ganong, W. F., in Reproduction in Domestic Animals, p. 185, Academic Press, New

York and London, 1959.

38. Green, J. D., Amer. J. Anat. 88, 225, 1951.

39. Greep, R. O., H. B. van Dyke and B. F. Chow, Endocrinology 30, 635, 1942.

40. Greep, R. O. and I. C. Jones, Recent Progr. Hormone Res. 5, 197, 1950.

41. Hair, G. W. and J. F. Mezen, Endocrinology 25, 965, 1939.

42. Hammond, J. Jr., Nature, Land. 167, 150, 1951.

43. Harris, G. W., Proc. Roy. Soc. B 122, 374, 1937.

44. Harris, G. W., /. Physiol. 107, 418, 1948.

45. Harris, G. W., /. Physiol. Ill, 347, 1950.

46. Harris, G. W., Neural Control of the Pituitary Gland, Edward Arnold, London, 1955.

47. Harris, G. W., Bull. Johns Hopk. Hosp. 97, 358, 1955.

48. Harris, G. W. and D. Jacobsohn, Proc. Roy. Soc. B 139, 263, 1952.

49. Haterius, H. O., Proc. Soc. exp. Biol, N. Y. 31, 1112, 1934.

50. Haterius, H. O. and A. J. Derbyshire, Jr., Amer. J. Physiol. 119, 329, 1937.

51. Heape, W., Proc. Roy. Soc. B 76, 260, 1905.

52. Hellbaum, a. a. and R. O. Greep, Amer. J. Anat. 67, 287, 1940.

53. Herbert, J. and S. Zuckerman, Nature, Lond. 180, 547, 1957.

54. Herbert, J. and S. Zuckerman, /. Endocrinol. 17, 433, 1958.

55. Hill, M. and A. S. Parkes, Proc. Roy. Soc. B 113, 537, 1933.

56. HiNSEY, J. C. and J. E. Markee, Proc. Soc. exp. Biol., N. Y. 31, 270, 1933.

57. HoHLWEG, W. and M. Dohrn, Wein. Arch. inn. Med. 21, 337, 1931.

58. Jefferson, J. M., /. Anat., Lond. 75, 106, 1940.

59. JocHLE, W., Endokrinologie 33, 129, 1956.

60. JocHLE, W., Endokrinologie 33, 190, 1956.

61. Kallas, H., C.R. Soc. Biol., Paris 100, 979, 1929.

62. Kallas, H., Klin. Wschr. 9, 1345, 1930.

63. Luce-Clausen, E. M. and E. F. Brown, /. Nutr. 18, 551, 1939.

64. Markee, J. E., J. W. Everett and C. H. Sawyer, Recent Progr. Hormone Res. 1, 139,

1952.

65. Markee, J. E., C. H. Sawyer and W. H. Hollinshead, Endocrinology 38, 345, 1946.

66. Marshall, F. H. A., Quart. J. micr. Sci. 48, 323, 1904.

67. Marshall, F. H. A., /. exp. Biol. 17, 139, 1940.

68. Marshall, F. H. A. and F. B. Bowden, J. exp. Biol. 11, 409, 1934.

69. Marshall, F. H. A. and E. B. Verney, /. Physiol. 86, 327, 1936.

70. Martini, L., L. Mira, A. Pecile and S. Saito, /. Endocrinol. 18, 245, 1959.

71. Mazzi, v., Z. Zellforsch. 48, 332, 1958.

72. McCann, S. M., R. Mack and C. Gale, Endocrinology 64, 870, 1959.

73. Nikitovitch-Winer, M. and J. W. Everett, Endocrinology 63, 916, 1958.

74. Pfeiffer, C. a., Amer. J. Anat. 58, 195, 1936.

75. Popa, G. T. and U. Fielding, /. Anat., Lond. 65, 88, 1930.

76. Popa, G. T. and U. Fielding, /. Anat., Lond. 67, 227, 1933.

77. Rasmussen, a. T., Endocrinology 23, 263, 1938.

78. Rowan, W., Proc. Boston Soc. Nat. Hist. 38, 147, 1926.

79. Thomson, A. P. D., Proc. Roy. Soc. B 142, 126, 1954.

74 G. W. Harris

80. Thomson, A. P. D. and S. Zuckerman, Proc. Roy. Sac. B 142, 437, 1954.

81. Vivien, J. H. and J. Schott. C.R. Acad. Sci., Paris 244, 1263, 1957.

82. VOGT, M., J. Physiol. 100, 410, 1942.

83. Walker, D. G., C. W. Asling, M. E. Simpson, C. H. Li and H. M. Evans, Anat. Rec.

114. 19, 1952.

84. Walker, D. G., M. E. Simpson, C. W. Asling and H. M. Evans, Anat. Rec. 106,

539, 1950.

85. Weinberger. L. M. and F. C. Grant, Arch, intern. Med. 67, 762, 1941.

86. Wells. M. J. and J. Wells, J. exp. Biol. 36, 1, 1959.

87. WiNGSTRAND. K. G., The Structure and Development of the Avian Pituitary, p. 316.

C. W. K. Gleerup, Lund, Sweden.

DISCUSSION

Chairman: Dr. Warren O. Nelson

Dr. Vaughn Cruchlow: We have followed the work of Donovan and van der Werff ten
Bosch, reviewed this morning by Professor Harris, with a great deal of interest. In
collaboration with Miss Elwers, we have undertaken a series of experiments in the
rat to examine the anatomic specificity of lesions that hasten puberty, and to determine

Fig. 1. Projections of effective hypothalamic lesions on a midsagittal diagram of the
diencephalon. Abbreviations used: AH, anterior hypothalamic area; ARC, arcuate nucleus;
CC, corpus callosum; DM, dorso-medial nucleus; M, massa intermedia; OCH, optic
chiasm; MB, mammillary body; PV, paraventricular nucleus; VM, ventromedial nucleus.

whether the amygdaloid complex might be implicated in the neural mechanisms
which are postulated to inhibit gonadotropin secretion. A more complete account of
this work was published recently (I).

The methods used were similar to those outlined by Bogdanove and Schoen (2) who
also observed the puberty-inducing effects of anterior hypothalamic lesions. All

Discussion

animals were lesioncd at 18 to 20 days of age, examined daily for vaginal opening,
weighed 2 to 3 times a week and killed at 33 days of age. Littcrmates were used as
controls.

In brief, the results obtained with a series of 23 hypothalamic lesions and 7
blank operated rats were similar to those discussed this morning by Dr. Harris: lesions
in the anterior hypothalamus were associated with precocious stimulation of the
reproductive system.

Table 1 . Effects of Amygdaloid Lesions on Body and Organ
Weights and Vaginal Opening

Body weights
at autopsy

Organ weights — nig/100 gm body weight

Number of
open vaginas

Uterus

Ovaries

Adrenals

Controls

(24 rats)

105.1 ±1.65*
93-118

86.8 ±3.08
56-120

21.9±0.81
16-29

23.1+0.86
17-35

Ineffective lesions
(27 rats)

100.0±1.92
74-116

79.8±3.12
55-117

22.7 + 0.96
11-31

22.8 ±1.40
16-31

Effective lesions
(16 rats)

101.7±2.95

77-124

169.9 ±8.88
128-241

27.4±2.09t
15^1

24.4 ±0.63
18-29

* Mean + standard error.

t Probably significantly different from controls {P < 0.05).

Figure 1 summarizes the antero-posterior locations of the nine lesions that were
judged effective on the basis of uterine weights that were significantly heavier (P < 0.01 )
than those of 18 control rats. As illustrated, one lesion was large and involved most of
the structures in the anterior hypothalamus. The remaining lesions were more discrete
and, with the exception of one in the basal septum, involved parts of the medial
anterior hypothalamus. It should be noted that several of these lesions were effective
without sharing a common area of destruction.

Of the 14 ineffective lesions in this series, bilaterally symmetrical destruction was
found in the thalamus, lateral hypothalamus, lateral preoptic region and olfactory
bulb. Four ineffective lesions were grossly asymmetrical.

These data are in agreement with previously published work regarding the following
points: (1) lesions placed in the rostral hypothalamus induced precocious sexual
development, (2) no single hypothalamic structure could be implicated, (3) some
degree of anatomic specificity was suggested by the number and location of ineffective
lesions, and (4) the stress of cerebral trauma did not appear to be an adequate stimulus
for early ovarian stimulation.

In contrast to the observations of Bogdanove and Schoen, the presence of corpora
lutea in ovaries of rats bearing effective hypothalamic lesions was not indicative of
damage to the arcuate nucleus : three of the four rats of this series that had corpora
lutea in their ovaries had lesions that spared the arcuate nucleus. Also, a small effective
lesion in this nucleus did not result in ovulation and luteinization. It appeared that
effective lesions, regardless of location, triggered prematurely an orderly sequence
of events which culminated in ovulation and corpora lutea formation, and autopsy at
day 33 might interrupt this sequence at any one of several stages.

Having established some confidence in the specificity of this lesion response, we
next directed our attention to the amygdaloid complex. Table 1 summarizes some of
the results obtained. Twenty-four control rats had a mean uterine weight of 86.8 mg/
100 gm body weight. Sixteen rats with lesions had uteri which were significantly

Fig. 3. Amygdaloid lesions effective in increasing ovarian and uterine weights.

Discussion

heavier (P<0.01) than the controls and were considered efTectively lesioned. Twenty-
seven lesioned rats had uteri which were comparable to those of the controls and were
designated as ineflectively lesioned. The mean ovarian weight of the effectively lesioned
animals was significantly greater (/'<0.05) than the mean of the controls; three pairs
of these ovaries had corpora lutea. No differences were observed in body or adrenal
weights.

Figure 2 shows on a composite diagram the bilateral destruction produced by all
amygdaloid lesions associated with increased uterine weight. The area included
portions of the cortical, medial and basal medial nuclei and had a longitudinal extent
of about 1 mm. In contrast to the results obtained in the hypothalamus, these lesions

Fig. 2. Diagram of a transverse section through the amygdaloid complex showing the
total area destroyed by all effective lesions (dark shading), and the location of ineffective
lesions in adjacent brain structures (dotted lines). Abbreviations used: BL, basal amygdaloid
nucleus, lateral part; BM, basal amygdaloid nucleus, medial part; C, claustrum; CE, central
amygdaloid nucleus; CO, cortical amygdaloid nucleus; L, lateral amygdaloid nucleus;
M, medial amygdaloid nucleus; OT, optic tract; PYR, pyriform cortex; ST, stria terminalis.

all shared a common area of destruction, indicated by the dark shading, that included
parts of the medially located nuclei and the area between which contains the converging
fibers of the stria terminalis. Bilateral involvement of this composite area was question-
able in one effective lesion, and one was located in the anterior caudato-putamen
complex. The dotted lines mark locations of all ineffective lesions placed bilaterally
in the immediate vicinity of the effective amygdaloid area with the exception of one
that was located in the composite area. In addition, bilaterally symmetrical ineffective

78 Discussion

lesions were located in the posterior extreme of the amygdala and in the thalamus.
Eleven ineffective lesions were clearly asymmetrical. Two representative effective
amygdaloid lesions are shown in Fig. 3.

These data suggest that a selected part of the amygdaloid complex may be included
in neural mechanisms which are active in the inhibition of gonadotropin secretion
in immature female rats. We have just begun to look for the anatomical connections
that may relate this temporal lobe structure with the anterior hypothalamic area. In
a few preliminary experiments, lesions in 24 rats that have failed to destroy the stria
terminals bilaterally have been ineffective while two rats with lesions that conclusively
destroyed this tract on both sides have shown precocious gonadal stimulation.

REFERENCES

1. Elwers, M. and V. Critchlow, Am. J. Physiol. 198, 381, 1960.

2. BOGDANOVE, E. M. and H. C. Schoen, Proc. Soc. Exp. Biol. 100, 664, 1959.

INTERACTIONS BETWEEN THE CENTRAL

NERVOUS SYSTEM AND HORMONES

INFLUENCING OVULATION*

Charles H. Sawyer and M. Kawakami
Department of Anatomy, University of California, Los Angeles
and Veterans Administration Hospital, Long Beach, California

INTRODUCTION
Even before the essential role of pituitary hormones in the process of ovulation
was suspected, it was recognized that activation of ovulation in certain species
required the nervous stimulation related to coitus. Haighton (1) suggested
this as early as 1797, but Heape (2) is generally credited with the discovery
of this reflex type of ovulation, which is the rule in rabbits, cats and several
other species. After the convincing demonstration of hypophysial involvement
in the ovulation process over 30 years ago by Smith and Engle (3) numerous
attempts were made to analyze the mechanisms by which the nervous system
activates the release of pituitary gonadotropin — not only in the reflex
ovulators but also in the more numerous spontaneously ovulating forms.
These experiments, involving central and peripheral nerve lesions, pituitary
stalk sections, hypophysial transplants, electrical stimulation techniques,
neurohumoral stimulants and pharmacological blocking agents, have been
reviewed comprehensively by Benoit and Assenmacher (4).

During the 1920s and early 1930s, the physiology of the ovarian hormones,
estrogens and progesterone, was also being elucidated (5). The secretion of
these steroids was shown to be under the control of pituitary gonadotropins
and the latter, in turn, were visuahzed by several workers, including Moore
and Price (6) in 1932, to be influenced by a direct feed-back of target organ
steroids to the hypophysis. However, because castration cells did not develop
in transplanted pituitary glands, Hohlweg and Junkmann (7) proposed the
existence of a hypothalamic "sex center" which controlled the release of
pituitary gonadotropins and which was affected by the sex steroids in their
feed-back circuit. Recently Flerko and Szentagothai (8) have provided
evidence in the rat of a direct antigonadotropic action of ovarian steroids at
the hypothalamic level by observing the action of ovarian fragments trans-
planted into the region of the paraventricular nuclei.

* Supported in part by a grant (B-1162) from the National Institutes of Health.

Charlks H. Sawyer and M. Kawakami

That sex steroids do, directly or indirectly, innucncc the central nervous
system is evidenced also by their obvious effects on reproductive behavior
(9, 10). A direct action is implied by the results of experiments of Kent and
Libcrman (11), Fisher (12) and Harris, Michael and Scott (13) in which they
injected steroids directly into the brain. Whether the hypothalamic area
controlling gonadotropic function is identical to the area controlling repro-
ductive behavior and whether either is a primary focus of steroid action are
questions to be considered in the present paper.

In this report the authors attempt to summarize their recent experiments
on the effects of pituitary and gonadal hormones on thresholds of central
nervous activity as assessed by electroencephalographic (EEG) recording
methods. These effects are correlated with changes in estrous behavior and
thresholds of pituitary activation in the rabbit. Earlier results obtained with
electrical stimulation and lesioning techniques are presented as an introduc-
tion to the anatomy of the hypothalamus, rhinencephalon and brainstem.

STIMULATION-LESION EXPERIMENTS;
THE ANATOMICAL SUBSTRATE

Activation of the release of pituitary ovulating hormone in the rabbit by
localized electrical stimulation of the hypothalamus and preoptic area,
respectively, was achieved in 1937 independently by Harris (14) and Haterius

OPTIC
CHIASM

NFUNDIBULAR
PROCESS

Fig. L Location of gonadotropic and sex behavioral areas in the hypothalamus of the

female rabbit and the female cat. C&R TROPIC, common area controlling release of

pituitary ovulating hormone in the cat and rabbit. CB and RB, areas in which lesions

induce permanent anestrus in the cat and rabbit respectively.

Interactions between the Central Nervous System and Hormones 81

and Derbyshire (15). Their findings have been confirmed repeatedly during the
past 20 years, and a basal tuberal area especially sensitive to this type of
stimulation has been outlined by Saul and Sawyer (16, 17) (Fig. 1). Localized
electrolytic lesions in the middle of this area block copulation-induced
ovulation in the rabbit with or without causing ovarian atrophy (18,19).
An almost identical site, extending from ventromedial nuclei to mammillary
bodies, has been delineated in the cat hypothalamus by Robison and Sawyer

OLFACTORY,
BULB

LAT
OLFACTORY
STRIA

AMYGDALA

Fig. 2. Relationships of rhinencephalic structures and sites of lesions. A, transection of
olfactory tracts or removal of bulbs; B, transection of fornix; C, septal lesion; D, amygdaloid
lesion. MB, mammillary body; MFB, medial forebrain bundle; PIT, hypophysis. From

Sawyer (19).

(20, 17) (Fig. 1) in which stimulation during estrus induces ovulation and
lesions cause ovarian atrophy. Differential regions have been outlined which
appear to control reproductive behavior in the two species (Fig. 1). Stimu-
lation of these areas does not induce ovulation, and lesions do not lead to
ovarian atrophy but do produce a condition of permanent anestrus which
cannot be reversed by exogenous estrogen; ovulation can still be induced
by direct stimulation of the gonadotropic area.

Projecting into the hypothalamus are numerous fiber tracts from the
rhinencephalon or limbic lobe, the part of the brain which Papez (21) proposed
as the anatomical substrate of emotion. These pathways include the medial
forebrain bundle from olfactory and other rostral areas, the fornix from the
hippocampus and the stria terminalis from the amygdala. The projections
are now considered two-way circuits (22), but evidence of their involvement

82 Charles H. Sawyer and M. Kawakami

with reproductive behavior and neuroendocrine function persists. Koikegami
et al. (23) were the first to report that stimulation of medial amygdaloid
nuclei induces ovulation, and olfactory activity has been implicated in
pharmacological induction of ovulation in the rabbit (24). Lesions in the
amygdala and underlying pyriform cortex lead to hypersexualism in males of
various species (25, 26). The lesions in the female rabbit rhinencephalon
depicted in Fig. 2 did not inhibit reproductive behavior or block copulation-
induced ovulation (19). However, there were some indications that removal
of the olfactory bulbs and section of the fornix (combined lesions A and B)
lead to a condition of behavioral hypersexualism in these females. The
mammillary body, which receives projections from these areas and in which
lesions lead to anestrus, will assume a position of considerable importance
in the estrous behavior of the female rabbit if later experiments confirm
these preliminary findings.

The brainstem reticular activating system (27) is also morphologically and
functionally closely related to the hypothalamus and its activity. This
system is especially sensitive to several of the drugs found to block ovulation
in the rabbit and rat (28, 29). However, these drugs have been shown to be
capable of blocking ovulation at the hypothalamic level (16), and Critchlow's
(30) midbrain lesions which blocked ovulation in the rat did not necessarily
destroy the reticular activating system.

AFTERREACTION TO COITUS; FEED-BACK HYPOTHESIS

In an effort to obtain neural correlates of pituitary activation by recording
EEG activity simultaneously from several regions of the brain under
conditions stimulatory to the adenohypophysis, chronic depth electrodes
were implanted in the brains of many female rabbits. While continuous EEG
records were being made these rabbits were free to move about, eat, drink
and even to copulate with or fight other rabbits. Copulation in the estrous
rabbit or vaginal stimulation in the estrous, estrogen-treated rabbit (31) was
used to trigger the release of pituitary ovulating hormone. An example of
the type of EEG change seen under these conditions (32) is contained in
Fig. 3. During the stimulation period the changes were almost entirely
artifacts attributable to movement. Within several minutes, however, the
record characteristically assumed a "sleepy" appearance with spindle bursts
in the frontal cortex and related areas (Fig. 3, B). The "sleepy" record
continued from several minutes to half an hour or more and was replaced
by a most unusual EEG pattern (Fig. 3, C-E). What appeared to be a
hyperaroused record, with 8-sec sinusoidal waves predominant in several
rhinencephalic areas related to the hippocampus, was associated with
behavioral depression. The rabbit lay prone with her head on the floor (Fig.
4, c-e), her ears bent back, eyes partially closed, pupils constricted, brady-
cardia and depressed respiration. On recovery her EEG record reverted to

Interactions between the Central Nervous System and Hormones 83

a pattern of ordinary arousal (Fig. 3, E); she raised her head, stood up and
usually went to the food bowl or extracted a pellet of feces from her anus
and chewed it (Fig. 4, f).

A B 7 MIN.

MALE MOUNTS FEMALE EJACULATION

C 12 MIN.

HEAD DEPRESSED ISEC

D 15 MIN. E 16 MIN.

MW>(llll%l#t*^^ ^VVUVMMWMaM V^^V*»WlMrW^VW|^f/lW^A^'^vVv>'^^ '

I • ' lOOuV

HEAD ELEVATED

Fig. 3. EflFects of coitus on the EEG of an unanesthetized unrestrained female rabbit with
electrodes permanently implanted in her brain. EEG channels: FC, frontal cortex; LC,
limbic cortex; APV, anterior paraventricular nucleus (thalamus); SP, septum; MM, medial
mammillary nuclei; CC, corpus callosum; VHPC, ventral hippocampus; RET, midbrain
reticular formation. From Sawyer and Kawakami (32).

84 Charles H. Sawyer and M. Kawakami

This afterreaction to coitus, whose EEG characteristics were observed
simultaneously with the behavioral changes, seems to occur ordinarily in
the undisturbed female rabbit. It does not develop in a noisy room and it was
missed in earlier observations probably because its behavioral characteristics,
in the absence of a simultaneous recording of the unusual EEG pattern, are
not dramatic. It cannot be induced in the anestrous rabbit by vaginal stimu-
lation but it is readily evoked by this method in the estrous, estrogen-treated
female. It does not occur in the male rabbit as a sequel to copulation.

At first it was thought that the EEG afterreaction did in fact represent
correlates of nervous activation of the hypophysis. However, it soon became
apparent that the time course was too late for such a relationship. An anti-
nervous blocking agent must be injected within a minute post coitum to
prevent ovulation (33) whereas the period of "EEG hyperarousal" or
hippocampal hyperactivity may not appear for half an hour or more post
coitum. By this time presumably considerable ovulating hormone has already
been released, for enough has reached the circulation within an hour to make
the further presence of the pituitary gland unnecessary for ovulation (34-36).
So if the EEG afterreaction is more than coincidentally linked to the release
of ovulating hormone it is more likely related to the discharge process itself
or perhaps to the action of the released hormone on the brain as a direct
feed-back mechanism. The reaction occurs in ovariectomized rabbits so the
principal target organ of ovulating hormone is not involved in the feed-back
mechanism (32).

This feed-back hypothesis led to attempts to induce a spontaneous EEG
afterreaction, in the absence of coitus or vaginal stimulation, with the use
of exogenous pituitary hormones and placental gonadotropins (37). The
attempts were successful with purified preparations of pituitary luteinizing
hormone (LH) (Fig. 5, A-D), human chorionic gonadotropin (HCG), equine
gonadotropin (PMS) and also with lactogenic hormone (LTH) and the
neurohypophysial principles, oxytocin and vasopressin. The other adeno-
hypophysial tropins, follicle stimulating hormone (FSH) (Fig. 5, A^-D^),
thyrotropin (TSH), adrenocorticotropin (ACTH) and growth hormone
(somatotropin), all gave negative results. Interestingly all of the pituitary
principles whose injection resulted in an EEG afterreaction are released in
response to coitus. The results are consistent with the hypothesis that the
post-coital EEG afterreaction is functionally related to the feed-back of
these released pituitary hormones. Teleologically such a system would serve
a useful purpose in shutting off the hypothalamo-hypophysial mechanism
for activation of release of ovulating hormone.

The essential nature of the EEG afterreaction is incompletely understood.
It has certain characteristics of a psychomotor seizure, and it appears to be
related to the condition of adynamia described by Hess (38) and the "arrest
reaction" of Hunter and Jasper (39). The latter is likened to a petit mal attack.

Fig. 4. Behaviorof the female rabbit during and after coitus. From Sawyer and Kawakami (32).

Interactions between the Central Nervous System and Hormones 85

Whether the latter conditions are influenced by hormones was not reported.
Hormonally-induced changes in the rabbit EEG and behavior have been

A. BEFORE LH (5 U.) B. 10 MIN. AFTER LH C. 15 MIN. D. 17 MIN.. STANDS UP

Fc ^^^f^^tf^^^^i^ 'l{^^^^ltM^I^\^>^\% ^mmm^44MPm0n >^^^4f\Hi^'i^^\^{4^i^

sMA ^t^WM^VAV-v^M'^VM^ iflf^j^h^^M^W^i*^ Www(%^\l'j»WY^Jwf^^ f^iitf^hW^^
Apv vtf(mmH\^>^'''^'^^ ^%Y'f^^*4<'^^(i^■^1#v^. '»rtrt|ttt*^^i/'* V#/I|p^

lACC ^^/Hll*lMW^M#^fs^ ^^.W'A'^'^^-^^^Wli ^'^^'^i^'WtW/^M^'-^* ^^^^^^W/ltji^lVf^^

'^'ktf!^M^i;i*Mm^* fliJlH^li\^i¥fffA^^^ HW'**^>>h',vA^v^M'^Miif ^^^fmf^'^^w^f^fit^j^^

a! BEFORE FSH (20 U.) B! 30 MIN. AFTER FSH C! 35 MIN. Dl 60 MIN. "^^

'VAf4/y*l/'yWV^^•^W•AVV*^'^< ^^\^*)hVAH^^V''^'.^^^^^^^ V^^v4^V-.vV■'^'^V«v''v^\A V%'^'vV'W^''\'V^V-^"'"'''''^v'^

/rt,'|^#f#^^'A*M'#W^ V^V<,Wr^v^A4^M-A»|«^ V\/v'^a/\/^-vvvW\/^ Vv^'A/Va^vvA/Vv^^aVH

w^^^^^^j^'f^^iifWi /^^VMW/MW'j^Jp ^i^n''^f\il^^A/f'\'^■' ^vVV-^j^-^w-VvvV

tW^K'|VKY^'*>v.wM\(rt \^J/\^}ji,^tjf^!i{%4i^^^^ ^Wha.^^Vw^ntw yyAvW^vv^-AA/v

^W fV^^M^H^'^W^ VI/AaAA^'^^vWVA W'AfMjV^^

FF yi

DMT

Fig. 5. Effects of intraperitoneal injections of LH and FSH on the EEG. Abbreviations
(cf. Fig. 3): OLF.B, olfactory bulb; SMA, supramammillary area; NACC, nucleus
accumbens; FF, fimbria of fornix; DTM, nucleus dorsomedialis thalami. From Kawakami

and Sawyer (37).

reported extensively by Faure (40, 41). His olfacto-bucco-ano-genito-sexual
syndrome has certain phases similar, if not identical, to stages in the EEG
afterreaction sequence.

THRESHOLDS OF EEG AROUSAL AND EEG AFTERREACTION

It was soon discovered that the EEG afterreaction could readily be evoked
in the estrous, but not in the anestrous, rabbit by low frequency (5/sec)
electrical stimulation of the hypothalamus or rhinencephalon (37). The
afterreaction often occurred too quickly to have been mediated by the release

86 Charles H. Sawyer and M. Kawakami

and feed-back of pituitary hormones and it must have been induced by more
direct means. In Fig. 6, B the sleep spindles appeared within 30 sec of
stimulating the septum for 30 sec at 5/sec, pulse duration 0.5 milliscc; the
phase of hippocampal hyperactivity started within one minute. The threshold

A. EEG AROUSAL

, Ret. F. 500/sec ^

B. EEG AFTERREAGTION "^^

BEFORE STIM. SP 30 SEC. I MIN.

Lc</,s»^wvtMv.l'Kf.VfW\v/,^^^^^^^^^^^^ 4MWM'''4<'V'<«W^^^^ kmmfm>:iiMV:mii<ikitmz i

SP v,y^H^v,^wjfAw^fMw«^'^ {i<MM^f^WMi¥fi\i' w«ww4'^t*Wtff^i^>'*yw^ l

MM v-w«vJMH-4<*V\UH'M;Wi4*i'M'J*i» ^t^l'^\^'f>*rt^tMi^'M'^^fi'>^W^A-\''* \ViMJJK'f^MlW^*f,'flW^<v#|Vy,rvW^^^^^ )
RET j^uvv(,*»aW.Wavv,Vm*^M\''*>Wv\'*a^'''^ k'/*^Vi'>V'^%M7'*>vMW/AllH'M'* 'illW(frt•'1^'^VW«♦^'^«»«^*■W*^^^^^^^^ 1

IOO>iV
I SEC

Fig. 6. EEG records of arousal (A) and afterreactions (B). Abbreviations: cf. Fig. 3.

Explanation in text.

is defined as the lowest voltage which will induce a complete EEG after-
reaction within 30 min of a single 30-sec period of 5/sec stimulation. If a
positive response occurs in considerably less than 30 min it is considered
appropriate to test a lower voltage without waiting for the full half-hour to
elapse.

A completely different phenomenon is the EEG arousal response (Fig. 6,
A). Here a short, five-second burst of high frequency (300/sec) stimulation
applied to the midbrain reticular formation or related areas will, if above
threshold, cause a desynchronization of the frontal cortex EEG pattern and
a theta synchrony in the limbic cortex. If far above threshold, the response
will outlast the stimulus, and behavioral arousal may occur: the rabbit may
sit up or stand and look alert.

The "alert" theta rhythm of the limbic cortex, hippocampus and other
areas is of lower frequency (4-6/sec) than the afterreaction phase of hippo-
campal hyperactivity (7-9/sec). During the latter phase the rabbit is so

Interactions between the Central Nervous System and Hormones 87

depressed behaviorally that the threshold of EEG and behavioral arousal
is elevated even higher than during sleep.

With the techniques of measuring the two thresholds available for register-
ing indices of the functional state of the brain, the effects of sex steroids on
these thresholds were assessed and correlated with their known effects on
behavior and on pituitary activation.

EFFECTS OF PROGESTERONE

Some years ago at Duke University, in work only recently published in
detail (42), it was discovered that progesterone in the estrous or estrogen-
treated rabbit exerts a diphasic effect on the threshold of pituitary activation.
During the first few hours after injection of progesterone (2 mg s.c, in oil)
the threshold is lowered, as evidenced by the finding that the ovulatory
sequence can be initiated by vaginal stimulation, a method which is practically
ineffective in the absence of progesterone. By 24 hr after progesterone
treatment, however, the pituitary activation threshold is highly elevated : not
only is vaginal stimulation ineffective but so is the coital stimulus itself,
provided the rabbit will mate. Behaviorally during this latter period the
rabbit is distinctly less estrous whereas during the first few hours after
progesterone she seems to be "hotter" than when only estrogen is supplied.
Thus there appears to be a diphasic effect of progesterone both on estrous
behavior and on pituitary activation, the second or inhibitory phase of
which is much better known than the earlier phase of facilitation.

The curve in Fig. 7 shows the diphasic effect of an injection of progesterone
on the EEG arousal threshold and the continued elevation of the threshold
following a second injection of the steroid 24 hr after the first (43). This
curve is paralleled by the changes in EEG afterreaction threshold tabulated
at the bottom. During the period of lowered thresholds, the rabbit attacked
another female, mated with a male and revealed EEG afterreactions to
coitus and to vaginal stimulation as well as to the electrical stimulation
employed to assess the afterreaction threshold. As the threshold rose the
rabbit became anestrous and EEG afterreaction became difficult or impossible
to achieve even with electrical stimulation of the hypothalamus.

Figure 8 shows not only the two threshold curves during the first 10 hr
after a single injection of progesterone to an ovariectomized estrogen-primed
rabbit but also depicts the duration of the phases of the EEG afterreactions.
Both thresholds remained depressed from one and one-half to four and
one-half hours after the steroid injection. It is apparent that the rabbit,
although estrogen-primed, was anestrous prior to, and later than six hours
after progesterone treatment, but that during the period of lowered thresholds
she mated and revealed the EEG afterreaction to coitus and to vaginal
stimulation. During this stage the sleep spindles of the EEG afterreaction
started immediately on electrical stimulation and once post-coitally.

Charles H. Sawyer and M. Kawakami

-//-

ESTROGEN-PRIMED
OVARIECTOMIZEO
I 1999

BEHAVIOR ATTACKED ?^
MATED WITH .^ --
EEG AFTERREACTION ^
COITUS
VAGINAL STIM
THRESHOLD
(STIM. VMH SEC)

8
TIME

Q 24 28
HOURS AFTER

46 SO 54 66

FIRST PROGESTERONE

0 5V,0.IV,0.IV -, 15V
0.25V 0025V 0 5V

Fig. 7. Diphasic effect of progesterone on thresholds of EEG arousal (curve) and EEG

afterreaction (tabulated below), and prolonged elevation of thresholds following second

injection of progesterone. From Kawakami and Sawyer (43).

OVARIECTOMIZEO ESTROGEN-PRIMED?

• EEG AROUSAL

* EEG AFTERREACTION
A NO AFTERREACTION

■A A.

»^

•^./"

-a 4-T »

3 4 5

HOURS AFTER

6 7 8

PROGESTERONE

< •- >

I HIPP.
HYPERACT.

□ SPINDLE
BURSTS

V C E VC E EC

V-VAGINAL STIM., C-COITUS. E

E V E CEV

■ELECTRIC STIM.

ICOITUS
iREFUSEO

Fig. 8. Thresholds and EEG afterreaction data during the first 10 hr after progesterone
treatment of an ovariecloniizcd estrogen-primed rabbit. Open triangles represent
unsuccessful attempts to elicit the EEG afterreaction. From Kawakami and Sawyer (43).

Interactions between the Central Nervous System and Hormones 89

EFFECTS OF ESTROGEN, LOW DOSAGE

In the progesterone experiments described above tiic ovariectomized
rabbits were primed for two days witii estradiol bcnzoate (0.08-0.1 mg s.c,
in oil) daily. This treatment usually neither lowered the thresholds appreciably
nor brought the rabbits into heat. However, in the intact ancstrous rabbit,
possibly through synergism with endogenous progesterone, treatment with
exogenous estrogen often lowered both thresholds. An example of this is

4 \ TO 4 V.

• EEG AROUSAL

4 EEG AFTERREACTION

4 NO AFTERREACTION

- 025 o S

HOURS AFTER PROGESTERONE

I I LATENCY

E V C V C E EVC V CEVE C V

-ELECTRIC STIM, V-VAGINAL STIM., C-COITUS

Fig. 9. Thresholds and EEG afterreaction data following estrogen and subsequently
progesterone treatment of an intact (non-castrate) female rabbit. From Kawakami and

Sawyer (43).

seen in Fig. 9. On the day after the first injection of estrogen, the still
anestrous rabbit reveals a lowered EEG afterreaction threshold to electrical
stimulation. On the day following the second estrogen injection the EEG
afterreaction threshold is depressed still further and the arousal threshold
somewhat lowered. At this time, prior to treatment with progesterone,
the now estrous rabbit copulates and reveals an EEG afterreaction which
is not, however, fully evocable by vaginal stimulation. Progesterone lowers
the thresholds still further and during the next few hours even vaginal
stimulation induces the EEG afterreaction. Between six and eight hours after
progesterone administration the afterreaction threshold rises sharply while
the arousal threshold slopes upward gradually.

Treatment of estrous rabbits with exogenous estrogen for two days or
anestrous rabbits for four days lowered the threshold of pituitary activation
to such an extent that ovulation could be induced in 40-50 % of the cases by

Charles H. Sawyer and M. Kawakami

vaginal stimulation (31). When apparently estrous rabbits were treated for
four days with estrogen, an appreciable number of them ovulated "spon-
taneously" during the winter and spring months but not during the summer
(44) (Fig. 10). In a limited number of rabbits with chronically implanted
electrodes, the EEG afterreaction and arousal thresholds, and the effects of

Ci 10-

Months

Total No.
Rabbits

Jan.
Feb.

Mar.
Apr.

May

June

Oct.

Nov.
Dec.

Fig. 10. Relalive incidence of estrogen-facilitated spontaneous ovulation in the rabbit
during various seasons of the year. From Sawyer (44).

steroids upon them, were assessed throughout the year (43). The most
dramatic difference between February and June thresholds lay in the very low
values of EEG afterreaction threshold in late February; even after pro-
gesterone the higher June threshold did not come down to the pre-progesterone
value in February. In some of these experiments coitus in June was not
followed by an afterreaction.

EFFECTS OF HIGH DOSAGES OF
ESTROGEN OR TESTOSTERONE

In experiments such as those illustrated above in which progesterone and
low dosages of estrogen were tested, the EEG arousal and afterreaction
thresholds generally changed in a quite parallel manner. Under conditions
in which both thresholds were minimal the pituitary activation threshold
was also lowest and the rabbit was in heat; the elevation of both thresholds
was correlated with anestrus and an elevated pituitary threshold.

It is possible with high dosages of estrogen or testosterone to separate
the two thresholds in a given animal and to study the resultant changes in
behavior and pituitary threshold. Five daily injections of 0.5 mg estradiol

Interactions between the Central Nervous System and Hormones

benzoate or 5 mg testosterone propionate (Fig. 11) result in lowered EEG
arousal thresholds and elevated EEG afterreaction thresholds. At the end of
treatment with either steroid, the rabbits are highly estrous but copulation
is not followed by ovulation. The latter condition may be described as an
elevated pituitary activation threshold; this may be correlated with the

100%

12 3 12 3

EFFECT ON EFFECT ON EEG

EEG AROUSAL AFTERREACTION

THRESHOLD THRESHOLD

0.5 MG ESTRADIOL BENZOATE
DAILY FOR 5 DAYS

4 5 6 4 5 6

EFFECT ON EFFECT ON EEG

EEG AROUSAL AFTERREACTION

THRESHOLD THRESHOLD

5 MG TESTOSTERONE PROPIONATE
DAILY FOR 5 DAYS

Fig. 1 1 . Relative thresholds (expressed as percentages of pretreatment levels considered
to be 100%) of EEG arousal and EEG afterreaction after prolonged treatment with high
dosages of estrogen and treatment with androgen. The numbers (1-6) under the bars

identify individual rabbits.

elevated afterreaction threshold while continued estrus may be correlated
with the lowered EEG arousal threshold. Zondek and Sklow (45) noted the
inhibitory effect of high dosages of estrogen and testosterone on electrically
stimulated ovulation in the rabbit.

EFFECTS OF CERTAIN PITUITARY
AND PLACENTAL HORMONES

As was mentioned earlier, treatment with certain pituitary or placental
gonadotropins, lactogen and neurohypophysial hormones was often followed
by the appearance of a "spontaneous" EEG afterreaction. It was proposed
that the response might represent a natural feed-back mechanism to shut off
further neural activation of the hypophysis. It was, therefore, of interest to
study the effects of these agents on the two thresholds.

Figure 12 illustrates a representative response to these substances. Exerting
little effect on the EEG arousal threshold, the gonadotropin caused a rapid

Charles H. Sawyer and M. Kawakami

lowering of the EEG afterreaction threshold to the point at which a
"spontaneous" afterreaction occurred. For some hours thereafter the
threshold remained at relatively low levels but ordinarily only one spontaneous
afterreaction followed such an injection. In this particular case (Fig. 12)
the rabbit had been pretreatcd with estrogen and a temporary condition of

VOLTS

a iG

CO 15

2 3 4 5 6 7

TIME IN HOURS AFTER HCG

[ HIPP.
HYPERACT.

VCESV ECV EVC ECV

V-VAGINAL STIM.,C-COITUS, E-ELECTRIC STIM., S-SPONTANEGUS

rr: SPINDLE
LiJ BURSTS

I [latency

\—i COITUS
L-J REFUSED

Fig. 12. Effect of human chorionic gonadotropin (HCG) on EEG thresholds in the
estrogen-primed ovariectomized rabbit. In the unprimed castrate rabbit HCG still depresses
the EEG afterreaction threshold but the occurrence of estrus and the slight depression in
arousal threshold seen here do not occur in the absence of exogenous estrogen. From

Kawakami and Sawyer (43).

estrus followed HCG treatment, although the arousal threshold was only
slightly depressed. In the absence of estrogen neither estrus nor any effect on
the arousal threshold was usually seen, although the EEG afterreaction
threshold was reduced to the level at which a spontaneous response occurred.
The results support the concept of a close relationship between the EEG
afterreaction threshold and pituitary activation and indicate that the influence
of these hormones on the nervous system, as well as that of the steroids,
is one of altering thresholds rather than acting as stimulants per se.

EFFECTS OF THE NEW PROGESTOGENS

Some of the newer progestational compounds have been reported to have
very prolonged actions (46) and to be strongly inhibitory to ovulation (47).
Their effects on the two thresholds were naturally of considerable interest.

Interactions between the Central Nervous System and Hormones

The progestational effects of 17a-hydroxyprogesterone caproate (Delalutin)
are particularly long lasting (48). Interestingly enough (Fig. 13) this esterified
steroid exerts a diphasic effect on both EEG afterreaction and arousal
thresholds and both phases are very much prolonged. By way of contrast
the effect on the EEG afterreaction threshold of a single injection of 25 mg

1.5

'0.5-

k EEG AFTERREACTION

FOLLOWING 25 MG PROGESTERONE

>6.5V >65V

D.-.0

EEG AROUSAL D AND
EEG AFTERREACTION ■
FOLLOWING 25 MG OF
DELALUTIN

8 16 24 32 40 48

TIME IN HOURS AFTER STEROID

Fig. 13. Prolonged diphasic effect on EEG thresholds of treating an estrogen-primed
ovariectomized rabbit with a single injection of 1 7a-hydroxyprogesterone caproate
(Delalutin). The figures (5.25 V, >6.5 V) at the upper right refer to oif-limits values of EEG
afterreaction thresholds. The time course of changes in EEG afterreaction threshold
following a similar dosage of progesterone is included for comparison.

progesterone is included in Fig. 13. Its phase of elevated threshold is termi-
nated long before the completion of the first phase (lowered threshold)
following Delalutin. In keeping with the functional concepts relative to these
phases expressed above, during the Delalutin-prolonged first phase the rabbit
will mate and ovulate; whereas she remains in an anestrous anovulatory
condition during the phase of elevated thresholds.

Of the 19-nor steroid gestagens which have proven such potent inhibitors
of ovulation as to receive extended clinical trial as contraceptives, the
following have been tested for their effects on the two EEG thresholds:
1 7a - ethynyl - 1 9 - nortestosterone (Norlutin), 1 la - ethyl - 1 9 - nortestosterone
(Nilevar) and Ha-ethynyl, A^'^°'-estrenolone (norethynodrel, which with
added estrogen is known as Enovid). All of these agents affected the two
thresholds in the differential manner illustrated in Fig. 14, prepared from
norethynodrel data: they left the EEG arousal threshold essentially un-
changed but rapidly raised the EEG afterreaction threshold. In confirmation
of Pincus et ah (49) we found that the rabbits would readily mate 24 hr after

Charles H. Sawyer and M. Kawakami

the injection of 1 mg of any of these steroids but that such copulation was
not followed by ovulation. Their differential elevation of the particular EEG
threshold which we have come to associate with the threshold of pituitary
activation, while leaving estrous behavior and its associated EEG threshold
unaffected, makes these gestagens ideal antifertility agents, at least for the

5 p

O D-f-O-U

■3 z

<
■2 q: 5

16 24 32

HOURS AFTER

48 56

NORETHYNODREL

Fig. 14. Differential eflFect of norethynodrel on the EEG afterreaction and EEG arousal
thresholds. Norlutin and Nilevar exerted similar effects.

rabbit. It is conceivable that the record of effects of new steroids on the two
EEG thresholds in the rabbit might prove a useful index in screening anti-
fertility agents.

DISCUSSION

The results of the present experiments, as well as those in which injections
of hormones directly into the brain influenced behavior (11, 12, 13), leave
little doubt that hormones can act directly on elements within the brain.
Ralph and Fraps (50), for example, have reported that the intrahypothalamic
injection of tiny amounts of progesterone will induce premature ovulation
in the hen.

It may be that the hormone receptors within the brain, the areas most
sensitive to the endocrine agents, are identical to the hypothalamic "centers"
whose destruction eliminates behavioral or gonadotropic function. It should
be possible, under this hypothesis, to activate the "centers" individually by
localized hormone injections, and such appears to be the case (12, 13). With
systemic treatment with effective dosages of estrogen and progesterone the
two systems, behavioral and gonadotropic, are associated with EEG thresholds
that change in a remarkably parallel manner. Such parallel changes coordinate

Interactions between the Central Nervous System and Hormones 95

coital behavior witii a responsive pituitary-gonad axis. Gonadotropins,
testosterone, the 19-nor gestagens and high dosages of estrogen affect the
thresholds, and perhaps the receptors, differentially, thus permitting estrous
behavior without ovulation and ovulation without estrous behavior.

It would appear that both the facilitory and the inhibitory influences of
the sex steroids on the adenohypophysis are attributable to, or mediated by,
their actions on the nervous system. There may be multiple receptors within
the brain which are influenced in a coordinated manner by endogenous
hormones or systemically administered exogenous hormones. Bodily needs,
according to Dell (51), demand a nonspecific excitatory state for appetitive
behavior; this condition is induced by the effects of elements in the internal
environment on the brainstem reticular system. Consummatory behavior
then produces changes which depress the generalized reticular activity and
vigilance. The present results are consistent with this scheme, and they point
to sex steroids as crucial elements of the internal environment responsible
for the vigilant appetitive phase. Consummatory depression of the arousal
system is effected by, or coordinated with, unusual activation of a rhin-
encephalic-hypothalamic circuit, probably involving actions of pituitary
hormones on the nervous system.

SUMMARY
The hormonal feed-back circuit in the rabbit by which ovarian steroids
alter pituitary susceptibility for ovulation and coordinate this condition with
the estrous state has been shown to include the action of the steroids on two
thresholds of activity in the brain. The EEG arousal threshold appears to be
concerned with estrous behavior while the EEG afterreaction threshold
parallels the threshold of pituitary activation. The natural EEG afterreaction,
which is a common sequel to coitus in the rabbit, seems to represent an effect
of the released pituitary hormones on the nervous system, perhaps in the
nature of a negative feed-back to stop further release of gonadotropin.
Certain steroids appear to be excellent antifertility agents by virtue of a
differential elevation of the EEG afterreaction threshold and the absence
of an effect on the EEG arousal threshold. The results are consistent with
the concept that hypothalamic "centers" controlling sex behavior and
gonadotropic secretion may represent important neuroendocrine receptors
of hormonal influence on brain function.

Acknowledgments — The authors wish to thank the Schering Corporation
for the estradiol benzoate (Progynon B), Dr. J. D. Fisher of Armour
Pharmaceutical Corporation for the pituitary hormones. Dr. E. C. Reifenstein
of E. R. Squibb and Sons for Delalutin, Dr. D. A. McGinty of Parke, Davis
and Co. for Norlutin and Dr. F. J. Saunders of G. D. Searle and Co. for
norethynodrel and Nilevar employed in the experiments. The figures were
drawn by Charles Bridgman and photographed by Timothy Dodge.

96 Charles H. Sawyer and M. Kawakami

REFERENCES

1. Haighton, J., Phil. Trans. Roy. Soc. 87, 159, 1797.

2. Heape, W., Proc. Roy. Soc. B 16, 260, 1905.

3. Smith, P. E. and E. T. Engle, Amer. J. Anat. 40, 159, 1927.

4. Benoit, J. and 1. Assenmacher, J. Physiol. (Paris) 47, 427, 1955.

5. Allen, E., Se.x ami Internal Secretions, Williams and Wilkins, Baltimore, Md., 1932.

6. Moore, C. R. and D. Price, Amer. J. Anat. 50, 13, 1932.

7. HoHLWEG, W. and K. Junkmann, Klin. Wochschr. 11, 321, 1932.

8. Flerk6, B. and J. Szentagothai, Acta Endocrinol. 26, 121, 1957.

9. Beach, F. A., Hormones and Behavior, Hoeber, New York, 1948.

10. Saw"^ er, C. H., in Handbook of Physiology: Neurophysiology (Edited by H. W. Magoun,

J. Field and V. E. Hall), p. 1235, American Physiological Society, Washington,
D.C., 1960.

11. Kent, G. C. and M. J. Liberman, Endocrinology 45, 29, 1949.

12. Fisher, A. E., Science 124, 228, 1956.

13. Harris, G. W., R. P. Michael and P. P. Scott, in Ciba Foundation Symposium on

Neurological Basis of Behavior, p. 236, J. and A. Churchill, Ltd., London, 1958.

14. Harris, G. W., Proc. Roy. Soc. B 122, 374, 1937.

15. Haterius, H. O. and A. J. Derbyshire, Amer. J. Physiol. 119, 329, 1937.

16. Saul, G. D. and C. H. Sawyer, Federation Proc. 16, 112, 1957.

17. Sawyer, C. H., in conference on Endocrinology of Reproduction (Edited by C. W.

Lloyd), p. 1, Academic Press, New York, 1959.

18. Sawyer, C. H., in Physiological Triggers (Edited by T. H. Bullock), p. 164, American

Physiological Society, Washington, D.C., 1957.

19. Sawyer, C.H.,J. Exper. Zool. 142, 227, 1959.

20. RoBisoN, B. L. and C. H. Sawyer, Physiologist 1, 72, 1957.

21. Papez, J. W., A.M.A. Arch. Neurol. Psychiat. 38, 725, 1937.

22. Adey, W. R., in The Reticular Formation of the Brain (Edited by H. H. Jasper, L. D.

Proctor, R. S. Knighton, W. C. Noshay and R. T. Costello), p. 621, Little, Brown,
Boston, Mass., 1958.

23. KoiKEGAMi, H., T. Yamada and K. Usui, Folia Psychiat. Neurol. Japan 8, 7, 1954.

24. Sawyer, C. H., Amer. J. Physiol. 180, 37, 1955.

25. Schreiner, L. and A. Kling, J. Neurophysiol. 16, 643, 1953.

26. Green, J. D., C. D. Clemente and J. DeGroot, J. Comp. Neurol. 108, 505, 1957.

27. Magoun, H. W., A. Res. Nerv. & Ment. Dis. Proc. 30, 480, 1952.

28. Sawyer, C. H., B. V. Critchlow and C. A. Barraclough, Endocrinology 57, 345,

1955.

29. Sawyer, C. H., in The Reticular Formation of the Brain (Edited by H. H. Jasper,

L. D. Proctor, R. S. Knighton, W. C. Noshay and R. T. Costello), p. 223, Little,
Brown, Boston, Mass., 1958.

30. Critchlow, B. V., Endocrinology 63, 596, 1958.

31. Sawyer, C. H. and J. E. Markee, Endocrinology 65, 614, 1959.

32. Sawyer, C. H. and M. Kawakami, Endocrinology 65, 622, 1959.

33. Sawyer, C. H., J. E. Markee and B. F. Townsend, Endocrinology 44, 18, 1949.

34. Fee, A. R. and A. S. Parkes, /. Physiol., London 67, 383, 1929.

35. Smith, P. E. and W. E. White, J. Amer. Med. Assn. 97, 1861, 1931.

36. Westman, a. and D. Jacobsohn, Acta obst. gynec. Scandinav. 16, 483, 1936.

37. Kawakami, M. and C. H. Sawyer, Endocrinology 65, 631, 1959.

38. Hess, W. R., Das Zwischenhim, Basel, 1949.

39. Hunter, J. and H. H. Jasper, EEG Clin. Neurophysiol. 1, 305, 1949.

40. Faure, J., Rev. Path. Gen. et Physiol. Clin. 57, 1029, 1263, 1445, 1957.

41. Faure, J., J. Physiol. Paris 48, 529, 1959.

42. Sawyer, C. H. and J. W. Everett, Endocrinology 65, 644, 1959.

43. Kawakami, M. and C. H. Sawyer, Endocrinology 65, 652, 1959.

44. Sawyer, C. H., Endocrinology 65, 523, 1959.

45. Zondek, B. and J. Sklow, Endocrinology 28, 923, 1941.

46. Junkmann, K., Recent Prog. Hormone Research 13, 389, 1957.

Interactions between the Central Nervous System and Hormones 97

47. PiNcus, G., J. Rock, M. C. Chang and C. R. Garcia, Federation Proc. 18, 1051, 1959.

48. Kessler, W. B. and A. Borman, Ann. New York Acad. Sci. 71, 486, 1958.

49. PiNcus, G., M. C. Ckang, M. X. Zarrow, E. S. E. Hafez and A. Merrill,

Endocrinology 59, 695, 1956.

50. Ralph, C. L. and R. M. Praps, Endocrinology 66, 269, 1960.

51. Dell, P. C., in Ciba Foundation Symposium on Neurological Basis of Behavior, p. 187,

J. and A. Churchill, London, 1958.

DISCUSSION

Chairman: Dr. Warren O. Nelson

Dr. William Hansel: Among the previous speakers, Harris in particular has pointed out
the importance of the hypothalamus in regulating the secretion of the gonadotropins
necessary for follicular growth and ovulation. Sawyer has described a typical electro-
encephalographic (EEG) arousal pattern, which occurs after stimulation of the
mid-brain reticular formation and an EEG afterreaction which occurs following
stimulation of hypothalamic and rhinencephalic loci in rabbits. A lowered arousal
threshold was correlated with the induction of estrous behavior; a lowered after-
reaction threshold appeared to be related to the release of pituitary ovulating hormone.
Everett has shown that stimulation of the preoptic area consistently induces ovulation
in rats given appropriately-timed injections of the ovulation-blocking drugs atropine
and pentobarbital.

These results inevitably raise two major questions. The first of these concerns the
nature of whatever humoral substances act between the hypothalamus and the adeno-
hypophysis. The second concerns the afferent pathways, particularly those from the
uterus, normally involved in activating those elements of the central nervous system
which affect the neurohumoral regulation of the anterior pituitary.

The results of some of our recent studies on ovulation in the bovine are of particular
interest in regard to both of these questions. Impressed with the possibility that
oxytocin of hypothalamic origin might be involved in some way in the regulation of
the secretion of anterior pituitary gonadotropins. Hansel et al. (Proc. Ilird Symposium
on Reproduction and Infertility (Ed. Gassner), Pergamon Press, 1958) tested the effects
of injecting this hormone at the beginning of estrus on ovulation time in heifers.
Ovulation in the bovine normally occurs about 12 hr after the end of an 18-hr estrous or
"heat" period. In the oxytocin-treated heifers, the average time of ovulation was
hastened by 5 hr, a result which might have been predicted on the basis of the recent
finding by Sawyer and Kawakami that this hormone lowers the EEG afterreaction
threshold, which appears to be related to the release of pituitary ovulating hormone.

Armstrong and Hansel {J. Dairy Sc. 42, 533-542, 1959) later studied the effects of
daily doses of oxytocin given at various times during the estrous cycle on ovarian
function and cycle length in heifers. It soon became apparent that oxytocin administered
on days 1 to 7 or 3 to 6 inclusive of the normal 22-day estrous cycle inhibited the
development of the corpus luteum and produced a precocious estrus by the 8th- 10th
day of the cycle.

These results provided the first direct evidence for an effect of a neurohypophysial
hormone on estrous cycle regulation and ovarian function in any species and, further,
suggested that the administered oxytocin inhibited the production or release of
luteotropin. However, in a subsequent experiment, oxytocin produced precocious
estrus even when given concurrently with a prolactin preparation of bovine origin.

More recent results (/. Dairy Sc, I960 (In press) have served to emphasize the
fundamental role played by the uterus in regulating cycle length and ovarian
functions in the bovine. As in several other species, corpora lutea persist and estrous
cycles do not occur in cattle after hysterectomy. Oxytocin injections proved incapable
of inducing estrus in hysterectomized heifers.

This result led to studies of the effects of uterine dilatation and irritation on ovarian
function and cycle length. Dilatation of the uterus by self-retaining rubber catheters,
held in the uterus during the first 7 days of the cycle by small inflatable balloons,
caused shortened estrous cycles, often 8 to 12 days in length, in a large proportion
of the treated cows and heifers. In a similar experiment it was found that the infusion

Discussion 99

of 2 to 5 ml of raw semen, or the sediment obtained by centrifuging raw semen and
preputial fluids containing large numbers of bacteria, into the uteri of heifers during
estrus also induced precocious heat.

All of these treatments involving uterine insults also resulted in marked inhibition
of the development of the corpus luteum. In some cases cystic corpora lutea resulted ;
in others the corpora lutea were simply quite small. Relatively few normal functional
luteal cells were present in either case.

The physiological role which oxytocin plays in the regulation of the estrous cycle in
cattle has not yet been established. It is conceivable that oxytocin injections, uterine
dilatation, and the infusion of materials containing large numbers of bacteria into the
uterus all cause luteal inhibition and precocious estrus by interfering with the normal
production of some luteotropic substance by the bovine endometrium during the
first half of the estrous cycle. Experiments now being carried out in which bovine
endometrial extracts are injected into normal and pseudopregnant rats should provide
an answer to this question.

Uterine stimulation in the bovine causes oxytocin release (Hays, R. L. and N. L. Van
Demark, Endocrinology 52, 634-637, 1953) and it is tempting to assume that the
uterine dilatation and irritatioii in these experiments caused oxytocin release, which
in turn inhibited luteotropin secretion either directly, or indirectly by influencing the
hypothalamic release of some other neurohumor. The failure of oxytocin to induce
estrus in hysterectomized heifers argues against such an interpretation, but this
subject needs further study since the ovarian changes in these animals were not carefully
followed and since it has also been found that multiple ovulations can occur in the
ovaries of gonadotropin-treated, hysterectomized heifers in the absence of estrus.

Although these experiments indicate that oxytocin injections inhibit luteotropin
secretion in the bovine, there are indications that exogenous oxytocin has the opposite
effect in the rat (Benson, C. K. and S. J. FoUey, J. Endocrinol. 16, 189, 1957; and
Desclin, L., Ann. Endocrinol. 17, 586, 1956). In some preliminary experiments (un-
published) we have produced deciduomata in 4 of 8 oxytocin-treated rats by passing
threads through their uteri 6 days after estrus and stimulation of the cervix, as compared
to 0 of 6 rats treated in the same way but given no oxytocin injections. These results
again suggest a luteotropic response to injected oxytocin in the rat.

Although it has not been possible to produce ovulation in the rabbit by oxytocin
injections or by continuous infusion of oxytocin into the carotid artery over a period
of 2 hours, there are some indications of increased gonadotropin secretion in the
rabbit as a result of oxytocin injections. Armstrong and Hansel {Internal. J. Fertil. 3,
296-306, 1958) have reported increased testis weights and seminiferous tubule
diameters, and increased interstitial cell development in immature rabbits injected
daily with oxytocin for 11 weeks. Martini et al. {J. Endocrinol. 18, 245, 1959) have
reported an increased urinary gonadotropin excretion in rabbits injected with oxytocin-
containing preparations. Preliminary results indicate that oxytocin injections have
no effect on estrous cycle length in normal ewes and guinea-pigs.

One of the most perplexing problems related to this subject has been the apparent
lack of specific and repeatable effects of the various ovulation-blocking drugs. This
has perhaps been more obvious in our work with cattle than it has been in experiments
with other species. Atropine given at the beginning of estrus blocks ovulation in about
75% of the treated animals, but the blockage is temporary and ovulation usually
does occur a few days later and in the absence of a second estrus. Concurrent injections
of atropine or reserpine reduce the percentage of heifers that respond to daily oxytocin
injections by a precocious estrus, but some heifers do have shortened cycles. Results
such as these have been difficult to inteipret, and may even suggest that the blocking
drugs accomplish their effects in some non-specific manner such as by reducing
blood flow through the portal vessels. Worthington {Endocrinology 66, 19-31, 1960)
has recently reported a reduced blood flow in the portal vessels in the mouse after
injections of certain blocking drugs.

The reports of Sawyer and Kawakami are of particular importance in that they
provide for the first time a common physiological effect of all the blocking drugs

100 Discussion

and steroids, i.e. they all elevate the EEC afterreaction threshold. These findings
fit many of the known facts and can be used to explain many of our most puzzling
experimental results. They are particularly impressive, for example, when applied to
our results of experiments on the efTccts of progesterone on ovulation in the bovine.
Small doses of progesterone injected within 2 hours after the beginning of estrus
hasten ovulation, presumably by lowering the threshold for the release of pituitary
ovulating hormone, so that this event occurs at an earlier than normal time. On the
other hand, daily injections of larger amounts of progesterone from the 15th day of
the cycle onward delay both estrus and ovulation until 4 to 5 days after cessation of
the injections, presumably by maintaining elevated arousal and afterreaction
thresholds.

Evidence has been accumulating to suggest that the neurohumors involved in
anterior pituitary gonadotropin secretion are of hypothalamic origin, and that the
blocking drugs exert their eflfects at more remote sites in the central nervous system.
Perhaps the best of this evidence is Everett's demonstration of ovulation in the
atropinized rat in response to electrical stimulation of the preoptic region. These
results all suggest that the next major advance in our knowledge of the mechanism
of ovulation is very likely to come about as a result of preparing hypothalamic extracts
and injecting these into suitably prepared experimental animals, as Harris has already
suggested.

^\(^At

THE PREOPTIC REGION OF THE BRAIN AND
ITS RELATION TO OVULATION*

John W. Everett

Nearly thirty years ago Hohlweg and Junkmann (23) postulated the
existence of a sex center in the hypothalamus. Today there is no doubt that
many of the sexual, as well as non-sexual, functions of the adenohypophysis
are under control of the central nervous system through the mediation of
the hypothalamus and the special neurovascular linkage afforded by the
hypophysial portal veins. Theory has moved on and now one postulates
multiple mechanisms separately controlling diverse aspects of adenohypophy-
sial function. One may question whether anatomically discrete "centers" exist;
there is good reason to think that elements of several mechanisms may be
anatomically interwoven and that each may involve an interplay among
several parts of the brain.

We are concerned here with only one of these mechanisms and with only
one basic method of experimental study, electrical stimulation of the brain.
No attempt will be made to review in detail the historical background for
the induction of ovulation by this means. It is only necessary to call to mind
a series of studies by naming the investigators : Marshall and Verney (28) ;
Haterius and Derbyshire (21); Harris (19,20); Markee, Sawyer and
Hollinshead (27); Kurotzu, Kurachi and Ban (26). Whereas these several
investigations were carried out in the rabbit, a species that ovulates "reflexly",
more recent studies have shown that ovulation can be induced by similar
means in the rat, an animal that normally ovulates spontaneously. The first
published record is the abstract of a paper by Critchlow (6), noting that
proestrous cycling rats, in which the spontaneous ovulation was prevented by
the administration of pentobarbital, could be induced to ovulate by electrical
stimulation of the hypothalamus with electrodes resting close above the
median eminence. This work was reported in full in 1958 (7). Meanwhile,
Bunn and Everett (4) had been successful in inducing ovulation by stimula-
tion of the amygdaloid complex in rats that had been made constant-estrous
by continuous illumination.

The experiments that will be reported here are directly based on Critchlow's
work, which in turn was based on the work of Everett and Sawyer (13). These

* These investigations were partially supported by grants from the National Science
Foundation (G4431 and G9841).

101

102 John W. Everett

workers had demonstrated that pentobarbital sedation of the cycling rat
during a certain "critical period" on the day of proestrus will predictably
block the expected ovulation for a 24-hr period. In rats that have been sub-
jected to controlled illumination of 14 hr daily the critical period extends
from 2.00 p.m. until after 4.00 p.m. It had first been defined by the use of
atropine, a potent and predictable blocking agent for ovulation in both the
rabbit and the rat (15,32,33).

In the summer of 1958 R. L. Riley and J. W. Everett set out to repeat
Critchlow's experiment in a small series of rats, in preparation for attempts
to induce ovulation during pseudopregnancy. We were gradually led into
exploration of more and more rostral regions, eventually finding that the
preoptic area could give more predictable results than had been possible
in the tuberal region. We were briefly joined by Dr. C. D. Christian. During
the summer of 1959 J. R. Harp joined us and undertook a study of thresholds
in the preoptic region.

METHODS

The methods employed can best be described by giving an account of the
standardized procedures that were used in the late phases. Departures from
these standards will be noted whenever they are of significance.

As in previous investigations in this laboratory we employed rats of an
inbred strain derived from Osborne-Mendel stock. The animals were
regularly cycling adult females characteristically in the age range of 5 to 10
months and weighing 200 to 250 g. It is our practice to maintain at all
times a group of 50 to 70 potential experimental subjects, from which vaginal
smears are prepared daily 6 days a week. As animals are removed for
experiments, others are added from time to time. Thus we have at all times
a large control group. In the selection of an experimental subject it is
demanded that she have a vaginal smear history of at least two 4-day cycles
or two 5-day cycles in sequence immediately preceding the cycle in progress
(9). Unless otherwise stated, it will be understood that subjects in proestrus
were 4-day cyclic rats and had just experienced a diestrous interval of 2 days.
Subjects said to be in diestrus day 3, on the other hand, were 5-day cyclic
rats. Inasmuch as spontaneous "pseudopregnancy" occasionally occurs in
this stock, inevitably a few "diestrous" rats turned out to have a leucocytic
vaginal smear on the day after experimental treatment. Data from such
animals are excluded for present purposes. Unless otherwise specified, all
stimulations were confined to the interval between 2.00 and 4.00 p.m. Even
on diestrus day 3 it has been shown that sensitivity to progesterone (as an
ovulation incitor) is maximal during the afternoon hours (12). Predictability
of the hours of the "critical period" is assured by a regime of 14 hr of daily
illumination.

The Preoptic Region of the Brain and its Relation to Ovulation 103

All animals were anesthetized with pentobarbital, 35 mg/kg body wt.,
injected intraperitoneally. In proestrous rats the injection was given at 1.50 to
2.00 p.m. In the diestrous rats, the time of injection was often advanced
to 1.30. Sometimes as many as four rats were operated upon during the
following two hours and, thus, stimulation of the brain was brought about
at necessarily varying intervals after injection of the barbiturate. There
were no indications of variable results because of this.

Fig. 1. Diagrammatic representation of the rat hypothalamus in sagittal section, from a
camera lucida tracing of a hemisected head. A concentric electrode is drawn to scale at
the upper left. Scale markings are in millimeters. The cranial floor and pituitary gland are
shown in broken lines, as are the midline projections of several nuclei. Key: AC — anterior
commissure, ARC — nucleus arcuatus, FX — fornix, MI — massa intermedia, MMB — mam-
millary body, OCh — optic chiasma, ON — optic nerve, PIT — pituitary, PO — preoptic nucleus,
PV — paraventricular nucleus, SC — suprachiasmatic nucleus, VM — ventromedial nucleus.

While the animal was being placed in the stereotaxic apparatus, brief
supplementary anesthesia with ether was administered. This was sufficient
to inhibit reaction to exposure of the skull and drilling.

Electrodes were stainless steel 36 gauge wires, Teflon insulated, in 0.40 mm
stainless steel tubing insulated with FormVar, Each element was bared
at the tip (cf. Fig. 1), and the wire extended slightly beyond the shield
(< 0.5 mm). Dual assemblies were prepared by soldering two of the con-
centric units in parallel to opposite sides of a shaft of steel tubing whose
diameter was appropriate to give the desired spacing of 1.2 to 1.5 mm.

The stimulating current was taken from a Grass S-4C stimulator and
isolation unit with a 200 k^ resistor in each lead and with the electrode core
anodic. For monitoring current an oscilloscope was connected across a low
value resistor in series with one of the leads, and the system was calibrated

104 John W. Everett

with a precision microammetcr and continuous d.c. current. Unless otherwise
stated it will be understood that the stimulus consisted of monophasic,
1-nisec pulses, at a frequency of 100/sec, in 30-sec trains at 30-sec intervals.

On the morning after stimulation the reproductive tracts were removed
under ether anesthesia. The ampullas and adjacent turns of the oviducts
were microscopically explored for ova (9). The ovaries were examined in
physiological saline under the dissecting microscope. When fewer than 7 or 8
ova appeared in the ampullas, special attention was paid to the ovaries for
signs of partial activation. No rigorous histological search was made, however.
The brain was fixed by perfusion of the head with 10"o formalin in saline.
Paraffin sections were cut at 25 micra and these were subsequently stained
by the Luxol fast blue-cresyl fast violet technique.

EXPERIMENTS AND OBSERVATIONS

Exploratory Studies

The early phases of the investigation were reported briefly to the Endocrine
Society (11). These experiments are of interest at the present time largely
because they eventually led us to explore the region between the rostral
margin of the optic chiasma and the anterior commissure. The technique
was at first relatively crude: the electrodes were comparatively coarse and
stimulation parameters were quite different from those described above.
The pulse duration was unnecessarily long (15 msec at 30/sec), as was the
over-all period of stimulation, alternate 30 sec for 30 min. Voltages were
not excessive, ranging from 3 to 5.

There were 29 proestrous rats in which electrode tips rested within 2 mm
above the floor of the diencephalon or preoptic region (Series I). Sixteen
rats ovulated during the following night. In 6 cases the electrodes lay in the
preoptic region and 5 of the 6 ovulated, a fact that was especially interesting
because of the implication from Critchlow's study that the electrodes must
be close to the median eminence to be effective under pentobarbital anesthesia.
Figure 1 shows the preoptic nucleus projected on the mid-sagittal plane of
the rat brain.

Advanced Ovulation in Diestrous Rats

In rats that experience regular 5-day cycles the time of ovulation can be
advanced 24 hr by injection of progesterone on the third day of diestrus (9).
This effect, like spontaneous ovulation, is subject to blockade by atropine and
is presumably mediated through the central nervous system (12). The latter
study demonstrated that during the afternoon of diestrus day 3 there is a
limited period of sensitivity to progesterone approximately 24 hr in advance
of the "critical period" on the day of proestrus. There was thus excellent
reason to expect that electrical stimulation of the hypothalamus in late

The Preoptic Region of the Brain and its Relation to Ovulation 105

diestrus would induce ovulation one day early, especially if the stimulus was
administered during the late afternoon.

With techniques like those in Series I, 25 rats were stimulated on the third
day of diestrus during 5-day cycles (Series II). In fact these two sets of experi-
ments were carried out in parallel. Nine of the 25 rats ovulated during the
night following stimulation and, significantly, among them were all 6 rats
that had been stimulated in the preoptic region. When considered with the
results in the proestrus series, these observations demonstrated that in this
region one can work with a high degree of predictability.

To supplement the preliminary findings of Series II, 9 rats were stimulated
on diestrus day 3 with dual concentric electrodes placed in the preoptic
area (Series III). Parameters of stimulation were modified as follows : pulses
of 1 msec, 100/sec, 30 sec on and off" for 10 min. Voltage dial readings ranged
from 1.5 to 4.0. Series resistors were not employed. Ovulation was induced
in the 5 rats that were stimulated with voltages of 2.8 or more. Negative
results were obtained with 2.5 volts or less.

A normal number of eggs was shed in 8 of the 9 ovulated rats of Series II
and in all 5 of the ovulated rats of Series III. The exceptional animal produced
only one tubal ovum. The ovaries closely resembled those normally found
on the morning after spontaneous ovulation. The uteri were characteristically
contracted in the animals that had shed the full complement of ova, whereas
in the anovulatory specimens distended uteri were the rule. The vaginal
smears of all animals, whether ovulation had occurred or not, were of the
proestrous type. There was no evidence that the release of ovulating hormone
modified the vaginal sequence in any degree.

Comparative Thresholds, Diestrus vs. Proestrus

The next step was to determine, if possible, whether any difference in
threshold to electrical stimulation could be detected between late diestrus
and proestrus. It seemed especially appropriate to compare proestrus in the
4-day cycle with the third day of diestrus in the 5-day cycle. Earlier work
(12, 13) had suggested that in the latter type of animal a physiological block
delays the spontaneous ovulating stimulus to the pituitary 24 hr longer than
in the 4-day cyclic rat.

It was decided to monitor all stimuli for current by use of the oscilloscope.
A further change in circuitry was the introduction of the 200 kQ resistors in
the electrode leads to give a rectangular pattern on the oscilloscope screen.
In the absence of the resistors electrode capacitance creates a wave form
that is difficult to evaluate, with a high initial spike that falls logarithmically
to the end of the pulse and a negative spike after the break.

Two series of experiments were carried out, Series IV-A by James Harp
and Series IV-B by J. W. Everett. The two series will be presented in
parallel.

106

John W. Everett

Stimulus parameters were identical in respect to pulse duration (I msec)
and frequency (lOO/sec). The differences were as follows: In IV-A, the dual
electrode assembly was employed, the stimulus isolation unit was not used,
and the over-all stimulation period was 10 min. In IV-B, the single concentric
electrode and the isolation unit were employed, and stimulation lasted for
only 5 min. In IV-A there were 50 rats, equally divided between diestrus and
proestrus. In IV-B there were 21 rats in groups of 10 and 11, respectively.

Table 1. Results of Preoptic Stimulation Relative to Current and to Stage of the

EsTROus Cycle

Current, ^A

Diestrus*

Proestrus*

A. 100

70-75

+ + +

60-65

+ + + + +00

+ +

+ + + +0000

+ + + + +

+ + +000

+ + + +0

+ +000

+ +0000

B. 70-75

+ +000

00000

++++++

+ +000

* Each + and 0 indicates a rat with or without tubal ova.

Table 1 summarizes the results. The two sets of experiments point to a real
difference between diestrus and proestrus. In IV-A alone there is a consider-
able overlap and comparisons of the 40-50 /xA categories in the two columns
(7/14 vs. 11/12) or of the 50-65 fxA categories (9/15 vs. 10/10) show that in
neither case is the difference between the ratios significant at the 5% level.*
In IV-B, however, the difference between 6/6 and 0/5 in the 50 /nA categories
is significant at 1%*.

Statistics are perhaps less convincing, however, than the fact that the data
from both IV-A and IV-B trend distinctly in the same direction. It seems
especially noteworthy that in IV-B currents of 70-75 /uA were less uniformly
effective in diestrous rats than were currents of 50 p-A in proestrous rats.

Effects of Various Parameters

At this point it is appropriate to discuss the effect of variation of the several
parameters of stimulation (Series V): frequency, pulse duration, current and
total time. The survey is still far from exhaustive and will be extended from
time to time. It has two objectives: (1) to find an effective combination
that produces minimum brain damage, for subsequent use with indwelling

* The estimates of significance were obtained by use of the tables of Mainland and
Murray {Science 116, 591, 1952).

The Preoptic Region of the Brain and its Relation to Ovulation

107

electrodes, and (2) to determine the shortest over-all time of stimulation
that will be predictably effective.

Table 2 lists some of the combinations that were tried. The animals
represented were all 4-day cyclic rats in proestrus, with a single concentric
electrode in the preoptic region. For purposes of later discussion attention
is called to the first three lines of the table, which clearly show that a stimulus
of no longer than 60 sec can be fully effective. The one positive case among

Table 2. Results of Certain Modifications of the Parameters of Stimulation

Pulses

Pulse

Current,

Time

Coulombs

Result*

per sec

duration

xlO-*

msec

100

continuous

9.0

100

90 sec

+ +

100

60 sec

6.0

+ + +

100

15-20 sec

1.5-2.0

+ 000

0.5

on and off

3.75

100

5 min

100

0.5

10 min

7.5

100

0.5

100

10 min

15.0

100

0.25

100

5 min

3.75

100

0.25

200

5 min

7.5

5 min

3.75

+ 0

300

0.3

5 min

6.75

* Each + or 0 indicates a rat with or without tubal ova.

the four in which the stimulus lasted only 15-20 sec was only a partial
ovulation (5 tubal ova). The 60-sec examples constitute clear evidence of a
triggering action.

In addition to the sets of parameters given in the remainder of Table 2
there are those used in Series I and II, a pulse frequency of 30/sec and pulse
duration of 15 msec. Ovulation has thus been evoked, at least in some cases,
by pulse frequencies of 30-300/sec, pulse durations of 0.25-15 msec, currents
as low as 20 /zA and stimulation periods as short as 15 sec. Any statement
about the relative amounts of brain damage associated with the various
combinations of parameters would be premature at this time, inasmuch as
not all of the brains have been examined histologically.

Atropine Experiments

Experiments which pertain to the site of action of atropine as an agent
blocking the release of ovulating hormone (Series VI) were carried out by
J. R. Harp. The 1 1 subjects were 4-day cyclic rats in proestrus. Pentobarbital

108 John W. Everett

in the usual amount was given at 1.30 p.m. and was followed about 15 min
later by a subcutaneous injection of atropine sulfate (350 mg/kg) in physio-
logical saline. Everett and Sawyer (14) had shown that this dosage of atropine
is uniformly effective in blocking spontaneous ovulation. We are indebted
to Dr. C. D. Christian for determining that the combination of pentobarbital
and atropine is non-lethal.

The dual electrode assembly was employed and, again, the site of stimu-
lation was the preoptic region. Stimulus parameters were like those in Series
IV-A. Current varied from 50 to 150 fxA (Table 3).

Table 3. Preoptic Stimulation under the Combined Influence of
Pentobarbital and Atropine

Current, nA

Results*

150

controls

+ + +
+ +0
+ + + +0
0000000

* Each + and 0 indicates a rat with or without tubal ova.

The result was clear cut. All but two of the rats ovulated. Eight other
animals served as controls to show that the ovulations could not have been
the result of mutual counteraction of the drugs. All control animals were
treated with pentobarbital and atropine in the same manner as were the
exp( rimenta subjects ; two of the group were subjected to stimulation (65 /mA),
but 'he electrodes lay outside the intended location.

DISCUSSION

Without question the preoptic region of the rat remains sensitive to
electrical stimulation in spite of pentobarbital anesthesia, and as we have
just seen, in spite of the blocking action of atropine as well. Examination
of Critchlow's (7) diagram discloses three cases in which the electrode tips
were near the anterior end of the optic chiasma in a basal location; two were
positive. Although the electrode loci are represented in sagittal projection
within the chiasma itself, they presumably rested in the diagonal band on
either side of it. In many of our own cases the electrodes have also impinged
on the diagonal band. Yet they were often just as effective when placed more
dorsally.

Pentobarbital is thought to affect chiefly the multisynaptic pathways
such as those within the reticular system (2, 17). Sawyer, Critchlow and
Barraclough (31) reported that pentobarbital, atropine and morphine, in
doses adequate for blocking ovulation in the rat, all have similar action in

The Preoptic Region of the Brain and its Relation to Ovulation 109

depressing the extralemniscal reticuloactivating system. Critchlow later
observed that lesions which selectively destroy the mammillary peduncle
tend to block ovulation in rats, supposedly by destroying the fibers of that
system which ascend into the posterior hypothalamus. Sawyer, Critchlow
and Barraclough proposed that the reticular formation may act permissively
upon hypothalamic mechanisms that are more specifically in control of the
release of ovulating hormone from the hypophysis. It would be interesting
to test the effect of interrupting the mammillary peduncle on the results
of preoptic stimulation. Very possibly such lesions would have no more
effect than the addition of atropine to the pentobarbital-blocked rat. The
present data from experiments with atropine indicate that the introduction
of this second "blocking agent" does not elevate the preoptic threshold
above that seen with pentobarbital alone.

Unavoidably the stimulation experiments supply no firm assurance that
the preoptic region normally plays any role in ovulation. It is within the
realm of possibility that stimulating that part of the brain simply transmits
impulses back to the tuberal region by fibers that do not ordinarily function
in this way. One is reminded of Sawyer's observation (30) in rabbits sub-
jected to the combination of histamine and a low dose of pentobarbital,
which set up a characteristic pattern of electrical activity in the rhin-
encephalon. This was followed by ovulation. Under these extraordinary
circumstances the olfactory bulbs and their connections to the hypothalamus
were essential participants, whereas in coitally-induced ovulation the
olfactory bulbs can be spared (3). Although the fact is generally recognized
that bilateral lesions in the anterior hypothalamus characteristically result
in constant estrus in rats (1, 16, 18, 22, 25, 34) as well as in the guinea-pig
(8), it is also recognized that ovulatory cycles can be restored in such animals
by the administration of progesterone. Studies by Kawakami and Sawyer (24)
demonstrate that in rabbits the effects of progesterone are widespread within
the brain, influencing thresholds in the mid-brain reticular system, hypo-
thalamus and rhinencephalon. Greer (18) reported that many of his lesioned,
progesterone-treated rats not only regained cyclic function while they were
receiving the steroid, but continued to cycle after treatment was withheld.
Thus, it appears that if cells and/or fibers of transit within the preoptic region
do take part in the normal process of pro-ovulatory stimulation of the
adenohypophysis their roles are not obligatory.

In the face of this uncertainty, we can nevertheless make use of the preoptic
region in several ways. The data at hand bring out several new points of
interest. It is now adequately demonstrated that on diestrus day 3 of the
5-day cycle the hypophysis is already prepared to release the full quota of
ovulating hormone and will do so whenever it receives the necessary signal
from the nervous system. The physiological "block" that ordinarily delays
ovulation in these rats for another 24 hr is some factor operating within

1 10 John W. Everett

the central nervous system. That factor manifests itself in the elevated
preoptic threshold of the diestrous rat. With fair certainty the prediction
can be made that when put to the test progesterone or estrogen supplements
will bring the diestrus threshold to the procstrus level.

The 60-sec stimulations in Series V, even better than the 5-min stimulations
of Series IV, display a triggering effect. Closely allied with this may be the
all-or-none eflect observed at threshold levels of stimulation in Series IV.
Heretofore it had been thought that in the rat, quite unlike the rabbit, the
neural mechanisms that provoke release of ovulating hormone operate
continuously in an obligatory way during the half-hour or so occupied in
the discharge of the hormone (10, 14). That view was based on results of
atropine injection at various times during the "critical period". Numerous
cases of only partial interference with ovulation were encountered, as well
as the cases of complete blockade or complete ovulation. The proportion
of partial effects was strikingly like that observed in a parallel series of partial
hypophysectomies during the critical period. On the other hand, the adminis-
tration of a threshold dose of atropine before the critical period in another
group of rats resulted in an essentially all-or-none response. Thus, it seemed
that the partial effects obtained during the critical period either by the full
dose of atropine or by hypophysectomy must have been the result of
interruption of the discharge of ovulating hormone already in progress.
The frequency of the partial effects indicated that the atropine-sensitive
component must act for at least 10 min, and more likely about half an hour.
Although circumstantial evidence led to the conclusion that the site of action
of atropine lies in the central nervous system, there was no direct proof that
this applied to this species. It was necessary to fall back on the proof furnished
by experiments in the rabbit (33). There remained a shade of doubt, therefore.
Because of species differences and the pronounced differences in dosage and
route of administration, it was still possible that in rats there might be a
direct blocking action on the hypophysial cells. The doubt has now been
dispelled.

At the same time, however, the new experiments present us with a paradox.
It is now evident that a triggering stimulus of 60 sec or less can be effective
although it operates upon a part of the system less remote from the median
eminence than the blocking sites of pentobarbital and atropine. It thus
becomes necessary to inquire what happens within the hypothalamus in
response to the trigger. Does it set up some prolonged electrical activity?
This should be readily subject to direct test.

Finally, attention must be called to observations by Christian (5) who
noted ovulation in 5 estrous rabbits that ovulated after electrical stimulation
of the preoptic region, in spite of the fact that they had been pretreated
with atropine in amounts adequate to block the ovulation reflex. Saul and
Sawyer (29) reported negative results from similar experiments, stating

The Preoptic Region of the Brain and its Relation to Ovulation 1 1 1

that stimulations in the preoptic area were "completely ineffective".
Christian's observations are now amply confirmed.

SUMMARY

The preoptic region, in spite of pentobarbital anesthesia and relative
distance from the median eminence, remains highly sensitive to electrical
stimulation.

Stimulation of the preoptic region on diestrus day 3 will advance ovulation
approximately 24 hr.

The preoptic threshold is lower on the day of proestrus than on diestrus
day 3. Approximately similar results were obtained with (a) dual concentric
electrodes, no isolation, a 10-min stimulation period, and (b) single concentric
electrode, with isolation, and a 5-min stimulation period.

Preoptic stimulation under pentobarbital anesthesia will readily induce
ovulation in proestrous rats that have been given atropine in an amount
adequate by itself to block ovulation.

Exploratory study with varied parameters has given positive results in
proestrous rats with pulse frequencies of 30 to 300/sec, pulse durations of
0.25 to 15 msec, currents as little as 20 [j.A and stimulation periods as short
as 60 sec (100/sec, 1 msec, 100 /mA, single electrode). In controls with no
current, results were negative.

The data on the ineffectiveness of atropine show that the atropine-sensitive
components of the LH-release mechanism are more remote from the median
eminence than are the elements that can be activated by electrical stimulation
of the preoptic region.

COMMENT ADDED IN PROOF

Since this paper was presented, a direct correlation has been found
between positive results and the amount of electricity introduced, without
evident relationship to other parameters. In histologic sections of the brains,
areas of mild electrolytic damage were observed about the electrode tips in
all animals that ovulated. In negative cases, on the other hand, there was
often no apparent electrolysis; when it did exist the volume of affected tissue
averaged much less than in positive cases. Subsequently, good results have
consistently been obtained by use of a direct current of 100 /xA for 30 sec or
less, whereas control lesions of comparable dimensions produced by high-
frequency electrocautery have been ineffective. Thus, it seems that the positive
effect stems from chemical changes caused by the electrolysis. Doubtlessly the
irritative effects of the electrolysis persist long after the current is turned off.
This eliminates the paradox mentioned with respect to the atropine experi-
ments, but complicates interpretation of the difference in "threshold"
between diestrous and proestrous rats.

1 1 2 John W. Everett

REFERENCES

1. Alloiteau, J. J., Compt. rend. Soc. biol. 148, 875, 1954.

2. Arduini, a. and M. G. Arduini, /. Pharmacol. & Exper. Tfierap. 110, 76, 1954.

3. Brooks, C. McC, Amer. J. Physiol. 120, 544, 1937.

4. BuNN, J. P. and J. W. Everett, Proc. Soc. Exper. Biol. & Med. 96, 369, 1957.

5. Christian, C. D. and J. E. Markee, Anat. Rec. 121, 403, 1957 (Abstract).

6. Critchlow, B. v., Anat. Rec. 127, 283, 1957 (Abstract).

7. Critchlow, V., Amer. J. Physiol. 195, 171, 1958.

8. Dey, F. L., Amer. J. Anat. 69, 61, 1941.

9. Everett, J. W., Endocrinology 43, 389, 1948.

10. Everett, J. W., Endocrinology 59, 580, 1956.

11. Everett, J. W., R. L. Riley and C. D. Christl^n, Proc. of the Endocrine Society,

Atlantic City, N.J., June 1959.

12. Everett, J. W. and C. H. Sawyer, Endocrinology 45, 581, 1949.

13. Everett, J. W. and C. H. Sawyer, Endocrinology 47, 198, 1950.

14. Everett, J. W. and C. H. Sawyer, Endocrinology 52, 83, 1953.

15. Everett, J. W., C. H. Sawyer and J. E. Markee, Endocrinology 44, 234, 1949.

16. Flerko, B. and V. Bardos, Acta neurovegetativa 20, 248, 1959.

17. French, J. D., M. Verzeano and H. W. Magoun, A.M. A. Arch. Neurol. & Psychiatr.

69, 519, 1953.

18. Greer, M. A., Endocrinology 53, 380, 1953.

19. Harris, G. W., Proc. Roy. Soc, London, Series B, 122, 374, 1937.

20. Harris, G. W., J. Physiol. 107, 418, 1948.

21. Haterius, H. O. and A. J. Derbyshire, Jr., Amer. J. Physiol. 119, 329, 1937.

22. HiLLARP, N.-A., Acta endocrinol. 2, 11, 1949.

23. HoHLWEG, W. and K. Junkmann, Klin. Wchnschr. 11, 321, 1932.

24. Kawakami, M. and C. H. Sawyer, Endocrinology 65, 652, 1959.

25. KoBAYASHi, T., S. HiROSHi, M. Maruyama, K. Arai and S. Takezawa, Endocrinol.

Japonica 6, 107, 1959.

26. KuROTZu, T., K. Kurachi and T. Ban, Med. J. Osaka Univ. 2, 1, 1950.

27. Markee, J. E., C. H. Sawyer and W. H. Hollinshead, Endocrinology 38, 345, 1946.

28. Marshall, F. H. A. and E. B. Verney, /. Physiol. 86, 327, 1936.

29. Saul, G. D. and C. H. Sawyer, Federation Proc. 16, 112, 1957.

30. Sawyer, C. H., Amer. J. Physiol. 180, 37, 1955.

31. Sawyer, C. H., B. V. Critchlow and C. A. Barraclough, Endocrinology 57, 345,

1955.

32. Sawyer, C. H., J. W. Everett and J. E. Markee, Endocrinology 44, 218, 1949.

33. Sawyer, C. H., J. E. Markee and B. F. Townsend, Endocrinology 44, 18, 1949.

34. Van Dyke, D. C, M. E. Simpson, S. Lepkovsky, A. A. Koneff and J. R. Brobeck,

Proc. Soc. Exper. Biol. & Med. 95, 1, 1957.

DISCUSSIONS

Charles A. Barraclough: One of the principal difficulties encountered in an investigation
of the neural factors concerned with the control of ovulation in the rat is the fact that
this species ovulates spontaneously. Thus, the general approach used in investigations
of this phenomenon has been to study factors which will inhibit ovulation and to
correlate such inhibition with the destruction or depression of specific regions in the
central nervous system. Another method of study has been described by Dr. Everett
this morning in which the natural stimulus for ovulation is blocked by pentobarbital
anesthesia and ovulation is then induced by electrical stimulation of various hypo-
thalamic areas. Although this latter procedure permits a more accurate localization
of the regions of the hypothalamus concerned with the ovulatory discharge of gonado-
tropin from the adenohypophysis, under these conditions the factor of central nervous
depression with a drug is still present.

In our investigations we have used a preparation which does not require prior
inhibition of ovulation to study central nervous control of ovulation, the androgen-
sterilized rat. In previous studies we observed that administration of a single sub-
cutaneous injection of 1 .0 mg of testosterone propionate to the 5-day-old rat resulted in
permanent sterility (Barraclough, C. A., Ariat. Rec. 130, 267, 1958). When autopsied at
100 days of age, the ovaries of these animals contained numerous large vesicular
follicles as well as follicles in various other stages of development, but ovulation had
not occurred and corpora lutea were absent (Figs. 1 and 2). Furthermore, these ovaries
secrete estrogen as evidenced by the persistence of a comified vaginal mucosa. Seemingly
the particular malfunction in adenohypophysial gonadotropin secretion of the sterile
rat does not reside in the inability of this gland to secrete FSH or LH (ICSH) but
rather in the failure of this gland to release gonadotropin in sufficient quantity to
cause ovulation, a function controlled by the hypothalamus. Thus, it may be that
androgen administration during infancy alters hypothalamic-hypophysial inter-
relationships by rendering the hypothalamic areas responsible for the ovulatory
discharge of gonadotropin refractory to intrinsic activation. As such, the proper
impetus for the ovulatory release of gonadotropin is not supplied to the adenohypo-
physis and sterility ensues. To test this hypothesis, experiments were designed to
determine whether the pituitary of the sterile rat would respond to hypothalamic
activation by discharging sufficient gonadotropin to cause ovulation. Six adult sterile
rats (235-250 gm body wt.) were given an intraperitoneal injection of 25 mg/kg of
pentobarbital sodium. This dosage was selected as it does not block ovulation in the
normal cyclic rat nor the stress-induced discharge of ACTH, but will keep the animals
sufficiently subdued to be placed in a stereotaxis apparatus. In these rats, bipolar
concentric electrodes were stereotaxically oriented in the median eminence region of
the hypothalamus and stimulation was performed in this and subsequent experi-
ments using the following parameters: 100 ^A current delivered at a frequency of
100/sec with a duration of 1 msec, for 15-sec on/off periods over a 15-min total
period. These parameters were selected as they had been shown previously by Critchlow
(Anier. J. Physiol. 195, 171, 1958) to be effective in inducing ovulation in the Nembutal-
blocked rat, and they are quite similar to the parameters reported by Dr. Everett in his
studies. At autopsy, 24 hr after stimulation, the Fallopian tubes were examined for the
presence of ova and the ovaries for corpora lutea. All autopsy results and electrode
placements were confirmed histologically. Under these circumstances, electrical
stimulation of the median eminence failed to induce ovulation. However, considering
the ovarian-pituitary axis of the persistent-estrous rat, in which pituitary gonadotropin
is being released in response to the constant blood levels of estrogen, the possibility

113

114

Discussions

.5 ^

_, <« ca

b ^ B-| I

3 ^ H 3 ^

'•5 > X) . .

c 2> •' o CO

"^ < y CU o

C> - 3

X 4>

Oh "o

o c oi X 0- ^
•z: o <• u< «
J5 1- . , •^' 6

c o -— (u i: uS

■-S ° 2 o t, c

/" o 2 2 -a §

o _, J2 _: 5 -^

•S ;2 'g « -2 S

o. S y ^ 3 "^
^•■=^ s § «

C nj O t- C y

•art ' u

.s ^ a 5 H "^

pa •-

i2 « u e 3 g

> C ™ 1
:f .t; o I— I

Fig. 1. Normal rat ovary at 100 days of age.

^.jejss^ifci^fess^''

Fig. 2. Ovary of rat injected with 1.0 mg of testosterone propionate at 5 days of age and

autopsied at 100 days of age.

Fig. 3. Ovary of progesterone-primed, androgen- sterilized rat following median eminence
stimulation on the day of proestrus.

Discussions

115

existed that insufficient concentrations of gonadotropin were stored in the pituitary
to cause ovulation when released on hypothalamic stimulation. In order to assure
sufficient gonadotropin storage, six sterile rats were pretreated with progesterone in
a dosage calculated to block the secretion of gonadotropin (2 mg s.c. in oil). This
dosage of progesterone interrupted the persistent vaginal cornification and generally
induced 3 days of diestrus followed by a single day of proestrus. When no further
treatment was given, all rats returned to the persistent-estrous condition. If, however,
the median eminence was stimulated on the day of proestrus, ovulation occurred in
all animals (Fig. 3). Progesterone alone did not cause ovulation. It is apparent, there-
fore, that the sterile rat pituitary can function normally provided (a) proper gonado-
tropin storage is permitted and (b) an impetus for its release is supplied by the
hypothalamus.

Once assured that the progesterone-primed sterile rat could be induced to ovulate
on hypothalamic activation, we made a more specific study of the hypothalamic

Fig. 6. Midsagittal reconstruction of rat hypothalamus indicating extent of area which

when stimulated resulted in ovulation. Abbreviations: Hippo, Hippocampus; M, Massa

intermedia; PV, Paraventricular nucleus; SP, Septum; II, Optic nerve.

regions which would cause ovulation when stimulated. In this preparation, the positive
areas were found to occupy an area just rostral and caudal to the ventral medial and
arcuate nuclei (Figs. 4, 5, 6). Stimulation of the medial or lateral preoptic areas or the
mammillary body regions did not induce ovulation nor did stimulation of the lateral
hypothalamic or median forebrain bundle regions. These results are contrasted to those
of Everett in which ovulation could readily be induced by stimulation of the preoptic
area. This discrepancy raises several questions : (a) It has been demonstrated that the
malfunction in the ovulatory mechanism of the androgen-sterilized rat is not resident
in the adenohypophysis as such, but more likely at the hypothalamic level. Does the
failure of the preoptic region of this animal to induce ovulation in response to stimu-
lation indicate the site of "masculinization" ? (b) What specific structures are being
stimulated in the preoptic area to cause adenohypophysial activation in the normal
rat? The amygdala is known to contribute efferent fibers via the stria terminalis to
the hypothalamus and it has also been implicated in the control of ovulation. Is it
this tract which is being stimulated, and if so can ovulation be induced by preoptic
stimulation in animals with amygdaloid lesions in which fiber tract degeneration

116

Discussions

(stria temiinaiis) has occurred? With regard to the first question we have obtained
some recent data which would further tend to support the hypothesis that the anterior
hypothalamic area is the site of the deleterious androgen action.

The biphasic action of progesterone in first facilitating and then inhibiting the
discharge of gonadotropin in the rat is well recognized. Everett {Endocrinology 43,
389, 1948) has demonstrated that administration of progesterone to a normal cyclic

Fig. 7. Effects of spaced injections of progesterone on vaginal cycle of androgen-sterilized,

persistent-estrous rat. Abbreviations used in this and Fig. 8: I, Proestrus; III, Estrus;

L, Laparotomy; CL, Corpora lutea; A, Autopsy. Solid bars indicate persistent vaginal

comification ; blank spaces represent days of diestrus.

rat on the last day of diestrus will advance ovulation one day. Spaced injections of
progesterone when administered to the spontaneous persistent-estrous rat (DBN
strain) will likewise induce ovulation (Everett, J. W., Endocrinology 32, 285, 1943).
We have attempted also to ovulate the androgen-sterilized rat by either spaced or
daily injections of progesterone. Following the procedure described by Everett (1943)
for the induction of ovulation in the spontaneous persistent-estrous rat, single "inter-
rupting" dosages of 2.0 mg of progesterone were administered to each of 4 groups
of 8 adult sterile rats. This injection generally resulted in a 3-day period of diestrus
followed by one day of proestrus at which time a second "ovulatory" dose of proges-
terone was administered. Laparotomy was ordinarily performed 48 hr after the second
injection, at which time the ovaries were examined for the presence of corpora lutea.
Regardless of the dosage used, ovulation did not occur (Fig. 7). These results were
confirmed at autopsy by histological examination of all ovaries. In a second series of
experiments a single "interrupting" dose of 2.0 mg of progesterone was adminis-
tered to each of 4 groups of 8 animals. Following this single injection, daily sub-
cutaneous injections of either 0.25, 0.5, 1.0, or 2.0 mg were given to one or the other
of the four groups for a 3-to 4-\veek period. Twenty-four to 48 hr after the last injec-
tion, the animals were sacrificed and the ovaries examined for the presence of corpora
lutea. The effects of such treatment on the vaginal cycles are summarized in Fig. 8.
Although the vaginal cycles could be restored with the lower dosages, ovulation did
not occur in any of the groups studied.

These results suggest that progesterone does not facilitate ovulation by a direct
action on the adenohypophysis. As demonstrated previously, the pituitary of the

Discussions

117

sterile rat, following the "interrupting" dose of progesterone, stores sufficient gonado-
tropin to be released on hypothalamic stimulation and cause ovulation. However,
ovulation did not occur in any of the progesterone experiments regardless of the
dosage employed. This would tend to support the hypothesis that progesterone
facilitates ovulation in the rat by its action on the hypothalamus, perhaps in a fashion
described by Kawakami and Sawder {Endocrinology 65, 631, 1959) for the rabbit.

2,0

OSSmg Progesterone do.ly

1 1 IMl 1 1 1 1 1 1 1 1 ill

2.0

ii^Tvrijirri^ii^ii^

A-NoCL

2.0

1.0 mg. Progesterone <Joil»

1 11 11^1 111 1 1^1 nil i^LX—

A-NoCL

2 0
1

Mill i^TmTiri^i 11 1 iii[ij|

A-NoCL
1 1 I 1 1

Fig. 8. Effect of daily injections of progesterone on the vaginal cycle of the androgen-
sterilized, persistent-estrous rat.

The data further implicate the anterior regions of the hypothalamus as the specific
sites of progesterone action. Thus, prepubertal treatment of rats with androgen may
not only render the preoptic areas of the hypothalamus refractory to electrical stimula-
tion but to progesterone as well. Further evidence suggesting that progesterone may
exert its action at the preoptic area has been presented by Greer {Endocrinology 53,
380, 1953) and Van Dyke et al. {Proc. Soc. Exp. Biol. Med. 95, 1, 1956) who reported
that rats in which ovulation had been interrupted by anterior hypothalamic lesions
would not ovulate in response to progesterone.

These data, although in contrast to the observation reported by Everett for the
normal rat, do support the hypothesis that the preoptic region of the rat may be the
critical site for control of ovulation.

This work was supported by Grant Number RG-5496 from the United States Public
Health Service.

Chairman Nelson: We shall now have a period of general discussion. I think perhaps I
would like to call on Dr. Folley to contribute such remarks as he wishes to the dis-
cussion this morning.

Dr. S. John Folley: First, may I say what I should have said yesterday afternoon, when
Dr. Creep called on me. I want to express my sincere thanks to the appropriate people
who made it possible for me to come all the way from England to be present at this
wonderful meeting. It is particularly fortunate that arrangements could be made to
hold it in such magnificent surroundings which provide a wellnigh perfect environ-
ment for the discussion of a specialized subject by a small group such as this. I regard
it as a great privilege to be here.

1 1 8 Discussions

I feel that I should do something to justify my presence by making a few remarks
now regarding what we have heard this morning. We have had some most fascinating
papers which fully maintained the high standards set by the papers yesterday afternoon.

I was most interested in Dr. Sawyer's paper, and in this connection I would like to
refer to some observations on the ewe, which were reported in Nature last August
by Raeside and McDonald (Nature 184, 388, 1959), which seem to fit in very well
with his conclusions. As you know, the ewe is a seasonal breeder and these workers
investigated the threshold doses of estrogen required to induce estrus in spayed ewes
primed with progesterone. They found that less estrogen was required for this response
during the breeding season than during anestrum. This would seem to point to the
existence of a built-in rhythmic variation in the sensitivity of the so-called hypo-
thalamic "sexual center" which controls estrous behavior. On the other hand, the
threshold doses of estrogen necessary to induce characteristic changes in the chemical
properties of the cervical mucus were the same regardless of whether the treatment
was given during the breeding or non-breeding season. Thus peripheral responses to
estrogen appear to be constant irrespective of season.

Coming to Dr. Hansel's contribution, which interested me a great deal, I find it
very difficult to reconcile his results with those of other workers and of ourselves on
small animals. I think it is true to say that in laboratory animals, certainly rats and
rabbits, the experiments with oxytocin almost exclusively point to the release of
prolactin rather than gonadotropin. The best known exception is provided by the
results reported in Japan by Shibusawa and his collaborators who claim that oxytocin
releases gonadotropins as judged by an increased excretion of 1 7-ketosteroids in the
urine. Dr. Hansel himself, in a recent review, has ably discussed the Japanese results
and I thought he dealt with them admirably without appearing to be unduly critical.
Obviously, as Dr. Hansel pointed out, we cannot accept these results without further
confirmation. This being so, I think the balance of evidence from experiments on
small animals would appear, at least to me, to indicate that oxytocin, rather than
releasing gonadotropins, evokes the release of LTH, by which I mean prolactin.
How then can Dr. Hansel's interesting results be reconciled with this conclusion?
We know, as he made clear, that in the cow uterine interferences of various kinds
almost invariably cause the release of oxytocin. In passing, it might be interesting
in this connection to recall a curious custom practised by the women of certain
primitive tribes in Africa when they milk their cows. The custom is to blow into
the vagina of the cow just before milking, thus inflating it with air. This seems to
favor the occurrence of the milk-ejection reflex which, as you know, involves the
release of oxytocin. To return to our main theme, I cannot help wondering whether
Dr. Hansel's results might not be due to the presence of some polypeptide, different
from oxytocin but chemically related to it, which might have been present in the
preparations he used. In any event, I was interested in his suggestion that administered
oxytocin might feed back on the central nervous system. Especially is this so because
we have thought along these lines ourselves, in relation to our own experiments on
rats, in which we have evidence of prolactin release evoked by administration of
oxytocin. It seems quite possible that the doses of oxytocin used in Dr. Hansel's
experiments might inhibit the release of the animal's own oxytocin. Evidence indicating
the possibility of such a feed-back mechanism was provided some years ago by
Petersen and his colleagues (Donker, Koshi and Petersen, Science 119, 67, 1954)
who were studying the effects of regular injections of oxytocin in a cow just before
milking in order to cause more complete evacuation of the udder. When the treat-
ment was discontinued after 156 repetitions at hourly intervals the natural milk-
ejection reflex was significantly inhibited and it took some days before it returned.

Professor Harris showed some beautiful slides and I would like to refer to one in
particular, the one which illustrated various types of humoral mechanisms. There is
one other type of mechanism which he did not include, that I have often thought
might apply to the anterior pituitary. This is the direct chemical action of one type
of cell upon another by means of a cellular secretion. Looking in a general way at
the picture of anterior-pituitary function, as understood at present, the secretion of

Discussions 119

gonadotropins on the one hand and of LTH (or prolactin) on the other, at any rate
in the rat, seemed to be alternative functions. There are various circumstances in
which one can inhibit the secretion of gonadotropins, for instance by administering
reserpine or by high doses of estrogen, or especially by transplanting the pituitary
into the anterior chamber of the eye or under the capsule of the kidney. Here one
gets inhibition of gonadotropin release or virtual disappearance of gonadotropic
function while at the same time the release of prolactin is unhindered or even enhanced.
On the other hand, if the transplanted pituitary is replaced in its natural position
LTH secretion ceases and regular estrous cycles are re-established. Can it be that
the gonadotropes, nourished as they seem to be by their natural proximity to the
median eminence, exert by local humoral action an inhibitory influence on the acido-
phils, including those which secrete prolactin? This idea should be susceptible of
experimental test.

I should like to end these remarks by asking Professor Harris, referring to his very
interesting experiments with median eminence extracts, whether he has tried the
administration of extracts of whole posterior pituitary lobe by his very fascinating
and elegant pituitary plumbing technique? In addition I would like to know whether
he has made any pituitary infusions with adrenalin, noradrenalin, histamine or
serotonin ?

Dr. Geoffrey Harris: We have started preliminary experiments infusing posterior
pituitary preparations. We started with "Pitressin", but since this may be contaminated
with anterior pituitary hormones we have recently obtained a highly purified prepara-
tion of lysine vasopressin from Dr. A. V. Schally in Houston, and also some synthetic
arginine vasopressin from Dr. V. du Vigneaud. The results at the moment are too
few to warrant any comment.

With regard to the other point raised, concerning intra-pituitary infusions of
adrenalin and noradrenalin. Dr. B. T. Donevan and myself worked a few years back
on this point (/. Physiol. 132, 577-585, 1956). The technique differed a little in the
previous experiments from that presently used. Infusions were made under anesthesia
and through glass needles. However, we found that such infusions into the pituitary
glands of rabbits did not result in ovulation.

Dr. William Hansel: Dr. Folley has raised two interesting questions which deserve
comment. The first of these concerns the role of prolactin in the cow. There are at
least two experiments suggesting that prolactin is not luteotrophic in the bovine.
Wisconsin workers have attempted and failed to prolong the length of the estrous
cycle by daily injections of prolactin beginning at about the 15th day of the cycle
and continuing through the 22nd day. In some of our own experiments we have
attempted and failed to overcome the ability of oxytocin to produce precocious estrus
by giving concurrent prolactin injections. The prolactin used was of ovine origin. It
is possible that the dosages used in both of these experiments were too low.

Dr. Folley has also raised a question concerning the purity of the oxytocin prepara-
tions used in our work. In most of the experiments Armour's purified preparation
was used. In addition, the estrous cycle was shortened in several cases by injections
of a synthetic oxytocin preparation (Syntocinon, Sandoz Corp.). This preparation
was free of vasopressin, but probably contained some peptides other than oxytocin.
None of the preparations used possessed any measurable gonadotropic potency.

Chairman Nelson: I know that Dr. Segal wants to say something at this time, but I am
going to ask him to be brief.

Dr. Sheldon Segal: I think it is worthwhile spending more time on the subject of androgen-
sterilized rats for several reasons. This experimental condition bears on our under-
standing of the normally occurring differences in pattern of gonadotropin release
between males and females of a given species. As Dr. Barraclough has indicated, it
also suggests important considerations with respect to localization of neural areas
9

120

Discussions

controlling gonadotropin release. In addition, a complete analysis of this experimental
situation provides good evidence for the action of steroids on neural tissue, directly.
The Japanese workers, Takewaki and Tagasuki, have shown that the steroid-induced
sterility follows the post-natal administration of corticoids and estrogens, as well as
androgens. PfoitTcr (Amer. J. Amit. 58, 195-225, 1936) described the same result with
the implantation of new-born testes in litter-mate females.

The need for pre-treatment with progesterone to cause electro-stimulated ovulation
in these anovulatory animals has been interpreted by Dr. Barraclough to indicate
that without progesterone the anovulatory female pituitary is deficient in stored LH.
We have assayed these gonadotropins with respect to both total gonadotropins, based

Table 1. Gonadotropin Content of Pituitary Glands

Number

Average

Weaver-Finch test.

Group

pituitary

ovarian

Positive reactions

glands

weight* (mg)

weight t (mg)

total number

Normal <^

212

20/20

60-day-old

184

18/20

8.7 + 4

112

12/20

1/2

2/20

Anovulatory $

226

10/10

60-day-old

194

8/10

10.8 ±8

103

6/10

1/2

0/10

Normal ?

194

8/20

60-day-old

126

2/20

11.6±5

0/20

1/2

—

* Averages ± standard deviation calculated from the weights of 20 pituitary glands
of each type.

t Assay animals were immature female rats; control ovaries average 32 mg. All weights
represent average of 3 pairs of ovaries following a three-day injection period.

Table 2. Three Months Mating Record of Anovulatory Rats

Reaction to male

No. of
females

Post-coitus
vaginal smears

Indicated
ovarian events

Non-receptive
Receptive:

2 or 3 matings

3 or 6 matings

4 or 9 matings

2
4
12

Prolonged anestrus*
Short diestrust

cvct

Ovulation functioning C.L.§

Ovulation

No ovulation

* Pregnancy-type of vaginal smear, 13-22 days' duration.

t Diestrus smear, 3-5 days' duration, followed by continuous vaginal comification.

J Constant vaginal comification.

§ Corpora lutea.

Discussions 121

on ovarian weight increase in immature female rats, and specific LH content using the
Weaver-Finch test (Segal, S. J. and D. C. Johnson, Arch. d'Anat. Micros, et Morphol.
Exper. 48 bis, 261-274. 1959).

The assays show that, like the normal male, the anovulatory female pituitary is
richer in gonadotropins, both total and specific LH content, than the normal female.
(Table 1.)

In the same article {ibid.) we have reported on the mating reactions of anovulatory
females (Table 2). About 30% accept males. Some (about 10% of the total group
tested) will respond to the mating by spontaneous ovulation. The total results of
these studies indicate that the androgens administered post-natally have a direct
inductive effect on the neural centers controlling gonadotropin release and the
extent of this effect can vary among the treated animals. In some cases a partial
induction of the total gonadotropin-releasing neural mechanism(s) results from the
androgen treatment. Varying degrees of effect could be distinguished.

MECHANISMS CONTROLLING OVULATION OF
AVIAN AND MAMMALIAN FOLLICLES*

A. V. Nalbandov
University of Illinois, Urbana

It is generally conceded that mature follicles rupture in response to the action
of an ovulation-inducing hormone (commonly considered to be the luteinizing
hormone, LH), but the mechanism of ovulation remains unknown (7). In
many mammals the interval between LH release (or injection) and ovulation
is about 10 hr, but the changes which take place in the follicle wall between
the time when LH first bathes the follicular cells and the time when these
cells part along the stigma and allow the ovum to escape are practically
unknown.

It should be kept in mind that LH release from the pituitary is a relatively
sudden event which lasts 30 min in the rat (4), 60 min in the rabbit (5) and
26 to 150 min in the chicken (12), and that all protein hormones, and LH is
no exception, are destroyed very rapidly after they enter the circulation. Thus,
whatever influence LH has on mature follicles causing them to rupture
about 10 hr later is of transient nature and is certainly not sustained over
the whole interval between LH-release and ovulation. It seems that LH
initiates a change which then runs its course and terminates in ovulation.
The purpose of this paper is to present data on the ovulability of follicles and
to propose a theory of the mechanism of ovulation based on these data.

Several older theories on the mechanism of ovulation have been summarized
and reviewed by Hartman (6). Follicles do not rupture because their "ulti-
mate" size has been reached or because the interior pressure of the liquor
folliculi bursts the follicular wall. It is known that follicles can continue to
grow long past the time when they should normally rupture. Cysts are often
many times larger than follicles of ovulatory size and the internal pressure
in cysts is much greater than it is in follicles; yet, cysts may persist for weeks
or months without rupturing. In pigs, cattle and sheep, follicles become
flabby a few hours before ovulation even though there is no visible break
in the follicle wall and no detectable oozing of its contents. These facts
certainly do not argue in favor of intra-follicular pressure as being the cause

* Data presented were taken from the Ph.D. Thesis submitted by Howard Opel
(University of Illinois), 1960.

122

Mechanisms Controlling Ovulation of Avian and Mammalian Follicles 123

of ovulation. Similarly, one can discount the massaging effects of the fimbria
as aiding in ovulation since follicles rupture normally in animals in which
the fimbriae have been amputated or in which the whole reproductive tract
has been removed. Neither can intestinal pressure on the ovaries be called
upon as an aid in follicular ruptures since in sheep and rabbits ovulation
proceeds normally in exteriorized ovaries not in contact with the gut.

Rugh (11) and Wright (14) have found that in hypophysectomized frogs
follicles can be made to ovulate more readily than in intact frog females
(sample responses: 100% ovulation in hypophysectomized females vs.
30-40% ovulation in intact control frogs). To Wright this observation
suggested the possibility that the pituitary gland, due to unavoidable trauma
at the time of hypophysectomy, may release a substance which sensitizes
follicles and makes them more susceptible to the effects of ovulation-inducing
hormones. Although this sensitizing substance was not identified, it was
assumed to be the follicle-stimulating hormone (FSH). In another study
Wright (13) confirmed earlier observations that frog ovaries taken from
intact females can be made to ovulate in vitro. His data are of interest in
view of the discussion to follow. Wright found that, as the amount of frog
pituitary tissue added to the vessels containing frog ovaries decreased from
two to one and on down to l/16th of one gland, eflftciency of ovulation
increased from about 20 to 80%. Wright proposed that this decrease in the
efficiency of ovulation could be due to an excess of LH in the vessels contain-
ing the higher concentration of pituitary gland tissue. When the concentration
of pituitary tissue in the fluid bathing the ovaries was kept constant, efficiency
of ovulation gradually increased with time, being 0% at 5 to 10 hr after the
start of the in vitro trials and approaching 100% at 24 hr.

Most recently Bergers and Li (1) showed that ovaries of frogs pretreated
with extracts of frog anterior pituitary tissue ovulated in vitro in response
to ovine LH (ICSH) or growth hormone with about equal efficiency.
However, this is not as great as that obtained with frog pituitary gland
extracts. No in vitro ovulations were obtained with either prolactin or FSH.
Progesterone was also able to induce in vitro ovulations but the number of
eggs shed was below that obtained from the hypophysial hormones.

Chicken follicles too may ovulate in vitro provided they are exposed to
the endogenous hormones for an as yet undetermined minimum time prior
to being excised. According to Neher et al. (10), follicles removed one hour
prior to normally expected ovulation can ovulate in vitro, while preliminary
data (unpublished) suggest that removal 3 to 5 hr prior to expected rupture
is not followed by dehiscence.

In women, follicles are surrounded by a network of reticular fibers and
reticular cells which resemble smooth muscle cells without fibrils. In rabbit,
pig and sheep follicles, true smooth muscle cells are present either in both
the theca interna and the theca externa, or only in one of them but not in

124 A. V. Nalbandov

the other. In the folHcle walls of chicken and frog ovaries true smooth muscle
cells are present. The occurrence of smooth muscle cells in these and probably
other species made it reasonable to think that their presumed ability to con-
tract may play a role in bursting ripe follicles. Many abortive attempts have
been made to induce ovulation by substances known to cause contraction
of such fibers or by the electrical stimulation of the follicle wall (3). Oxytocin,
injected systemically into rabbits, not only does not hasten ovulation but
prevents it completely (2).

The injection of LH-containing gonadotropins may hasten ovulation by
several days in mares, or by several hours in chickens, pigs and cows.
Similarly, ovulation may be delayed by the use of such blocking agents as
atropine in rabbits and cows or dibenamine in chickens. Thus, the follicle
seems to become capable of ovulating long before it is normally called upon
to do so by endogenous LH. It also retains its ability to ovulate past the
normal time of rupture, if the release of LH is blocked or delayed by experi-
mental means. The follicle of the mare remains ovulable for three to seven
days and in the hen, under certain experimental conditions, it retains its
ability to ovulate for as long as three weeks after it has reached ovulatory
size (8).

Considering the data briefly summarized thus far, it appears justifiable
to conclude that follicles reach ovulability before their "destined" time to
rupture and retain their ability to ovulate for a considerable time after this
event should have normally occurred. The follicle, not unlike a sound
sleeper who will be awakened by an alarm clock, is unaware of its fate but,
like the well-rested sleeper, it is physiologically ready and waiting passively
for the signal to begin the final transformations leading to its ultimate fate —
ovulation. For the follicle the signal is the arrival of LH. This signal is
comparable to the ringing of an alarm clock which, having run down, leaves
no memory of its sound other than the effect it produces on the suddenly
altered metabolism of the awakened sleeper.

The data to be presented are concerned with the possible nature of the
transformations which take place in the follicle between the time it receives
the order to ovulate and ovulation itself.

Before discussing further the theoretical aspects of the problem of the
ovulability of the follicles, data will be presented bearing on this problem in
laying hens. Similar work is in progress in mammals but it is not sufficiently
conclusive to permit discussion at this time. The experimental work to be
presented involves laying hens which were hypophysectomizcd after they
had laid the first two eggs (Q and Cg) of their clutch which in these birds
normally consists of four or more eggs. Since, in the hen the interval between
LH release and ovulation is variously estimated to be 8 to 12 hr in length, all
hypophysectomies were performed about 1 8 hr before the expected ovulation
of the C3 follicle. Thus, there was a good margin of safety to make certain

Fig. 1. Ovary of normal intact laying hen.

5'7

Fig. 2. Ovary of hypophysectomized hen, 24 hr after operation. Intermediate atresia.

Mechanisms Controlling Ovulation of Avian and Mammalian Follicles 125

that ovulations induced after hypophysectomy were caused by exogenous
hormones rather than by the release of the hen's own LH. Success of treatment
was judged either by laid eggs or by the presence of ovulated ova at autopsy
which was performed at appropriate times following treatments.

In the absence of hormonal support the ovary of hypophysectomized hens
undergoes extremely rapid atrophy (Table 1 ; compare Figs. 1 and 2).

Table 1 . Effect of Hypophysectomy on Rate of Follicular Atresia
OF Laying Hens

Hours

No.

% Follicles atretic in weight class (g)

after
operation

of
hens

15 +

10-14.9

5-9.9

1-4.9

0.4-0.99

0.09-0.39

19.7

50.0

10.0

20.0

1.2

47.5

100.0

57.0

20.0

60.7

100.0

67.0

100.0

All follicles of measurable size

Attention is called to the fact that atresia begins not with the largest but
with the smallest follicles (Table 1, 6 hr). By 12 hr after operation it includes
the large follicles, but even by 18 hr the medium-sized follicles are not as
hard hit as are the two extreme size classes. By 24 hr after hypophysectomy
virtually all follicles of measurable size have become atretic.

On the basis of these data we know that, in the absence of exogenous
hormone support, we can count on an interval of about 12 hr after hypo-
physectomy during which most follicles of ovulable size can be caused to
ovulate with appropriate exogenous hormonal stimulus.

We shall first consider experiments in which an ovulating dose of LH was
injected into laying hens which were hypophysectomized after lay of the C^
follicle and 18 hr prior to the next anticipated release of their own LH. A
single intravenous injection of LH was given to some hens as early as 2 hr,
to others as late as 24 hr after hypophysectomy. The results of this experiment
proved to be as interesting as they were unexpected. It will be seen (Table 2)
that while at 2 hr all hens ovulated only one ovum, at 6 and 12 hr after the
operation the majority of hens ovulated two, and in one case even three ova.
The changes in the efficiency of ovulation, with increasing time after hypo-
physectomy, are further shown in the following comparison :

Hours after hypophysectomy : 2 3 4 6 12 15 18 24

Average No. of ovulations/hen: 1.00 1.25 1.25 1.88 1.63 1.38 0.63 0.13

In the intact laying hen it is not possible to induce more than one ovulation
which is always the largest follicle in the ovary. But, in hypophysectomized

126

A. V. Nalbandov

hens even immature follicles ovulate and all follicles appear to become
progressively more ovulable the longer they remain without gonadotropic
hormone support other than the ovulatory dose of LH. This holds true
only up to 12 hr after the operation, since after that time most follicles of
even remotely ovulable size become physically atretic and thus are incapable
of ovulating (Table 1). Of further interest is the fact that while most ova

Table 2. Effect of Time on Ovulability of Follicles of Hypophysectomized Laying
Hens injected i.v. with 4.0 mg of LH at Time Shovvt>i

Hours

No.

Average weight of ova

after

single

double

(g)

operation

hens

ovulations

18.4

17.7

16.3

17.0

16.3

14.9

7.7

18.4

17.4

15.0

11.1

17.6

17.0

15.4

13.7

17.5

17.2

14.9

10.2

14.9

14.6

12.1

9.8

17.1

16.8

10.2

—

17.0

16.8

11.3

—

LH preparation (Armour Lot No. R377201) contains FSH. C,, C^-
to hypophysectomy. Ij, Ij — ova induced by LH injection.
* One hen ovulated 3 follicles, one weighing 2.1 g.

-last ova shed prior

induced to ovulate after hypophysectomy (I^) weighed less than their normally
ovulated predecessors, their weights are still within the normal range. All Ig
ovulations, however, are very significantly below normal ovulatory size. In
spite of frequent and systematic attempts to induce ovulation of immature
follicles in intact laying hens with a gamut of doses of LH, this has never
been achieved in this laboratory or reported in the literature. It is interesting
that intact laying hens treated with progesterone will ovulate very immature
follicles with relative frequency. The reasons for this and the conditions
under which it occurs remain unknown.

In a second experiment the question was asked whether the sensitivity of
follicles to LH increases with time elapsing since hypophysectomy.
Accordingly hens were injected with graded doses of LH at 6 or 12 hr after
operation. This trial showed (Table 3) that at 6 hr no ovulations were
induced with doses below 0.50 mg of LH, while at 12 hr 0.20 mg of LH was
sufficient to cause single ovulations. Furthermore, double ovulations at 12 hr
were produced with much lower doses of LH than the doses required to
cause double ovulations at 6 hr. Attention is also called to the fact that even
mammoth doses of LH (up to 20.0 mg) did not inhibit ovulation or reduce
efficiency.

Mechanisms Controlling Ovulation of Avian and Mammalian Follicles 127

The observations presented in these experiments (Tables 2 and 3) led to
the postulate that ovulation may be normally a hormone withdrawal
phenomenon. To test this possibility further, a comparison was made
between ovulability of follicles which were exposed to LH alone, with those
which were given LH together with support by a gonadotropic hormone.
Since the LH preparation used was known to be heavily contaminated with

Table 3. Effect of Time on Dose of LH Required to Induce Single or Double
Ovulations in Hypophysectomized Hens

6 hr after operation

12 hr after operation

Dose of
LH

No.

No. of ovulations

No.

No. of ovulations

(g)

hens

Single

Double

hens

Single

Double

0.15

0.20

0.25

0.50

LOO

L50

2.00

4.00

6.00

8.00

• 20.00

—

Table 4. Effect of Hormonal Support on the Ovulability of
Follicles of Hypophysectomized Hens

No.

hens

First injection

Second injection

Hours

after

operation

(mg)

PMS

(CNU)

No. ovulations

Hours

after

operation

(mg)

No. ovulations

Single

Double

Single

Double

10
6

6
6

0.5
0.5

0
6

8
6

1
0

30
30

4.0
4.0

1
0

7
1*

4
4
4

6
6
6

2.0
4.0
4.0

1
0
0

4
4

18
12
30

4.0
4.0
4.0

0
0
0

* Weight 0.81 g.

FSH, and since even small doses of FSH may be sufficient to provide support,
it was decided to use the minimum effective dose of LH in order to minimize
the FSH effect. Two groups of hens were each injected with 0.5 mg of LH

128 A. V. Nalbandov

6 hr after operation. One of these groups received, simultaneously with LH,
an intramuscular injection of six Cartland-Nelson units of pregnant mare's
serum (PMS). Both groups responded to the LH injection by ovulations
(upper part of Table 4). Thirty hours after operation, a dose of LH was
injected which in previous experiments had been found maximally effective
in inducing double ovulations (Table 3). It will be noted that, while 8 of the
10 hens injected with LH alone ovulated (7 of them twice), only one double
and no single ovulations were obtained from the 6 hens supported with PMS.
If the initial ovulating dose of LH is high, no subsequent ovulations can
be obtained when the second dose of LH is given 12, 18 or 30 hr after
operation (bottom part of Table 4). While these results should be considered
tentative they may mean that enough FSH was contained in the initial dose
of LH to provide support and to prevent the ovulation of otherwise ovulable
follicles which should have ruptured after the second LH injection.

DISCUSSION

The data presented lead to the conclusions that ovulability of follicles is
greater in hypophysectomized hens than it is in intact control animals; that
ovulability increases progressively with time after hypophysectomy until
follicles become physically unable to ovulate; and that less LH is required to
ovulate follicles which have not had gonadotropic hormone support for a
longer time than those follicles which had been under the influence of
gonadotropin more recently.

In view of these findings the theory is proposed that ovulation is normally
a two-stage phenomenon. During the first stage follicles reach ultimate
ovulatory size, which is determined by the total available circulating tropic
hormones, distributed in the follicular circulatory system in accordance
with the vascular capacity of individual follicles. One indication that the
amount of circulating hormone limits follicular size is the fact that, in both
mammals and birds, follicles can be caused to grow beyond their normal
ovulatory size if exogenous gonadotropic hormone is injected. In the chicken
the normal follicular size hierarchy can be easily obliterated by the injection
of exogenous gonadotropins (Nalbandov, 1959). The individual vascular
system of avian follicles is thus seen as playing a vital role in determining
the rate of follicular growth. As the largest follicle approaches its ovulatory
size, the amount of blood flowing through its vascular system is thought to
be proportionally less than the amount available to smaller follicles. If this
assumption is correct (preliminary observations support it) then the amount
of hormone available per unit of follicular cells is also lower in the largest
follicles than in the smaller ones. Because of this reduction in the concentra-
tion of gonadotropic hormones, the largest follicle is viewed as having
reached a stage of "physiological atresia", during which hormone concentra-
tion is inadequate to maintain active proliferation of the cellular components

Fig. 3. Ovary of hypophysectomized hen remains atretic with inadequate gonadotropic
hormone support (0.25 mg of chicken pituitary day for 3 days).

Fig. 4. 0\ary of hypophysectomized hen restored to normal appearance with 4.0 mg of
crude chicken pituitary/ day for 3 days.

Fig. 5. Ovary of hypophysectomized hen ovcrsiimulatcd by injection
' ol" 2 I.U. FSH/day for 6 days.

Fig. 6. Multiple o\ulations induced in a hypophysectomized hen
injected with mammalian LH 6 to 12 hr after opeiation.

Mechanisms Controlling Ovulation of Avian and Mammalian Follicles 129

of follicles. The distinction then is that during the hormone-adequate phase
follicles are capable of rapid growth but are incapable of ovulating, while
during the hormone-inadequate phase they are in a stage of physiological
atresia when they can be made to ovulate because they are physiologically
essentially "inactive". If follicles remain without adequate gonadotropic
support too long, physical atresia sets in and they become incapable of
ovulating for obvious reasons.

The stage of "physiological atresia" which, according to the theory pro-
posed, is viewed as being due to a deficiency of gonadotropic hormone is
relatively prolonged, lasting days in mares and rabbits, and hours in other
mammals and in chickens. It is also distinguished by the fact that during
this phase follicles can ovulate at any time after they receive the LH-born
signal to do so. This view is supported by the experimental evidence presented
which shows that follicles, which have become ovulable as a result of hormone
withdrawal following hypophysectomy, can be made non-ovulable if they
receive support in the form of small or moderate doses of FSH-containing
hormones which presumably prevent them from becoming "physiologically
atretic" and hence ovulable.

The question now arises what physiological changes take place in the follicle
wall and especially in the stigma of follicles which are in the phase of physio-
logical atresia and which have received the signal that ovulation shall occur
about ten hours later.

The tentative theory is proposed that the effect of LH may be that of
causing either general follicular ischemia, or local ischemia which is restricted
to the stigma of follicles. In normal hens ovulation is demonstrably preceded
by a blanching of the wall of the follicle destined to ovulate, the stigma widens
measurably and the capillaries extending across it constrict. Eventually a
small rip appears in one corner of the stigma and the ovum bulges through it.
The rip widens and the ovum slips out of the follicular sac which collapses.
These conclusions are based on subjective but numerous observations which
do not lend themselves easily to quantitative measurements. Experiments
now in progress are designed to test the theory that ovulation is the result
of ischemia, although it is recognized that if ischemia is restricted to the
stigma area of the follicle, it will be difficult to measure minor differences in
the amount of blood present, especially in the smaller mammalian follicles.

In laying hens the mature follicle may be maintained in the ovulatory
state over prolonged periods of time. In hypophysectomized hens this can
be done by supporting the mature follicle with FSH-containing hormones. If
the dose of supporting hormone injected is chosen correctly, the follicle will
not ovulate nor will it become atretic. However, if an ovulatory dose of LH
has been administered to hens containing follicles which have reached the
"physiological atresia" stage, their ovulation cannot be prevented if support-
ing FSH treatment is begun at the time of hypophysectomy. These as yet

130 A. V. Nai hanoov

incomplete observations are interpreted to mean that the process of "physio-
logical atresia" is inevcrsiblc and that follicles which have reached that stage
have three possible fates they can be maintained in that piiase with small
doses of l^'SH-containing hormones, they can ovulate in the presence of LH,
or they can become physically atretic in its absence.

If gonadotropic hormones are injected into laying hens, ovulations are
stopped and, depending on the dose of hormone injected, the ovary will be
slightly stimulated or overstimulatcd. Ovulations will be held in abeyance
until in injection which will cause the ovulation of one or more follicles, all
of which will iinariably be near normal ovulatory size. These observations
are cited as additional evidence for the contention that immature follicles
receiving adequate gonadotropic hormone support are incapable of ovulating.
Only those follicles which have reached ovulatory size and are too large (or
too numerous in cases of superovulations) lo be adequately supplied by
gonadotropic hormone are capable of ovulating in response to ovulatory
doses of LH.

While additional work will have to be done, much of the evidence presented
for birds appears applicable to mammals. Meanwhile it is impossible to
discuss the subject in detail until additional evidence is obtained.

SUMMARY AND CONCLUSIONS

Data are presented to show that ovulability of follicles is significantly
greater in hypophysectomized hens than it is in normal controls, and that
the rale of ovulation increases as the interval from hypophysectomy to LH
injection increases. The sensitivity of follicles to l.H is increased in hypo-
physectomized hens and is significantly greater 12 hr after operation than
at 6 hr.

While it is never possible lo induce multiple ovulations or to cause ovula-
tions ol' immature follicles in inlacl hens not treated with hormones, this can
be done consistently in hypophysectomi/ed laying hens.

On the basis of these data the theory is proposed that ovulation is normally
due to non-support of the mature follicle by gonadotropic (FSH-containing)
hormones. This hormone withdrawal makes them capable of ovulating if
they receive the signal (LH) to do so.

The theory further proposes that LH acts on the ovulable follicle by causing
general or localized ischemia which results in necrosis of the stigma and leads
to its eventual rupture.

Comparative studies on the rate of blood How through mammalian and
avian follicles in relation to time of ovulation are being continued.

REFERENCES

1. Bergeus, a. C. J. and C. H. Li, Amphibian ovulation /// vitro induced l^y mammalian

pituitary hormones and progesterone, Eiulociiiiolo}^}' 66, 225, 1960.

2. Brinkhv, H., Unpublished data, I960.

Mechanisms Controlling Ovulation of Avian and Mammalian Follicles 131

3. Db'SHKiND, S., Observations on the mechanism of ovulation in the frog, hen and rabbit,

Western J. of Surgery Ohst. and Gynec. 55, 424, 1947.

4. EvtRETT, J. W., The time of release of ovulating hormone from the rat hypophysis,

Endocritwh^y 59, 580, 1956.

5. Fee, A. R. and A. S. Parkes, Studies on ovulation, f. The relation of the anterior

pituitary body to ovulation in the rabbit, /. Physiol. 67, 383, 1929.

6. Hartman, C. G., Ovulation, fertilization and the transport and viability of eggs and

spermatozoa, Sex and Internal Secretions, 2nd Ed., Williams and Wilkins, N.Y., 1939.

7. HiSAW, F. L., Development of the Graafian follicle and ovulation, Physiol. Rev. 11,

95, 1947.

8. Huston, T. M. and A. V. Nalbandov, Neurohumoral control of the pituitary in the

fowl, Endoerinoloffv 52, 149, 1953.

9. Nalbandov, A. V., Neuroendocrine reflex mechanisms. Bird ovulation. Comparative

Endocrinology, John Wiley & Sons, N.Y., 1958.

10. Neher, B. N., M. W. Olsen and R. M. Fraps, Ovulation of the excised ovum of the

hen, Poultry Sci. 29, 554, 1950.

1 1. RuGH, R., Relation of the intact pituitary gland to artificially induced ovulation, Proc.

Soc. Exptl. Biol. Med. 40, 132, 1939.

12. Van Tienhoven, A., The duration of stimulation of the fowl's anterior pituitary for

progesterone-induced LH release. Endocrinology 56, 067, 1955.

13. Wright, P. A., Factors affecting in vitro ovulation in the frog, J. Exptl. Zool. 100, 565,

1945.

14. Wright, P. A., Sensitization of the frog ovary following hypophysectomy, Physiol.

Zool. 19, 359, 1946.

DISCUSSIONS

Dr. Roland K. Meyer: I shall begin with an analysis of the tissues that compose the wall
of the follicle in the bird; the stratum granulosum is involved in the secretion of yolk
and perhaps progesterone, the theca interna in the production of estrogen; the smooth
muscle elements are contractile. Dr. Nalbandov has used menstruation as a model in
describing his concept of the mechanisms involved in ovulation in the bird. I would
like to use as a model the myometrium during pregnancy as it develops in preparation
for the expulsion of the fetus.

The development of the myometrium is influenced by both estrogen and progesterone,
as produced in early pregnancy by the ovary, later by the placenta. I suggest that the
smooth muscle cells in the wall of the follicle are likewise stimulated by estrogen and/or
progesterone produced in the adjacent theca interna and/or granulosum. The smooth
muscle elements are thus developed in preparation for the expulsion of the ovum which
is progressively increasing in size as the yolk is secreted. As in the pregnant uterus, the
wall of the follicle is subjected to increasing tension as the ovum increases in size. Just
prior to ovulation in the bird, under the inlluence of FSH and small amounts of LH,
progesterone is increased causing the release of larger amounts of LH, which causes a
further increase in distension of the follicle wall and tension of the smooth muscle. It
is postulated, as in the uterus at parturition, that under the influence of estrogen and
progesterone the muscle coat has become fully developed and begins to contract as
the optimum degree of stretching is reached.

As a consequence the vessels in the wall of the follicle are compressed and ischemia
occurs, especially in the stigma. The stigma disintegrates, and the contracting follicle
wall expels the ovum through the opening.

This concept is based on the assumption that ovulation is the result of an integrated
interaction of physical factors which are developed in the tissues of the follicle under
the positive influence of hormones. Unlike Dr. Nalbandov's explanation it does not
involve any elements of hormonal deprivation, or follicular atresia.

I have presented these thoughts as elements of a working hypothesis, even though
Dr. Nalbandov has stated that intrafollicular pressure and the smooth muscle of the
follicle are not considered to be very important factors in ovulation in birds.
Dr. Andrew V. Nalbandov: Well, in general, I am in sympathy with what Dr. Meyer
has said. It is hard for me to conceive of an ischemia, which would not lead to some
mild atresia, if you want to call it that.

I am grateful for your remarks, and the only thing I can say is that we will continue
to work on it and see what come out of it.

132

OVULATION IN THE DOMESTIC FOWL

Richard M. Fraps

Agricultural Research Service, U.S. Department of Agriculture
Beltsville, Maryland

Observations and experiments on many species have contributed much to
our knowledge of various aspects of ovarian development and ovulation in
birds. The common domestic fowl is, however, the only avian species for
which we have today any fairly substantial and coherent perspective — incom-
plete though this may be in many respects — of processes directly and in-
directly involved in ovulation.

A number of arguments might be advanced for the seemingly dispropor-
tionate concern with ovulation in the fowl, including such things as this bird's
ready availability, adaptability to experimental conditions and procedures,
and possession of convenient external indices of gonadal function (65). But
in addition to these obviously desirable attributes, the domesticated hen
continues to ovulate over much of the year, she does so in definite patterns
so arrayed as to constitute recurring cycles of considerable experimental
significance and, not least in importance, the time of most ovulations may be
predicted with a high degree of accuracy.

With good cause the hen thus deserves its favored position in the study of
ovulation in birds. Nevertheless, a sound knowledge of the physiology of
ovulation in birds can scarcely be based on any single species, and it is
regrettable that so Httle is known regarding these complex and undoubtedly
diversified phenomena among other species, and more particularly in wild
birds exhibiting restricted breeding seasons. This broader comparative know-
ledge seems all the more desirable in view of the suspicion that the domestic
hen has been so highly selected for egg production that her reproductive
processes can no longer be regarded as representative of birds generally and
of wild birds more specifically.

It is true that broody and incubation behavior have been greatly reduced
in many contemporary breeds of fowl, but the same can be said of those wild
species, such as the American cowbird and the European cuckoo, in which
brood parasitism has become established. It is also true that processes
responsible for follicular growth, maturation and ovulation proceed more
intensively in the contemporary domestic fowl than in her wild forebears, but
this can hardly be held to signify any qualitative change in underlying

133

134 Richard M. Fraps

mechanisms embodied, for example, in nervous, neuroendocrine and endo-
crine controls over ovarian function. These mechanisms may indeed be
basically much alike in all avian (and mammalian) species, despite the great
and obvious diversity of reproductive patterns exhibited by dilTering species.
For the time being, therefore, it seems reasonable to suppose that ovulation
and related processes in the domestic fowl proceed from and are mediated
through mechanisms fundamentally similar in all avian species, however
peculiar or unique or even artificial some final expressions of reproductive
processes may appear to be.

FOLLICULAR-PITUITARY RELATIONSHIPS

Ovarian function in the fowl and in most birds differs in at least two
obvious respects from that of mammals, as Nalbandov (44) has recently
emphasized. The ovarian complement of developing follicles consists typically
of an array which exhibits well-defined differences in size, not of a group
comparable in size through successive developmental stages as is commonly
seen in mammals. Of the bird's complement, only a single follicle, the largest
of the series, matures and is ovulated at a time. In contrast, the simultaneous
maturation and ovulation of a number of follicles is typical of mammals.
Nalbandov has called attention particularly to the point that birds must be
assured of "an endocrine mechanism permissive of the existence of a hierarchy
of follicles of graded sizes, only one of which is capable of ovulating at any
one time". Experiments directed toward the imposition and maintenance of
the typical follicular hierarchy in the hypophysectomized hen by simulation
of the naturally occurring "endocrine mechanism" are discussed by
Nalbanov elsewhere in this volume. Of more immediate concern here are
relationships between follicular development, maturation and ovulation in
the intact hen, relationships which require, to begin with, some understanding
of timing of these processes. Various aspects of the subject have been dis-
cussed earlier (15-17, 37).

The Ovulation Cycle

Under optimal (12-14 hr) photoperiods, the hen typically lays an egg on
each of two or more consecutive days, does not lay on one day and then lays
again on two or more consecutive days. The eggs thus laid on consecutive
days constitute a sequence (often but wrongly called a clutch). In sequences
of low to moderate length (2 to about 8 eggs), the first egg is laid during early
morning (or lighted) hours, subsequent eggs at later hours on successive
days until the sequence is completed with lay of a terminal egg during
afternoon hours. The interval between successive eggs of a sequence is thus
somewhat greater than 24 hr; the term lag has been proposed (15) to describe
the difference between the interval separating lay of consecutive eggs and

Ovulation in the Domestic Fowl

135

24 hr. Stated differently, lag is simply the difference in times of day at which
successive eggs are laid.

Time of oviposition, particularly in battery-caged hens, may be recorded
within almost any desired limits of accuracy. From such records of lay,
the time of ovulation of individual follicles constituting the corresponding
ovulation sequence may be estimated with fair accuracy. Briefly, each ovula-
tion except the first of a sequence occurs at a definite interval, of the order of
15-45 min and varying inversely with sequence length, following the pre-
ceding oviposition. The first ovulation of a sequence takes place on the day
before the second, and earlier than the second by not less than the extent
of lag between next to terminal and terminal ovipositions. These relationships
have been described in detail elsewhere (17).

Times of ovulation so calculated for White Leghorn hens, maintained under
lights from 6.00 a.m. through 8.00 p.m., and ovulating in sequences of two
to six members, are recorded in Table 1. Ovulation of the first member of

Table 1 . Times of Ovulations in Sequences of 2 to 6 Members, White Leghorn Hens

UNDER 14-HR PhOTOPERIOD (LiGHTS 6.00 A.M.-8.00 P.M.)

Ovulating follicles*

6.38*

11.10

—

5.58

9.56

12.39t

—

5.49

9.17

11.16

1.12

—

5.48

8.56

10.34

12.02

1.33

—

6.05

8.57

10.55

12.02

12.49

2.14

* From Fraps (17).

t Light faced figures, morning hours ; bold faced figures, afternoon hours.

sequences at about 6.00 a.m., the hour of onset of lights, is of no significance.
Under relatively lengthy photoperiods (e.g. 18 hr light), the first ovulation
takes place well after onset of lights. Under relatively short photoperiods
(e.g. 10 hr), it occurs sometime before onset of lights.

The extent of lag between successive members of the sequences for which
actual times of ovulation were given in Table 1 are recorded in Table 2,
together with total lag within the sequences — the difference, that is, in times
of day between first and terminal ovulations. Total lag obviously increases
with sequence length, but to a lesser extent in the longer sequences. In even
the lengthiest of sequences, total lag rarely exceeds some nine hours.

Heywang (33) published extensive data on intervals between lay of succes-
sive eggs by White Leghorn hens maintained under natural photoperiods for
a year at Glendale, Arizona. Lag in ovulation sequences of 2 to 13 members
has been calculated from these intervals and is presented graphically in Fig. L

136

Rk IIAKD M. FRAPS

Table 2. Lag (in hours) in Ovulation Sequences of 2 to 6 Members,
BASED ON Times recorded in Table 1*

Lag at successive places

Tnf al

h«

lag

2
3
4
5
6

4.53
3.97
3.47
3.13

2.87

2.72
1.98
1.63
1.97

1.93
1.47
1.12

1.52
0.78

1.42

4.53
6.68

7.38
7.75
8.15

* From Fraps (17).

The solid columns of each vertical bar measure lag, in hours (ordinates),
between successive ovulations; the solid plus superimposed open columns
measure the cumulative lag at third and subsequent places in the several
sequences; total lag is so indicated at the last place in each sequence.

SEQUENCE LENGTH

Fig. 1. Lag in ovulation sequences of 2 to 13 members. Solid bars, lag at successive places
in each sequence; solid with lined bars, cumulative lag. (From Fraps (17).)

Several characteristics of ovulation sequences are illustrated by these
histograms. The greatest value of lag appears in the two member sequences,
where there is, of course, only one place of lag, that between first and second
ovulations. In all other sequences the greatest value of lag is between first

Ovulation in the Domestic Fowl 137

and second ovulations, though this decreases as the number of members in
sequences increases from three to around seven or eight. But with this decrease
in lag between first and second ovulations with increasing sequence length,
there occur decreases in lag at subsequent positions, all of which become
fairly constant in sequences of seven or eight or more members. At sequence
lengths greater than seven or eight members, an increasing number of lag

0 24 46 72 96(0) 24

Ci \ ,-' Cz\ / CjA /' C|- \ ,' CzN

Ol' 02'

Fig. 2. Time relationships in a 4-day cycle (« = 3). Hours of darkness (8.00 p.m.-6.00 a.m.)
are set off by the vertical stippled bands. The days of the cycle, top of the figure, are each
divided in an "open" period and a period of lapse, p and q respectively on the last day of
the cycle (hours 72-96). Subscripts denote successive events or members: R, onset of
OIH releases; C, follicles; O, ovulations; L, ovipositions; M, "maturation curves" of
the follicles. Q indicates the approximate hour of excitation and onset of OIH release if
the sequence were continued. Primed designations apply to the succeeding cycle. Other
details in text. (Based on Fraps (16, 17).)

values approach or equal zero following decreasing order of lag in the first
several places. The interval between successive ovulations is then 24 hr.
Theoretically, at least, the number of members in a sequence may be increased
indefinitely with little or no increase in total lag beyond that seen in sequences
of some seven or eight members. It may be noted that lag always increases in
the terminal place or two before these lengthy sequences are terminated.

In regularly ovulating hens, the termination of one ovulation sequence on
a given day is followed almost invariably by the initiation of another sequence
on the second day thereafter; ovulation fails to occur, that is, on only a single
day. This single day on which ovulation fails to occur may be denoted con-
veniently as the day of lapse. Unless otherwise stated, we shall be concerned
with the interim between the terminal ovulation of one sequence and the
initial ovulation of a succeeding sequence only in this limited sense.

In Fig. 2, successive ovulations in a 3-member sequence are represented
by Ol, O2 and O3, the first and second ovulations of a succeeding sequence by
0( and Og. Lag of the second ovulation with respect to the first is indicated by
hOo, and of the third ovulation with respect to the second by hOg. Ovipositions

138 Richard M. Fraps

consequent upon successive ovulations are designated Lj, Lg and L3 and lag
by liLo and liLg. The time required for the egg to traverse the oviduct is
practically, if not quite, equal to the interval between a given ovulation
and the corresponding oviposition.

Ovulation Frequency

In hens exhibiting the typical "one day" lapse between sequences of n
members, ovulation frequency (/) is defined as /=/?/(/?+ 1 ), where /7+I is
equal to cycle length in days. The limit approached by nj(n+ 1) is unity. The
equation /=/;/(«+ 1) therefore expresses, for differing values of n, the
frequency of ovulation relative to the limit 1. In the 3-day cycle which has
proved so useful in much experimental work, n = 2 and /= 2/3 or 0.67. The
value of/ becomes 0.75 in the 4-day cycle, 0.80 in the 5-day cycle and so con-
tinues to increase by constantly decreasing increments as cycle length
increases. Since nj{n+ I) can only approach 1 as a limit, ovulation frequency
in the lengthiest of cycles can never quite attain 1.5 times the value of/ in the
3-day cycle. In the 2-day cycle, n= 1 and njn-\- 1 =0.50; birds so ovulating on
alternate days are not considered here because of the difficulty in predicting
continuation of the cycle. It is of interest to note, however, that hens ovulating
at this minimal rate or frequency (for the 1-day lapse) are in fact ovulating at
0.5 the maximal attainable frequency. Ovulation frequency thus measures a
fundamental aspect of the cycle which is obscured by sequence or cycle length
as such. The significance of ovulation frequency in other connections will
become apparent later.

Follicular Maturation and OIH Release

It has been assumed rather generally that the pituitary gonadotropin
directly responsible for ovulation in the intact hen is the luteinizing hormone
(LH), and further, the pituitary has been supposed by this author, at least,
to release LH episodically, and specifically for ovulation, in greater than the
"basal" quantities which, together with the follicle-stimulating hormone
(FSH), are required for follicular growth and maintenance. Recently, how-
ever, Nalbandov (44) has postulated for birds the existence of a single gonado-
tropic complex with FSH- and LH-like properties. A similar view has been
advanced by van Tienhoven (65) on somewhat different grounds.

Evidence for the view that LH is the pituitary gonadotropin immediately
responsible for the induction of ovulation in the intact hen has been reviewed
elsewhere (17). Briefly, LH preparations from sheep pituitaries were found
to be much more effective than were FSH preparations from the same source,
and the latter were effective only when administered at levels high enough to
carry appreciable quantities of LH (23). Fractionation of male chicken
pituitaries yielded an LH preparation roughly 500 times more effective than
was the FSH fraction (26), and again, the ovulation-inducing effect of the

Ovulation in the Domestic Fowl 139

FSH preparation could well be attributed to contamination with LH. On the
basis of these results, Fraps et al. (26) concluded that the luteinizing fraction
was "identical with the avian ovulation-inducing gonadotropin".

It is of some interest in connection with the proposed unitary concept that
similar ratios of gonadotropic activity were found in the pituitaries of cocks,
non-laying hens and laying hens when the glands were assayed for FSH
content mainly (55) or for ovulation-inducing eflFect (13).

Insofar as relationships between follicular maturation and release of
ovulation-inducing hormone (OIH) are in question, it is perhaps of little
importance whether we think in terms of LH or of the postulated gonado-
tropic complex. What is important is the timing of OIH release with reference
to follicular maturation and, to anticipate the final issue, whether or not the
timed release of OIH is under control of the central nervous system.

Returning to Fig. 2, the relationships believed to exist between follicular
maturation, OIH release, and ovulation are represented schematically for the
4-day ovulation cycle described earlier. Onset of OIH release during the first
"day" of the cycle is indicated by Rj; OIH acts on the mature follicle, Q,
to effect the first ovulation, Oi, of the cycle. In similar fashion, OIH releases
associated with Rg and Rg induce ovulation of the Cg and Cg follicles. No
release of OIH occurs on the following day, but does so on the day thereafter,
Ri' initiating a succeeding cycle.

As thus formulated, the onset of OIH release is assumed to take place at
an approximately constant interval before each corresponding ovulation of
the cycle. It follows that lag at Rg and Rg, indicated by hRg and hRg, are
the same as lag at Og and Og. And since all ovulations, whatever the length
of sequence, occur within restricted hours of the 24, the onset of correspond-
ing OIH releases must occur within similarly restricted, but earlier, hours of
the 24. Days of the cycle given in the topmost lines of Fig. 2 refer to this
aspect of the OIH release cycle, not to ovulation as such. Onset of OIH
release may occur within hours 0-8 or so of the cycle day, not during remain-
ing hours of the 24, set off by the horizontal bars near the top of Fig. 2.
The hours of the 24 during which onset of OIH release may occur have been
denoted the release or open period, the remaining hours the period of
lapse (17); these are indicated by p and q respectively between hours 72 and
96 (day 4) of the cycle.

To result in ovulation, the presence of a mature or ovulable follicle
obviously must be posited at the time of each OIH release; it does not follow
that the presence of an ovulable follicle is closely associated with OIH
release. Once a cycle is initiated with OIH release for ovulation of the Ci
follicle, successive follicles of the sequence must mature within the interval
(24 hr + lag) separating successive releases of OIH. The fact that this is so
seems obvious in the observation that, at the time of a given OIH release
(e.g. Ri of Fig. 2), the follicle next due to ovulate remains completely

140

RlCllAKl) M. FRAPS

indifferent to the ovulatory stimulus, yet the same follicle responds by
ovulation to the succeeding 01 H release, Ro of the sequence.

In our early experiments on the induction of ovulation, injections were
timed for effect on follicles subsequent to the lirst of a sequence (C^ follicles),
since in these the hour of normally expected ovulation could be predicted
accurately. When subsequently the response of the Ci follicle was investigated,
it was found — somewhat surprisingly at the time — that its ovulation could
be induced at considerably greater intervals before normally expected ovula-
tion than was possible with other follicles of the sequence (14, 21, 22). Or,
following injection of appropriate gonadotropins at equal but considerable
intervals before the hour of normally expected ovulation of C^ and Q
follicles, the C^ follicle was found to be much the more sensitive, as was
confirmed by Bastian and Zarrow (3). A similar differential in ovulatory
response of Ci and Q follicles to progesterone was described by Fraps
and Dury (23, 24).

Table 3. Approximate Quantities (mg/hen) of Male Chicken Anterior Pituitary
Powder Inducing Ovulation of Cj and C^ Follicles in about 50% of Intravenously
Injected Hens at Indicated Hours Following Preceding Ovulation (/7 = 2 for

ALL hens)

Hours from preceding
ovulation

"Best estimate" of 50% ovulation level

Ci follicle

Ca follicle

7
10
13
16
19

0.50
0.15
0.05
0.02
0.02

0.20
0.15
0.10-0.15
0.02
0.02

When the earliest hour at which notable sensitivity of the Cj follicle could
be demonstrated experimentally was considered with reference to time of
preceding ovulation rather than to time of next expected ovulation, its high
ovulability was seen to be attained at about the same interval following the
preceding ovulation as did subsequent follicles of the sequence. This supposi-
tion was tested by ascertaining the quantity of dried male chicken anterior
pituitary powder required to force ovulation of Cj and Cg follicles of
2-member cycles in about 50% of hens injected at increasing intervals follow-
ing the preceding ovulation. [Unpublished experiments of Fraps, Rothchild and
Nehcr; summarized by Fraps (17).] The "best estimate" of responses follow-
ing closely upon preceding ovulation leaves much to be desired, but ovulability
of Ci and Ca follicles clearly increases with increasing time from preceding
ovulation (Table 3). The similar and high sensitivities at 19 hr seem of particu-
lar significance, for following injections at this interval after the preceding

Ovulation in the Domestic Fowl 141

ovulation the C, follicle is forced to ovulate prematurely by no more
than about 3 hr in contrast with a prematurity of some 17 hr for the Q
follicle.

In an extensive series of experiments, Bastian and Zarrow (3) determined
the quantities of luteinizing hormone required to induce ovulation of first
and subsequent follicles of the sequence at stated intervals before the hour
of expected normal ovulation. Their results were in important respects very
similar to those described above, although they appear not to have recog-
nized the possibility of similar courses in maturation of Cj and Q follicles
with reference to hour of preceding ovulation. The possibility that failure of
the highly ovulable Cj follicle to ovulate earlier than it actually does because
of "lack of release of ovulating hormone" (14) is noted, but Bastian and
Zarrow consider also, and with greater favor, the possibility that the observed
high degree of sensitivity could be the result of "a release of the ovulating
hormone on the night prior to ovulation", but at levels inadequate to induce
ovulation. If, however, the course by which the Ci follicle attains ovulability
is in fact substantially the same as that of Cg follicles, no special condition
need be postulated for this fact, nor for its continuing and perhaps even
slightly increasing sensitivity to OIH preparations as it approaches the hour
of actual ovulation.

The foregoing observations are believed, in any event, to afford strong
evidence for the conclusion that the Ci follicle does in fact attain to ovulability
by substantially the same course, with reference to time of preceding ovula-
tion, as do other follicles of the sequence. In Fig. 2 the curves Mg, Mg and M/
are seen thus to stand in an approximately constant relationship with ovula-
tions Oi, O2 and O3 respectively. But since the onset of OIH release is believed
to take place at a constant interval before each ovulation of the cycle, the
courses of increasing ovulability represented by Mg, M3 and M/ bear also an
approximate constancy with respect to the postulated OIH releases, Ri, Rg
and R3. The question might then be raised as to whether OIH, or endocrine
factors associated with processes of follicular rupture, initiate maturation of
the succeeding follicle of the cycle. This author has more or less tacitly
assumed that OIH is the effective agent, but little evidence bears directly on
the issue. If the pituitary gonadotropin secreted into the blood stream is in
fact a single entity, as Nalbandov (44) and van Tienhoven (65) suggest, an
episodic release of OIH would imply relatively high levels of FSH as well as
of LH activity. The initiation of follicular maturation might then be attributed
to such episodically recurrent periods of high FSH activity, but this must
remain a matter of conjecture at the moment.

Pituitary Competence during the Period of Lapse

In Fig, 2, the Ci' follicle is seen to have become fully ovulable at about
the time Q, the interval between R3 and Q being made the same as between

142

Richard M. Fraps

Rg and R;,. If the OIH release sequence were continued in correspondence
with the foMicular maturation sequence, OIH release should therefore be
expected at or about the time of Q. Failure of OIH release to take place at
this time, or at any time during the period of lapse, might signify lack of
OIH reserves in the pituitary, or failure of the pituitary to respond to usual
stimuli. The possibility of OIH secretion at subovulatory levels, one aspect
of pituitary inadequacy, may reasonably be dismissed at the outset, since
subovulatory levels of ovulation-inducing gonadotropin have been shown to
result in follicular atresia (3, 21, 22), a condition rarely seen in the regularly
ovulating hen.

Table 4. Ovulations Added to Anticipated 2-member Sequences Following Successlve
Injections of Male Chicken Anterior Pituitary Tissue (AP) or Progesterone (Pg)

Injection

Ovulations added

Group

Hens

No.

Hormone

Quantity
mg

Interval
hr

Per hen

No.

Range

No.

1.0

2.4

0-5

1.0

3.0

1-5

0.3

2.0

0-5

0.6

2.5

1-5

0.9

2.5

From Neher and Fraps (45).

Evidence to be assessed later supports the view that progesterone effects
ovulation in the hen by way of the central nervous system, stimuli from which
cause the release of OIH from the pituitary. The induction of ovulation follow-
ing the systemic administration of progestcione at or about the time of C^
follicle maturation (Q of Fig. 2) should therefore signify pituitary competence.
In an attempt to ascertain the extent to which the two-member ovulation
sequence might be prolonged, Neher and Fraps (45) injected progesterone or
male chicken anterior pituitary tissue some 24-28 hr following the presumed
hour of terminal OIH release and repeated such injections at 24-, 26- or
28-hr intervals until the ovary failed to respond by ovulation. As is evident
from results recorded in Table 4, progesterone was about as effective as was
the pituitary preparation in extending the ovulation sequence, both in mean
number of induced ovulations per hen and in the upper limit attained in
some hens. Failure to induce more than about 5 successive ovulations follow-
ing progesterone injection was most probably caused by failure to maintain
the sequence of maturing follicles, not by failure of the pituitary to release
OIH, since the same upper limit also was encountered following injection

Ovulation in the Domestic Fowl 143

of the pituitary preparation. This view is borne out by the decreasing order
of yolk weights in the lengthier successions of induced ovulations. Mean
weights of the second normally ovulated and the succeeding four yolks for
the 13 hens in which ovulation was induced 4 times or more were 17.4, 16.8,
16.2, 15.5 and 14.3 g. The mean difference between first and last members of
the series, 3.1 g, suggests that the secretion of FSH (or of the gonadotropic
complex) did not keep pace with the enforced demand for follicles capable of
maturation and subsequent ovulation.

In any event, the level of pituitary response elicited repeatedly by pro-
gesterone at or near onset of the period of lapse lends no support to the view
that the normal ovulation sequence is terminated by pituitary inadequacy,
the period of lapse representing, as it were, a period of recovery (44). On the
contrary, onset of the period of lapse seems to indicate the abrupt intervention
of conditions which prevent response of an entirely competent anterior
pituitary to stimuli which otherwise are closely associated with the presence
of a mature follicle. And perhaps the resumption of ovulation, at a definite
hour of the 24 under a given photoperiod, constitutes equally cogent evidence
for a similarly abrupt termination of the conditions which impose the period
of lapse. If the relationship between mature follicle and pituitary response
seen during the course of the ovulation sequence depends upon a nervous
relay, so to speak, this relay appears not to respond, during the period of
lapse, to the usual stimuli associated with follicular maturation. OIH release
therefore fails to occur for lack of nervous activation of the pituitary, not
because of any defect in pituitary function. Evidence for this view will now
be considered.

NERVOUS CONTROL OF OIH RELEASE
Basically, the anatomical and functional relationships between the hypo-
thalamus and the pituitary appear to be much the same in birds and in
mammals. The absence of direct nervous connections between hypothalamus
and pars distalis and the existence of a well-developed portal system (30) is
firmly established in birds (29, 67). In birds, the neurohypophysis is separated
from the adenohypophysis by a connective tissue septum, thus eliminating, as
Harris (31,32) has emphasized, any possibility of vascular control of the
anterior pituitary by the neurohypophysis. In his comprehensive monograph
on the avian pituitary, Wingstrand (67) described the tracts from the hypo-
thalamus to the neurohypophysis and along their course, a special region of
the median eminence in the ventral wall of the infundibulum, notable for its
content of neurosecretory material. From this region the pituitary portal
vessels pass to the anterior pituitary. Wingstrand, as did Green and Harris
earlier (30), concluded that hypothalamic control of the anterior pituitary
was effected by transport of some neurohumor from this region of the median
eminence to the secretory cells of the pituitary.

144 RiC HARD M. FRAPS

Experimental evidence, based largely on mediation of the effects of light
to the gonads, strongly supports the conclusions of Wingstrand (67) and
Green (29). From a series of experiments on the drake, the results of which
were considered in two general papers, Bcnoit and Assenmacher (5, 6) con-
clude that lengthened photoperiod is no longer capable of inducing the usual
gonadotropic response of the anterior pituitary deprived of blood from the
specialized region of the median eminence. In two recent papers Assenmacher
(1) and Benoit and Assenmacher (7) have emphasized again the dependence
of gonadotropic function on the integrity of neurosecretory regions in the
hypothalamus, of the hypothalamico-hypophysial tract to the special zone
of the median eminence, and of the anterior portal vessels forming the final
link with the anterior lobe.

Hypothalamic-pituitary relationships have been investigated recently in
the male white-crowned sparrow, with special reference to neuroendocrine
functions in relation to photoperiod and gonadal response (46). The observa-
tions described by Oksche et al. are in accord with those of earlier
workers.

In the regularly ovulating hen, Shirley and Nalbandov (61) reported
complete interruption of the portal vessels to result permanently in "a condi-
tion indistinguishable from hypophysectomy as far as the ovary and the sex
hormone-dependent structures are concerned". Neurohypophysectomy, on
the other hand, had no such effect and, following an adequate recovery
period, ovulation proceeded at the same rate as in unoperated controls
(62).

As was noted earlier, these and other investigations have been concerned
mainly with seasonal or long-term gonadal responses, mostly to light, and
therefore with control of continuing secretion of pituitary gonadotropins.
The problem posed by OIH release may, at first sight, appear to be different
in some respects. The release of OIH is believed to be episodic, and to occur
in response to a specific stimulus of follicular or ovarian origin. It is at least
conceivable that such a stimulus, of "internal origin", might act directly on
the pituitary to cause the release of OIH. However, there is now good evidence
that this is not the case: whatever the stimulus for OIH release, it appears
to act initially at a neural level, thence over neuroendocrine pathways to the
anterior pituitary gland. This is not to say that the ovarian hormones may
not influence the anterior pituitary gland directly, but only that this appears
not to be true of OIH release.

Photoperiod and the Period of Lapse

We have called attention earlier to the highly significant circumstance that,
during most or all of the period of lapse, the ovary carries an ovulable follicle
and the pituitary is responsive to progesterone. What seems to be lacking is
some definitive connection between follicle and pituitary, a connection

Ovulation in the Domestic Fowl 145

dependent upon some element which is responsive to the follicular (or
ovarian) stimulus and which also can activate the anterior pituitary. More-
over, the period of lapse appears in a relatively constant relationship with
certain phases of photoperiod; it is in fact one aspect of the diurnal rhyth-
micity so evident, under a wide range of photoperiods, in the restriction of
ovulation or OIH release to certain hours of the 24. Considering these
relationships together, one would almost inevitably have to conclude that
the suspected non-functional link seen during the period of lapse between
follicle and pituitary was nervous in nature. No other structure or entity
could be expected to possess the characteristics apparently required to pre-
vent OIH release during an interim so closely associated with photoperiod.
One might therefore conclude that OIH release, when it occurs naturally,
does so over nervous and neuroendocrine pathways, the nervous component
becoming operative in association with specific phases of photoperiod. How-
ever simple and attractive such an argument may seem in retrospect, it does
not afford rigorous experimental evidence that OIH release is in fact dependent
upon neural activation of the pituitary, nor could it tell us what nervous
structures are essential.

Effects of Pharmacological Agents

Presumptive evidence pointing to neural participation in the mechanism
of OIH release is based on effects of pharmacological agents believed to act
at a nervous level. Much of this work, it should be noted, was inspired by
results described by the Duke University investigators in the rabbit and the
rat.

Progesterone has been used extensively in these investigations, and effects
on normally incident and progesterone-induced ovulation will be considered
together.

Nembutal (pentobarbital sodium), amongst other barbiturates, was shown
by Everett and Sawj^er (11) to block LH release in the rat. Everett subse-
quently (10) demonstrated Nembutal blockade of the LH release induced by
progesterone in 5-day cycling rats. In the hen, however, Bastian and Zarrow (2)
were unable to prevent either normally incident or progesterone-induced
ovulation by the administration of Nembutal. It was later observed by
Fraps and Case (19) that Nembutal, Dial (diallylbarbituric acid) and Ipral
calcium (probarbital calcium), following administration at 4.00 p.m. for
effect on the Cj follicle, caused premature ovulation in low to moderate
(13 to 28) percentages of injected hens. Dial and Nembutal were found also
to act synergistically with low levels of progesterone in the induction of
premature ovulation, not to block its action.

Fraps and Case (19) suggested that the ovulation-inducing effects of these
several barbiturates might result from neural excitation, secondary to depres-
sion, and consequent activation of the pituitary. But perhaps an alternative

146 Rk HARD M. FRAPS

explanation may be based on the supposition tliat these barbiturates suppress
activity in a region or "center" which inhibits, during the period of lapse,
another hypothalamic "center" directly responsible for neurohumoral activa-
tion of the pituitary. Such a view is in accord with the observation that release
of 01 H for C, ovulation is most closely associated with onset of darkness
(according to our calculations), and that light plus activity act to suppress
OIH release (3). The discovery of the "stimulatory" effects of lesions by
Donovan and van der Werff ten Bosch (8, 9), discussed elsewhere in these
proceedings (p. 56), may afford grounds for speculation on the operation of
such mechanisms on a diurnal scale.

Phcnobarbital sodium, injected under the same conditions as were
Nembutal, Dial and Ipral calcium, failed either to induce ovulation prema-
turely or to block ovulation of the Cj follicle (19). The drug was found how-
ever to prevent some 40-50% of expected ovulations of Q follicles (Fraps
and Conner, cited in (17)). Phcnobarbital sodium also effectively blocks the
ovulation-inducing action of progesterone and other steroids on the Ci follicle
when administered 30-40 min before injection of the steroids (17).

The action of other pharmacological agents has also been investigated in
the hen. Zarrow and Bastian (70) reported blockade of both normally
expected and progesterone-induced ovulation of the Cj follicle by the para-
sympatholytic drug, atropine and the adrenolytic agent, SKF-501. Dibena-
mine (A'^,A^-dibenzyl-B-chloroethylamine), presumably an adrenergic blocking
agent, was shown by van Tienhoven, Nalbandov and Norton (66) likewise
to block both normal and progesterone-induced ovulation. The drug was
increasingly effective in preventing normal ovulation as the interval between
injection and expected ovulation was increased from 6 to 14 hr, with the
notable exception of an unaccountably low incidence of blocked ovulations
at 12 hr. Their observations led van Tienhoven et al. to suggest that "the
stimulus for LH release and hence ovulation takes place about 14 hours
prior to follicle rupture", an interval considerably greater than that favored
by this author — some 8 hr — on other grounds.

The increasing effectiveness of presumptive blocking agents with increasing
interval from injection of submaximal levels to expected ovulation has been
observed often in our laboratory. When administered 38 hr before expected
ovulation of the Cj follicle, Dial, Nembutal, phcnobarbital sodium, Dibena-
mine, SKF-501 and atropine sulfate all effectively suppress ovulation (20), a
result which may possibly stem from interruption of mechanisms other than
those responsible for OIH release.

In a subsequent study, van Tienhoven (64) attempted to determine the
duration of stimulation of the hen's anterior pituitary for progesterone-
induced OIH release, using atropine and Dibenamine to block the release.
He noted a longer duration of stimulation from the adrenergic than from the
cholinergic component; for the adrenergic component the duration of

Ovulation in the Domestic Fowl 147

Stimulation was estimated to vary from about 26 min to 2.5 hr. van Tienhoven
believed his results to indicate a concurrent stimulation and release of LH
from the hen's pituitary,

Oviducal Suppression of 01 H Release

Huston and Nalbandov (35) reported that interposition of various obstruc-
tions, or even of a surgical thread, in the lower magnum of the hen's oviduct
interrupted ovulation without signs of other hormonal disruption. The combs
of all hens remained throughout the period of observation like those of
normally laying hens, betokening the continued secretion of estrogen and
thus of some LH secretion. Upon sacrifice of hens carrying such irritants for
as long as 20 days the ovary was found to bear a practically normal comple-
ment of follicles, with little or no evidence either of follicular overgrowth or
of atresia. No recently ruptured follicles were seen, thus disposing of possible
failure of the oviduct to engulf yolks from otherwise undetected ovulations.
The oviduct itself was equal in size to that of normally laying hens, indicating
the continued secretion of estrogen. In other hens, the injection of LH or of
progesterone was followed by ovulation and lay of normal eggs.

These observations were confirmed and extended by van Tienhoven (63),
who noted an increasing effectiveness of thread loops in the magnum with
increasing distance from the infundibulum, and more regular suppression
of ovulation by loops placed in the isthmus. Loops similarly placed in the
uterus, where the shell of the egg is deposited, were without eflFect on the
course of ovulation.

Huston and Nalbandov (35) believed the oviducal irritant to operate over
neurogenic pathways to block the usual activation of the pituitary for release
of OIH (or LH). Since either LH or progesterone will induce ovulation of
the mature follicle or follicles, the induced condition is apparently comparable
with that existing during the period of lapse, and nervous blockade of the
usual stimulus for OIH release might reasonably be postulated. The mechan-
ism by which such a blockade might be accomplished in the experimental
birds and the possible role of the oviducal egg will be discussed later.

Brain Lesions and Injections

The effects of electrolytic lesions in the hypothalamus have recently been
investigated in the normally ovulating hen (48). Exploratory experiments
soon indicated that lesions in a medial region in the ventral preoptic hypo-
thalamus caused an immediate and prolonged interruption of ovulation.
Lesions elsewhere in the hypothalamus also, as a rule, interrupted ovulation,
but not regularly nor immediately, nor generally for more than about 15 days.
Subsequently, lesions in the median eminence were often found to be effective
in the immediate interruption of ovulation, but this region was not adequately
investigated.

148

Richard M. Fraps

In view of the consistent interruption of ovulation following placement of
lesions in the ventral preoptic region, experiments were undertaken toward
further delimitation of the effective locus. This, as described by Ralph, "is
just dorsal to the optic chiasma, at the extreme rostral end of the hypothala-
mus, lies laterally less than 2 mm from the midline, and within a ventral por-
tion of the nucleus praeopticus paraventricularis". Lesions of 1 to 2 mm
diameter, placed within this region 0.5 to 1 mm on each side of the midline,
regularly prevented ovulation, while the response to smaller lesions so placed
was irregular.

The effects of hypothalamic lesions on progesterone-induced ovulation of
the Ci follicle were also investigated (51, 52). Progesterone was administered

m nn

Fig. 3. Mid-sagittal plane of chicken diencephalon on which certain hypothalamic nuclei
and the sites of all lesions made within 2 hr following administration of progesterone are
projected. Symbols indicate the approximate center of each lesion: O — ovulation;
A — failure of ovulation. 1 and 2 — principal and accessory parts of preoptic paraventricular
nucleus, 3 — lateral hypothalamic nucleus, 4 — mammillary nucleus, 5 — tuberal nucleus,
6 — median eminence, 7— optic chiasma, 8 — anterior commissure, 9 — posterior commissure,
10 — cerebellum. Fiber tracts not shown. Limits of nuclei are somewhat arbitrary.
From Ralph and Fraps (52).

Ovulation in the Domestic Fowl 149

subcutaneously, 1 mg/hen, at about 4.00 p.m. for effect on the Cj follicle.
Lesions varying in size and position were placed at known times thereafter.
Progesterone-induced ovulation was regularly prevented only by lesions
placed in the anterior region of the ventro-mcdian hypothalamus — the region
shown to be involved in normal ovulation — or along fiber tracts originating
in this region and directed caudally toward the median eminence (Fig. 3).
Ovulation was not regularly prevented by lesions placed elsewhere. In view
of these observations, it was suggested that certain neurones of the para-
ventricular nucleus may be the site of progesterone "excitation", although
the possibility that these neurones and their associated fibers are only elements
in a structural complex was not excluded.

Participation of the preoptic hypothalamus in the normal processes of
ovulation of the Ci follicle was found not to be essential beyond about 6 hr
before the event, since lesions placed at less than about 6 hr before expected
ovulation did not prevent its occurrence (48). Following the systemic injection
of progesterone, the integrity of the preoptic hypothalamus must be main-
tained for about 2 hr, that is, to within about 6 hr before the time of expected
ovulation (52). Observations based on the effects of lesions cannot define
the time of onset of hypothalamic activity in normally timed processes. But
since the same highly essential hypothalamic region becomes dispensable at
about the same hour before normal and progesterone-induced ovulation,
onset of activity may be inferred to occur by the same interval prior to normal
ovulation as does onset of activity associated with progesterone-induced
ovulation. As has been noted elsewhere (16, 17), ovulation of the Q follicle
follows systemic administration of progesterone by not more than 8 hr, and
thus "activation" of the hypothalamic region cannot occur at a greater interval
prior to ovulation. In these terms, the minimal duration of hypothalamic
participation in the ovulatory process, normally incident or progesterone-
induced, is of the order of 2 hr.

According to Rothchild and Fraps (58), the anterior pituitary must
remain in situ until some 4 to 6 hr before expected normal ovulation if
ovulation is to occur. The same authors (59) observed that removal of the
pituitary within 2 hr following progesterone injection prevented all expected
ovulations, and that the gland must remain in situ for 4 hr to assure maximal
incidence of progesterone-induced ovulation. The duration of pituitary
participation in the processes of ovulation, again either normal or induced
ovulation, would thus appear to vary between 2 and 4 hr. The lesser estimate
of pituitary participation, 2 hr, is clearly in good agreement with estimated
duration of hypothalamic participation in ovulatory processes, and may
indicate concurrent "excitation" and OIH release, as was surmised by van
Tienhoven (64) on other grounds. In some hens, however, ovulation
apparently required an intact pituitary over somewhat longer intervals from
the assumed onset of OIH release. It is difficult to say just how much of

150

Richard M. Fraps

the greater range in apparent duration of OIH release in the hypophysectomy
experiments can be attributed to difierences in techniques, birds, or in-
accuracies in estimating times of expected or actual ovulation. It seems
possible also, however, that an intact pituitary may be required beyond the
interim required for OIH release.

Progesterone is known to disappear rapidly from the blood stream.
Taking this fact into account, Rothchild and Fraps (59) thought it improbable
that progesterone could act for 2 to 4 hr to assure the release of OIH in
adequate quantities. Progesterone, they suggested, may act promptly and

Fig. 4. A parasagittal view of the hen's diencephalon and forebrain, showing the sites of
injections of progesterone made bilaterally at 1 mm. Solid circles, induced premature
ovulation; open circles, no premature ovulation; 1, posterior commissure; 2, anterior
commissure; 3, tractus septo-mesencephalicus; 4, optic chiasma; 5, oculomotor nerve; Pit,
pituitary; H, hyperstriatum; N, neostriatum; P, paleostriatum. From Ralph and Fraps (54).

over a limited time in effecting the release of OIH, the intact pituitary being
essential for some time thereafter for secretion of a hormone required
for maintenance of the ovulable follicle.

In further experiments, the ovulation-inducing effects of small quantities
of progesterone injected directly into various regions of the brain were
ascertained (54). Stereotaxic procedures used in placing lesions were followed
except for replacement of the electrode carrier by a microinjector with a
26 gauge needle. All injections into the brain were placed bilaterally, 5 /xg
progesterone in propylene glycol at each site in the definitive experiments.
Probably no more than half the quantity injected, or about 5 /ng/hen,

Ovulation in the Domestic Fowl 151

remained at injection sites, as some always followed the needle track and
appeared on the surface as the needle was withdrawn. All injections were
timed for effect on ovulation of the Q follicle, and results were established
by usual palpation procedures.

Ovulation was induced following injections, 1 mm bilaterally, in the
anterior and ventral hypothalamus, and in the caudal neostriatum (Fig. 4).
The more anterior and dorsal effective sites in the hypothalamus are found
within the preoptic paraventricular nucleus. Those along the dorso-caudal
surface of the optic chiasma lie in the anterior hypophysial tract, and the
four most posterior sites are within the tubero-mammillary region.

The stimulatory action of progesterone in the paraventricular nucleus and
in the anterior hypophysial tract might have been expected in view of the
earlier finding that lesions in these regions, placed within 2 hr following the
systemic administration of progesterone, regularly prevent the expected
ovulation. Such lesions, however, destroy only a part of the progesterone-
sensitive structures, and raise the question as to the effectiveness of lesions
in these structures. Exploratory probings indicated no interruption of
progesterone-induced ovulation following the placement of lesions of about
2 mm diameter in the neostriatum. The effect of lesions in the tubero-
mammillary region has not been investigated.

Two other investigations in this series may be mentioned briefly. Small
lesions in the median diencephalon of regularly ovulating hens interrupted
ovulation in most hens (53). Lesions in the preoptic hypothalamus, anterior
hypophysial tract or dorso-caudal thalamus resulted in lengthier
interruptions than did lesions in the central diencephalon, but there was
much variability. All lesions were placed 12 hr or more before next-expected
ovulation, and comparisons of relative immediacy of interruption of OIH
release are not possible. A selective effect on OIH release could not have
been detected in hens which resumed ovulation before termination of the
observation period (42 days), but the regressed condition of ovaries and
oviducts in some hens sacrificed at the close of this period points to a more
general interference with gonadotropin secretion.

Destruction of the supraoptic region of the hypothalamus of the hen was
shown by Ralph (50) to result, as a rule, in polydipsia. Most of the birds
were out of lay when selected for test, but a number resumed ovulation and
lay while under observation. Follicular maturation, ovulation and ovi-
position thus proceeded, apparently normally, in some birds bearing
extensive lesions and exhibiting polydipsia. The supraoptic nucleus would
therefore appear not to be essential for reproduction in the hen, at least not
under the conditions of these experiments. It is of some interest that the
lesions causing polydipsia were located, in all instances, lateral to the
paraventricular region shown to be essential for maintenance of gonadotropin
secretion and for OIH release (48, 52).

152 Richard M. Fraps

Assenmachcr (1) described testicular atrophy and failure to respond to
artificial illuniinalion in ducks bearing extensive lesions in the supraoptic
and paraventricular region of the anterior hypothalamus. These lesions
were hand placed, and possibly always damaged the paraventricular nucleus,
in which event there need be no incompatibility with the results described
by Ralph (50). Nor do Ralph's findings necessarily exclude participation
of the supraoptic region in the accelerated response which might be
expected under lengthened photoperiod.

Considering the results of these several investigations insofar as they bear
on gonadotropic functions of the anterior pituitary, Ralph (49) suggested
that afferent neural stimuli and the effects of hormones "are in some manner
mediated, in large part or entirely, by neurosecretory cells of the hypo-
thalamus, particularly those of the paraventricular nucleus, and it is the
activities of these cells which are responsible for regulation of gonadotropin
release in the hen". This summary view of hypothalamic function and
indispensability in the hen is in accord with conclusions arrived at by others
(see (60)).

While the central role of neurosecretory cells in regulation of pituitary
gonadotropin function seems thus to have been established, we should
emphasize again that we do not know the duration of the stimulus which
effects OIH release specifically. This may be brief, as was noted earlier. If
so, it is conceivable that the stimulus effecting "release" may act at the level
of the median eminence to cause or to permit an abrupt outpouring of
accumulated neurosecretory material into the portal vessels. In the male
white-crowned sparrow, Oksche et al. (46) state that the median eminence
can be regarded as a depot of neurosecretory material, exceeded only by
the neurohypophysis. They remark also on the reduced quantity of the
substance seen in the median eminence of birds on a 20-hr photoperiod
during the second half of the daily photoperiod and on its reaccumulation
during the dark period. It would obviously be of great interest to know
whether such a depletion of neurosecretory materials does or does not take
place in the hen in association with OIH release from the pituitary, not only
in the median eminence, but also in the paraventricular nucleus. Legait (40)
observed an association between reproductive condition of the hen and
apparent neurosecretory activity of cells of paraventricular and supraoptic
nuclei, but these observations were not related to presumed time of OIH
release.

HYPOTHESES OF THE OVULATION CYCLE

Several hypotheses have been proposed to account for lag, or for lag and
the period of lapse, in the hen's ovulation cycle (3, 15, 42-44). It is assumed
that external stimuli, and more particularly light, act through the central
nervous system to regulate, over neuroendocrine pathways, the output of

Ovulation in the Domestic Fowl

153

pituitary gonadotropin (whether FSH mainly, or the gonadotropic complex)
responsible for follicular growth and development. The frequency with
which follicles become available for the ovulatory process determines the
quantitative aspects of the cycle, viz., sequence length («), cycle length
{n+\) and ovulation frequency nj{n^ 1).

The hypothesis of the cycle proper proposed several years ago (15) was
essentially a statement of possible relationships between diurnally varying
thresholds of response in a neural component of the OIH release mechanism
and excitation hormone (progestagen?) concentrations associated with

Fig. 5. Diagrammatic representation of possible relationships between diurnal rhythmicity
in thresholds of response in a neural component of the OIH release mechanism (the curve
through El, Eg ... Eg and E/) and excitation hormone concentrations associated with
the follicles Cj, Ca . . . Cg and C/ in a 7-day cycle (n = 6). Zero hour corresponds to about
10.00 p.m. in hens under lights from 6.00 a.m. through 8.00 p.m. Based on Praps (15).

follicular maturation. These relationships are shown for a 7-day cycle
{n = 6) in Fig. 5. Thresholds of response (the inverse of sensitivity) are
described by the curve passing through Ej, Eg... Eg and E^'. Excitation
hormone concentrations associated with successive follicles of the sequence,
assumed to increase by substantially the same course with respect to the
preceding OIH release (or ovulation), are represented by Q, Cg-.-Cg and
Ci'. The first excitation, Ej, takes place on day 1 of the cycle at zero hour in
the figure (e.g. 10.00 p.m.), initiating the release of OIH which causes
ovulation of the C^ follicle. The second excitation, E,, occurs on day 2, some
several hours later than did Ei on day 1 , the third somewhat later on day 3,
and so on through Eg, which takes place about 8 hr later on day 6 than did
El on day 1 and completes the sequence. In this scheme, it is to be observed
that each excitation hormone curve beyond the second (Cg) is displaced, in
time of day, by the extent of lag associated with the previous excitation.
If this is true also of the Ci' curve, excitation cannot occur on day 7 because
of the relatively high nervous thresholds existing at the time of day at which
usually effective concentrations are attained. The period of lapse (hours 8-16)

154 Richard M. Fraps

thus intervenes, but since excitation hormone concentrations are assumed
to continue to increase during this period, the first excitation of the cycle.
El or El', takes place at relatively high threshold values. It is this circumstance
which, presumably, accounts for the relatively great extent of lag associated
with E2 and thus with lag in ovulation of the second follicle of the sequence
(Fig. 1).

In this formulation of cyclic relationships, considerable emphasis has been
placed on the role of diurnal periodicity (or rhythmicity) in thresholds of
response in the neural component of the system (15-17). There can be little
doubt that some phase or phases of the prevailing photoperiod determine in
large measure the hours of the 24 within which nervous activation of the
pituitary for OIH release may normally occur. In this sense the meaning of
diurnal periodicity is reasonably clear. The supposition that, within this
period, thresholds of response vary with time of day introduces, however,
a notion of rhythmicity rather than of simple periodicity. The postulated
rhythmicity may be considered in part at least a characteristic of the "center"
exhibiting diurnal periodicity, or an expression mainly of ovarian (and
perhaps other) hormone actions on such a center. While in one form or
another it does seem necessary to postulate varying parameters of nervous
response to an excitation hormone, it is not supposed that the relationships
represented in Fig. 5 are the only ones possible.

Estrogen

Although the nature of the delaying action of exogenous estrogen on
ovulation of the C^ follicle contributed to formulation of the hypothesis
discussed above, it was not until the observation of a similar gonadotropin-
induced delay, presumably mediated through increased levels of endogenous
estrogen acting at a neural level, that the substance was seriously thought to
play a part in the appearance of lag (25). The normal OIH release represents
certainly an increase in circulating gonadotropin levels, whether of LH
alone or of the gonadotropic complex. We might reasonably expect such a
release to effect, as presumably did the injection of LH or of LH + FSH, an
increase in levels of circulating estrogen. There are also grounds, to be dis-
cussed later, for believing that the oviducal egg may stimulate estrogen pro-
duction during some 4 to 5 hr following its ovulation. However this may be,
estrogen levels in the regularly ovulating hen would appear to vary in a
pattern which is closely associated with the occurrence of OIH release. It
may be suggested then that relatively high estrogen levels so generated act
to suppress the appearance of low thresholds (or high sensitivity) in the neural
component of the OIH release mechanism. With subsequently decreasing
estrogen levels, at a time related to time of preceding OIH release (and possibly
the early oviducal egg), thresholds in the neural component would be expected
to fall and excitation to become possible. Each OIH release (and egg) except

Ovulation in the Domestic Fowl 155

the last of the sequence would thus become a factor in determination of time
of the succeeding excitation and therefore of the extent of lag. The last OIH
release, by delaying onset of low thresholds to or beyond the time of day at
which the period of lapse intervened, would thereby terminate the sequence.
Estrogen levels presumably would be low at the hour of excitation and
OIH release for the first follicle of the succeeding cycle or sequence, and excita-
tion would occur in response to the appropriate phase of photoperiod at the
onset of the "open" period, which by definition is the case.

This schematic statement of presumed periodicity in estrogen levels and
effects is no doubt overly simple. We do not know, for example, when
inhibitory levels may be attained, although gonadotropin injected as much
as 13 hr before estimated hour of expected OIH release for ovulation of C2
follicles effectively blocked the release (25). The considerable interval (24 to
29 hr) between a given OIH release and an effect on the succeeding OIH
release thus would seem to present no problem.

Progesterone

Since progesterone has been shown to effect OIH release over the same
hypothalamic structures involved in the normal release and, in addition, in
similar relationships insofar as these have been determined, it has been
suggested that progesterone (or a progestagen) might be the natural ovarian
hormone eliciting nervous "excitation". If this were so, we should be able to
adduce some evidence that progesterone is produced by the hen's ovary and
is found in the blood stream.

Using the bioassay of Hooker and Forbes (34), progestogenic activity was
demonstrated in the blood of actively ovulating hens (27). In other tests, the
same authors found blood levels of what then was believed to be progesterone
to exceed 5 jixg/ml (unpublished results). Although the Hooker-Forbes test
is now known not to be specific for progesterone, the inference based on this
test apparently was confirmed when the substance was identified on chromato-
grams of extracts of ovaries of regularly laying hens (39). Progesterone was
found in extracts of maturing as well as of ruptured follicles, but these authors
failed to detect the substance in the blood of ovulating hens. This was
accomplished, hovv'ever, by Lytic and Lorenz (41) in extracts of samples
consisting largely of blood from the ovary "prior to contact with the liver or
any capillary bed". Their extracts were estimated to contain an average of
about 0.05 jLtg/ml blood. In comparison with values yielded by the Hooker-
Forbes test, this may seem a very low concentration, but physicochemical
determinations of progesterone in the systemic blood of pregnant women
have likewise failed to yield values comparable with those indicated by the
bioassay of Hooker and Forbes (68). Other naturally occurring compounds,
metabolites of progesterone, now are known to exhibit progestational activity
by the Hooker-Forbes and Clauberg tests and are therefore considered to be

156 Ri( HARD M. F'rai'S

gestagens (69). While such compounds have not been demonstrated in the
blood of hens, it seems not improbable that the Hooker-Forbes test measures
"the circulating form or forms of the luteal hormone" (12) in the hen
as in other species. It is of some interest in this connection that Lytle and
Lorenz (41), referring to earlier work by Lytle, state that chemical analysis
failed to identify progesterone in blood drawn by heart puncture, although
this blood yielded positive responses by the Hooker-Forbes test. Lytle and
Lorenz note also that relatively large samples, drawn to circumvent loss in
peripheral tissues but less completely defatted than were their definitive
samples, uniformly failed in chemical tests to yield measurable quantities of
progesterone while eliciting positive responses in the Hooker-Forbes bioassay.

The demonstration that progesterone is formed in the hen's ovary, is
secreted as progesterone into the systemic blood, and is associated with
progestogenic activity as measured by the Hooker-Forbes test, would appear
to support the conclusion that the naturally occurring "excitation" hormone
is a progestagen if not progesterone itself.

The stimulus for the postulated formation of progesterone in the maturing
follicle must remain a matter of conjecture. It seems possible that the same
gonadotropin release causing ovulation of the mature follicle may initiate in
the succeeding follicle the processes leading to the elaboration of progesterone.
Theoretically, at least, prolactin may be involved in the maintenance of
progesterone production, or the "basal level" of LH may be a factor. The
subject obviously calls for more attention than has been accorded it in the past.

A not unrelated question concerns possible functions of the hen's ruptured
ovarian follicle which, as van Tienhoven (65) has recently emphasized again,
is not to be confused with the mammalian corpus luteum. The ruptured
follicle is essential for oviposition (57), and it contains progesterone (39).
Practically nothing else seems to be known about the structure. Its rapid
resorption following ovulation need not exclude some important short-term
role in the cycle, but one could only speculate on what this might be.

The Nalbandov Hypotheses

Two explanations of the ovulation cycle have been developed by
Nalbandov (42, 44). Both stem from the results of experiments, described
earlier, demonstrating the suppression of LH release for ovulation, but not
of other gonadotropic-dependent functions, by irritants in the magnum or
isthmus of the oviduct (35, 63). In accounting for their observations, Huston
and Nalbandov (35) postulated that the pituitary of the ovulating hen secretes
FSH and LH at a continuing and relatively steady basal level; periodically,
LH is released in greater quantities to effect ovulation. The oviducal irritant
was believed to suppress, over neurogenic pathways, only the periodic LH
releases required for ovulation. These authors, and Nalbandov (42), con-
sidered also the possibility that the presence of an egg in the magnum might

Ovulation in the Domestic Fowl 157

likewise suppress the periodic LH release required for ovulation. On this view,
neurogenic inhibition of the ovulatory LH release mechanism ceases when the
egg clears the magnum (or isthmus) and "LH is secreted in sufficient quantities
to cause the next ovulation" (42).

In a recent reconsideration of the problem, Nalbandov (44) points out
that the period during which the neurogenic stimulus may act is no more
than about 5 hr following ovulation. In the two-member sequence, the 5-hr
period following ovulation of the C^ follicle would thus end 15-16 hr before
OIH release for ovulation of the second follicle, assuming 8 hr to elapse
between OIH release and ovulation. Even supposing an improbable 14-hr
interval between OIH release and ovulation, the neurogenic stimulus would
cease 9-10 hr before the second release of OIH in the 2-member sequence.
In the light of such considerations and, in addition, the failure of the earlier
hypothesis to account for the period of lapse, Nalbandov (44) recently pro-
posed a different interpretation of effects of the neurogenic stimulus (or
inhibition) from the oviduct.

The hypothesis now proposed rests on several related propositions. Light
is believed not to regulate "rhythmicity of the laying cycle of birds", although
it does determine rate of pituitary function and thus has a "permissive
effect" on reproductive performance. The bird's pituitary is assumed to
secrete a single gonadotropic complex with FSH- and LH-like properties
rather than the two separate entities usually assumed. Secretion of this com-
plex is suppressed during passage of the egg through the magnum and
isthmus of the oviduct, a period of some 4-5 hr. Secretion of the gonadotropic
complex is resumed when the egg clears the isthmus and circulating gonado-
tropin slowly returns to pre-inhibition levels; with attainment of these levels,
ovulation is induced.

Of these several assumptions, the crucial one with respect to the timing of
ovulation is clearly that of pituitary recovery following the 5-hr period of
inhibition. As stated by Nalbandov, sequence length "would be determined
by the rate at which the pituitary gland could recover from each episode of
neural inhibition. Thus, rapid recovery would permit long clutches, while
slow recovery would result in short clutches." The period of lapse is accounted
for similarly: "With each succeeding cycle of inhibition and release hypo-
physial recovery rate becomes slower until at the end of the clutch the
pituitary gland does not recover in time to cause the ovulation of the next egg,
and the clutch is interrupted."

Several implications of the concept of pituitary recovery following episodes
of inhibition may be noted. Rate of recovery would plainly have to be very
finely adjusted to account for lag relationships seen in the ordinary ovulation
sequence, an improbable demand upon "recovery" in any guise. In sequences
of three or more members, rate of recovery would actually increase, not
decrease, with the several successive episodes of inhibition following the first,

158 Richard M. Fraps

since the intervals between successive ovulations arc decreasing. In lengthy
sequences, recovery would proceed at the same, and at a relatively rapid rate,
not at onset of the sequence but during those phases in which lag approaches
or equals zero (Fig. 1). But supposing these and other aspects of recovery
within the sequence to be accounted for, there remains the formidable period
of lapse. We have seen earlier that through most or all of this period there
coexist an ovulable follicle and an apparently competent pituitary. If recovery
were indeed a decisive factor in pituitary function it would thus appear to
have been completed by about the same course as is assumed following
episodes of inhibition within the sequence. Yet the first ovulation of the
oncoming sequence occurs in association with the prevailing photoperiod,
many hours later than would be expected in terms of pituitary recovery. The
simple fact that ovulation of the Cj follicle does occur in close association
with some phase of photoperiod over a wide range of photoperiods (38)
would seem to cast doubt, apart from any other consideration, on the postu-
lated role of pituitary recovery during the period of lapse.

One is certainly inclined to agree with Nalbandov that the oviducal egg
most probably does play a role in some aspect of the ovulation cycle. If the
hypotheses proposed by Nalbandov (42, 44) in this connection seem unsatis-
factory, we should perhaps inquire whether the experimental observations on
which these proposals are based have in fact been accounted for adequately, or
if not, whether more likely explanations can be suggested.

The experimental oviducal irritant appears to maintain a gonadotropic
hormone balance similar in some important respects to that imposed by
the continuing administration of FSH or PMS (4). The daily injection of
such preparations in adequate quantities maintains follicular growth but
invariably interrupts ovulation after a day or two, thus resulting in a gradual
accumulation of ovulable follicles (28). Small follicles may also be caused to
grow more rapidly than usual, further increasing the mass of follicular tissue.
Under these conditions we should certainly expect higher than normal
estrogen levels, and it is not likely that these would show much diurnal
variation, certainly not under the pressure of daily PMS injections. On the
basis of evidence advanced earlier, the total suppression of 01 H release can
be attributed to these continuing high estrogen levels, and the site of estrogen
action would be in some neural component of the OIH release mechanism (25).

In view of the fact that oviducal irritants and continuing gonadotropin
administration are similarly effective in suppressing OIH release, it may be
suggested that the oviducal irritant acts over neurogenic pathways to stimu-
late or to maintain those nervous activities, ordinarily periodic, which are
associated with the output of gonadotropins at a level favoring the secretion
of estrogen into the blood stream at concentrations capable of blocking
excitation for OIH release. In these terms, the oviducal irritant acts as a
stimulus at the neural level, and only secondarily in an inhibitory capacity.

Ovulation in the Domestic Fowl 159

It may be objected that the follicular aggregates resulting from the oviducal
thread and continuing gonadotropin administration are not comparable,
the former representing over long periods an essentially normal hierarchy,
whereas the latter comes to include a number of ovulable follicles as well as
rapidly growing smaller follicles. The differing ovarian complements may
simply reflect quantitative differences in stimulation, since Huston and
Nalbandov (35) note that in some of their early experiments, in which key
chains and other large irritants were employed, the ovary sometimes carried
"six or more follicles of ovulatory size". They observed also, in hens carrying
only the oviducal thread, "a few sporadic ovulations which were widely
spaced", suggesting a relatively moderate stimulation (and moderate estrogen
inhibition) under these conditions. On the other hand, most if not all descrip-
tions of the ovary following gonadotropin administration have been based on
manifestly heavy stimulation.

If a continuing oviducal irritant may act in the manner suggested, the
oviducal egg during its passage to the uterus may likewise stimulate the
elaboration and secretion of estrogen. We have considered already a possible
role of varying estrogen concentrations in the ovulation cycle, namely, their
participation in timing of successive excitations in a manner which may
account, in part at least, for lag and termination of the sequence. Possibly
the oviducal egg is of greater importance in this respect than is the release
of OIH. Perhaps the actions of OIH and the oviducal egg are related in
some fashion not presently suspected. Whatever the facts may finally turn
out to be, the role suggested here for the oviducal egg seems in accord with
experimental evidence concerning the action of estrogen in the hen's ovula-
tion cycle, as well as with a plausible interpretation of the effects of the
continuing oviducal irritant.

It is well known that ovulation may occur in hens whose oviducts are
incapable of engulfing the ovulated yolk, either as a result of surgical
operations on the oviduct (47) or of naturally occurring conditions (36).
The timing of successive ovulations in such hens, not presently known,
might tell us much concerning the possible participation of the oviduct in
the ovulation cycle. By X-ray or other techniques it should be possible to
establish this obviously important datum.

The Hypothesis of Bastian and Zarrow

These authors (3) based their hypothesis of the ovulation cycle on the
postulation of "two separate and independent cycles" which "interact in
such a way as to result in the typical ovulatory cycle of the hen", to result,
that is, in the appearance of what we have called lag, and the period of
lapse. One of their concepts is that there is present an effective ovulatory
stimulus (LH or OIH) over an extended period, e.g. 8 hr, each night, including
the night preceding the day during which ovulation fails to occur. According

160 Richard M. Fraps

to the second concept, follicles attain to maturity or ovulahility at fairly
regular intervals in cycles or sequences of given length. It is recognized that
follicular maturation is a gradual process, and ovulahility therefore a relative
condition.

The interaction of these two "cycles" means essentially that if a follicle
attains to ovulahility at a sufficiently early time within the diurnally recurrent
period of elevated LH levels, it is ovulated. But if a follicle, i.e. the oncoming
Cj follicle, comes to high sensitivity too late in a given LH release period,
its ovulation is carried over to the following period, by which time it has
become highly responsive, presumably in part because of the maturation
promoting action of LH during the preceding night when this follicle
approached but did not quite achieve response to prevailing LH levels. With
some minor qualifications concerning follicular maturation, Bastian and
Zarrow believed their hypothesis capable of accounting also for lag in the
sequence, and thus for the "asynchronous ovulation rhythm of the
hen".

Bastian and Zarrow advanced no direct evidence in support of their main
premise, the recurrent and prolonged secretion of LH during the same hours
of each 24. This concept appears to have had its origin in recognition of the
synchronization with photoperiod of the hours of the 24 within which OIH
release occurred, together with participation of the central nervous system in
control of pituitary gonadotropin secretion. If some phase of photoperiod,
such as onset of darkness, invariably activated the nervous component of
the system and thus caused the pituitary to release LH, such release would
of course be expected on the night preceding the day of no ovulation. As we
have seen earlier, release of LH during this night appears to be unnecessary
to account for the subsequent high terminal ovulahility of the C^ follicle, a
conclusion which of itself need not disprove the postulated release. But if
LH is actually so released, the oncoming Ci follicle would be subjected,
through at least a part of the night preceding LH release for its ovulation,
to what in effect would appear to be subovulatory levels of the gonadotropin,
a condition which often results in atresia, as Bastian and Zarrow (3) them-
selves and others (21, 22, 64) have found experimentally. Atresia might also
be expected to intervene at or near the termination of the ovulating sequence
if in fact the ovarian follicles mature at fairly regular intervals, as is postulated
by Bastian and Zarrow. The grounds for questioning the validity of this
second postulate have been discussed in connection with follicular maturation
and need not be repeated here. It is of some interest to observe, however,
that even though the order of follicular maturation described earlier and
represented in Fig. 2 be accepted, the release of LH during the night preceding
the release actually effecting ovulation of the Cj follicle — during the
period, p, of the figure — might also be expected to result not infrequently in
atresia.

Ovulation in the Domestic Fowl 161

As has been noted elsewhere (18), Bastian and Zarrow and this author are
in agreement in assigning to photoperiod the basic role of timing the appear-
ance and termination of the "open" period of low thresholds in the neural
component of the OIH (or LH) release mechanism. But while Bastian and
Zarrow conceive of an immediate and constant functional relationship
between the appearance of the open period and OIH release, much evidence
reviewed in this paper impresses the conviction that timing of the specific
nervous activity resulting in OIH release is conditioned largely by the
ovarian hormones and the order of follicular maturation.

REFERENCES

1. AssENMACHER, I., Arch. Anat. microsc. et Morphol. exp. 47, 447-572, 1958.

2. Bastian, J. W. and M. X. Zarrow, Pioc. Soc. Exp. Biol, and Med. 79, 249-252, 1952.

3. Bastian, J. W. and M. X. Zarrow, Poid. Sci. 34, 776-788, 1955.

4. Bates, R. W., E. L. Lahr and O. Riddle, Ainer. J. Physiol. Ill, 361-368, 1935.

5. Benoit, J. and I. Assenmacher, Arch. Anat. microsc. et Morphol. exp. 42, 334-386, 1953.

6. Benoit, J. and I. Assenmacher, /. Physiol. (Paris) 47, 427-567, 1955.

7. Benoit, J. and I. Assenmacher, Recent Prog. Hormone Res. 15, 143-164, 1959.

8. Donovan, B. T. and J. J. van der Werff ten Bosch, /. Physiol. 147, 78-92, 1959.

9. Donovan, B. T. and J. J. van der Werff ten Bosch, /. Physiol. 147, 93-108, 1959.

10. Everett, J. W., Anat. Rec. 109, 291, 1951.

11. Everett, J. W. and C. H. Sawyer, Endocrinology 47, 198-218, 1950.

12. Forbes, T. R. and C. W. Hooker, Endocrinology 61, 281-286, 1957.

13. FRAPS, R. M., Anat. Rec. 87, 443, 1943.

14. FRAPS, R. M., Anat. Rec. 96, 573-574, 1946.

15. FRAPS, R. M., Proc. Natl. Acad. Sci. U.S. 40, 348-356, 1954.

16. FRAPS, R. M., Memoirs Soc. Endocrinol. No. 4, 205-219, 1955.

17. FRAPS, R. M., in Progress in the Physiology of Farm Animals, vol. 2 (Edited by John

Hammond), pp. 661-740. Butterworths Scientific Publications, London, 1955.

18. FRAPS, R. M., in Photoperiodism and Related Phenomena in Plants and Animals (Edited

by R. B. Withrow), pp. 767-785, Publ. No. 55, Am. Assoc. Adv. Sci., Washington,
D.C., 1959.

19. FRAPS, R. M. and J. F. Case., Proc. Soc. Exp. Biol, and Med. 82, 167-171, 1953

20. FRAPS, R. M. and M. H. Conner, Nature 174, 1148-1149, 1954.

21. FRAPS, R. M. and A. Dury, Anat. Rec. 84, 453, 1942.

22. FRAPS, R. M. and A. Dury, Anat. Rec. 84, 521-522, 1942.

23. FRAPS, R. M. and A. Dury, Anat. Rec. 87, AA2-AAZ, 1943.

24. FRAPS, R. M. and A. Dury, Proc. Soc. Exp. Biol, and Med. 52, 140-142, 1943.

25. FRAPS, R. M. and H. L. Fevold, Proc. Soc. Exp. Biol, and Med. 90, 440-446, 1955

26. FRAPS, R. M., H. L. Fevold and B. H. Neher, Anat. Rec. 99, 571-572, 1947.

27. FRAPS, R. M., C. W. Hooker and T. R. Forbes, Science 108, 86-87, 1948.

28. FRAPS, R. M. and G. M. Riley, Proc. Soc. Exp. Biol, and Med. 49, 253-257, 1942.

29. Green, J. D., Amer. J. Anat. 88, 225-312, 1951.

30. Green, J. D. and G. W. Harris, /. Endocrinol. 5(3), 136-146, 1947.

31. Harris, G. W., Physiol. Rev. 28, 139-179, 1948.

32. Harris, G. W., Monographs Physiol. Soc, No. 3. Edward Arnold, London, 1955.

33. Heywang, B. W., Poid. Sci. 17, 240-247, 1938.

34. Hooker, C. W. and T. R. Forbes, Endocrinology 41, 158-159, 1947.

35. Huston, T. M. and A. V. Nalbandov, Endocrinology 52, 149-156, 1953.

36. HuTT, F. B., K. Goodwin and W. D. Urban, Cornell Vet. 46, 257-273, 1956.

37. Lacassagne, L., Annales de Zootech. 5, 335-362, 1956.

38. Lanson, R. K., Unpublished Ph.D. thesis. Rutgers University, New Brunswick

New Jersey, 1959.

162 Richard M. I- raps

39. Layne, D. S., R. H. Common, W. A. Maw and R. M. Fraps, Pioc. Soc. Exp. Biol, and

Med. 94, 528-529, 1957.

40. Legait, H., Arch. Anal, miaosc. cl Moiphol. exp. 44, 323-343, 1955.

41. Lytle, I. M. and F. W. Lorenz, Naiine 182, 1681, 1958.

42. Nalbandov, a. V., Potd. Set. 32, 88-103, 1953.

43. Nalbandov, A. V., Reproductive Physiology, W. H. Freeman, San Francisco, 1958.

44. Nalbandov, A. V., in Comparative Endocrinoloi;y (Edited by A. Gorbman), pp. 161-

173, John Wiley, New York, 1959.

45. Neher, B. H. and R. M. Fraps, Endocrinology 46, 482^88, 1950.

46. Oksche, a., D. F. Laws, F. I. Kamemoto and D. S. Farner, Z.Zellforsch. 51, 1^2,

1959.

47. Pearl, R. and M. Curtis, /. Exp. Zool. 17, 395^24, 1914.

48. Ralph, C. L., Anat. Rec. 134, 411-431, 1959.

49. Ralph, C. L., Chicago Acad. Sci., Special Pid^l. No. 14, 4-5, 1959.

50. Ralph, C. L., Am. J. Physiol. 198, 528-530, 1960.

51. Ralph, C. L. and R. M. Fraps, Anat. Rec. 130, 360-361, 1958.

52. Ralph, C. L. and R. M. Fraps, Endocrinology 65, 819-824, 1959.

53. Ralph, C. L. and R. M. Fraps, Am. J. Physiol. 197, 1279-1283, 1959.

54. Ralph, C. L. and R. M. Fraps, Endocrinology 66, 269-272, 1960.

55. Riley, G. M. and R. M. Fraps, Endocrinology 30, 537-541, 1942.

56. RoTHCHiLD, I., Fed. Proc. 8, 135, 1949.

57. RoTHCHiLD, I. and R. M. Fraps, Proc. Soc. Exp. Biol, and Med. 56, 79-82, 1944.

58. ROTHCHILD, I. and R. M. Fraps, Endocrinology 44, 134-140, 1949.

59. ROTHCHILD, I. and R. M. Fraps, Endocrinology 44, 141-149, 1949.

60. Scharrer, E., in Comparative Endocrinology (Edited by A. Gorbman), pp. 233-249,

John Wiley, New York, 1959.

61. Shirley, H. V. and A. V. Nalbandov, Endocrinology 58, 477-483, 1956.

62. Shirley, H. V. and A. V. Nalbandov, Endocrinology 58, 694-700, 1956.

63. VAN Tienhoven, a., Anat. Rec. 115, 374-375, 1953.

64. van Tienhoven, A., Endocrinology 56, 667-674, 1955.

65. van Tienhoven, A., in Reproduction in Domestic Animals, vol. II (Edited by H. H. Cole

and P. T. Cupps), pp. 305-342, Academic Press, New York, 1959.

66. VAN Tienhoven, A., A. V. Nalbandov and H. W. Norton, Endocrinology 54, 605-61 1 ,

1954.

67. Wingstrand, K. G., The Structure and Development of the Avian Pituitary, C. W. K.

Gleerup, Lund, Sweden, 1951.

68. Zander, J., Nature 174, 406-407, 1954.

69. Zander, J., T. R. Forbes, A. M. Von MOnstermann and R. Neher,/. Clin. Endocrinol.

and Metab. 18, 337-353, 1958.

70. Zarrow, M. X. and J. W. Bastian, Proc. Soc. Exp. Biol, and Med. 84, 457-^59, 1953.

HORMONAL AUGMENTATION OF FERTILITY
IN SHEEP AND CATTLE

John Hammond, Jr.
Cambridge University School of Agriculture

INTRODUCTION

A QUARTER of a century has passed since Cole and Miller (18) used gonado-
tropin to obtain fertility in anestrous sheep. In reviewing the progress which
has been made since then, I intend to deal principally with the control of
ovulation and estrous behavior, largely neglecting the many other factors —
including fertilization and fetal loss — that intervene between mating and
weaning.

Hormonal control of ovulation has potential agricultural uses in two main
fields. Given a satisfactory technique of transplantation, there will be genetic
applications such as the multiplication of offspring from particular dams, and
the acceleration of a breeding program by production of young from im-
mature females. This might find wide application, but yet could be worth-
while on a small scale. The other type of application, increasing the number
of young born, is only likely to be worthwhile if it can be carried out widely
and cheaply.

For this reason most investigators have used the gonadotropins of pregnant
mare serum (PMS) and human pregnancy urine (PU). Those workers who
have employed pituitary extracts have generally administered predominantly
follicle-stimulating preparations subcutaneously, and given LH-rich extracts
intravenously. To avoid cumbersome phraseology, I shall use the (inaccurate)
terms "FSH" and "LH" in referring to these pituitary extracts. Unless other-
wise specified, it should be understood that PMS and "FSH" have been
given subcutaneously and PU and "LH" intravenously.

While PMS hormone circulates in the mare in enormous quantity, a
succession of follicles develop and ovulate (70) ; yet the urinary estrogen is
not obviously raised (17) and relatively small amounts of exogenous estrogen
given at this time will induce abortion (21). Thus PMS appears to have the
properties ascribed by Simpson, Li and Evans (72), in 1951, to purified FSH.
In all the work with farm animals one has to allow for endogenous hormone
production comiplicating the response; on the other hand, we may perhaps
be allowed the simplification of regarding PMS as a pure type of FSH.

163

164 John Hammond, Jr.

NORMAL REPRODUCTIVE PATTERNS

The sheep has a restricted breeding season which is photoperiodically
regulated. Breeds difler in the length of breeding season and also in the degree
of ovarian activity during anestrus. There are dilTerences in the normal inci-
dence of twin and multiple ovulations in different breeds. The first ovulation
of the breeding season is not accompanied by estrus (36), and the time of this
ovulation may be hastened by the introduction of a ram into the ewe flock (73).
So-called "silent heats", ovulation unaccompanied by estrus, may also occur
during the breeding season, particularly in animals growing under poor
nutritive conditions (38). Heat without ovulation may occur at the end of
the season (I).

The cow, on the other hand, though probably affected by photoperiod,
breeds throughout the year. Silent heats however do occur, and even anestrus
has been observed, mostly in heifers under poor winter feeding conditions.
The incidence of twinning may be as high as 4% (30), but in general it is
very low, especially in beef breeds.

Ignoring considerable seasonal and individual differences, the cycle of the
sheep may be said to last 16 or 17 days, with heat lasting about 30 hr and
ovulation occurring at about the end of heat. The cycle in the cow lasts
20-21 days, heat lasts about a day, and ovulation occurs 10 hr or so after
the end of heat (16).

It is not unusual to speak of "follicular" and "luteal" phases of the
ruminant cycle, but there is no event such as menstruation to demarcate the end
of the luteal phase. Grant (37) has constructed an average curve for the
growth and regression of the sheep corpus luteum, but size does not neces-
sarily parallel activity. Japanese workers (56, 57) consider the corpus luteum
to be non-functional if injected estrogen induces estrous behavior. Their
results appear to indicate that estrus can be advanced by 2-3 days, possibly
by more.

When the corpus luteum is removed from the ovary, follicle growth,
estrus and ovulation follow, and the cycle rhythm is rephased. In sheep the
interval is 2-4 days (52); in cattle estrus most commonly occurs 4 days later
but a 3-day interval is nearly as frequent. If one accepts that this represents
the normal rate of follicle development one may conclude that, in the cow,
the corpus luteum regresses, and follicle growth starts, about 3 days before the
onset of heat and that in the sheep the interval is probably less. Alternatively,
normal follicle growth is slower and the two phases of the cycle overlap.

The chances of survival of induced multiple pregnancies seem to differ
in the sheep and cow. In the sheep there is a loss of fertilized ova at and before
the stage of implantation (11, 62). There seems to be a maternal restriction
upon litter size at an average figure of, in general, less than 3. With very
large numbers of ovulations, Casida et al. (11) noted a tendency to total loss
after the stage of implantation.

Hormonal Augmentation of Fertility in Sheep and Cattle 165

In the cow there seems to be early partial loss (35), but with only 4 or 5
ovulations total loss has been noted at about half term (42) or earlier (9, 35).
In the cow therefore very close control is required over the number of
ovulations, but in the sheep this seems of little importance.

OVULATION AND HEAT IN ANESTRUS

Most workers have found that a single injection of FSH or of PMS will
induce ovulation in almost all treated sheep. Estimates of the time of ovula-
tion, based upon the time of slaughter and the appearance of the induced
corpora, range from 24 to 72 hr after injection, most commonly within 48 hr
(44, 61). A group of animals treated by Robinson (61) provide an exception;
some failed to ovulate even after two treatments with 800 i.u. PMS and there
does not seem to have been very much follicle growth. While some of these
animals were of a breed with a more restricted season than those usually
treated, all apparently had in common a poor nutritional status.

After a single injection of FSH, PMS or PU the number of ovulations has
nearly always been within the normal range for the breed, and the ovulations
apparently occurred synchronously (34, 44). Instances have been noted of
two series of ovulations following a single injection of PMS : this may account
for multiple corpora lutea in some ewes so treated by Robinson (61). Casida
and colleagues (4, 54) have obtained multiple ovulations in anestrous sheep
with repeated FSH injections followed by LH; it seems unlikely that all the
ovulations were synchronous.

Although the number of ovulations has been relatively constant, the extent
of follicle development has in general paralleled the dosage of FSH or PMS,
but this is by no means always obvious with PMS (44).

Whereas a single gonadotropin treatment induces ovulation, this is rarely
accompanied by heat. Furthermore, artificial insemination has usually failed
to produce fertilization of the ova shed (41, 44). This has been attributed to
failure of sperm transport (58) and there is no reason to doubt the maturity
of the ova shed (5).

The few sheep coming on heat have usually been found to have had a
corpus luteum regressing at about the time of injection and so have been not
anestrous in the strict sense. Two treatments with PMS, a cycle interval
apart, have been used to induce ovulation accompanied by fertile mating (18).
The success achieved has been very variable: sometimes very different results
have been obtained by the same workers in successive seasons (79). There is
no obvious reason for doubting that the second treatment also induces
ovulation: yet heat is often not shown. Gordon (34) obtained heat in only
4 of 59 ewes treated at 16-day intervals. Failure of proper luteal function has
been suggested, but Robinson (61) found no evidence for alteration of the
period of luteal function, and modifications of PMS dosage and of the
interval between treatments have met with no great success.

166 John Hammond, Jr.

In contrast to the frequent failure of heat to attend a second induced
ovulation, there is a marked tendency for heat to occur spontaneously at a
cycle interval after treatment (44). Furthermore, fertility to service at such
heats appears good; Gordon (34) had 1 1 lactating ewes which came on heat
in this way, and 8 of them lambed.

Attempts have been made to obtain heat with ovulation by combined
treatment with estrogen and PMS. However, while estrogen alone will some-
times induce ovulation, given with PMS it sometimes prevents the ovulation
which might otherwise have been expected. Hammond (41) concluded that
estrogen caused a discharge of endogenous gonadotropin and produced
ovulation only in those animals which had already a large follicle, while
PMS would indirectly cause ovulaton, triggering a pituitary discharge with
estrogen from the ripened follicle. In animals whose follicles were small
at the time of treatment insufficient pituitary stores would remain to
ovulate the follicles when grown. Alternatively, a premature discharge may
render the follicles incapable of ovulating. He found cystic follicles far
more often with the combined treatment than with either substance given
separately.

Besides interference with ovulation, there was the difficulty that heat and
ovulation were not synchronized; the latent period between estrogen and
heat was greater than that between PMS or estrogen and ovulation. Estrogen
induced heat more effectively in animals in which ovulation was blocked. A
regressing corpus luteum is normally required for estrus, but secretion from
newly formed corpora antagonized the estrogen.

Robinson and colleagues (53, 64, 67, 69) have investigated estrogen
progesterone interaction in the spayed ewe. Progesterone pretreatment
lowers the threshold dose of estrogen needed to cause estrous behavior
and also shortens the latent period before heat is manifested; 50% of treated
animals came on heat within 36 hr of estrogen administration. Maximal
response to a dose of estrogen (which, given alone, was subthreshold)
required more than 6 days' pretreatment with progesterone and an interval
of 24-48 hr between the final dose of progesterone and administration of the
estrogen. It appears that progesterone produces transitory sensitization to
estrogen; the proprioceptor concerned is not in the uterus, as had been
suggested, because hysterectomy did not affect response.

Estrus following a single injection of PMS has been obtained by pretreat-
ment either with testosterone (19, 61) or with progesterone (26, 63).
Progesterone has usually been given in oil over a period of 3-15 days,
followed by PMS 2 or 3 days later. In these circumstances the ovulation
rate has been normal (26, 34, 65). There was a tendency to multiple ovulations
when a single large dose of progesterone (75 mg) was followed by PMS 2 days
later (65). Robinson (65) reported great uniformity in the time of onset of
heat, but when Gordon (34) used suspensions of crystalline progesterone

Hormonal Augmentation of Fertility in Sheep and Cattle 167

time of onset of heat was erratic. Those that came on heat also ovulated and
had a normal number of corpora lutea; but many of the others also ovulated,
and these had an appreciably higher average ovulation rate.

Testosterone given at the same time as PMS, or one day earlier, tended
to block ovulation, and cystic or luteinized follicles were common (61).
Testosterone thus appears to share with progesterone the property — more
apparent when results in the breeding season are considered — of blocking
an ovulating release of endogenous gonadotropin.

When prolonged treatment with progesterone is given, there is a distinct
tendency for ovulation and heat to follow cessation of treatment, even though
no gonadotropin is administered (23, 26, 65) — just as it may follow regression
of an induced corpus luteum. This might be explained by supposing that
progesterone, besides blocking pituitary release of hormone, also causes its
accumulation and hence a tendency for discharge when progesterone is
withdrawn.

Almost without exception, ovulation occurs when PMS is given 2-3 days
after a series of progesterone injections (2, 26, 34, 48, 65). Raeside and
Lamond (60) got better results with this schedule than with PMS alone. The
incidence of estrus, as reported by these workers and by others (22, 66), was
generally 80-100%. Fertility, however, is more variable, and it is difficult to
know whether this is due to minor differences in method of treatment,
differences in the animals treated, or merely in quality of insemination. In
non-lactating sheep Dutt (26) found 50% of ova fertilized; Dauzier (22) and
Gordon (34) report conception rates near normal (70-80% and 70%)
and also definitely low (43%), while Robinson (66) obtained very few
pregnancies.

There seems to be a definite difference in response of lactating and of non-
lactating ewes, which has been observed both with PMS twice at a cycle
interval (49), and also with a single PMS treatment following progesterone
(34). Both the incidence of heat in those treated, and the proportion of
those served lambing, is lowered by lactation.

When a ewe lambs early in the breeding season there is a lactation anestrus
of about 6 weeks (34). When lactation is combined with seasonal anestrus it
seems likely there will be a greater degree of ovarian inactivity, and hence
possibly a greater average time interval between PMS injection and ovulation.
It may be that the time relationship between heat and ovulation is affected,
but this has not been investigated, nor have the frequencies of ovulation and
of fertilization been determined in the ewe treated while lactating.

OVULATION IN THE BREEDING SEASON

Midcycle and Pregnancy

For a variety of reasons, induction of ovulation during the luteal phase of
the cycle has not been widely attempted. Russian workers had found that
12

168 John Hammond, Jr.

midcycle ovulalion did not affect Ihc length of cycle in sheep or cattle (44).
It is thus unlikely that ova so shed could reach implantation and maintain
a corpus luteum of pregnancy. The treated animals rarely come on heat;
sometimes they show signs of heat but refuse to accept the male. After
insemination the ova are usually not fertilized (54, 71, 78), possibly because
the sperm are not capacitated (13); furthermore, insemination through the
cervix uniformly caused pyometra (78). Poor recovery of the ova shed, once
suspected to be due to failure to leave the follicle, is probably due to disturbed
ovum transport. Rapid tubal transport under the influence of the corpus
luteum (62, 71) would cause the ova to reach the uterus before they were
likely to be able to survive in the uterine secretions (12).

Pregnant animals have been treated rarely, and usually inadvertently.
Ovulation has occurred after FSH as a single dose (sheep, 44) or repeated
doses (cow, 9), after PU following PMS (cow, 43), and after PU alone
(sheep, 62). But it does not seem to be induced easily by a single dose of
PMS (cow, 43; sheep, 62).

During the luteal phase of the cycle, Casida et al. (9) found that repeated
subcutaneous pituitary injections caused follicle growth, but did not
uniformly produce ovulation. However, similar treatment (or with FSH)
when followed by an intravenous injection consistently induced multiple
ovulation. Multiple ovulation in sheep has been brought about in the same
way (54). Repeated injections of FSH, followed by PU or LH, have also
been used to induce multiple ovulation in cattle (78).

After a single dose of FSH to sheep in the luteal phase, ovulation or
luteinized follicles were sometimes observed (44), but not after PMS. In
cattle Folley and Malpress (31) noted what they called "shock" ovulations
of one or two follicles which sometimes occurred within 48 hr of a single
dose of FSH but not of PMS.

In the presence of an active corpus luteum, ovulation in cows rarely
occurred after PMS (71); it happened more often with a high dose, and more
readily after FSH (43). Multiple ovulation was, however, readily induced
when PMS was followed by PU (7, 71).

Rowson (71) drew attention to quantitative and qualitative differences in
the response of cows to crude and purified PMS. Doses assayed as equipotent
in the rat were not so in cows. The purified material produced less follicle
growth and furthermore a smaller proportion of the large follicles ovulated
when PU was administered. While this might be due to loss of synergistic
LH activity during purification it is conceivable that differences in rate of
absorption or elimination are responsible.

The effect of a single large dose of gonadotropin may be prolonged (31).
Brock and Rowson (7) found the number of follicles ovulated by PU after
PMS increased until the interval between the two treatments was at least
7 days. Abnormal, cystic looking, and partly luteinized follicles may be seen

Hormonal Augmentation of Fertility in Sheep and Cattle 169

after massive or prolonged treatment (9, 29), but Folley and Malpress (31)
found this condition transitory; a persistent cystic condition, such as some-
times occurs in infertile cows, was not produced.

Follicles developed by PMS or FSH in the presence of a corpus luteum do
not in general ovulate spontaneously; one may suppose that progesterone
blocks an endogenous ovulating release of hormone. The blockage is probably
not absolute, for estrogen can induce midcycle ovulation (sheep, 44). Con-
ceivably a partial pituitary "escape" might cause ovulation, or, being
inadequate for that, be enough to luteinize a follicle or make it cystic.
However, "shock" ovulations (or abortive attempts at ovulation) might also
be due to a sudden rise in the level of gonadotropin circulating; and would
then presumably be more likely with larger doses, greater ease of absorption
(or intravenous administration), and with greater luteinizing activity of the
material used — with FSH rather than with PMS.

AFTER REMOVAL OF THE CORPUS LUTEUM

Haimnond and Bhattacharya (43) found that, when given to cows at or
after the time of corpus luteum removal, PMS and FSH could induce twin
or multiple ovulations, but in about 50% only one egg was shed. They found
that the times of heat and of ovulation were advanced. Rowson (71), however,
often found delay or failure to ovulate when he gave purified PMS at
expression of the corpus luteum, and subsequent treatment with PU often
did not induce ovulation. Umbaugh (75) reports that FSH in subcutaneous
waxy implants, made when the corpus luteum was removed, did not produce
multiple ovulation; but many follicles were observed to ovulate within about
30 hr when the same material was given again four days later, this time
intravenously.

From small series of cows given PMS at two dose levels 0-5 days before
expression of the corpus luteum Hammond and Bhattacharya (43) concluded
that, in general, the longer the interval between doses and the larger the dose,
the greater was the number of ovulations and the shorter the interval to
ovulation after expression of the corpus luteum. However, they noted on the
one hand animals in which a large dose produced little follicle growth, and
on the other, multiple ovulations from a small dose. Modification of dosage
and interval failed to yield twin ovulations consistently (42).

This procedure was also technically unsatisfactory for producing multiple
ovulations because of the risk of damaging follicles when expressing the
corpus luteum. Follicles which were ruptured or bruised sometimes luteinized
and then might block further ovulation.

Dowling (25) used this same procedure to produce muhiple ovulations
both with FSH and with purified PMS. He found the interval to heat was
in most cases decreased. Whereas most ova were fertilized after FSH, very
few were cleaved in PMS-treated animals. This may be related to greater

1 70 John Hammond, Jr.

follicle development, and larger numbers of corpora, in the latter group,
and to accelerated tubal transport. An association between multiple corpora
and degenerate o\a was noted by Brock and Rowson (7) in cows in which
estrus was delayed following PMS administration at the time of corpus luteum
removal.

The number of ovulations was greater as the interval between injection and
heat increased (7): one may suppose that the longer the PMS has to act, the
larger will be the number of follicles mature enough to respond either to an
endogenous ovulating release of hormone or to administered PU.

This factor of timing may have affected the observations of Rowson (71)
regarding the influence of preliminary removal of the corpus luteum on the
OMjlating effectiveness of PU following PMS treatment. But other data (7)
support the finding that, with PMS followed by PU, fewer follicles, and a
smaller proportion of those reaching a large size, ovulate if the corpus
luteum has been removed. A similar difference (71) existed between the
response to whole serum and to processed PMS given at the time of corpus
luteum removal (with no subsequent PU). There were fewer ovulations with
processed PMS: indeed many cows so treated failed to ovulate within a
period of about a week.

The papers quoted all agree on individual variation in the follicle growth
produced, but there are divergent opinions as to whether the general effects
to be expected from PMS given at the time of corpus luteum removal are
acceleration or delay of heat and ovulation, and ovulation of one or of many
follicles. Factors possibly responsible for these differences include not only
the different forms in which PMS was given, but also different dose levels,
those of Rowson being generally higher.

Dowling points out that the cow can produce enough hormone to ovulate
many artificially stimulated follicles, and scanty data provided by Brock and
Rowson suggest that PU given at heat, following PMS given when the corpus
luteum was removed, does not increase the number of ovulations.

The finding of many large follicles and few corpora after a dose of PU which
is known to be effective in ovulating a large proportion of a similar number of
follicles would appear to indicate that when the PU was given the follicles
were either too immature to respond or else were already cystic.

It seems possible that a small dose of PMS might speed follicle growth
after corpus luteum removal, and so, indirectly, hasten ovulation; but a
large dose, rapidly absorbed, might provide a premature or subthreshold
stimulus to ovulation and thus abort the larger foUicles. Ovulation would
then be delayed until a fresh generation of follicles matured.

AFTER REGRESSION OF THE CORPUS LUTEUM
The aims and methods of investigation differ with sheep and cattle and it
is therefore convenient to consider the species separately.

Hormonal Augmentation of Fertility in Sheep and Cattle 171

Treatment of cattle towards the end of the cycle, either with FSH or PMS,
has consistently induced multiple o\"ulation (9,10,25,29,31,78), though
there is a tendency to reduced response with repeated treatments (77).
Though multiple o\'ulations may be readily obtained, it would appear that
the actual number is not easily predictable. Sometimes poor recoven.' of ova
and apparent failure of fertilization have been reported (25, 29). It has
sometimes been the practice to give an intravenous injection at the time, or
predicted time, of heat (9, 29, 78), but there does not seem to be any definite
indication that this procedure results in a larger number of OMilations or
better fertility.

With a standard dose of PMS, Hammond and Bhattachar>a (43) considered
that the OMjlator\- response was less erratic when given 3 days before the
time, or presumed time, of heat than when given at the time of corpus
luteum removal. Twin OMilations were general under the former conditions.
However, similar treatment of animals allowed to calve gave less good results
(42), There was, in practice, considerable difficulty in timing the injection so
that heat followed 3 days later. 0\iilation counts by rectal palpation of
corpora (which were not entirely accurate; on occasion there were more
cahes bom than corpora counted) revealed twin ONTilations in a minority.'
and occasional animals with 4 or 5 corpora lutea. Contributon." to these
results are probably indi%idual variation of cycle length and individual
breed and perhaps seasonal differences in sensitivity.

Recently Gordon (35) has been tr>ing similar treatment on a larger scale,
and has had better success both in timing of the injection and in choice of
dosage level. Preliminan.' results based on rectal palpation (and which
await the tests of panuntion and of funher experience) indicate a considerable
discrepancy between number of corpora lutea and number of fetuses.

In the cow (8) \\ ith good qualit)' insemination the 0N"um is nearly always
fertilized but about 30"-\-, fail to stinive, so that there is only about 70'^^ o
conception to ser\ice at a given heat period. Gordon's figures suggest that
with twin ONulations the conception rate is greater than this, but the chances
of both ova surviving are rather poor. This contrasts with Dutt's (27) finding
in the sheep of 143°o lambing in sheep with estimated 147''n ONtilation.

A single FSH injection to sheep, given towards the end of the cycle, has
been noted to produce luteinization of unoMilated follicles as well as multiple
oNulation (44); but luteinized follicles were detected only in sheep killed
se\eral days after ON"ulation. It is thus concei%able that Gordon may have
been misled about the number of twin ON^ulations — as opposed to twin corpora
— in his animals.

In sheep, PMS given on the 12th or 13th day of the cycle increases the
ONtilation rate, and there is a general parallelism between dose and oMilation
rate (2, 62. 76). There is general agreement that the range of response
increases with dosase. sinsle 0%'ulations occunins e%en with the hisher dose

172 John Hammond, Jr.

levels. This treatment has the effect of shortening the cycle slightly (2, 62,
76), but does not appear to afTect the length of estrus (62).

Treatment with a large dose, repeated at heat, reduced the fertility of a
flock allowed to lamb (62), but smaller doses have raised the lambing per-
centage, without at all affecting the conception rate, in a series of 1200
treated ewes (33). However, a small dose can seriously affect conception rate
(76).

Ewes injected between the 12th and 14th day of the cycle had a high
conception rate, but those treated on the 10th and 1 1th day did not. Wallace
notes that the effect was even more marked if expressed in terms of interval
between treatment and heat: for intervals of over 5 days conception was very
poor. It should be stressed that any effect of treatment on cycle length was
very slight. Though the effect of treatment on the non-pregnant animals is
unknown it may reasonably be presumed that they did not have multiple
ovulations, because in those pregnant (which includes the great majority of
those served within 5 days) the maximal average ovulation rate, of just over 2,
was found in those on heat at no more than 2 or 3 days after treatment.

Thus there is no obvious ground for assuming disturbance either of the
time relationship between heat and ovulation, or of fertilization or tubal
transport associated with multiple corpora lutea. With these excluded,
there remain failure of ovulation or ovulation of defective ova. If the latter
be accepted for the sheep, it may well apply also to the cattle results already
quoted (7, 25).

AFTER PROGESTERONE TREATMENT

In the absence of the bull, heat is not easily detected in beef cattle suckling
calves. Treatment by injection at a known stage of cycle is therefore not easily
practicable. Even when heat is detected, individual variability hampers
accurate prediction of the next estrus. Prolongation of the cycle by pro-
gesterone treatment therefore may be of advantage to ensure more precise
timing of the endogenous ovulatory discharge. Casida and colleagues have
prolonged the cycle by daily injections of progesterone in oil (sheep, 28;
cow, 14). With high enough dosage ovulation is inhibited, but follows
cessation of treatment. With lower dosage there may be formation of cystic
follicles. After a single treatment with crystalline suspensions there has
been irregularity about the time of onset of heat, silent heats, low fertility
after mating, and a marked tendency to formation of cystic follicles (22, 24,
55). Even with daily injections in oil there has been some abnormality,
principally increased incidence of silent heats (29, 46, 74). Clearly careful
control of dose level and of the decrease in blood concentration are necessary
to achieve normal heat and ovulation.

Robinson (68) got very good synchronization of estrus and ovulation (90%
estrus within 24 hr) with daily progesterone followed by PMS. In this

Hormonal Augmentation of Fertility in Sheep and Cattle 173

experiment the lambing percentage was not significantly raised, but there
was no reduction of conception rate. Rowson (71) found that progesterone
given after removal of the corpus luteum protected follicles stimulated by
PMS from loss of capacity to ovulate. It seems therefore that this type of
treatment offers considerable prospects of success.

OVULATION BEFORE PUBERTY

The ruminant ovary contains Graafian follicles at birth. Mansour (50)
gave a single dose of PMS to lambs at different ages and observed increasing
response with increase of age and of body weight. One-week-old animals
showed no obvious follicle growth, later there were luteinized follicles, and
later still ovulations. Progesterone treatment preceding PMS enhanced the
response.

Ovulation in calves, sometimes multiple, has been obtained with repeated
FSH followed by LH (9, 10). Marden (51) noted greater frequency of multiple
ovulations after two treatments, and seems to have had some success with a
single series preceded by progesterone. Similar treatment by Black et al. (6)
did not noticeably enhance the ovulation rate.

So far as one can tell, the response before puberty does not differ from the
extremes of response found in anestrus.

OTHER POSSIBILITIES

So far administration of gonadotropins has mainly been considered.
Steroid, or other, stimulation of endogenous gonadotropin secretion might,
if practicable, well prove cheaper than administration of PMS.

Induction of ovulation in anestrous sheep by progesterone has already
been mentioned. In sheep in which the cycle was prolonged with progesterone
the ovulation rate tended to be decreased (28), though in the sow (3) an
increase has been noted.

Estrogen implants given to induce lactation in cattle (20) inhibited the
ovarian cycle, which was not immediately resumed upon cessation of treat-
ment. There was a period of cystic follicle formation followed by one in
which twin ovulations, and calvings, were more frequent than normally.

The cyst formation one may attribute to failure of pituitary hormone
reserves for ovulation to be accumulated in the absence of a corpus luteum.
In the treatment of chronic cysts in cattle (39) the cyst is ruptured and a
fresh follicle develops which is itself liable to become cystic. But this follicle
may be induced to ovulate by PU (43) or to luteinize by manual rupture
before the granulosa degenerates. Thereafter a normal cycle is resumed.
It is not easy to see how altered pituitary reserves could also account for
the occurrence of twin ovulations. It might be that the normal extent of
stimulation of follicle growth is limited by estrogen, and that heavy and
prolonged estrogen treatment desensitized the regulating mechanism.

174 John Hammond, Jr.

DISCUSSION

Both in immaturity and with poor nutritive conditions it seems that there
may be impaired follicle growth and ovulation in response to PMS. It
also seems that pituitary extracts are then more cftective than is PMS. If
this is because PMS requires the synergism of endogenous LH, one
might suppose that immaturity and low plane of nutrition depress LH
secretion.

It is an accepted belief with sheep that "flushing" — raising the plane of
nutrition shortly before mating — increases the ovulation rate. Wisconsin
workers (32) would revise this, and say that flushing raises the rate to normal.
However that may be, Wallace (76) found that both PMS treatment and
flushing raise the ovulation rate, and that both also shorten the cycle length.
This evidence might be taken to suggest that poor nutrition depresses FSH
secretion.

However, one thing that seems well established is that the ovulation rate
depends not only on the amount of hormone available for follicle growth
but also on the time available for its action. A change in ovulation rate is
not necessarily due to an altered quantity of secretion.

There is a seasonal change in ovulation rate (1, 40, 47, 52) and this is not
of nutritional origin (59). The ovulation rate rises to a maximum at a time
when estrus is most intense and conception rate highest (1). The cycle length,
however, is not then at a minimum; on the contrary, there is a tendency for
the length to increase in the first part of the season (2, 40).

Work at Cornell (45) shows the ovulatory release of hormone to be neuro-
genic and, in the cow, that it occurs after the start of heat. Either delay in
this release or advancement of the stimulus to follicle growth relative to
luteal regression might alter ovulation rate.

There seems no reason to doubt that steroids act centrally in the induction
both of heat and of the ovulatory discharge from the pituitary. Quite apart
from the results of Clegg et al. (15) with hypothalamic lesions, the hormone
work on sheep would seem to indicate the points of action differ for the two
effects. Progesterone appears to antagonize estrogen at each, but possibly
the steroids interact differently at the two sites.

The occurrence of silent heats after hormone treatment, or under poor
nutrition, might be due to factors of timing, or of level of estrogen secretion
under altered FSH : LH balance, or even of some adrenal corticoid antagon-
ism to heat but not to ovulation.

Estrogen appears to provoke an explosive ovulatory discharge. The
discharge of hormone on progesterone withdrawal — which leads eventually
in some anestrous sheep to ovulation — initially must cause follicle growth
and is probably not similarly explosive. A sudden rise in hormone level seems
likely to impair the capacity of follicles to ovulate. If one considers how one
or two follicles gain an advantage over the rest, an initially slow, continuous

Hormonal Augmentation of Fertility in Sheep and Cattle 175

and increasing release of hormone would appear probable, such as might
occur if its secretion rate were inversely related to the level of circulating
progesterone.

Consistently to obtain multiple ovulation artificially one depends upon
luteal — or progesterone — restraint of the ovulating discharge. In the normal
breeding season of the sheep, lengthening of the cycle — and so, perhaps, of
luteal function — is associated with increased ovulation rate. In ruminants
at least, the factors regulating follicle growth seem at the present time scarcely
separable from those governing luteal function.

REFERENCES

1. AvERiLL, R. L. W., Studies on Fertility 7, 139, Oxford, 1955.

2. AvERiLL, R. L. W., /. Agric. Sci. 50, 17, 1958.

3. Baker, L. N., L. C. Ulberg, R. H. Grummer and L. E. Casida, /. Animal Sci. 13,

648, 1954.

4. Bell, T. D., L. E. Casida, G. Bohstedt and A. E. Darlow, /. Agric. Res. 62, 573, 1941.

5. Berry, R. O. and H. P. Savery, in Reproduction and Infertility, III, Symposium

(Edited by F. X. Gassner), p. 75, Pergamon Press, London, 1958.

6. Black, W. G., L. C. Ulberg, R. E. Christian and L. E. Casida, /. Dairy Sci. 36,

274, 1953.

7. Brock, H. and L. E. Rowson, /. Agric. Sci. 42, 479, 1952.

8. Casida, L. E., Iowa State Coll. J. Sci. 28, 119, 1953.

9. Casida, L. E., R. K. Meyer, W. H. McShan and W. Wisnicky, Amer. J. Vet. Res. 4,

76, 1943.

10. Casida, L. E., A. Nalbandov, W. H. McShan, R. K. Meyer and W. Wisnicky,

Amer. Soc. Animal Prod. 33, 302, 1940.

11. Casida, L. E., E. J. Warwick and R. K. Meyer, /. Animal Sci. 3, 22, 1944.

12. Chang, M. C, Nature, Lond. 161, 978, 1948.

13. Chang, M. C, Endocrinology 63, 619, 1958.

14. Christian, R. E. and L. E. Casida, /. Animal Sci. 1, 540, 1948.

15. Clegg, M. T., J. A. Santolucito, J. D. Smith and W. F. Ganong, Endocrinology 62,

790, 1958.

16. Cole, H. H. and P. T. Cupps, Reproduction in Domestic Animals, New York, 1959.

17. Cole, H. H. and G. H. Hart, J. Amer. Vet. Med. Ass. 101, 124, 1942.

18. Cole, H. H. and R. F. Miller, Amer. J. Physiol. 104, 165, 1933.

19. Cole, H. H., G. H. Hart and R. F. Miller, Endocrinology 36, 370, 1945.

20. Day, F. T. and J. Hammond, Jr., /. Endocrinol. 4, 53, 1944.

21. Day, F. T. and I. W. Rowlands, /. Endocrinol. 5, 1, 1946.

22. Dauzier, L., Ann. Zootech. 7, 341, 1958.

23. Dauzier, L. and S. Wintenberger, Ann. Zootech. 6, 49, 1957.

24. Donker, J. D., J. R. Nichols, E. F. Graham and W. E. Petersen, in Reproduction and

Infertility, III, Symposium (Edited by F. X. Gassner), p. 171, Pergamon Press,
London, 1958.

25. Dowling, D. F., /. Agric. Sci. 39, 374, 1949.

26. DuTT, R. H., /. Animal Sci. 12, 513, 1953.

27. DuTT, R. H., /. Animal Sci. 13, 464, 1954.

28. DuTT, R. H. and L. E. Casida, Endocrinology 43, 208, 1948.

29. DzuiK, P. J., J. D. Donker, J. R. Nichols and W. E. Petersen, Minn. Agric. Exp.

Sta. Tech. Bull. 222, 1958.

30. Erb, R. E. and R. A. Morrison, /. Dairy Sci. 42, 512, 1959.

31. FoLLEY, S. J. and F. H. Malpress, Proc. Roy. Soc. B132, 164, 1944.

32. Foote, W. C, a. L. Pope, A. B. Chapman and L. E. Casida, /. Animal Sci. 18, 453,

1959.

1 76 John Hammond, Jr.

33. Gordon, I.. /. Agric. Sci. 50. 123, 1958.

34. Gordon. I., J. Agric. Sci. 50, 152, 1958.

35. Gordon, 1., Personal communication, 1959.

36. Gr.\nt, R., .\aiure, Lond. 131, 802. 1933.

37. Gr-vnt, R., Trans. Row Soc. Edinb. 58, 1, 1934.
3S. H.\FEZ, E. S. E., J. .Agric. Sci. 42. 199, 1952.

39. H.VMNJON-D, J., let. .\fed. 34, 63S, 1939.

40. H.vsiMONT), J., Jr., /. .Agric. Sci. 34, 97, 1944.

41. H.vMMONT>, J., Jr., J. Endocrinol. 4, 169. 1945.

42. H.\MMOND, J., Jr., /. .Agric. Sci. 39, 222, 1949.

43. Ha.\(MON"d, J., Jr. and P. Bh.\tt.\ch.jiRY.'\, J. .4gric. Sci. 34, 1, 1944.

44. H.\MN!ONT). J.. J. H.\ms!OND, Jr. and .\. S. P.\rices, J. Agric. Sci. 32. 308, 1942.

45. H.\NSEL, W. and G. W. Trimberger, J. .Animal Sci. 10, 719, 1951.

46. Hl-nter, G. L.,y. Endocrinol. 10, 13 P, 1954.

47. Hunter, G. L., J. .Agric. Sci. 52, 282, 1959.

48. Hunter, G. L., G. P. Bishop and D. L. Brown, /. Agric. Sci. 51, 129, 1958.

49. jLT)0\TrcH, S. S. and M. W Fosienko, Trans. All Union Sov. Res. Inst. 10, 65, 1939.

50. M.\NSOUR. -A. M., /. Agric. Sci. 52. 87, 1959.

51. M.\RDEN, W. G. R., /. Agric. Sci. 43, 381, 1953.

52. McKenzie, F. F. and C. E. Terrill, .\fo. .Agric. Exp. Sra. Res. Bull. 264, 1937.

53. MooRE, N. W. and T. J. Robinson, /. Endocrinol. 15, 360, 1957.

54. MuRPHREE. R. L., E. J. Warwick. L. E. Casid.\ and W. H. McShan. /. .Animal Sci. 3,

13. 1944.

55. Nellor, J. E. and H. H. Cole. /. .Animal Sci. 15. 650. 1956.

56. NiSHiK.-\WA. Y., N. Ku"RODA and Y. Aw.a.i, Bull. .\at. Inst. .Agric. Sci. {Chiba) GIO, 165,

1955.

57. NiSHiK_\WA, Y., N. KLTiODA and '^'. Aw.\i, Bull. Nat. Inst. Agric. Sci. (Chiba) GIO,

209, 1955.

58. POLONTZOVA, \'. \'. and S. S. jLT)0\TrcH, Trans. All-Union Sou. Res. Inst. 10, 127, 1939.

59. Radford. H. M., .Austr. J. .Agric. Res. 10, 377, 1959.

60. Raeside, J. I. and D. R. L.\mont), Austr. J. Agric. Res. 7, 591, 1956.

61. Robinson, T. J., /. .Agric. Sci. 40, 275, 1950.

62. Robinson. T. J., /. Agric. Sci. 41, 6, 1951.

63. Robinson, T. J., Nature, Land. 170, 373, 1952.

64. Robinson. T. J., Endocrinology 55, 403, 1954.

65. Robinson, T. J., J. Endocrinol. 10, 117, 1954.

66. Robinson. T. J., /. .Agric. Sci. 46, 37, 1955.

67. Robinson, T. J., /. Endocrinol. 12, 163, 1955.

68. Robinson, T. J., Austr. J. Agric. Res. 7, 194, 1956.

69. Robinson, T. J., N. W. Moore and F. E. Bintt. /. Endocrinol. 14, 1. 1956.

70. Ro\\-l.\n-ds, I. W.. /. Endocrinol. 6. 184, 1950.

71. RowsoN, L. E.. J. Endocrinol. 7. 260, 1951.

72. Simpson. M. E., C. H. Li and H. M. Ev.vns, Endocrinology 48, 370. 1951.

73. THONfPSON. D. S. and P. G. Schinckel, Emp. J. E.xp. .Agric. 20. 77, 1952.

74. Trimberger, G. \\'. and \V. Hansel. /. .Animal Sci. 14, 224, 1955.

75. Umbaugh, R. E.. .Amer. J. let. Res. 10, 295, 1949.

76. Wallace, L. R.. J. Agric. Sci. 45. 60, 1955.

77. WiLLETT, E. L., p. J. BucKNER and W. H. McSh-^n, /. Dairy Sci. 36. 1083, 1953.

78. WiLLETT, E. L.. W. H. McSh.\n and R. K. Me^tr, Proc. Soc. E.\p. Biol, and .Med. 79,

396, 1952.

79. Zaw.\dowsicv, M. M. and Z. S. Marguus, Trans. Dyn. Dec. 11, 80, 1939.

discussio;ns

Chairman : Frederick Hisaw

Dr. William F. Ganong : I asked previously that I be excused from the discussion until
Mr. Hammond's paper had been given because my experience has not included any
work related to avian ovulation. From the point of view of the neuroendocrinologist,
there is one point that might be made relative to Dr. Nalbandov's paper. I appreciate
the fact that he is not yet ready to extend his hypothesis to mammals, but there are
situations in the rat in which there is a good deal of FSH secretion, and still ovulation
can be brought about. There are a number of reports, the most recent being that of
Van Dyke, Simpson and co-workers (Proc. Soc. Exp. Biol, and Med. 95, 1, 1957),
of persistent estrus following anterior hypothalamic lesions. The ovaries of these

SITE OF HYPOTHALAMIC LESIONS IN 7 EWES WITH CYCLIC
OVARIES BUT ABSENT HEAT PERIODS

INCLUSIVE AREA
DESTROYED BY LESIONS

AREA COMMON TO
ALL LESIONS

Fig. 1 . Reconstruction of lesions on midsagittal section of the hypothalamus. MI, massa
intermedia; MB, mammillary body; OC, optic chiasm; PIT, pituitary.

animals contain many follicles and the uteri are enlarged, so presumably a high
level of FSH secretion is present continuously. Injection of purified LH leads to
prompt ovulation of many of the ovarian follicles.

Mr. Hammond has raised a number of questions about the interrelations in the
sheep and the cow between the mechanisms responsible for the production of heat
and those responsible for ovulation. Certainly, there seems to be little doubt that heat
and ovulation can be separated by appropriate brain lesions in experimental animals.

Dr. Clegg and I have been interested in the role of the hypothalamus in the regulation
of the sexual cycle of the sheep. We have now examined the brains of 39 ewes in which
localized destruction of various parts of the hypothalamus has been produced stereo-
taxically (Clegg, M. T., J. A. Santolucito, J. D. Smith and W. F. Ganong, Endocrinology
62, 790, 1958). Lesions were made during the breeding season in all these animals.
Twenty-two unoperated animals served as controls. We have observed an absence of
heat periods after production of the lesions in 22 of the 39 operated animals. Five of
these ewes were killed after the normal controls entered the anestrus season, so it was
impossible to say whether or not pituitary stimulation of the ovaries had been
inhibited. The ovaries of the remaining 17 were examined while the normal control
animals were still cycling regularly. Nine of them showed acyclic ovaries, i.e. corpora
lutea were absent and all ovarian follicles were small. In eight ewes, corpora lutea
and/or large ovarian follicles were present. Since regression of the corpus luteum is
normally complete a day or two after the next heat, the presence of a corpus
luteum indicates that ovulation has occurred in the past three weeks. The possibility

177

1 78 Discussions

of a persistent corpus in these animals was ruled out by examining the ovaries at
laparotomy and later, at autopsy. Accordingly, in eight ewes the behavioral manifesta-
tions of heat were abolished by hspothalamic lesions, presumably without affecting
pituitary gonadotropin secretion. The area destroyed by the lesions in se%en of these
animals is shown in Fig. 1. Part of the brain of the other sheep was inadsertently
destroyed, so detailed localization was not possible. The se\en lesions were in the
basal ponion of the h>pothalamus, sharing in common an area of destruction just
in front of the infundibulum and above the median eminence.

Lesions in other pans of the h>pothalamus in 17 animals had no effect on either
ovarian cycling or heat. The areas of destruction in these sheep are showTi in Fig. 2.
It is apparent that extensive lesions in the diencephalon did not affect sexual behavior.

SITES OF HYPOTHALAMIC LESWNS K 17 EWES WITH HCfiVAL
HEAT PERIODS AND CYCUC OVARIES

:£5'=7r£D BYLE30NS

Fig. 2.

Indeed, in a number of instances, ewes with control lesions accepted the male less
than 24 hr postoperatively, while still staggering from the effects of the pentobarbital
anesthesia. Therefore, the data indicate that the effect of lesions on sexual behavior is
specific, and depends on a reasonably discrete area in the anterior h>pothalamus.

The idea of a diencephalic centre concerned with sexual behavior is, of course, not
new. Dempsey and Rioch (/. Neurophysiol. 2, 9, 1939j and Bard (Res. Publ. Assn.
Nerv. Ment. Dis. 20, 551, 1940) originally presented evidence for such a centre by
comparing the sexual responses of decorticate and decerebrate guinea-pigs and cats.
Subsequently, Brookhart and his associates (Endocrinology 28, 561, 1941) obser\ed
absence of mating behavior in female guinea-pigs with anterior hvpoihalamic lesions,
in some cases without ovarian atrophy. Sawyer and Robison (/. Clin. Endocrinol.
and Metab. 16, 914, 1956) reported similar results following lesions of the anterior
hypothalamus in cats, as Dr. Sawyer mentioned this morning. The exact role played
by this "centre" in heat is not clear. Harris, Michael and Scott (Ciba Symposium on
Neurological Basis of Behavior, p. 236, London, 1958) were able to produce heat in
ovariectomized cats by the implantation of minute amounts of estrogen in the posterior
hypothalamus, while implantations in the anterior hvpothalamus, other parts of the
brain, and the periphery were ineffeai\e. An interesting feature of these experiments
was the seemingly fixed latent period of three days between hormone implantation
and the onset of heat. Somewhat similar results but with a shorter latent period have
been obtained in rats by Fisher (Reticular Formation of the Brain, p. 251, Boston, 1958).
Delgado (Abstr. list Inter. Congr. Physiol., p. 29, 1959) has reported "increased sexual
aaivity" in monkeys following remote control stimulation of the h>pothalamus, but
except for this observation, there is little data on whether or not sexual receptivity can
be induced by electrical stimulation of appropriate diencephalic centres. An indirect
connection between the hypothalamic centre and the behavioral events has also not
been ruled out. As Mr. Hammond said, his original suggestion that tonic contractions
of the uterus play a role in heat (Hammond, Jun., /. Endocrinol. 4, 1 69, 1 945) is probably
not true for sheep, since Robinson (Endocrinology 55, 403, 1955) was able to produce
heat in hysterectomized ewes. However, the cow is apparently different. The cow

Discussions 179

becomes anestrus after hysterectomy, and Dr. Hansel pointed out that even when
ovulation is induced by administration of exogenous gonadotropins, the hysterectom-
ized cow does not show behavioral estrus. This apparent species difference certainly
invites further investigation.

Our studies in the sheep therefore add this species to the list of animals in which a
hypothalamic centre must be intact for heat to occur. This centre is probably stimulated
directly by estrogens, and it is an inviting hypothesis that the aaion of progesterone
in potentiating the heat-producing action of estrogen rests in some sort of a p.nming
action on this brain centre. Certainly, there is ample precedent for an action of
progesterone on the brain in the data presented by Dr. Sawyer this morning, and

SITE OF HYPOTHALAMIC LESOHS W 9 EWES WITH NO HEAT
PERIODS AND ACYCUC O^RIES

Fig. 3.

progesterone therapy not only lowers the heat-producing threshold for estrogen, but
is essential if heat periods are to recur c>'clically (Robinson, Endocrinology 55, 403,
1955).

The brain also appears to be involved in the control of anterior pituitary secretion
of gonadotropins in the ewe, as in other species. As indicated above, nine of the ewes
in our series showed in addition to absence of beha\ ioral estrus, only small follicles
and no corpora lutea in their ovaries. This fact indicates that periodic stimulation of
the ovary was no longer present after the lesions were made. The sites of these lesions
are shown in Fig. 3. These animals also had ventral hypothalamic lesions, but the
common area of destruction in these sheep was more ventrally and caudally located
than the common area in the sheep with the absent heat only. All these animals had
some pituitary stalk damage, but the lesions probably did not produce their effect
by damaging the pituitary blood supply because in those animals in which they were
studied, thyroid function and adrenal size and morphology were normal. In two of
the animals, 17-hydroxyconicoid levels in the peripheral blood following surgical
stress were abnormally low, but in the remaining animals they were normal (Clegg
and Ganong, Endocrinology, in press, I960).

We have been interested in correlating the physiological effects of these hypothalamic
lesions with changes in the gonadotropic potency of the anterior pituitary. The LH
potencv' of the pituitaries from the animals with lesions has been measured by the
ventral prostate response in h\'pophysectomized assay rats, and the follicle-stimulating
potency by the effect on ovarian weight in immature rats receiving chorionic gonado-
tropin (Clegg et ai, Endocrinology 62, 790, 1958). The values found in normal ewes,
ewes with lesions that did not affect the sexual c>cle, and ewes with c>'clic ovaries
but absent heat periods are summarized in Table 1. The differences between the latter
two groups of animals and the normal controls are not statistically significant, an
additional piece of evidence in favour of the concept of a hypothalamic centre concerned
with sexual behasiour which is independent of the areas concerned with regulation of
gonadotropin secretion by the pituitary. We do not as yet ha%e sufficient data for
statistical analysis of pituitary gonadotropin content in sheep with lesions and acvclic
ovaries. However, it is interesting that in the two ewes assayed to date, a slight

180

Discussions

depression of LH activity and a relatively marked depression of FSH potency was
present. There is no comparable data on sheep and very little information on other
species in the literature. Bogdanove, Spirilos and Halmi {Htulociinolo^y 51, 302, 1955)
found that total gonadotropin content was low in the pituitaries of rats with hypo-
thalamic lesions and testicular atrophy. Davidson, Contopoulos and Ganong

Table 1. Pituitary Gonadotropin Content of Sheep
Values are means + standard error of the mean. Assayed against Armour FSH and LH.

FSH

Armour units

mg equiv.

per ant. lobe

1 2 unoperated ewes ; cycling normally

1.84 + 0.24

20.8 ±1.3

11 ewes with lesions; cyclic ovaries,

1.57 + 0.27

23.0 ±6.4

normal heat periods

6 ewes with lesions; cyclic ovaries,

1.42 ±0.25

23.1 + 7.8

heat absent

EFFECT OF HYPOTHALAMIC LESIONS ON
PITUITARY GONADOTROPHIN CONTENT IN MALE DOGS

16r

TESTES PRESENT

CASTRATE

14 -

FSH ICSH
CONTROL

FSH ICSH
LESION OF
POSTERIOR
TUBER CINEREUM

FSH ICSH
CONTROL

FSH ICSH

LESION OF

POSTERIOR

TUBER CINEREUM

Fig. 4.

{Endocrinology, in press, I960) found depression of both FSH and LH activity in
dogs with posterior median eminence lesions and testicular atrophy. In the rat and the
dog, lesions which led to testicular atrophy were generally more posterior than those
in the ewes with acyclic ovaries, but the significance of this point is difTicult to assess.
There was some discussion this morning about the locus of the feedback of gonadal
hormones in regulating gonadotropin secretion. I noticed that most of the speakers
were noncommittal, indicating the site of feedback in their diagrams by arrows
pointing both to the pituitary and hypothalamus. It is interesting in this regard that
while castration causes a sharp rise in the pituitary content of both FSH and LH

Discussions

181

(ICSH) in the male dog, the castrate dog with a hypothalamic lesion shows approxi-
ately the same low level of gonadotropin as the non-castrate lesion dog. This is shown
in Fig. 4, which summarizes data obtained using Dr. Simpson's assay method for the

Normal rats

No. of animals (29)

Lesions of
hippocampus,
thalamus,
cortex

(20)

Lesions of Lesions of

anterior tuberal

hypothalamus region

(8)

\^ j = Day of vaginal opening

= Day of first estrus

I =Standard error
Fig. 5. EfTect of brain lesions on the onset of puberty.

gonadotropins (Davidson, Contopoulos and Ganong, Endocrinology, in press, 1960).
This suggests that the feedback mechanism regulating gonadotropin secretion in the
male dog is primarily at the hypothalamic rather than the pituitary level. In the case

182

Discussions

of ACTH and TSH, there is considerable evidence that the feedback is at the level of
the pituitary, so apparently the mechanism involved in gonadotropin secretion is
dilTcrent.

Dr. Harris and Dr. Critchlow have presented data from their laboratories
indicating that certain hypothalamic and limbic lesions are associated with precocious
puberty in female rats. The data are quite striking and consistent, but I must admit
that I am somewhat surprised at their inability to localize this response to a single

Area common to
lesions in 8 rats

Sagittal section

Ventral view

Fig. 6.

portion of the hypothalamus. In my laboratory, Mr. Gellert has been working on
this problem for two years. Because true precocious puberty is properly defined as the
early onset of otherwise normal sexual cycles, we have produced lesions in various
parts of the brain in immature female rats, and then followed them and their controls
until all were cycling. By serially sectioning the brains, we have located the lesion in
each of the animals and then divided the animals into groups on the basis of common
areas of destruction. In Fig. 5, the mean age for vaginal opening and onset of first
estrus are shown for normal controls, animals with lesions in the anterior hypothalamus,
animals with lesions elsewhere in the brain, and animals with a common area of

Discussions

183

destruction in the posterior tuberal region. There is no significant acceleration of
puberty in any of the groups except the last, but there is a clear-cut and highly
significant acceleration of puberty in the animals with posterior tuberal lesions.

Notice that there is a fair amount of variation in the time of onset of puberty in
the rats with anterior hypothalamic lesions. A few individual animals in this group

Area common to
: lesions in 8 rats

Sagittol section

Ventral view

Fig. 7.

matured quite early. Accordingly, if we had analysed our data in the manner used by
Harris and Critchlow, we might have called a few of these animals precocious; but
the average for the group is not different from the controls.

The common area of destruction in the animals with posterior tuberal lesions is
shown in Fig. 6. The inclusive area destroyed by lesions of the anterior hypothalamus
is shown in Fig. 7. It seems quite clear that precocious puberty is a consistent finding
when a small area in the arcuate nucleus, immediately above the infundibulum, is
destroyed (Gellert and Ganong, Acta Endocrinol., in press, 1960). In recent experiments
we have also found precocious puberty after lesions of the amygdala, confirming
Dr. Critchlow.

1 84 Discussions

I must say that I am pleased that the site of effective lesions in our rats is in the same
general area as the tumors associated with precocious puberty in humans. On the
other hand, the fmdings raise important questions about the mechanism involved
in the early onset of cycling in the experimental animals. Dr. Harris mentioned this
morning, and 1 would like to emphasize it again, the possibility that the effects of
these lesions are not due to interruption of some sort of inhibitory mechanism, but
possibly the lesions are stimulatory in themselves. We know that the arcuate nucleus
is involved in the regulation of gonadotropin secretion in the adult rat. Is it possible,
therefore, that irritation around lesions destroying only part of this nucleus in immature
animals stimulates the adjacent intact portions? Another unsettled question is why
hypothalamic lesions are effective only in female animals. These are problems which
can only be answered by future research.

M. C. Chang: I should like first to express my sincere thanks to our hosts for the invitation
and to congratulate the previous speakers. Dr. Nalbandov presented beautiful photo-
graphs and interesting results on which I can only express my admiration. Then he
concluded with the provocative idea that "ovulation is normally a process of physio-
logical atresia which occurs as the result of absence of hormones rather than their
presence and is thus comparable to menstruation" and that "LH (or another substance?)
produces its effect on ovulation by initiating the process of atresia perhaps by initiating
ischemia". It is very important for the progress of science to have theories to work on
but I should like to pass a few comments for our discussion: (1) If ovulation occurs
as a result of absence of hormones rather than their presence then hypophysectomy,
the removal of FSH and LH should induce ovulation. But according to his results,
a small amount of LH was still needed. (2) Using hypophysectomized animals to
prove or to disprove a particular point is perfectly reasonable, but one must bear in
mind that hypophysectomy may increase the threshold of one physiological process
or decrease the threshold of another. How far the information obtained from hypo-
physectomized animals can be generalized to such an extent as a physiological process
of ovulation in an intact animal is worthy of consideration. (3) Follicular atresia and
menstruation, I think, are not comparable to ovulation because the former two
processes are degenerative and regressive processes while the latter is an active and
progressive physiological process. (4) Does ischemia play a part in ovulation? After
reading Dr. Nalbandov's abstract, we ligated the left ovarian artery of two rabbits,
then gave LH for the induction of ovulation. When examined subsequently the right
ovaries were found to have ovulated normally while the left ovaries failed to ovulate.
When we ligated the left ovarian artery about two hours before the expected time of
ovulation the left ovaries again failed to ovulate. It seems that ovulation requires a
normal supply of blood, and perhaps a larger than normal blood supply, at the time
of ovulation and that severe ischemia would prevent ovulation rather than initiate
ovulation.

Mr. Hammond gave us an excellent review on the artificial induction of ovulation
in sheep and cattle. He mentioned the importance of nutrition in relation to the
induction of ovulation. Here I should like to stress the influence not only of nutrition
but also of environmental factors. Dr. Fernandez-Cano and I (Amer. J. Physiol. 196,
653, 1959) have reported that in the rat following stress, such as brief changes of
environmental temperature or reduced atmospheric pressure, there would occur
inhibition of estrus and ovulation for a long time, about two to three estrous cycles.
It seems to me that for the induction of ovulation by administration of hormones
one should pay attention not only to ovulation but also to the proper estrous behavior,
the transportation of sperm and eggs, the capacitation of sperm and the fertilization
of eggs, and the proper implantation of eggs under the administration of hormones.
If any one of these processes is upset by hormonal treatment the fertility of animals
hardly can be improved.

Since this conference is mainly dealing with ovulation I should like to introduce here
some results of my own. In 1944 Mr. Hammond, Jr. and I injected two groups of
pregnant rabbits with 50 LU. or 500 LU. of HCG and we observed a large number

Discussions

185

of fresh corpora lutea in the ovaries (from 2 to 35). The majority of the animals
ovulated a larger number of eggs than expected. In the accompanying table I present
data collected more recently. It seems that ovulation can be easily induced in the
pregnant rabbits and that about half of the pregnant animals superovulate; that is,
ovulate a larger number of eggs than expected. The eggs are perfectly normal as shown
by the presence of the first polar body and the second maturation spindle. They are
physiologically normal because they can be fertilized either in vitro or after transfer
to the fallopian tubes of mated rabbits. When a few pregnant rabbits were bred to
males no ovulation occurred. Injection of gonadotropic hormone intraperitoneally
into pregnant rats also induces ovulation, but only a small number of eggs were

Table 1. Induction of Ovulation in the Pregnant Rabbit by
Administration of Sheep Pituitary Extract

Total
No. of
animals

No. of
animals
failed to

ovulate

Average No. of

ovulation spots

or eggs recovered

Estrous animals bred 2-3 times
Non-pregnant animals intravenous injection of

28-42 I.U. of pituitary extract
Pregnant animals (20-29 day) injection of 28-42

I.U. of pituitary extract

42
46

9.3 (2-17)

9.7 (1-15)

14.7 (4-31)

found from a few rats ovulated. You may recall that Burdick and Crump have
reported that pregnant mice can be induced to ovulate by injection of chorionic
gonadotropin (Endocrinology 48, 273, 1951). I wonder whether the induction of
superovulation in the pregnant rabbit could throw some light on the hormonal
control of ovulation.

Chairman Hisaw: Dr. Breneman, would you like to add something to the discussion?

Dr. W. R. Breneman: I have only one or two points to make relative to Dr. Nalbandov's
paper. I like his ideas and in line with his conclusions and also at the suggestion of
Dr. Fraps we have been attempting to inhibit one ovulation in hens by the adminis-
tration of lithosperm. This material, an extract of the plant Lithospermutn ruderale,
will inhibit LH after mixture in vitro and will also inhibit the effect of LH on the
testes of chicks in vivo.

Although Dr. Nalbandov did not point this out, most of you know that egg-laying
in the hen usually occurs a little later on each succeeding day. It is possible to anticipate,
therefore, the time of an ovulation and make lithosperm injections before ovulation
occurs. When an injection is made approximately one hour before the anticipated
ovulation, that ovulation is usually inhibited but succeeding ones occur normally.
Originally we gave as much as 40 mg of lithosperm intraperitoneally but recently,
with improved extracts, we find 1.0 mg is an ample amount to produce inhibition.
That is, one ovulation is skipped.

Follicle growth continues when low dosages are given but is stopped with the high
doses. Our current data indicate that it is possible to inhibit FSH in vivo with lithosperm
but the dose required to inhibit FSH is many times that which is necessary to inhibit
LH. It also requires much more lithosperm to inhibit FSH in vitro than it does LH.

Dr. S. J. Folley: I want to mention the case of the goat. Unlike what H. H. Cole showed
many years ago for the ewe, in the female goat it is frequently possible, by a single
injection of PMS, to induce not only ovulation but also estrus during the anestrous

1 S6 Discussions

season. In such cases it is often possible to obtain a fertile mating. In some exp>eriments
we did ten years ago in our laboratory, we found that a single injection of 1200 I.U.
PMS into anestrous goats was often followed by fertile mating. I think this occurred
in about 22 "„ of the females injected.

In other experiments on the quantitative effects of PMS on the ovaries of virgin
goats, we found that small doses (about 400 I.U.) of PMS would cause ovulation
without estrus, while it took between 1000 and 1200 I.U. to cause noticeable effects
on follicular growth.

Thus the female goat seems to be somewhat different from her near relative, the
ewe, in the following respect: there is, in many cases, no need to give two injections,
spaced a cycle apart, in order to achieve out-of-season breeding.

Dr. Villee: I should like to ask Dr. Nalbandov whether he believes the results he obtains
are due to a direct action of the protein hormones on the hen's ovaries, or whether
some steroid might intervene between the protein hormone and the tissue.

Dr. Nalbandov: May I start with Dr. Chang's comments. The references to the role of
"atresia", "necrosis" and "ischemia" in the ovulatory process should be regarded as
relative and not absolute terms. When I say that ischemia precedes the rupture of
the follicle, I don't mean to imply complete cessation of blood flow but a reduction
in the rate of flow and in the amount of blood. I agree that if one were to tie off the
blood supply of an ovary or of an individual follicle these structures would invariably
and inevitably disintegrate rapidly. This is not a physiological process and you cannot
expect follicles or ovaries to continue normal function under these conditions. You
next stated that if the proposed theory is correct, one should expect ovulation to occur
in the hypophysectomized animal without exogenous hormone. According to the
theory proposed ovulation does not follow a hormonal vacuum (as in hypophysectomy),
but is caused by a relative reduction in the amounts of hormones made available to
the follicle. This reduction in available hormone may be caused by a reduction in
blood flow or, as Dr. Meyer suggests, may be due to the increase in the turgidity and
fullness of the follicle which leads to a constriction of blood vessels and a reduction
in the amount of blood flowing through. Referring to the slide shown by Dr. Meyer,
I should like to suggest that his data support the contentions outlined by me, since the
maximum ovulation rate occurs about 18 hr (and perhaps even later) after the injection
of the ovulator, instead of occurring at the usually accepted time of about 10 hr after
LH injection.

In reply to the last question I should like to confuse the issue by presenting a few
preliminary observations on the role of progesterone in the ovulability of eggs. I
remind you of the statement that in the normal laying hen it is never possible to induce
the ovulation of obviously immature follicles with exogenous gonadotropins. However,
tiny immature follicles can be induced to ovulate with relative frequency in intact
hens if no treatment other than progesterone is given. Furthermore, hypophysectomized
hens can be given a minimum dose of LH which is adequate to induce a single ovulation.
If we now add progesterone to this minimum dose of LH, we can occasionally induce
multiple ovulations. In this last experiment progesterone does not act on the missing
pituitary gland, but it could act on the hypothalamus causing it to release ovulation-
inducing substances which cooperate with exogenous LH to increase the frequency
of follicles ruptured. It is, of course, also possible that in both experiments progesterone
acts on the follicle directly and increases its sensitivity to LH. Which interpretation is
the correct one, remains to be seen.

Dr. Robert Noyes: I would like to raise a question concerning the mechanism of ovulation.
Is it possible that LH acts by causing the dissolution of the granulosa? As you know
one can grow granulosa cells of pre-ovulatory follicles in tissue culture but this
becomes impossible after the granulosa cells have been exposed to LH.

Dr. Nalbandov: This observation seems to reduce the importance of the vascular system
in ovulation and emphasizes the possible significanee of LH. It is obvious that a lot
more work is needed before the process of ovulation is completely understood.

Discussions 1 87

Chairman Hisaw : The session is now open for general discussion of the papers of this
morning.

However, if there is no objection I might start things rolling by mentioning one or
two thoughts that have entered my mind. Several years ago Dr. A. Albert and I had
an opportunity to make observations, of a rather general nature, on ovulation in the
smooth dogfish (Mustelus canis). Ovulation occurs in the vicinity of Woods Hole,
Massachusetts, during the last of June and the first of July. Approximately 6 to 12
mature follicles are situated far apart on a very large ovary and apparently one or two
ova are ovulated at a time. The intervals between ovulations are probably quite long
as each ovum must be provided with an elaborate membranous capsule. After ovulation
has begun and one or more eggs have been released, hypophysectomy prevents further
ovulation, which can be initiated by implanting pituitaries from other fish. I mention
this with the thought that the smooth dogfish may be a suitable animal to use in the
study of ovulation.

I also should like to mention some recent experiments by Mr. R. D. Lisk, a student
in our laboratories, on effects of implanting fine needles containing estradiol-lVp in
different areas of the hypothalamus of sexually mature rats. The needles were fashioned
from 27-gauge hypodermic needles. The estrogen was warmed to the point of melting
and only the amount that could be drawn into the needle by capillary attraction was
used. Under this condition the hormone available to the region in which the needle
was implanted was the small amount that dissolved out from the tip end of the needle.

When such implants were made in the area of the arcuate nucleus estrous cycles
ceased and after thirty days the uterus resembled that of a castrated animal. The ovaries
contained no large follicles and the interstitial tissue was atrophic. Similar effects
were produced in the male in which, after thirty days, the atrophy of testis, prostate
and seminal vesicles approached that found about thirty days after hypophysectomy.
It is of interest that such implants in other areas of the hypothalamus did not produce
these effects in the male but in the female such implants in the mammillary bodies
were about as effective as those in the arcuate nucleus.

Dr. William F. Ganong: These results are reminiscent of experiments reported by Flerk6
and Szentagothai {Acta Endocrinol. 26, 121, 1957) in which implants of ovarian
tissue were made in the anterior hypothalamus in rats, and extreme atrophy of the
uterus resulted. Control implants of other tissues were ineffective. These and other
experiments suggest that estrogen feeds back to the anterior hypothalamus to inhibit
FSH secretion. Maybe Dr. Harris would comment on his work on stilbestrol
implantation in cats.

Dr. Geoffrey Harris: I believe the work you mention was that of Flerk6 who transplanted
minute fragments of ovarian tissue into the hypothalamus. If these transplants were
placed near the paraventricular nuclei, atrophy of the uterus ensued. Similar transplants
into the mammillary body or hypophysis, or liver grafts near the paraventricular
nuclei, did not have this effect. From this and other experiments Flerkd concluded
that the action of estrogens in inhibiting FSH secretion is on some nervous structure
in the paraventricular region of the anterior hypothalamus.

The question of hypothalamic localization of endocrine functions can certainly be
very difficult. Donovan and van der Werff ten Bosch, whose work was discussed this
morning, were unable to localize their lesions to any precise hypothalamic structure.
The effective lesions were, however, situated in the anterior hypothalamus. I think that
the suggestion of Dr. Vaughan Critchlow, that these lesions may be interrupting some
diffuse fibre system, such as the stria terminalis, may well be important in this respect.
The problem of the site of lesion in the hypothalamus which results in precocious
puberty was raised by Dr. Ganong this afternoon, while Dr. Sawyer this morning
discussed the areas of the hypothalamus involved with patterns of sexual behavior.

In respect of estrous behavior in cats, Dr. R. P. Michael and myself found a few
years ago (Harris, G. W. and R. P. Michael, /. Physiol. (Lond.) 142, 26P (1958)) that
implants of minute amounts of stilbestrol, fused onto the end of a needle which was

1 88 Discussions

inserted into ihe posterior hypothalamus, activated mating behavior in female cats.
Similar implants in other parts of the brain did not produce this result. Since cats with
mammillary body implants showed sustained mating behavior in the presence of
persistently anestrous genital tracts, it was concluded that the hormone action was
local and not general. Dr. Sawyer has, 1 know, found evidence that the region of the
hypothalamus involved with sexual behavior in the cat lies more anteriorly. What
the answer here is I don't know. The only thing that strikes me in this connection, and
this 1 have discussed before with Dr. Sawyer, is that the production of a positive
response by some experimental procedure involving the hypothalamus is probably
more significant than the loss of a response. The hypothalamus is obviously concerned
with many autonomic and endocrine functions. Therefore, the loss of a particular
behavior pattern following a hypothalamic lesion might be brought about in many
indirect ways, such as through failure in food intake, loss of control of body temperature
or blood pressure, and so on. On the other hand the excitation of a behavioral pattern
when it would not otherwise be present is probably much more specific.

Dr. Ernest Knobil: Mr. Hammond described a cystic ovary which, if ruptured mechani-
cally, would undergo luteinization. Does this mean that there is normally a
decompression of the follicle when luteinization occurs under hormonal influence?

Mr. John Hammond, Jr.: The experiments were my father's, on the cow. After rupture
of the cyst, you get another follicle to ovulate. You can induce this by injection of
pregnancy urine; or, if you manually rupture the follicle, then you get luteinization
of that same follicle. After luteinization, you can feel a great crack across the corpus,
instead of an ovulation point. 1 have done this myself. I feel that you may stimulate
a follicle to the point of being able to luteinize; but that luteinization may not follow
unless the pressure inside the follicle is released.

I mentioned, I think, that when you express the corpus (following a PMS injection)
you may get luteinization of ruptured follicles. I have in one or two cases bruised
such a follicle and got a localized patch of luteal tissue in the wall of the follicle.

Dr. Ernest Knobil: I think most of us believe the hormone acts directly on the granulosa
cells and transforms them into lutein cells.

Dr. Roy O. Creep: I should like to ask Dr. Harris to elaborate a little more on his concept
of how the hypothalamic hypophyseal system works. He stated earlier that he makes
an extract of the median eminence and does not include the hypothalamus on the basis
that the active principle, whatever it might be, would thereby be diluted.

1 should like 10 know how he visualizes the production of the active substance as
a product of the nerve endings of fibres emanating from somewhere in the hypo-
thalamus. I should like to know more about how this substance is produced in the
median eminence, if indeed it is produced there. Or, does it migrate from somewhere
in the hypothalamus? Surely, there must be some correction between the median
eminence and the hypothalamus.

Dr. Geoffrey Harris: What I was trying to say this morning is this — the hypothesis is that
nerve tract(s) pass through the hypothalamus and have their termination on the
sinusoids of the primary plexus of the portal vessels in the median eminence. It is
supposed that at this site some humoral substance is transferred from the nerve
terminals into these vessels, and is then carried to the gland cells of the anterior
pituitary where it exerts a regulating influence. Such a hormonal substance might well
be present along the whole length of the nerve fibres, in the same way that acetylcholine
is known to be present along the whole nerve fibre in the case of cholinergic neurons.
It might then be argued that extracts of the hypothalamus would contain any active
material involved with these nerve tracts but, on the other hand, such material would
be expected to be greatly diluted by substances from nerve tissue adjacent to the tracts.
In the case of the median eminence, however, we have here a minute piece of tissue
in which the relative nerve tracts are focused. Wc might therefore expect to obtain more
concentrated extracts, weight for weight of nerve tissue, from this area.

Discussions 189

Chairman Hisaw: Does that satisfy your curiosity?

Dr. Roy O. Creep: I should like to know whether he thinks the neural secretory material
has anything to do with it, particularly that which has been identified in the supra-
optico-hypophyseal tract.

Dr. Geoffrey Harris: I am a little bit doubtful about that for various reasons. One
reason is that if the supraoptico-hypophyseal tract is stimulated electrically, ovulation
does not necessarily occur. I am rather hesitant, therefore, about accepting this tract,
or the innervation of the neurohypophysis, as being concerned in the neural
mechanism underlying LH release in the rabbit. However, I think a polypeptide
related to those known to be present in the neurohypophysis may well be concerned.
If such a polypeptide is liberated at nerve terminals in the median eminence, the
mechanism could I suppose be referred to as neurosecretory in type.

Dr. Roy O. Creep : I do not know of any other fibre tracts where there is thought to be
movement of material. The idea of axial flow, of neurosecretory material in the tract,
is now being questioned rather seriously.

There is another question I would like to ask Dr. Harris. Has he any evidence as
to whether the active extract of the median eminence yields positive results by any of
the classic tests for neurohypophyseal activity ?

Dr. Ceoffrey Harris: I think it is almost certain that such principles would be present
in our extracts. The only thing I can say at the moment is that a rough calculation
based on the amount of hormone known to be present in the posterior pituitary glands
of rabbits and the proportion of the rabbit neurohypophysis formed by the median
eminence, would indicate that only small amounts, of the order of 100 m U posterior
pituitary hormone, would be present in the extract of one rabbit median eminence.

Referring to the idea of neurosecretion, the nerve fibres innervating the posterior
pituitary would seem to be analogous to those presumed to exist on the present
hypothesis. Posterior pituitary hormone does apparently exist, in one form or another,
through the whole length of the neurons which innervate the posterior pituitary gland.
Whether this material is in fact moving centrifugally along the nerve fibre is doubted
by some workers, and it may be that what is liberated at the nerve terminal is actually
formed at the terminal. I don't know what the answer is to this particular point, but
it certainly seems as if the active material is present along the whole length of the fibre.

Dr. William F. Canong: I should like to rise in defence of the median eminence. I admit
that I have a vested interest. However, if we could switch for a moment to the regulation
of ACTH secretion, the evidence here is that lesions in the mid-portion of the median
eminence are the only ones which will block ACTH release. In stimulation experiments,
ACTH secretion follows stimulation of the median eminence, the posterior tuberal
region and the orbital surface of the frontal lobes. According to Mason {Endocrinology
63, 403, 1958), stimulation behind the mammillary bodies, where the reticular fibres
sweep into the hypothalamus, is also effective. Therefore, my concept is one of
multiple inputs, coming down to a final, common pathway, the median eminence.
I should like to ask Dr. Harris the same question he was asked by Dr. Folley this
morning, but possibly with a slightly different emphasis. How do you feel about
putting materials which are vasoactive directly into the pituitary? You recall this
was a considerable problem some years ago, when people put materials directly on
anterior pituitary transplants in the eye.

Dr. Ceoffrey Harris: The only thing I can say about that is that we have infused other
vasoactive materials into the pituitary without getting similar responses.

Dr. Cregory Pincus: If there is a portal system present, can the blood flow back to the
median eminence from the pituitary ?

Dr. Ceoffrey Harris: All the evidence indicates that blood flows only from the median
eminence to the pituitary gland. This may be taken as established. There is no evidence
that blood ever flows up the portal vessels to the median eminence.

190

Discussions

Dr. Roland K. Meykr: 1 shall describe data obtained in my laboratory by Mr. W. F.
Strauss. The experiment was based on the publications of H. H. Cole (Am. J. Physiol.
119, 704, 1937) who reported mating and fetal development prior to parturition in
immature rats treated with pregnant mare serum gonadotropin (PMS). In our experi-
ment female rats of the Holt/man strain were injected subcutaneously during the
morning of the 30lh day of life with one single dose of 0.4 Cartland-Nelson unit of
Gonadogen (The Upjohn Company). Forty-eight hours later one or two females were
placed with two adult males. Seventy-two hours after PMS injections, vaginal smears
were taken; sperm or a vaginal plug was considered as evidence that mating had
occurred.

He started with 144 female rats but many of these were used for other studies as
the experiment progressed. On the basis of the data obtained from this group we
predict that in a comparable group of 100 rats, 86 would mate, 81 would have an average

5 100-

• INDIVIDUAL ANIMALS

-o-AVERASE WHEN MORE THAN ONE RAT
AUTOPSIEO AT A QIVEN HOUR

HOURS AFTER OVULATOR WAS INJECTED

Fig. 1. Number of ova recovered from oviducts of immature hypophysectomized rats
injected subcutaneously with a FSH preparation, and intravenously with a preparation
containing both FSH and LH activity.

of 10 implantation sites on the 7th day after ovulation, and 75 would parturate an
average of 8.5 young (average gestation 22.5 days). The young mothers would lactate
and raise an average of 7.2 young to time of weaning.

Another group of immature females were treated with PMS as described for the
first group, except that they were not allowed to mate. The time of the first and subsequent
estrous periods was determined by use of vaginal smears. The first estrous smear after
the one associated with vaginal opening occurred at an average of 40 days of life,
compared with an average of 43 in untreated control rats. The succeeding cycles in the
PMS-treated group were shorter and less variable than in the controls.

At this time I also would like to discuss a group of data from rats related to
superovulation and tubal transport of ova. Although tubal transport is a topic outside
the scope of this Conference, it can be an important factor in experiments concerned
with the quantitative comparison of the effectiveness of ovulators. In these studies the
usual procedure is to count the number of ova recovered from the tubes at a definite
time after administration of the ovulator. The data which I will present are taken from
the thesis of one of my students. Dr. Rae Whitney (Rae Whitney, Doctor of Philosophy
Thesis, University of Wisconsin, 1944).

Discussions 191

Sprague-Dawley rats were hypophysectomized when 29 or 30 days of age. They
were injected subcutaneously with a FSH preparation made by trypsin digest method
(W. H. McShan and R. K. Meyer, J.B.C. 132: 783, 1940). This preparation causes the
development of follicles in the hypophysectomized rat, and when administered over a
period of 10 days repairs ovarian interstitial cells and causes localized thecal luteiniza-
tion and occasionally one to few corpora lutea. The FSH was injected once in the
afternoon of the first day and twice daily for the next four days, a total of nine injec-
tions. At the time of the last injection, an intravenous injection was made of an
unfractionated gonadotropic preparation, which was relatively rich in FSH and LH
activity.

At varying times after the ovulator was injected, animals were killed and the ovarian
bursa, oviducts, uterus and body cavity were flushed with saline. The number of ova in
the washings was recorded.

The data are presented in terms of the number of ova recovered from the oviducts
between 12 and 35 hr after the injection of the ovulator (Fig. 1). The maximum
number of ova recovered was found between 16 and 20 hr. Between 20 and 24 hr
the number of ova found in the oviduct was much smaller. It was during this time that
one to five eggs were recovered from the body cavity of a few of the rats; ova were
not recovered from the uterus before 48 hr after the ovulator was injected. We believe
that when large numbers of ova are ovulated some of them accumulate in the
bursa and are extruded through the bursal pore into the body cavity, thus accounting
for the decrease found between 20 and 24 hr. A second peak in the number of ova was
found between 23 and 26 hr. We do not have a satisfactory answer for this unexpected
second peak. It has been suggested that ova found during this time are from a second
group of follicles which were ovulated some hours after those which shed the eggs
accumulating in the bursa and oviduct between 16 and 20 hr.

It is suggested that under the conditions of this experiment, and in similar experiments
in which superovulation is experimentally induced in rats, the function of the
oviduct is aberrant due to abnormal estrogen-progesterone levels. The practical
implication of this concept is that in comparative studies of ovulators of different kinds
the amount of gonadal hormones produced by different ovulators may vary, thus
affecting the function of the oviduct, and the distribution of the ova in the different
parts of the tract. It is also probable that when large numbers of ova are rapidly ovulated
they accumulate in the bursa and many of them are forced through the bursal pore
into the body cavity. This and/or the hormonally induced dysfunction of the oviduct
are factors which should be considered in the development of methods which depend
upon the recovery of ova for evaluating the effectiveness of ovulators.

THE INDUCTION OF OVULATION IN THE

HUMAN BY HUMAN PITUITARY

GONADOTROPIN

Carl A. Gemzell

Department of Obstetrics and Gynecology, Karolinska Hospital
and King Giislaf Vs Research Institute, Sweden

The clinical effects of gonadotropins, both pituitary gonadotropins and those
obtained from extra-pituitary sources, such as pregnant mare serum or urine
from pregnant, castrated or menopausal women, have been disappointing.
In some cases, a polycystic enlargement of the ovaries has been reported but
the finding is inconsistent. It is questionable whether the follicular growth
induced results in maturation of an ovum to the graafian stage of development
or whether an ovulation takes place when the luteinizing factor is added.
The small number of pregnancies reported following such treatments indicates
that an ovulation is brought about only occasionally or independently of
the treatment.

The reason for the negative clinical results may be sought in the fact
that gonadotropins obtained from other species have been used. Witschi (I)
has shown that species specificity exists between gonadotropins of mammalian
and amphibian origin and similar results in monkeys have been reported by
Simpson and van Wagenen (2). An FSH preparation isolated from monkey
pituitaries produced repeated ovulations in the monkey whereas FSH from
sheep or pig pituitaries was less active. A similar specificity exists for other
pituitary hormones such as growth hormone (GH). Li and Papkoff (3) have
suggested that differences in biological activity result from differences in
chemical structure. Human GH, for example, has a smaller molecular weight,
an isoelectric point more on the acid side and different amino-acid end-groups
than GH obtained from bovine pituitaries.

Antigonadotropic factors may also be the cause of the negative results.
It has been noticed for a long time that the ovarian response to continued
injections of gonadotropins gradually diminishes. Pregnant mare serum
gonadotropins and those from sheep or pig pituitaries cause the appearance
of antigonadotropic substances in blood as early as four weeks after the
beginning of the treatment. Human chorionic gonadotropin or gonadotropin
from the urine of castrated or menopausal women, however, does not give
rise to antihormone formation, apparently because of its homologous origin.

192

Induction of Ovulation in the Human by Human Pituitary Gonadotropin 193

These findings suggest that in order to obtain chnical effects with gonado-
tropin preparations from human pituitaries or urine should be used.
Gonadotropins from the urine of castrated or menopausal women, which
have mainly FSH activity, have been available for a long time, but the
preparations are of low biological activity and their clinical effects are
unsatisfactory. An FSH preparation obtained from human pituitaries was
found to be quite active (4). When administered over long periods of time
it did not evoke any formation of antigonadotropic factors.

A difficult problem in clinical practice is to prove if and when an ovulation
takes place. Spontaneous ovulations do give rise to a number of signs that
separately or together give rather good evidence — the rise in body tempera-
ture, the secretory reaction of the endometrium and the changes in vaginal
smear and cervical secretion. These signs are all due to the release of free
progesterone from a fresh corpus luteum.

In the case of ovulation induced by exogenous gonadotropins, however,
these signs may not be valid. The normal physiological functions of the
ovaries require certain ratios of FSH to LH and a slight change in these
ratios may change the secretion of the ovaries. Administered in unphysio-
logical doses, they may be effective in maturing the follicles without actually
bringing about an ovulation. It is also possible that exogenous gonadotropins
disturb the normal mechanism of ovulation in which a group of follicles are
brought to a certain point of maturation and then undergo atresia while the
favored one will continue to full development. Instead, the gonadotropins
may bring several follicles to full maturation and thus bring hormone
production to levels far above the normal.

The evidence for ovulation presented previously at this Conference is
from carefully controlled animal experiments. Our results of gonadotropin
studies in the human are somewhat less straightforward owing to the various
conditions and the differences in the material. Clinical studies are often
fraught with difficulties that are for the most part insurmountable. Every
examination must be carried out in the interest of the patient and has to be
justified from the point of diagnosis or treatment. Thus, in most cases,
the proof of ovulation must rest on circumstantial rather than direct
evidence.

The only absolute proofs of ovulation following the administration of
gonadotropin are pregnancy or a fresh corpus luteum. To confirm a corpus
luteum an abdominal exploration is usually necessary although sometimes
culdoscopy may suffice.

We hesitate to employ surgical operations because the stimulated ovaries
are very fragile and easily damaged. Furthermore, since surgical intervention
is seldom justified, we have usually relied on circumstantial evidence such as
an increase in pregnanediol excretion or secretory reaction of the
endometrium.

194 Carl A. Gemzell

SUBJECTS AND METHODS

Ovulation was induced in young women with primary or secondary
amenorrhea with an FSH preparation obtained from human pituitaries
and with a Swedish commercial preparation of human chorionic gonado-
tropins (Gonadex-Leo). All the patients were treated with human chorionic
gonadotropin (HCG) several months before the administration of FSH in
order to exclude the possibility that HCG alone could induce ovulation.

Preparation of human pituitary FSH. Human pituitaries obtained from
autopsy cases were frozen and lyophilized. The dried glands were cut into
small pieces and extracted in cold CaO-solution at pH 9.3 under continuous
stirring. After centrifugation the clear supernatant was brought to 55%
saturation by the addition of saturated ammonium sulfate. The precipitate
was discarded and the clear supernatant was brought to 75% saturation by
the addition of solid ammonium sulfate. The precipitate was collected by
centrifugation, dissolved in water, dialyzed and lyophilized. This product
was called human pituitary FSH and was used in the clinical trials.

Potency of human pituitary FSH. The human pituitary FSH was assayed
against the provisional human menopausal gonadotropin (HMG-20A)
standard preparation. On a weight basis the partially purified human pituitary
FSH was thirty to fifty times as potent as the HMG-20A standard preparation
when assayed by methods measuring total gonadotropin or FSH activities.
In the ventral prostate test, which is considered to be specific for LH activity,
the human pituitary FSH was only approximately 5 times as potent as
HMG-20A.

Purification of human pituitary FSH. A further purification of the human
pituitary FSH was carried out by Dr. P. Roos in Uppsala employing ion
exchange chromatography and zone electrophoresis. A fraction was obtained
which is more than 2000 times as active as HMG-20A.

Achninistration of human pituitary FSH. The human FSH preparation was
administered in daily doses of 10 mg during a 10-day period. The 10 mg dose
was chosen as it gave a significant increase in ovarian size and estrogen
excretion in a hypopituitary dwarf. A dose of 1 mg per day had no effect
and doses of 2 and 5 mg gave only a slight increase in proliferative endometrial
activity. The 5 mg dose was tried in several cases without any effect. It
may be suggested that a relatively large dose has to be administered in
order to initiate the follicular growth; later a smaller dose may be enough.
Thus, the effective daily dose of FSH corresponded to about 500 mg of the
HMG-20A standard and the total dose during the 10-day period to about
5000 mg.

Repeated treatments with human pituitary FSH were performed in at
least 10 women. All of these 10 women responded to the first treatment as
well as to the subsequent ones. A young woman with primary amenorrhea
was treated during a period of 2 years and received more than 1 gm of FSH.

Induction of Ovulation in the Human by Human Pituitary Gonadotropin 1 95

Following each treatment a polycystic enlargement of the ovaries and an
increase in the estrogen excretion were found. No untoward effects, such as
fever or local reactions at the site of injections, were observed.

Criteria of ovulation. The following criteria of ovulation were employed:
uterine biopsy, chemical determinations of estrone, estradiol- 17^, estriol
and pregnanediol.

Table 1 . Evaluation of Endometrial Activity

Proliferation

Secretion

Atrophy

Weak

Moderate

Intense

Early secretory phase
(preparedness)

Full secretory
phase

No glandular
mitosis

>8*

<8->2

15-18
day of eyelet

19-28
day of cycle

* Number of glandular cross-sections studied, necessary to detect one mitosis (Tillinger
and Westman, 1957).

t Basal vacuolization similar to the one found in normal cycles (Noyes et ai, 1950).

The endometrial activity was estimated according to Table 1 .

The endometrium was atrophic (A) when no mitosis was found in sections
of the glandular epithelium, weakly proliferative (P) when more than 8 cross-
sections were required to detect one mitosis, moderately proliferative (P)
when less than 8 but more than 2 cross-sections were necessary and intensely
proliferative (P) when less than 2 were required to find one mitosis.
Endometrial secretory activity was differentiated into early secretion (ES)
with basal vacuolization, similar to that found in the 15th-18th day of the
normal cycle and full secretion (S) representing the 19th-28th day of the cycle.

Urinary Steroid Assays. Estrogen assays were restricted to the estimation
of the 3 "classic" estrogens — estrone, estradiol- 17/3 and estriol. The method
of Brown (5) was used, with a slight modification as described by Diczfalusy
and Westman (6) and Brown et al. (7). The term "estrogen" will be used to
denote estrone, estradiol- 17/3 and estriol.

Pregnanediol was estimated according to the method of Klopper et al. (8),
but the color correction equation of Allen (9) was used. The evidence in
favor of this modification has been presented by Diczfalusy (10).

RESULTS
In evaluating the effect of human pituitary FSH it must be kept in mind that
the preparation contains small amounts of LH and that the patients have
their own pituitaries which may release FSH and/or LH. It would have been
advantageous if hypophysectomized patients could be tested. We have only
two who to a certain degree meet this requirement — a hypopituitary dwarf

196

Carl A. Gemzell

with advanced hypogonadism and a young woman who was recently operated
upon due to a chromophobe adenoma. The other patients tested had a

HCG(6000lu/(l)

FSH(lCmg/d)

(Ettront (>jg/48hrs)

CIstrodiol-17p(pg/4Bhrs

astriol(>jg/«8hrs)

Prtgnonediol (mg/48 hrs)

17-OHCS {mg/;8hrs)

17-KS(fng/48hrs)

Endomatriol Activitjr
I A A

J i

?5/ 30/ 5/ 10/ 15/

/l1 /ll /12 /l2 /12

Fig. 1. Urinary excretion of estrone, estradiol- 17(5, estriol, pregnanediol, 17-hydroxy-
corticosteroids and 17-ketosteroids before and following the administration of human
chorionic gonadotropin (HCG) and — two and a half months later — of human pituitary
follicle-stimulatin ghormone (FSH). Endometrial activity in biopsies: A = atrophic

endometrium.

long-lasting amenorrhea with atrophic or weakly proliferative endometrial
activity indicating little or no ovarian function.

Induction of Ovulation in the Human by Human Pituitary Gonadotropin 197

Following the administration of 10 mg of human pituitary FSH over a
10-day period a polycystic enlargement of the ovaries was found in 27 out

(18)

Case^ A F. Age 20 year.
FSH(10mg/d) HCG (6000IU/d)

iiiwuiii u;

Estrone (jjg/48hrs.)

300 J

200.

100.

■■^1 ^ n

200,

Estradiol -17/3 (jjg/AShrs.)

100.

- mM ,m _

800.

600.

400.

200.

Pregnanediol (mg/A8hi-s.)

'"L

20_|17-OHCS (mg/AShrs)
10

20.17-KS (mg/i8hrs)
10

Endometrial Activity

1959 10/2

20/2 28/2 5/3 10/3

Gemzell 29/1-60

Fig. 2. Urinary excretion of estrogen, pregnanediol, 17-hydroxycorticosteroids and

1 7-ketosteroids before and following the administration of FSH and HCG. Endometrial

activity : P — proliferative, ES = early secretory reaction.

of 40 women, an increase in estrogen excretion in 16 and an increase in
pregnanediol excretion in 4 out of 30 women. Of 27 women with atrophic
endometrium before the treatment 16 responded with proliferative activity,

198 Carl A. Gemzell

none with secretory reaction. Of 10 women with proHferative endometrial
activity before the treatment 7 showed secretory reaction. However, 11
women out of 40 did not show any response to the administration of human
pituitary FSH. Eight of these 11 women were operated upon and subsequent
examination at operation revealed very hypoplastic ovaries entirely lacking
germinative tissue. The 1 1 women who did not respond to human pituitary
FSH had a pathologically elevated urinary excretion of gonadotropin while
all the women who responded to human pituitary FSH had a low or normal
gonadotropin excretion.

Figure 1 shows the effect of human pituitary FSH on the urinary excretion
of estrogen and pregnanediol and on the endometrium of one of the 1 1
women in whom surgical exploration revealed ovaries without germinative
tissue.

It follows from Fig. 1 that human pituitary FSH had no effect on the
steroid excretion and the endometrium. Thus, it may be tentatively postulated
that in order to obtain an effect with human pituitary FSH the ovaries must
have germinative tissue (11).

Figure 2 shows the effect of human pituitary FSH and human chorionic
gonadotropin (HCG) on a hypopituitary dwarf with primary amenorrhea
and marked hypogonadism. Her endometrium was atrophic before the
treatment.

FSH alone increased the urinary excretion of estrogen. The first increase
was noticed in the urine on the 5th day of the treatment but already on the
2nd day the patient complained about tension in her breasts and an increase
in vaginal discharge. After the last injection of FSH the urinary excretion of
estrogen decreased. Pelvic examination revealed that the ovaries were
enlarged, with diameters of about 6 cm. When HCG was administered 8 days
after the last injection of FSH an ovulation took place probably within 24 hr
as indicated by the rise in pregnanediol excretion and the secretory reaction
of the endometrium.

Figure 3 shows the effect of FSH and HCG on a 24-year-old woman with
secondary amenorrhea and atrophic endometrium.

HCG alone had no effect. After administration of FSH the urinary
excretion of estrogen rose to very high levels, the size of the ovaries increased
and the endometrium changed from atrophic to proliferative. When HCG
was administered 24 hr after the last injection of FSH an ovulation occurred
within 48 hr, as indicated by the rise in pregnanediol excretion, drop in
urinary estrogen excretion and the secretory reaction of the endometrium.
Figure 4 shows a similar effect in a 31 -year-old woman with atrophic
endometrium.

A very strong effect of human pituitary FSH was found in a 25-year-old
woman with underdeveloped secondary sex characteristics, secondary
amenorrhea and an atrophic endometrium (Fig. 5).

Induction of Ovulation in the Human by Human Pituitary Gonadotropin 199

She was treated with HCG alone, with FSH followed by HCG and with
FSH and HCG simultaneously. HCG alone had no effect. FSH caused a
marked increase in the urinary excretion of estrogen, evident as early as
after 5 days of treatment. The urinary excretion of estrogen reached a very

500.

HCG(6 000LU/dJ

mm ,

Estrone {>ig/48hrs.)

Case S L Age 2iyear.

FSH (lOmg/d) HCG(6000LU/d)

mrnmrnmni

Estradiol-17/3t>jg/4ehrsJ

Endometriol Activity

15/4

25/, 2C/8

5/9 10/g

Gemzcll 9/2-60

Fig. 3. Urinary excretion of estrogen, pregnanediol, 1 7-corticosteroids and 1 7-ketosteroid&
before and after the administration of HCG and FSH. (O) = day of ovulation.

high level, almost 5 mg per 48 hr. The ovaries increased in size during the
same time, attaining a diameter of about 5 cm. When HCG was administered,
4 days after the last injection of FSH, an ovulation took place within 24 hr
as indicated by the sharp rise in pregnanediol excretion and the secretory
14

200

Carl A. Gemzell

reaction of the endometrium. During the administration of HCG the ovaries
increased further in size and reached the umbilicus. By a culdoscopy a large
folHcular cyst was evacuated and 750 ml of follicular fluid was collected and
analyzed for estrogen. The fluid contained all three estrogens — estrone,

Case M U Ag* 31 year

^ HCG(6000lU./d) FSHdOmg/d) HC6(fiOOOlU «1

400 .
200.

iiiiiii ; iiiiiuiiiiii

Estrone (pg/48hrs) '

400 .
200.

Estrodiol-17/3(pg/48hrs)

1600.
UOO.
1200.
1000.

800.

600.

400.

200.

Estriol (pg/48hrs)

20.
10.

Pregnonediol (mg /48 hrs )

30.,
20.
10.

17-OHCS (mg/48hrs) ' ^

■ ill J

20.
10.

17-KS (mg/48hrs) '

Endometrial Activity
A A 1 A P (0) ES

?9/12

5/1

10/1

21/2

10/3

Fig. 4. Urinary excretion of estrogen, pregnanediol, 17-corticosteroids and 1 7-ketosteroids
before and following the administration of HCG and FSH.

estradiol- 17j8 and estriol. Following the withdrawal of the follicular fluid
the urinary excretion of pregnanediol decreased from 140 mg to 60 mg per
48 hr. When FSH and HCG were administered together an ovulation
occurred on the 6th day of treatment as indicated by the rise in pregnanediol

Induction of Ovulation in the Human by Human Pituitary Gonadotropin 201

Cot* es Ag« 2S)«ar

HCGieoOOiU /4) FSHdOme/dl HCG (6000 lUW)

JTTTT] liiiiuiii mm

Culdeicopy

EfXJom«Inol ArtMly

mmmi

l7-OHCS(mQ/4»hr«)

jE] ' Sj aVj 30/9 '"10 ^ItS "10 »'10 '0(11 JOfll

SmiaU 3/2-iO

Fig. 5. Urinary excretion of estrogen, pregnanediol, 17-corticosteroids and 17-ketosteroids
before and following the administration of HCG and FSH.

202

Carl A. Gemzell

excretion and the secretory reaction of the endometrium. The elevated
level of urinary pregnanediol lasted for about two weeks and a menstrual
bleeding occurred when the excretion ceased.

Cose A S Age 25yMr

FSH (lOmg/d)

liiilliill

HCG(6000lU/d)
Estrone (>jg/48hrs) n

30h Estriol (>jg/48hrs)
20

8_i Pregnonediol (mg/48hrs)
6

30J T7-KS (mg/48hrs)
20

Endometriol Activity
P (0) S

18/-,

"3 30/3 10/4

Fig. 6. Urinary excretion of estrogen, pregnanediol, 17-corticosteroids and 17-ketosteroids
before and following the administration of FSH and HCG. The patient was operated upon

April 1st.

The effect of FSH seemed to be a function of time. Following a 20-day
treatment with human pituitary FSH in a 28-year-old woman with secondary
amenorrhea, the ovaries reached a diameter of 12 to 15 cm and the urinary

Induction of Ovulation in the Human by Human Pituitary Gonadotropin 203

FSHlTOmg/d} HCG (40001 U I

iUllUUl i

'Vio 20/10 "no 30/10 ''11 10/11 '5/n

Fig. 8. Urinary excretion of estrogen, pregnanediol, 17-corticosteroids and 17-ketosteroids

before and following the administration of FSH and HCG. Following the single intravenous

injection of HCG the urine was collected in 3 8-hr samples.

204 Carl A. Gemzell

excretion of estrogen an amount of 6.6 mg. A 10-day treatment in the same
woman yielded ovaries with a diameter of approximately 5 cm and a urinary
estrogen excretion of only 4.0 mg.

Figure 6 shows the efTect of human pituitary FSH in an amcnorrheic
woman with proliferative endometrial activity indicating some ovarian
function.

Following the administration of FSH a modest increase in ovarian size
and estrogen excretion occurred. On the 6th day of treatment an ovulation
took place, as indicated by the rise in pregnanediol excretion, the drop in
estrogen excretion and the secretory reaction of the endometrium. The day
after the last injection of FSH the patient underwent surgery and the ovaries
were polycystic, enlarged and a single corpus luteum was found in one of
them. An ovarian resection was performed and by histological examination
the corpus luteum was found to be 4 days old (Fig. 7).

The low excretion of estrogen and pregnanediol found in this case was
probably due to the fact that only one follicle matured and developed into
a corpus luteum.

The effect of human pituitary FSH in an amenorrheic woman with
secondary amenorrhea and proliferative endometrium is shown in Fig. 8.

As in the previous case, FSH alone caused an ovulation on the 6th day of
treatment as indicated by the increased excretion of pregnanediol and the
secretory reaction of the endometrium. Twenty-four hours after the last
injection of FSH a single dose of HCG was administered intravenously.
The urine was collected in 8-hr samples immediately following the injection.
The HCG injection caused even during the first 8-hr period a very marked
increase in the urinary excretion of estrogen; the excretion of pregnanediol,
in marked contrast, was unaffected.

Of 50 amenorrheic women treated with HCG alone only 2 ovulated.
The effect of HCG and FSH in one of these is shown in Fig. 9.

Following treatment with HCG an ovulation took place as indicated by
the rise in pregnanediol excretion and a fresh corpus luteum observed by
culdoscopy. When this patient, who had proliferative endometrium, was
treated with FSH alone a polycystic enlargement of the ovaries and a marked
increase in the urinary excretion of estrogen occurred, but there was no indica-
tion of ovulation.

The second amenorrheic woman, who ovulated following treatment with
HCG, reacted in a similar way on the administration of FSH.

In five other amenorrheic women, repeated ovulations were induced
at certain periods of time. Two became pregnant, each on the second
attempt.

Figure 10 shows the successful result in a 29-year-old woman who had a
secondary amenorrhea of about 7 years' duration and who had been married
for 6 years.

Fig. 7. Enlarged polycystic ovaries with a corpus iuteum in the right one found

at laparotomy.

Fig. 1 1. The double ovum twins.

Induction of Ovulation in the Human by Human Pituitary Gonadotropin 205

Human pituitary FSH was administered in order to prove that her ovaries
responded. A schedule was prepared for induction of ovulation at certain
points of time. The first attempt was a failure but the second one was success-
ful. A rise in body temperature occurred at the time when ovulation was

Cose EG Age 26year
HCG (6000IU/d) FSH (lOmg/d)

ITHT] . Uliilliii

Estrone (pg/iShrs)

400
300
200
100 .

200 ■ Estradiol-17/3(pgM8hrs)
100 .

Endometnol Activity
P S

\ 15/^ 20/, , 10/5 15/5 20/5 26/5

Fig. 9. Urinary excretion of estrogen, pregnanediol, 17-corticosteroids and 1 7-ketosteroids
before and following the administration of HCG and FSH.

predicted to occur. When 2 weeks later no menstrual period appeared and
the temperature was still elevated a pregnancy was suspected. Two weeks
later positive pregnancy tests confirmed the diagnosis. The patient delivered
double ovum twins 265 days later (Fig. 11).

Unfortunately, only in a few cases was it possible to examine the ovaries
following treatment with human pituitary FSH and HCG. Following FSH
alone the ovaries showed a great number of follicular cysts of various sizes.

206

Carl A. Gemzell

The granulosa of these follicles was often damaged, probably due to rapid
growth and the consequent change in intrafollicular pressure. Following FSH
and HCG administration, polycystic, enlarged ovaries, either with a single

HCGieOOOlU)

fTTTn

Ettront (pgi —
Estrod.ol-n^(p9] —
Estnol [pgl

PregnOfwdtoUmsl

Celt SC Ag>29(tar

HCG(3000IU)

60 J 17-KStmg.l

Bttedir>g
Endometrioloctfvity:

t t t

27/10 30/0 1/11 s/n in2 ira ^2 ^2 »ij ^2 ^ih 5/, «„ "io^^ Wj W2 ^ b ^

FSHdOmg)

K0160001U)

uiiiiii;^ui

Estrone

(«)

Eslrod«jl-T7^(W)|

Eslriol

iw)

Temperature CC ]

Endometrial activity;

2O/3 25/3 30,3

2O/5 2^5

Fig. 10. Induction of ovulation and pregnancy in an amenorrheic woman. The second
attempt was successful as is shown by the 2 positive pregnancy tests about 5 and 6 weeks

after the time of ovulation.

corpus luteum or with a great number of corpora, were observed. In the
latter cases the ovaries were hemorrhagic with follicles of various size filled
with fresh coagulated blood. In the abdominal cavity hemorrhagic yellow

Induction of Ovulation in the Human by Human Pituitary Gonadotropin 101

fluid was often found, probably originating from the ruptured follicles. The
stimulated ovaries were very fragile and ruptured easily upon handling. Two
to three weeks later the enlarged ovaries were reduced in size and could not
be felt by pelvic examination.

DISCUSSION

The enlargement of the ovaries and the high excretion of estrogen following
the administration of FSH indicated that a large number of follicles were
stimulated. During a normal menstrual cycle several follicles are brought
to a certain point of maturation and then undergo atresia while a single one
takes the lead to its full development. It was likely that the exogenous FSH
disturbed this mechanism and brought all the stimulated follicles to full
maturation. When these matured follicles were exposed to the luteinizing
factor, luteinization occurred in all of them at the same time which resulted
in several ovulations and corpora lutea formations. Whether these enlarged
follicles were able to deliver normal ova was questionable. It might be
suggested that the rapid growth and the changes in intrafoUicular pressure
distributed the normal development of the ova. However, at least in two cases
the induced ova were fertilized and developed into normal fetuses.

The primordial follicles of the ovaries, as was shown in this study, have to
be stimulated by the exogenous FSH for about 6 days before the luteinizing
factor is effective. When the follicles reached this state of maturation
luteinization took place very rapidly and a corpus luteum was formed within
24 hr. The luteinization of the ovaries was followed by a severe pain in the
lower abdomen.

The strong effect of the exogenous FSH on the ovaries might indicate that
the doses were too large or that the hormone was administered during too
long a time. In several cases half the dose (5 mg) was administered without
any effect. It was possible that the first doses of FSH have to be rather large
in order to initiate follicular growth. After the follicles have been stimulated,
smaller doses might be sufficient. Furthermore, the period of 10 days might
also be too long, for the maturation necessary for the luteinization to occur
was reached already within 6 days. After an ovulation has occurred the
remaining follicles are still responsive to FSH stimulation and continue
growing and produce large amounts of estrogen.

The tremendous rise in pregnanediol excretion seen in a couple of cases
suggests that the amount of HCG administered might also be too large. In
one case where a single corpus luteum was found, the pregnanediol excretion
was 8 mg per 48 hr which was a quite normal level during the luteal phase.
The high level of 100 to 140 mg per 48 hr found in one case might indicate
that 10 to 15 corpora lutea had been formed. In a patient operated upon this
suggestion was confirmed; the high excretion of 80 mg of pregnanediol was

208

Carl A. Gemzell

correlated with 5 corpora lutea. It seems also important that HCG was
administered during a relatively short period of time, for HCG caused further
enlargement of these ovaries which were stimulated by FSH.

Table 2. Inducing Ovulation by FSH ( + LH) in Amenorrheic Women
WITH Various Endometrial Activity

Endometrial activity

No. of
patients

Increase in
ovarian size

Increase in
estrogen
excretion

Ovulation

Atrophic
Without pituitary
With pituitary

Proliferative

2
16
10

0
0

Secretory

FSHtLH)

♦ Estrogens

FSH(LH)

t Estrogens

Fig. 12. The mechanism of ovulation in amenorrheic women with atrophic endometrium
(1 and 2) and in those with proliferative endometrial activity (3).

The FSH preparation used in this study caused an increase in the produc-
tion and release of estrogen even in a patient without a pituitary. A similar
increase following the administration of a highly-purified preparation of
FSH has not been observed in hypophysectomized animals. Only after small

Induction of Ovulation in the Human by Human Pituitary Gonadotropin 209

amounts of LH were added did the follicles produce and release estrogen.
As the human pituitary FSH preparation contained small amounts of LH
it was impossible to draw any conclusions on this subject. The problem will
not be solved until a pure human pituitary FSH preparation is available and
is injected into hypophysectomized individuals.

The response to human pituitary FSH was different in amenorrheic women
with atrophic endometrium indicating no ovarian activity and in those who
have proliferative endometrial activity indicating some ovarian function
(Table 2). None of the women with atrophic endometrium ovulated following
the administration of FSH alone while 7 out of 10 with proliferative activity
ovulated.

It seems most likely to assume that the difference is at the pituitary level.
The pituitaries of the first gioup of women lacked the capacity to release
LH when stimulated by estrogen while the pituitaries of the second group
released enough LH for an ovulation to take place (Fig. 12). It might also be
suggested that the two amenorrheic women who ovulated on the administra-
tion of FSH had pituitaries which were insufficient in LH. One of them
ovulated repeatedly during one year following the administration of HCG.

Acknowledgement. — This work has been done in collaboration with Dr. E.
Diczfalusy and Dr. K.-G. Tillinger, Karolinska Hospital, Stockholm.

REFERENCES

1. WiTSCHi, E. and C. Y. Chang, Symposium on Comparative Endocrinology, John Wiley,

1959.

2. VAN Wagenen, G. and M. E. Simpson, Endocrinology 61, 316, 1957.

3. Li, C. H. and H. Papkoff, Science 124, 1293, 1956.

4. Gemzell, C. a., E. Diczfalusy and K. G. Tillinger, J. Clin. Endocrinol. 18, 1333,

1958.

5. Brown, J. B., Biochem. J. 60, 185, 1955.

6. Diczfalusy, E. and A. Westman, Acta endocrinol. 21, 321, 1956.

7. Brown, J. B., R. D. Bulbrook and F. C. Greenwood, /. Endocrinol. 16, 49, 1957.

8. Klopper, a., E. a. Michie and J. B. Brown, /. Endocrinol. 12, 209, 1955.

9. Allen, W. M., J. Clin. Endocrinol. 10, 71, 1950.

10. Diczfalusy, E., Acta endocrinol. 20, 216, 1955.

11. Gemzell, C. A., E. Diczfalusy and K. G. Tillinger, Acta Obst. et Gyn. Scandinav.

38, 465, 1959.

DISCUSSIONS

Chairman: AsrwooD

Chairman Astvv<x)d: Thank you very much for that fine presentation. Dr. Gemzell. I
think we might have a brief discussion, before going on to the next paper. Dr. Segal,
do you have any remarks to make at this time ?

Dr. Sheldon Seg.al: Dr. Gemzell's interesting studies and the results he has recorded
speak for themselves so eloquently that there is very little left to question. I have but a
few minor points of interest to raise. Until now, when pituitar>- gonadotropins ha\e
been extracted from animal glands, we have been shackled, to a certain extent, by
the practical expedience- of using whate\ er glands that could be obtained under slaughter-
house conditions. This has made it almost impossible to extract separately male and
female pituitaries. Since the program of extracting himian piluitaries for gonadotropins
is still in its infanc>\ it might be possible to establish a collection procedure which
would permit taking advantage of sex-specific characteristics. All would agree, on the
basis of total gonadotropin assays, that quantitative differences exist and it is far
from imreasonable to assimie that qualitative differences might be imcovered which
would play an important role in the biologic activity of human pituitary extracts. I
would urge Dr. Gemzell to consider this possibility when making collections for future
extraaions.

The results indicate that there was a remarkable imiformity in the time required
for ovxilation after the supplementing dose of HCG was administered. In most
instances it appeared to take approximately 10 hr. In a few cases, however, the evidence
did seem to indicate a longer period of delay. This final maturation period of the
follicle and enclosed ovum may be viewed as highly significant toward assuring the
egg normalcy. The condition of the released egg is particularly important in these
considerations since human gonadotropins will find widespread usage in cases of
infertility in which induced o%Tilations will be given the greatest opportunity for
subsequent fertilization and development. With this in mind, it would seem advisable
to eliminate the use of HCG as the supplementary, ovulation-inducing substance
and as soon as adequate supplies are available, establish the dosage levels required
to complete with pituitary gonadotropins, the entire process of follicle stimulation,
final maturation of the ovoim and ovxJation. The work reported by Dr. Simpson
earlier in this Conference could be used to great advantage in determining the dosage
ratios that would be required. In brief, I am contending that ovulation is a continuous
process including the various steps mentioned above. The gametes released following
the stimulation by human pituitarv- gonadotropin as an initial step followed by HCG
stimulation to carry the process to completion may not have the same opportunity
for normalcy as gametes that have developed completely under stimulation by pituitary
gonadotropins.

My final comment is with respect to Dr. Gemzell's finding of multiple-follicle-
stimulation following the administration of human pituitary FSH. It raises an
interesting speculation on the possible phenotypic expression of a gene action known
to exist in humans. .Multiple or polyovular ovulations occur with familial and even
racial distribution. For example, they occur less frequently among Japanese families
than in Caucasians. To say that the phenomenon is controlled genetically, as all would
agree, does not delve very deeply toward understanding the physiologic differences
that exist at the level of the ovary. One could speculate in terms of gene penetrance,
postulating that the greater the penetrance the greater restriction placed on the number
of follicles stimulated at each cycle. The physiologic mechanism of the gene action

210

Discussions 211

is sxiggested by Dr. Gemzell's studies. He has overcome the genetic teadeacy for
monofollicuJar development by increasing circulating levels and or by altering ratios
of pituitary gonadotropins to levels that are apparently out of the normally produced,
genetically established range (1 refer here to the frequent observation at laparotomy of
multiple-follicle-stimulation and not to the single case of twinning, interesting thou^
it may hc). It would seem that the phenotypic expression of this character controlling
multiplicity of oviilations may simply be in the normal gonadotropin levels for diflFerent
races or families or, more Ukely, the sensitivity of the developing follicles to a given
level of gonadotropins. The faa that no large differences in "normal" gonadotropin
excretion levels have been found among various races may reflect the grossness of
our present gonadotropin assays.

Chairman Astwood : There are a couple of brief comments, I believe, that may be made
at this time.

Dr. Duncan E. Rftd: I would Uke to ask Dr. Gemzell whether he has attempted to
prolong the normal menstrual cycle with himian chorionic gonadotropin. Also, I
should like to know if he has treated women, who might be classified as "chronic
aborters"', during the critical period of implantation and early placentatkm by
administering human chorionic gonadotropin in the hope of prolonging the cmpos
luteimi imtU such time as the syncyiium began to produce sufBcient amotmts of sex
steroids.

Dr. Claude A. VniFF: May I ask a question? I would like to know whether Dr. Gemzell
has used any of the LH, which is a by-product of his preparation of FSH, following
the administration of FSH, instead of using the chorionic gonadotropin.

I noted in yoiu" preparation the LH does come out in a separate fraction.

The other question I have is this. Did this lady who produced the twins have any
family history of twinning?

Dr. Janxt Mc.ARTHt,"R : I w-as intrigued by the mention in Dr. Gemzell's abstract of an
inhibitor)" aaion of progesterone given concomitantly with FSH. Would you be
willing to discuss this a little further?

Dr. Carl Gemzell: In answer to Dr. Reid's question, we found liia: if FSH wus adminis-
tered after an ovtilation w^as brought about, it was possible to prolong the c>"cle. As
long as FSH was administered, there w^s an increa-e in follicular size and estrogen
excretion and no bleeding occurred, ^"hen the administration of FSH ceased, a
menstrual bleeding occurred, usually within one week.

We have speculated whether it is necessary to add something more for the corpus
hiteum to function and produce steroids. However, when we measured the urinary
excretion of steroids there was always a large amount of progesterone produced. The
corpora lutea produced in this way lasted about two weeks and when the pregnanediol
excretion ceased, a bleeding occurred within one or two da.ys.

It is difficult to state exactly when an OMiladon takes place following the adminis-
tration of FSH. In tw o cases we gave HCG intravenously 24 hr after the last injection
of FSH and collected the urine in 3 8-hr samples. Unfortunately both of these womm
had already ovulated on the administration of FSH alone, ^^'e are planning similar
experiments in order to find out just how long a lime it wiU take to in<htce oviilation
in ovaries which have been primed with FSH.

^"hen HCG was administered to women wiio had been treated with FSH they
consistently felt a severe pain in the abdomen about eight to ten hours later. It may
be suggested that this pain indicates the luteinization of the ovaries.

\N e have not done any work on the purification of human pituitary LH but we are
collecting the fractions which contain the LH activity.

The w Oman w ho delivered twins had had no previous record of twins in her family.

■^^e have treated a number of amenorrheic women with progesterone and FSH in
order to find out if the ovarian response was the same as following the administration
of FSH alone. The first 5 women treated showed no ovarian response and we thou^

212 Discussions

that it was possible to inhibit the effect of FSH on the ovaries by simultaneously
administering progesterone (100 mg/day, intramuscularly). However, later experiments
have shown that it is possible to obtain an increase in estrogen excretion with no
change in ovarian size. The urinary excretion of estrogen following FSH plus
progesterone is much lower than following the administration of FSH alone. These
experiments are going on at the present time and I hope to be able to report on them at a
later occasion.

FACTORS INFLUENCING OVULATION AND
ATRESIA OF OVARIAN FOLLICLES

SoMERS H. Sturgis

The human ovary at birth shows a cortex tightly packed with primordial
follicles, and almost no interstitial tissue. We may estimate that there are
upwards of five hundred thousand eggs in these newborn ovaries from some-
what meager evidence such as the finding of a Swedish investigator who
counted four hundred and twenty thousand eggs in the ovaries of a 22-year-
old normal girl who died suddenly (1). In the human as in other mammals,
generally none are left after the age of sixty. If one ovulation were achieved
with regularity every month of life from the age of twelve through fifty,
then less than five hundred eggs in such a girl would ever achieve ovulation.
By far the vast proportion, therefore, are lost in the process of atresia which
begins at birth or before, and continues through to the menopause. The
chance, then, that any given egg in the neonatal ovary will achieve ovulation
is considerably less than one in a thousand. All the other eggs are wasted as
their follicles degenerate, and eventually atrophy to an amorphous hyahnized
scar. It is important to emphasize that atresia is the usual life story and course
of the primate egg and follicle. It is only the unusual egg that matures in a
ripening follicle and goes on to ovulate.

The study of ovulation control must embrace an understanding not only
of the mechanisms behind the dramatic success of the unusual follicle that
ovulates, but also of the background and physiologic causes for the much
more common process of atresia. This process is going on constantly through
the normal cycle in adult ovaries in follicles of various stages of development,
but there are distinct waves of atresia related to certain times of the cycle. It
is hard not to believe that there must be a functional element significantly
added to the activity of the adult ovary by the dozens of follicles undergoing
atresia at any given time. The reasons for this will be stated later. It is
tempting to hope that the causes for atresia might be sufficiently understood
so that one might also heighten or accelerate this phenomenon. If hormonal
interactions are involved, these might offer a means for physiologic control
of ovulation by some direct action on preovulatory follicles causing all to
start dissolution before they reached full maturity.

The massive wastage of germ cells appears to be a rule of nature. Two
results of this loss of follicles in the primate ovary are clearly recognized. In

213

214 SoMERS H. Sturgis

the first place, the interstitial tissue of the mature ovary is gradually built up
by the theca of atretic follicles, and the fibrous organization of their remains.
It seems likely that such an increase in bulk of interstitial tissue may be
necessary before any one follicle in the ovary is enabled to achieve full
maturation at or after puberty. The second, and perhaps much more signifi-
cant aspect of the dissolution of eggs and follicles in mature life probably
relates to the limitation of offspring to that which is typical for each species.
At least in the monkey where the steps of atresia of the ovarian follicle have
been studied in detail, it is apparent that this process wipes out all follicles
of second rank in each cycle, the ones that ordinarily would be most likely next
to mature and ovulate. Perhaps the most dramatic feature of nature's own
control of ovulation in the monkey, and probably the human, is the induction
of atresia in all but one of the ripening follicles each month.

Clearly this is not a local phenomenon such as one due to mounting
intraovarian pressure associated with the rapid spurt of growth of the
maturing follicle, because second rank follicles are wiped out equally just
prior to ovulation in the contralateral ovary as well. Although atresia of
lesser follicles continues unabated at all times of the cycle, yet this is a wave
of dissolution that is significantly present during the ovulation phase.

It is important, then, to review the stages of atresia as seen in the monkey
ovary in an attempt to fit these processes into what is known of gonadotropin
stimulation and steroid response. The examples to be shown are from the
beautiful collection of monkey ovaries in the Carnegie Institute of Embryology
where a study was made through the courtesy of Dr. George W. Corner (2).
Figure 1 shows the egg and surrounding cumulus on day 13 just before
ovulation. The egg shows the first maturation spindle. The granulosa cells
of the cumulus are beginning to separate with edema fluid. The theca interna
layer is thin and delicate and hard to demonstrate. The diameter of this
follicle was seven thousand microns. It was judged to be within 24 hr of ovula-
tion. At the same time, in the same monkey, Fig. 2 indicates two follicles of
second rank. These could be found by tracing down serial sections to measure
in largest diameter nine hundred to twelve hundred micra. The striking
features are first, the dissolution of the granulosa indicating the first sign of
impending atresia, and second the dramatic thickening of the theca interna
layer. To make the comparison of this theca hypertrophy with that of the
maturing follicle more obvious, Fig. 3 shows the thin undeveloped theca
layer of the maturing follicle and Fig. 4 shows in higher power the thick,
juicy apparently secretory theca interna layer of the follicles going into
atresia.

Within the next two or three days, these large follicles collapse rapidly and
here in another specimen (Fig. 5) is seen, with Mallory's connective tissue
stain, a follicle undergoing atresia with the egg already amorphous and
degenerate. One can see the condensation of fibers between the cells of the

Factors Influencing Ovulation and Atresia of Ovarian Follicles 215

theca interna forming the wavy line tliat will become the hyaloid membrane .
of later atretic follicles.

The same process probably occurs in human ovaries, although there is not
yet available today sufficient material to follow the same stages as closely.
The most striking feature of these observations for the present discussion is *
the hypertrophy of theca interna that appears coincident to the earliest sign
of atresia in those follicles of second rank. This feature occurs coincidentally -
with the formation of the first polar body or second maturation spindle of
the mature follicle about to ovulate. Incidentally, a careful study of rat ovaries
under various stimuli fails to reveal any theca interna thickening coincidental
to the cleavage of the ovum that typifies early atresia in this species. The
absence of this theca interna thickening in an animal that can readily accom-
modate an average litter of nine in comparison with its presence as seen in
the monkey in the eight to ten follicles wiped out each month, might lend
suggestive support to the thesis that the factors causing this theca hypertrophy
in the primate may be responsible in some way for the limitation of ovulation
to a single follicle each month.

It is difficult to escape the probability that this clearly defined structure
plays some endocrine role in the cycle. Other endocrine events of consequence
are happening as well. The maturing follicle shows a tremendous spurt
of growth from day 12 to day 14 of the cycle. This is simultaneous with '
the first high point in estrogen production during the menstrual cycle. In the
last 24 hr before ovulation, there is also a sudden surge of production of the
pituitary gonadotropin causing an LH effect. McArthur has documented *
such a peak in a normal cycle (3), and this has been confirmed by Taymor (4).
There is considerable evidence to suggest that the surge in estrogen produc-
tion by the spurting growth of the major follicle causes the release of this LH.
It may not even be estrogens themselves, but breakdown products that have
this result. Thus, if one castrates a rat and transplants one of the ovaries into
the spleen, the steroids produced by the transplanted ovary will be brought
in the portal circulation directly to the liver, and there become inactivated.
The continuing atrophy of the uterus in such a preparation confirms that
estrogens have not escaped into the general circulation from the liver. Yet,
the transplanted ovary becomes converted into an almost solid luteal body.
It seems probable in this case that the breakdown products of estrogen liberated -
from the liver are responsible for the LH and perhaps LTH coming from the
pituitary that causes such luteinization of the transplanted gonad (5). Now,
just as we have seen in the monkey that the period of theca hypertrophy in
atretic follicles is short lived, about two to four days, so also have studies *
shown that the peak of LH is hmited to the same time interval. It is unfortu-
nate that we do not have any evidence of this LH peak yet available from the
monkey nor do we have serial sections of sufficient human material to show
that the theca proliferation in the human is similarly a transient phenomenon.

216 SoMERS H. Sturgis

It seems probable, however, that the same time relationships apply both to
monkey and human. As yet, we have no clear explanation for this wave of
atresia, but before seeking to clarify this point it is worth noting some other
aspects of atresia of the ovarian follicle.

As well as appearing as part of the normal life cycle of follicles in the
ovary, there are other situations where abnormal atresia of ovarian follicles
occurs. First, this has been noted to occur under instances of excessive and
non-physiologic gonadotropin stimulation. Velardo (6) this month has
, reported follicle cysts, fragmented ova and degenerating follicles when
large amounts of gonadotropins were given to hypophysectomized animals.
Parkes has stated (7) that if one ovary is removed and a part of the other,
then the remainder under the influence of the whole gonadotropic output
responds with multiple cysts and follicular degeneration. Thus, follicles and
eggs are rapidly "consumed". Two other situations in the human are also
connected with the development of theca luteinization and cystic follicles.
First, it is not uncommon in the newborn to see very marked theca luteiniza-
tion in an immature cystic and degenerating follicle. A second abnormal
situation is that seen in the polycystic ovary syndrome. It is to be noted that
amenorrhea or anovulatory flows are characteristic of this clinical condition.
The many small cystic follicles show characteristicaUy the marked thickening
of the theca interna. It is interesting that although spot checks of assays for
LH in these so-called Stein-Leventhal cases have not always shown an
elevation of LH, yet in McArthur's careful daily studies (3), a recurrent ebb
and sway, up and down production with peaks every few days were docu-
mented throughout a month.

We have previously mentioned that the hypertrophied theca interna looks
like endocrine tissue that is generally associated with steroid production. Ten
years ago, we suggested (8) that this might be principally estrogens to support
the level of these hormones in the circulation at the time of the cycle most
important for many aspects of reproductive physiology. At the same time,
there is considerable evidence that progesterone may be produced even before
ovulation and the formation of the corpus luteum. In 1958 it was shown
that human CG caused depletion of the ascorbic acid content of the rat
ovary, and Parlow has demonstrated (9) the same effect from purified LH
in the gonadotropin-primed, hypophysectomized rat. Using the histochemical
staining techniques developed by Deane and others at Harvard, we have been
interested to localize the concentrations of ascorbic acid in these ovaries.
It is found that this substance is confined almost entirely to the corpora
lutea where it is seen as a diff'usely scattered fine, granular deposit. After a
dose of LH to these animals, the ovary shows grossly a depletion of from
35 to 50%, and the ascorbic acid distribution changes to that of rather
massive agglomerates of the granules. This effect is not well understood.
Ascorbic acid is found also in interstitial cells of unprimed ovaries, but never

Fig. 1. Egg and cumulus of maturing follicle in the ovary of Maccacus rhesus on day 13.

Under higher power the egg shows the first maturation spindle. The granulosa is beginning

to show a loosening up due to the appearance of edema fluid. The theca interna is thin

and delicate. The diameter of this normal follicle was seven thousand micra.

Fig. 2. Two more follicles in the ovary of the same monkey shown in Fig. 1 . These measure

approximately one thousand micra in diameter. Although the egg is relatively intact, the

dissolution of the granulosa is apparent. The theca interna in both these second rank

follicles is markedly thickened.

».^-

^^'9:

Yf^

•» •

Fig. 3,

High power of the thin and delicate theca interna layer of a
mature follicle at ovulation time in Maccacus rhesus.

Fig. 4. High power view of the thick theca interna layer in a
follicle undergoing atresia at ovulation time.

Fig. 5. A further stage in the atresia of the ovarian follicle is seen here under Mallory's
connective tissue stain from a monkey on day 17. The egg is amorphous and degenerate.
The cavity of the follicle is collapsing and is bounded by a wavy line representing the
inner margin of the thick theca interna layer. This layer is losing its appearance of a

secretory tissue.

Factors Influencing Ovulation and Atresia of Ovarian Follicles 1\1

in healthy granulosa tissue. It is only seen in the granulosa of follicles that
are starting to degenerate. It is tempting to believe that this substance might
be mobilized as a precursor to progesterone production by thecaluteal or
corporaluteal tissue. Let us now trace the sequence of events that appear to
be validated by the evidence reviewed above. Throughout the first ten days
or so of the proliferative phase of the menstrual cycle in the primate, many
small follicles are developing and contributing in a minor degree to the slowly
increasing level of circulating estrogen before they are lost in the process of
atresia. By the eleventh or twelfth day of the cycle, perhaps a dozen or so
follicles achieve a major degree of development, but only one of these generally
proceeds with a tremendous spurt of growth towards maturation on day
14. A rapid increase in circulating level of estrogens is noted at this i
time, and coincident with this or shortly after it, there is found a first peak of
gonadotropins producing LH effect. In this upsurge of follicular growth, only
the major follicle survives and achieves maturation while all others of second
rank are lost within twenty-four hours of ovulation by successive stages in
the atretic process. One of the most striking features of this is the proliferation ,
of theca interna which appears to coincide with the elevation in LH excretion
and it subsides as this LH peak flattens out by forty-eight hours after ovula-
tion presumably due to the inhibiting action of progesterone from the
developing corpus luteum. The steps that lead the mature follicle to ovulate,
a separation of cumulus and granulosa cells by intracellular edema, extrusion
of the first polar body and development of the second maturation spindle,
the migration of the follicle towards the cortex and actual extrusion of the
egg through the stoma, all have been explained as functions of the peak of
LH at mid-cycle. Possibly, these are steps that attend the fully developed
follicle which may be relatively autonomous and independent of this
gonadotropin by this time. Perhaps a more important eff'ect of this peak of
LH is that of instituting the process of atresia in the second rank follicles. '

SUMMARY

The interplay between pituitary gonadotropins and the ovary of the primate j
at time of ovulation not only may insure that one follicle achieves maturation, 1
but also may precipitate dissolution of the next largest follicles in both
ovaries at that time. It is suggested that this is the mechanism through which
ovulation is generally limited to one or two follicles each month. It has been
emphasized that this atresia of contending follicles occurs prior to ovulation,
and thus cannot be associated with the function of the post-ovulatory
corpus luteum. The institution of atresia might well be due to the action of
LH on these "second rank" follicles that are immature and unable to with- '
stand such stimulation. It is at the time of the mid-cycle peak of LH eff'ect
that these show dissolution of granulosa and hypertrophy of theca interna.
A striking example of this is sometimes seen in the neonatal ovary where

218 SOMERS H. Sturgis

theca luteinization of immature follicles occurs presumably in response to
the LH elTect of circulating maternal gonadotropins. Another example of
theca proliferation of immature follicles associated with fluctuating LH
peaks is also found in the polycystic ovary syndrome. The theca activity in
these follicles that are destroyed lasts only a few days in the monkey, probably
also in the human. It is highly probable as well that this tissue produces
steroids during the transient phase of its existence. Since estrogens are of
prime importance at this critical time in the cycle to stimulate optimal
cervical secretions, tubal peristalsis and so on, it is a likely guess that this
theca thickening helps maintain the level of circulating estrogens. The transient
proliferation of theca in early atretic follicles may also be the source of
progesterone production before ovulation occurs. Preliminary studies of
concentrations of ascorbic acid, typically seen in fully formed corpora in
rat and human, are noted in the rat in the theca and granulosa of unruptured
follicles only when the latter show signs of early dissolution. It is possible
that ascorbic acid appears as a precursor in progesterone production. The
depletion of ascorbic acid caused by giving doses of LH in the presence of
fully formed corpora is not clearly understood. However, this is a wholly
unphysiologic experiment, since in the presence of functioning corpora
lutea normally the pituitary does not excrete LH.

It may be theoretically possible to utilize the above reasoning to create a
chronic state of anovulation such as exists in the Stein-Leventhal ovaries, by
the correct timing and dosage of substances with LH effect. These would
have to be given repeatedly to overstimulate each wave of developing follicles
while they are still immature, before any one has reached that stage of maturity
and developmental autonomy beyond which the further steps in maturation
will inevitably lead to ovulation. Anovulatory cycles thus produced need not
be considered necessarily damaging to the ovaries. The use of LH substances
in this regard would only be an extension of a normal physiologic process
causing the waste of one more follicle each month — a minor loss in relation
to the tens of thousands degenerating through a lifetime. Whether or not if
this scheme is successful it would eventually produce a persistent and
relatively irreversible situation as is found in the polycystic ovary, is a matter
of pure speculation.

REFERENCES

1 . Corner, G. W., The Hormones in Human Reproduction, Princeton University Press, 1946.

2. Sturgis, S. H., Contributions to Embryology 33, 67, 1949.

3. McArthur, J., F. Ingersoll and J. Worcester, /. Clin. Endocrinol. 18, 1202, 1958.

4. Taymor, M. L., Fertil. & Steril. 10, 212, 1959.

5. Sturgis, S. H. and W. Achilles, Endocrinology 49, 720, 1951.

6. Velardo, J. T., Science 131, 357, 1960.

7. Parkes, a. S., in Conference on Mechanism of Ovulation sponsored by the Planned

Parenthood Federation of America, August 1959.

8. Sturgis, S. H., /. Fertil. & Steril. 1, 40, 1950.

9. Parlow, a.. Fed. Proc. 7, 402, 1958.

qCxICa^\

DISCUSSIONS

Dr. McArthur: Dr. Sturgis has put histochemical techniques to good use in localizing
the ascorbic acid present in the corpora lutea and interstitium of human ovaries, and
has alluded to the fact that ascorbic acid may be implicated in steroid secretion. It
is known that PMS, HCG and LH are all capable of effecting ovarian ascorbic acid
depletion. Hov^'ever, it has proved difficult to establish a firm connection between this
depletion and the secretion of any particular steroid or class of steroids.

Dr. Albert Parlow, who is working in our laboratory, has made an interesting
new observation which appears to shed light upon this problem. Because of the

Table 1 . The Induction of Estrogen Secretion by means of HCG
Treatment in Hypophysectomized Pseudopregnant Rats

Interval after

hypophysectomy

(months)

No. of
rats

No. of rats showing
vaginal comification
after HCG treatment

Length of period during

which vaginal comification

could be maintained

(days)

0.0

3.25
6.50
9.50

similarity between the response of the rat ovary to LH and HCG, Dr. Parlow undertook
to confirm and extend an important study by Dr. Greep. It will be recalled that in
1938 Greep {Endocrinology 23, 154, 1938) found that adult female rats which were
treated with pituitary extract and then hypophysectomized would respond to injections
of chorionic gonadotropin by secreting estrogen, even after a post-hypophysectomy
interval of as long as 15 days. The injection of LH, on the other hand, in the form
available at that time, appeared to be without effect.

Dr. Parlow's first step was to treat rats with PMS and HCG in order to induce the
formation of heavily luteinized ovaries and the state of pseudopregnancy. A single
subcutaneous injection of PMS (50 I.U.) was given to 25-26-day-old female rats, and
was followed, 56-65 hr later, with a single s.c. injection of HCG (25 I.U.). Five days
after the HCG injection the animals were hypophysectomized and treated with 2.5 I.U.
of HCG twice daily after the lapse of various time intervals, with results which are
shown in Table 1. The secretion of estrogen was readily demonstrable by vaginal
comification. The appearance of such an ovary is shown in Fig. 1 . It will be noted
that there are no large antrum-containing follicles in the ovary, and that only primordial
follicles, corpora lutea and interstitial tissue are identifiable. That the principal site
of action of HCG is the corpus luteum is shown by the fact that 25-26-day-old rats
which had not been pre-treated with PMS and HCG, and therefore possessed no
luteal tissue, failed to respond to HCG 7 days after hypophysectomy.

Rats made pseudopregnant and subsequently hypophysectomized in the same
manner secrete estrogen in response to stimulation with LH also. One week after
hypophysectomy LH (NIH-LH-Sl), 0.16 ^g twice daily for 3 days, effected vaginal

219

220

Discussions

cornification 96 hr after the first injection; one month after hypophyscctomy, LH
0.32 fig twice daily for 3 days was effective in 50% of the animals tested (Table 2).
FSH, ACTH, GH and LTH were without cfTcct.

Thus, from Dr. Ast wood's experiments (Emlocrinohi^y 28, 309, 1941) it would
appear that the secretion of progesterone by the corpus luteuni of the rat may be
under the control of LTH, and from Dr. Parlow's study that the secretion of estrogen
may be under the control of LH. This demonstration of a luteotropic action of LH
in the rat tends to place the corpus luteum in physiologic alignment with the adrenal
cortex and its response to ACTH.

Table 2. The Effect of LH and FSH administered 80 Days after Hypophysectomy

UPON the Secretion of Estrogen by Corpora Lutea persisting in the Ovaries of

Rats which had been pre-treated with PMS and HCG.

Gonadotropin

Dose

No. of
rats

No. of rats in

which vaginal

cornification was induced

NIH-LH-SI
NIH-FSH-Sl

3Mg

2Mg

400 /ig

5
5
5

4
2
0

Dr. Roy O. Greep: I am very much interested in this observation. I well remember the
experiments with HCG and the available luteinizing hormone in hypophysectomized
adult female rats. I was greatly impressed with the fact that the LH then available
would knock out the corpora lutea in 48-72 hr. Admittedly the LH was not pure
and did produce some follicle stimulation. Later, at the Squibb laboratories we
obtained a luteinizing preparation that was more highly purified. I tried the same
experiment again and it did not work. I did not smear the animals and could very
well have missed a response in terms of estrogen secretion as Dr. Parlow has now
described.

Dr. Sturgis raised the point that it isn't the estrogens that cause the secretion of
LH, but the metabolic product of estrogen. I would like to point out that under these
circumstances described, you have essentially a "castrate" type of pituitary. It will
contain a lot more luteinizing hormone, and there is evidence that it also secretes more.
This would account for the spleen-implanted ovaries filled with corpora lutea. I don't
think that one needs invoke metabolic products to account for ovaries of that appear-
ance, under the circumstances.

Chairman Astwood: We might limit our discussion, now, to five or ten minutes, and then
go on with Dr. Rock's paper, and then take as much time as there is left for further
discussion.

Dr. Carl Gemzell: Dr. Sturgis mentioned the polycystic ovary syndrome, and he also
mentioned the excellent studies that Dr. McArthur has done with these patients.

We have treated a couple of cases with FSH, and in all these cases we obtained
ovulation much earlier than the previous three or four days, which I think confirms
the thought of Dr. McArthur that if there is too much delay it may induce FSH.

Regarding the question of progesterone production in these follicles that Dr. Sturgis
brought up, we have no cases where the progesterone is produced in the follicles
before ovulation or before the factor is added.

Dr. Ernest Knobil: I have a question to ask Dr. McArthur. What is the current status
of the improved method, as far as assaying LH in biological fluids is concerned?
Can this now be done successfully ?

Fig. 1. Appearance of the ovary of an immature female rat which had been rested for 60 days

after treatment with PMS and HCG and subsequent hypophysectomy, and which was

actively secreting estrogen in response to HCG treatment.

Discussions 221

Dr. Janet McArthur: Dr. Parlow discussed this recently at the N.I.H. Gonadotropin
Workshop. He has found that the ascorbic acid depletion method is very satisfactory
for the assay of pituitary LH. However, there appear to be interfering substances, both
in plasma and urine, which prevent valid assays of the LH content of these fluids.

Dr. Roy Hertz: I want to thank Dr. Sturgis for his paper. There is, however, one phase
of follicular development which I think is being largely overlooked.

You will recall that in that day-old ovary there was represented nothing but the
primordial type of follicle, and we have very little knowledge actually of what trans-
forms the primordial follicle into an antrum-containing follicle.

In the new-bom rat, just as in the human ovary, the ovary at birth is made up
entirely of such follicles in immediate juxtaposition to each other, with a very small,
fine stroma between them, and there is no indication of any follicular organization
in any part of the ovary at that time. It is not until about the eleventh day, post-natally,
that one begins to see the beginning of granulosa cell development and an antrum
formation. It is at that point that one gets the first responsiveness to gonadotropin.
Up to eleven days, you can give massive doses of gonadotropin to the new-bom rat,
and get no response, until the follicle has become organized sufficiently to have an
antmm of its own.

In the rabbit, this process takes ten weeks post-natally. So for ten weeks, during the
post-natal period, we have this pre-pituitary process going on, with follicular differ-
entiation, and the development of initial sensitivity to stimulation.

We became interested in what was involved in this process, and what role the pituitary
may play in the process, and therefore grafted day-old ovaries under the kidney
capsule of the mother of the young. She had just given birth to these babies. We
then hypophysectomized the mother immediately. We found that this entire process
of sensitization to gonadotropic hormone is independent of the pituitary. It goes
along well, in a completely hypophysectomized female. It is not dependent upon
any specific factor from the host; it seems to proceed quite independently of
any known pituitary factors.

We do see that during this process there is a substantial mortality in the primordial
ova. Their numbers progressively decline. There is something which they are contri-
buting, or which their mortality is contributing, to the process.

This is an area which I feel, from a clinical standpoint, also, is being neglected.
For instance, we now have four patients with ovarian hypoplasia, and biopsies of
their ovaries show the identical histological picture that you have described for the
ovary of the new-bom.

It seems that in such individuals, this pre-pituitary process has gone up to the point
of gonadotropin sensitization. These patients have ample gonadotropin in the urine,
actually high levels, and yet the ovary has not gotten to the point of responsiveness.

Dr. Gregory Pincus: We have also been conducting some studies with human pituitary
FSH. The sample we used was prepared by Dr. Li and is very low in LH. With
this we did not get an increase in estrogen production until HCG was also given.
I would like to ask Dr. Gemzell whether he observed any estrogen production when
he used his very highly purified FSH, which is probably more nearly free of LH.

Dr. Carl Gemzell: We have not done any experiments with the highly purified FSH as yet.
The chemist who is woiking on it is more interested in finding out something about
its physical-chemical properties; but I hope that when he is through we will be able
to test it.

I don't know how much LH there is in Dr. Li's preparation of FSH. It is very likely
that the contamination with LH is of great importance.

I haven't had any experience with the preparations of various activities, so I can't
answer your question.

INHIBITION OF OVULATION IN THE HUMAN

John Rock

Free Hospital for Women, Massachusetts
I. AUTOGENOUS INHIBITION OF OVULATION

Before discussing methods of suppressing ovulation in the human, it might
be well to review briefly various aspects of autogenous failure of ovulation.
We find this process inhibited not only in many different clinical conditions,
but also in several physiological states (1,2).

A. In Physiological States

There is physiological anovulation before puberty, as also after the cUmac-
terium. Moreover, oligo-ovulation is a comparatively frequent gynecological
diagnosis among adults (1,3). It denotes habitual failure of ovum release each
year, for more than four weeks, or even for a few months, yet without
discernible pathology. Of course in such cases we infer dysfunction of the
"feed-back" or "push-pull" process, either as a weak "push" from gonadal
hormones, or resistance to "push" in the hypothalaraic-pituitary partnership.
Furthermore, even in normally cyclic women, anovulatory cycles are occa-
sionally interspersed among the usual ovulatory ones (1).

During the normal cycle, we have, of course, the postovulatory relative
progestinism, the latter prevailing also in pregnancy with a hyperestrogeno-
progestinism; and in lactation, we relate the usual anovulation to a similar
prolactinism.

Anovulation may also occur as an accompaniment of a stress reaction
disturbing hypothalamic function. The follicular inactivity of anorexia
nervosa may be similarly indicted with probable assistance from dietary
deficiency (4).

B. In Pathological Conditions

Leaving aside intrinsic ovarian insufficiency (hypoplasia ovarii) as an
obvious cause of anovulation, other clinical conditions accompanied by
failure of ovulation may be considered under two headings : those involving
(1) extrapituitary pathology and (2) intrapituitary pathology.

1. Extrapituitary pathology. Extrapituitary pathology may cause sex
hormone imbalance toward what one might rather vaguely term androgenicity
— as with an arrhenoblastoma, or a hylar-cell tumor, or with hyperadrenalism
— and thus hinder ovulation. In like manner, the ovulatory mechanism may

222

Inhibition of Ovulation in the Human 223

be deranged in what we could call conditions of relative estrogenicity, such
as with cystic-stromal hyperplasia, as well as with granulosal cell tumor, or
with dysthyroidism.

Yet another manifestation of extrapituitary pathology that inhibits ovula-
tion is what clinicians might call progestinicity, such as is attributed to theca-
lutein or corpus-lutein cysts, as if ever they do produce, for any length of
time, a progestin — which I rather doubt. We also find anovulation with
the chorionic gonadotropism incident to chorionepithelioma.

2. Intrapituitary pathology. Among diseases involving intrapituitary
pathology, anovulation is associated with Simmonds' disease (hypophyseal
cachexia), as well as with Sheehan's disease (postpartum pituitary necrosis),
with Cushing's disease (basophilism), Addison's disease (hypobasophilism),
and the Chiari-Frommel syndrome (pituitary adenomatosis), as also with
inanition, doubtless made more harmful to the pituitary by coincident
avitaminosis and contributory hypothalamic deprivation. (It is difficult to
define the relative roles of nutritional deficiency and of stress reaction in the
neurosis that manifests itself in anorexia nervosa.)

II. EXOGENOUS INHIBITION OF OVULATION

A. Reasons for Suppressing Ovulation

We might ask: "Why suppress ovulation?" It could be a simple exercise in
biological research. We do not quite do that in humans, if we can help it. On
the other hand, ovulation has been prevented therapeutically in order to
relieve dysmenorrhea (5). Essential dysmenorrhea occurs only from what is
improperly called a "secretory" and, more properly, a "progestational"
endometrium. Furthermore, one might suppress ovulation to avoid Mittel-
schmerz, or even to prevent conception.

B. Means of Inhibiting Ovulation

With the latter aim in view, i.e. to control fertihty, particularly in certain
overpopulated areas, several methods of suppressing ovulation have been,
and are still being, investigated (6-9). The requisites for ovulation have been
reviewed by the previous speakers: the organs, the tissue systems, the
hormones, and the various unctions. Thus one might find means of suppress-
ing ovulation by disaflfecting one or another of these numerous required
cellular composites.

One can destroy the primordial follicles, as by radiation; or one can
castrate. Specific thalamic function may be disturbed by scaring a woman
"to death". Then she would not ovulate by virtue of stress reaction resulting
in hormonal disturbance of thalamic neurones and their dependent pituitary
cells. Normal cyclic function in these mid-brain nuclei may also be upset by
direct medicinal modification of sex hormone concentrations. This will be
discussed later.

224 John Rock

Furthermore, in recent years there have been two Hnes of investigation
with plant extracts, leading to reports of possible inactivation of gonado-
tropins by: (1) a postulated descnsitization of the ovary to gonadotropins by
lithospermum (9, 10); and (2) interaction of quinones from the Indian garden
pea with gonadotropin so as to nullify the latter (9, 1 1).

III. INHIBITION OF OVULATION BY THE 19-NOR STEROIDS

Since none of the methods mentioned above seemed to offer a satisfactory
solution to the problem of fertility control, and since, in harmony with the
long-recognized ovulation-inhibiting action of progesterone recently re-
affirmed (12-14)*, certain artificial progestins, the so-called 19-nor steroids,
had also been found by Pincus and his associates (14, 17, 18) to inhibit ovula-
tion in animals, Dr. Garcia and I were fortunate to obtain these steroidal
substances from Dr. Pincus. Oral administration in women on cycle-days
5 through 25 showed that these steroids had the same ovulation-suppressant
effect as in laboratory animals (14, 19-23). Some of them, however, were
more potent than others. One of them in particular, 17a-ethinyl-5(10)-
estraeneolone, possessed such a high degree of ovulation-inhibitory, as well
as other qualities, that it was chosen for use in large-scale field studies organ-
ized by Dr. Pincus, first in Puerto Rico and later in Haiti (8, 24-33).

It was unfortunate, perhaps, that we were supplied with the best prepara-
tions first. Our enthusiasm for some of the later, less effective ones was
insufficient to encourage us to utilize our patients in the way animal experi-
menters so easily do their subjects. Possibly, therefore, some of the conclusions
suggested by our negative results with the newer preparations derive only
from a sample that is deficient in the number of cases as well as in variety of
dosage. Presently, I shall discuss our experiences with several of these steroids
of various degrees of efiicacy.

First, I wish to state that Dr. Pincus provided not only the material and
the motivation for these projects, but he also organized them. For the tables
to be shown in connection with the field studies, Dr. Pincus compiled the
data derived from the clinical observations which Dr. Garcia and I, together
with several physicians in the island areas, were able to supply.

A. Nature of the Ovulation-inhibiting Steroidal Substances

Certain of these synthetic steroids, the so-called 19-nor steroids, are shown
in Fig. 1 in relationship to the naturally occurring hormones, progesterone
and testosterone.! The nortestosterones, norethindrone (Norlutin — Parke-
Davis) and norethandrolone (Nilevar — Searle) were found to be very effective,

* The ovulation-inhibiting function of the corpus luteum had been recognized even
long before the isolation of progesterone (6, 15, 16).

t Although ovulation is also inhibited by these naturally occurring hormones, as well
as by estrogens in both natural and synthetic form, their use for this purpose is undesirable.

Inhibition of Ovulation in the Human

225

as was also norethynodrel, which by its molecular pattern is seen to be not a
testosterone, but is more closely related to the classical estrogens. Details
of the differences in molecular configuration among these three compounds,
as well as the biological properties correlated with these differences, have
been reviewed previously (34-36).

NORETHANDROLONE
I7«:-ETHYL-I9-N0RTEST0STER0NE, NILEVAR: G D. SEARLE a CO.

NORETHYNODREL

I7«6-ETHINYL- 5(10)- ESTRAENEOLONE
ENOVI0*G D SEARLE SCO

NORETHINDRONE

1 7o<l- ETHINYL- 1 9- NORTE STOSTE RONE
^ORLUTIN PARKE, DAVIS 8 CO.

EACH IO-m» TABLET OF ENOVID, IN ADDITION TO 9 65 mg. NORETHYNODREL, CONTAINS
0.15 mg. ETHYNYLESTRADIOL-3-METHYL ETHER.

Fig. 1. Three commercially available synthetic 19-nor steroids are shown in relationship

to the naturally occurring hormones, progesterone and testosterone. (After Crosson, J. W.,

New Synthetic Steroid Progestins. Fertil & Steril. 10, 361-373, 1959.)

Norethynodrel (17Q:-ethinyl-5(10)-estraeneolone) is prepared and manu-
factured in combination with a small amount of 3-methyl-ether of ethynyl-
estradiol. This estrogen component was found to be present in some of the
original theoretically pure preparations of the 19-nor steroid. Since later
products lacking the estrogen were not as effective, the 3-methyl-ether of

226

John Rock

ethynylestradiol is now purposely added to the norethynodrel. The lO-mg
tablet marketed by G. D. Searle & Co., under the name of Enovid,
contains 9.85 mg of norethynodrel and 0.15 mg of the 3-methyl-ether
of ethynylestradiol.

Owing to its strong progestational effect, Enovid has proved of extreme
value to the clinician in the treatment of certain gynecological disorders (35,
37). Furthermore, since Enovid is the 19-nor steroid most extensively utilized
in the field studies relating to fertility control in Puerto Rico and Haiti (v.s.),
most of my subsequent remarks will deal with this particular synthetic
gestagen.

B. Nature of the Ovulat ion-Inhibiting Action of Enovid

It seemed of interest to determine which of the two components of Enovid,
i.e. the norethynodrel or the 3-methyl-ether of ethynylestradiol, constitutes
the active ovulation-depressing agent.

Table 1. Effects of the 3-Methyl-ether of Ethynylestradiol on
Normally Cyclic Women*

Patient

Dose

(mg)

cycle

No.

Ovulation Indexf

Pregnanediol
(mg per day)

Cycle
length
(days)

Days

flow

Re-

Body

Endometrial

actions

temperature

biopsy

P.M.

0.250

n.d.

0.1 = -

—

n.d.

0.1 = -

n.d.

0.2 = -

—

L.M.

0.125

0.4 = -

12?

0.0 = -

—

0.1 = -

—

R.P.

0.125

0.2 = -

—

0.2 = -

—

0.5 = ±

E.S.

0.125

0.2 = -

n.d.

0.6 - +

n.d.

0.1 = -

J.B.

0.050

0.1 = -

—

0.1 = -

* Abbreviations: n.d. = not done; + = positive; — = negative,
t Figures = cycle-days when ovulation was indicated.

While some have attributed this role of Enovid to its estradiol component,
we, on the other hand, are skeptical of this. For, as shown in Table 1, even

Inhibition of Ovulation in the Human

111

though rather low pregnanediol values were found in patients with the use
of the 3-methyl-ether of ethynylestradiol alone, it was not as regular and
dependable in its ovulation-inhibiting action as is norethynodrel. Moreover,
the clinical value of the 3-methyl-ether of ethynylestradiol was diminished,
inasmuch as the flow following its withdrawal was uncertain both in time
and in quality.

In an effort to discover the mechanism whereby Enovid exerts its ovulatory-
inhibiting action, assays of urinary FSH were carried out on a few patients
in Worcester under Dr. Pincus' (25) direction before, during, and after
medication (Table 2).

Table 2. Effects of Enovid on Urinary Follicle Stimulating Hormone

Subject

Age

Output (mouse units/24 hr)

Premedication

Medication

Postmedication

No. 1
No. 2
No. 3
No. 4

42 <5)
60 <■"

144
24
32
39

60 '1'
7.2 <2> 0 '3)
0
69 <8)

79.2 "»)
16 '6)
48 '9'

(1) 20 mg/day for 4 days.

(2) 20 mg/day — collection on 6th day.

(3) 20 mg/day — collection on 10th day.

(4) Six weeks after medication.

(5) Premenopausal — collections at midcycle — received 20 mg/day.

(6) Next midcycle.

(7) 10 mg/day for 4 days.

(8) Collected on the 4th day of medication.

(9) Collected 10 days after last medication.

One patient, aged 56 (No. 1), who, before treatment, had excreted 144 mouse units of FSH
per 24 hr, diminished her output to 60 mouse units following medication with 20 mg per
dayof Enovid for 4 days. In another woman, 54 years of age (No. 2), the FSH value decreased
from 24 to 7.2 mouse units per 24 hr after she had taken 20 mg per day for 6 days ; more-
over, the urine collected on the 10th day of treatment showed no detectable FSH. Six
weeks after cessation of medication, however, her FSH urinary content had risen to 79.2
mouse units per 24 hr. On the other hand, in a third menopausal patient, aged 60 (No. 4),
treated with only 10 mg a day for 4 days, urinary assay of FSH on the 4th day of medication
showed an elevation as compared to the pretreatment value. Moreover, in this case, the
postmedication value, 10 days after cessation of therapy, was less than during treatment.
The lower dose of Enovid administered to patient No. 4, or, possibly, a difference in threshold
response, may account for the different result.

In a premenopausal woman, aged 42 (No. 3), who also received 20 mg per day of Enovid,
collections were made at midcycle. Whereas the midcycle premedication value was 32
mouse units per 24 hr, and the postmedication sample, collected at midcycle 10 days after
cessation of therapy, showed 48 mouse units per 24 hr, FSH was not detectable in the 24-hr
urine specimen collected at the midpoint of the medicated cycle.

228

John Rock

Because of the highly probable "feedback" of progesterone-suppression
of LH, it seems very likely that the strongly progestational Enovid exerts the
same influence. The gonadotropin-depressant action of norethynodrel, both
in animalsand in women, has been demonstrated by several other investigators
(38, 39).

C. Indices of Ovulation-Suppression with Enovid and Norlutin

The effect of Enovid, as of Norlutin (norethindrone), on pregnanediol
excretion is at least very suggestive of inhibition of ovulation. As shown in
Table 3, the average premedication pregnanediol excretion in 40 ovulatory

Table 3. Effects of 17a-ETHINYL-19-NORTESTOSTERO>4E (I) and 17a-ETHINYL-5(10)-ESTRA-
ENEOLONE (II) UPON CYCLE LENGTHS, INDICES OF OVULATION, AND StEROID OUTPUT IN

Normally Ovulating Women

Compound

No.

cycles

Mean
cycle
length
(days)

Basal
tempera-
ture
(%-)

Endo-
metrial
biopsy
(%-)

Vaginal
smear

(%-)

Preg-
nanediol
(mg per

day)

17-Keto-

steroids

(mgper

day)

Control
I*
II**

40
62
34

27.2 ±0.51
28.5 ±0.68
26.7 ±0.48

92
82

76
93

0
81

3.4 ±0.27
0.34 ±0.066
0.30 ±0.074

5.2 ±0.47
4.8 + 0.40
4.5 ±0.47

* 10-40 mg/day. ** 10-20 mg/day.

cycles was 3.4 mg per day. With each of the two administered steroids, the
average pregnanediol output was found to be only about 10% of this pre-
treatment value (20).

Absence of secreted progesterone is also reflected in the atypy of response
in the other common indices of postovulatory corpus-luteum activity. Since
in each of these tests the normal critical effect is due to progesterone,
and the two artificial steroids are called "progestins" because of the fact that
their action resembles that of progesterone, it is not surprising that inferences
from temperature graphs, endometrial biopsies, and vaginal smears, although
somewhat less exact, are similar to those from biochemical assay of an
excreted product of progesterone itself (22).

In order to obtain more direct evidence of the effect of these steroids on
ovulation, a careful study was made of the ovaries of women who had taken
Norlutin (norethindrone) for one to 3 cycles before required laparotomy (20,
22). Whether operation took place late in the medicated cycle or early in
the next untreated cycle, there was no evidence of corpus-luteum formation.
More recently, these observations have been repeated with Enovid both by
our own group (40) and by the Japanese investigator, Matsumoto (41). In
neither of the two series was there any morphologic sign of recent ovulation.

Inhibition of Ovulation in the Human 229

D. Indices of Ovulation-Suppression with Other \9-Nor Steroids

Methylpregnone,* another 19-nor steroid more recently tested by us, did not
give consistent results as far as ovulation v^as concerned (33). This is indicated
in the normal pregnanediol excretion, as well as in the qualities of the endo-
metrial specimens taken on or about cycle-day 21 (Table 4), The increase in
basal body temperature might have been due to the thermogenic effect of
the administered norsteroid.

Table 4. Effects of 17a-HYDROXY-6a-METHYLPROGESTERONE-17-ACETATE Alone on Normally

Cyclic Women f

Ovulation index {

Dose

Cycle

Pregnanediol

Cycle
length

Days
of

Patient

Basal

Endo-

Reactions

(mg per day)

No.

tempera-
ture

metrial
biopsy

(mg per day)

(days)

flow

C. R.

1: days 5-21
2: days 22-25

0.3=-

Sp.

J. S.

2.6= +

—

3.2= +

—

1.5= +

—

E. D.

4: days 5-17

—

n.d.

n.r.

B.T.

M. C.

—

1.2= +

B.T.

—

0.8= +

B.T.

—

1.2= +

—

G. S.

-1-

n.d.

0.2=-

n.r.

+ ?

n.d.

2.4= +

—

n.d.

4.8= +

n.r.

—

t Abbreviations: n.d. = not done; Sp. = spotting during medication; B.T. = breakthrough bleeding;
+ = positive; — = negative; n.r. = no record.
X Figures = cycle-days when ovulation was indicated.

As shown in Table 5, still another 19-nor steroid, 17a-(l-methallyl)-19-
nortestosterone, supplied to us by G. D. Searle & Co. as SC-8117, likewise
was not too effective. It, also, was associated with an increase in basal body
temperature. While this steroid does possess certain progestational qualities,
it did not seem, in the dosage used, to suppress ovulation, except in rare
instances.

IV. FERTILITY CONTROL WITH ENOVID

Table 6 shows the extent of the work organized by Dr. Pincus (30) up to
November, 1958. The field work is at present supervised by Dr. Manuel
Paniagua and Dr. Adaline Pendleton in Puerto Rico and by Drs. Rene Nicolas,

* 17a-hydroxy-6a-methylprogesterone-17-acetate (SC-9686 — Searle and R-2076 — Root
Chemicals), the same as Provera (Upjohn).

230

John Rock

Table 5. Effects of 17a-(l-METHALLYL)-19-NORTESTOSTERONE Alone and in Combination with
Estrogen (Ethynylestradiol-3-methyl Ether*) in Normally Cyclic Women!

Ovulation

indcxj

Dose

Estrogen

cycle

Pregnanediol

Cycle
length

Days
of

Patient

Body

Endo-

Reactions

(nig)

No.

tempera-
ture

metrial
biopsy

(mg per day)

(days)

flow

T. H.

0.6= +

—

17?

0.2=-

—

18?

0.7= +

J. B.

n.d.

4.8= +

13?

1.8= +

—

3.1 = +

—

C. K.

1.2= +

—

0.3=-

—

1.6= +

B.T.

A. K.

7.6= +

0.3 = -

—

2.9= +

—

A.N.

0.3=-

1.1 = +

—

0.8= +

—

M.J.

1.0= +

—

0.2=-

—

1.1 = +

—

S. Y.

n.d.

0.4=-

—

n.d.

3.3= +

n.d.

1.0= +

A. P.

EE3ME 0.05

n.d.

0.4=-

—

0.6= ±

—

B.T.

—

0.2=-

—

J. B.

EE3ME 0.05

21?

—

0.1 = -

—

* Designated in the table as EE3ME.

t Abbreviations: n.d. = not done; +=positive; — =negative; B.T. = breakthrough bleeding.

I Figures = cycle-days when ovulation was indicated.

Table 6. Fertility Control with Enovid: Description of Projects

Project

Date

begun

Total No. of

subjects to

November 1958

No. of
active
cases

Total No. of

cycles of

experience

No. of
woman-
years

San Jaun
Humacao-R
Humacao-P
Haiti

April 1956
April 1957
June 1957
Dec. 1957

438
117
126
149

211

105

108

4988

1410

658

1077

382

115

830

519

8133

635

Inhibition of Ovulation in the Human

231

Raymond Borno, and Vergniaud Pean in Haiti. Dr. Celso-Ramon Garcia,
who largely planned the clinical aspects of these projects, makes periodic
visits to Puerto Rico and Haiti for consultation, collection of biopsy material,
and examination of patients.

The regimen adopted in the island projects entails cyclic medication with
10 mg per day of Enovid from cycle-days 5 through 24, inclusive, i.e. a total
of 20 pills a cycle, or one less pill than in the schedule first followed in the
local cases (v.s.).

As of November, 1958, 830 subjects had participated in the experiment
(Table 6). Of this number, there were 519 who were still using the medication.
In all, there were 8133 cycles of experience, the sum total of which added up

Table 7. Fertility Control with Enovid: Mean Age of Subjects and Pregnancy
Rates Before and During Medication in the Four Projects

Mean

age

(years)

Pregnancy rate per 1(X) woman-years

Per cent reduction

Project

Before medication

medica-
tion

Marriage
years

Exposure

years

pregnancies

fertility

San Juan
Humacao-R
Humacao-P
Haiti

27.2
26.9
28.4
30.7

60.9
68.0
55.8
60.2

244
272
222
241

3.2

0.9?

2.0

3.4

95
99
96
95

98.7
99.7
99.1
98.6

All

28.0

61.2

246

2.7

98.9

to 635 woman-years. In Table 7 are seen the pregnancy rates before and during
medication in the four projects. Whereas the mean pregnancy rate before
treatment had been 61.2 per 100 woman-years, it decreased during medication
to 2.7, representing "a 96 per cent reduction in the pre-medication rate, and in
terms of years of exposure to the chances of conception (i.e., eliminating
pregnancy times in pre-medication years) a 98.9 per cent reduction in fertility"
(30). It should be noted that the frequency of coitus remained essentially
the same during medication as it had been prior to treatment (Table 8).

With the most recent survey, as of November, 1959, the number of cycles
had increased to more than 12,000; and the total number of women treated
to about 1200. We think we have a fairly dependable picture of what this
material will do. The pregnancy rates, as of November, 1959, are shown in
Table 9.

Here we see more than 10,000 cycles during which no tablets were missed.
Within this group, there is one questionable case of a pregnancy in a social

232

John Rock

worker who at fust said thai she took all the tablets but later, when the
figures were brought to her attention, admitted that she may have forgotten
some.

When patients missed tablets, follicles were sometimes ready to rupture,
and not much of a release was required to enable some of them to do so.

Table 8. Fertility Control with Enovid: Mean Frequency of Coitus Reported
PER Month in Premedication and Medication Cycles

Cycle No.

Humacao-R

Humacao-P

Haiti

Premed.

6.2

8.7

8.6

1-2

6.5

9.0

8.1

6.5

9.4

9.5

5-8

6.7

9.9

10.1

9-12

6.5

8.9

10.7

13-16

6.4

—

17-20

6.2

—

% increasing

% decreasing

% no change

Table 9. Fertility Control with Enovid: Pregnancy Rates according to Number

OF Pills Missed vs. Postmedication Pregnancy Rate

(All Projects Combined: Data Tabulated as of November, 1959)

Pills
missed

No. of
cycles

Pregnancies

Number

Rate*

1-5
6-19

10,705

1,116

422

1?
4
14

0.12
4.6
42.9

12,243

2.8

Postmedication rate*

186

* Pregnancy rate per 100 woman-years.

There were some 1500 cycles in which medication was intermittent. In the
group in which tablets were omitted on not more than 5 days, 4 pregnancies
occurred. There were 14 pregnancies when medication was missed on more
than 5 days.

V. OTHER EFFECTS OF ENOVID
A. Effects on the Menstrual Cycle

1. Cycle length. One almost indispensable clinical quality in an ovulation-
suppressant is its capability to be used effectively without disrupting the

Inhibition of Ovulation in the Human

233

pattern of normal cyclic menstruation. Women throughout the world seem
to value what they otherwise call "the curse". In Table 10 are shown the
mean lengths of cycles recorded in the different areas of the field study where
the most numerous observations were made (30).

Table 10. Fertility Control with Enovid: Mean Menstrual Cycle Lengths (Days)
in relation to the number of tablets missed

Project

Mean cycle length (days)
according to number of tablets missed

1-5

6-19

San Juan
Humacao-R
Humacao-P
Haiti

28.0 + 0.05
29.7±0.10
28.6 + 0.1-+
29.3 + 0.

26.3 + 0.27
30.7 + 0.84
28.1+0.97
30.1+0.43

30.2 ±0.53
33.6+1.56
20.5+1.52
29.0+1.75

We find that the ordinary interval of about 28 days is generally maintained
if the patient takes the tablet, as directed, from day 5 through day 24. Those
who occasionally omit the tablets, or take them a little longer than prescribed,
will menstruate earlier or later, according to the modification of the pre-
scribed regimen. This will change the mean cycle lengths. The more the
regimen is modified, the greater will be the variation in the mean cycle lengths.

2. ''Breakthrough bleeding.''' Suppression of ovulation by use of the "pill"
under consideration is not completely without minor disturbances. There is

Table 11. Fertility Control with Enovtd: Incidence of Breakthrough Bleeding
AS % OF Total Cycles according to Cycle of Medication

Cycle No.

San Juan

Humacao-R

Humacao-P

Haiti

4.8

6.0

11.9

6.7

3.8

0.9

4.9

0.0

2.0

2.5

1.6

1.5

1.0

1.5

2.5

5-9

2.3

0.6

0.0

2.2

10-14

1.9

0.9

3.3

4.2

15-19

0.9

0.0

20-24

1.1

0.0

25-29

2.9

30-37

1.0

Mean (all

cycles)

2.0

1.2

3.8

2.7

occasionally slight to moderate pink or red discharge from the endometrium
during medication: a little of what we term "breakthrough bleeding"
(Table 11).

234

John Rock

This is rather easily controlled by increasing the dosage. If the daily dose
is 10 mg, a per diem increase of 5 mg usually stops the bleeding. We have seen
that such staining occurs more often in the early than in the later cycles of
treatment. This is clearly shown in Table II. A contributory factor in this
connection may be the patient's tendency in earlier cycles to fail to adhere to
the regimen as prescribed. However, it must be remembered, in considering
these tabulated figures, that some of the women who have this early bleeding
drop out of the treated group; this naturally leaves a lower average number
of affected patients in the later cycles.

Table 12.

Fertility Control with Enovid: Incidence of Amenorrhea in
Various Cycles of Medication

Cycle No.

San Juan

Humacao-R

Humacao-P

Haiti

2.0

1.0

5.1

0.0

1.0

2.5

4.8

0.0

1.7

5-9

1.2

1.9

2.8

10-14

0.6

0.0

15-19

0.0

20-24

0.0

25-29

30-37

0.0

Mean (all

cycles)

1.2

3.2

3. Amenorrhea: ''Occult regression of the endometrium." One interesting
observation, so-called "occult regression of the endometrium", sometimes
incorrectly termed "silent menstruation", shows that menstruation is not in
essence a breakdown, but only a regression of the endometrium. This may
be complete, yet without bleeding. The sudden occurrence of amenorrhea
after perhaps a number of regular cycles during treatment usually disturbs
the patient. When menstruation fails to appear after she stops the medication
as prescribed, she believes she must be pregnant, but she is not. The tempera-
ture graph descends to the premedication level. Then, after about 10 to 20
days, without intervening catamenia, ovulation will again take place.

Hence patients who are using these steroids for contraceptive purposes
must fix the regimen entirely on the occurrence of menstruation. If this does
not follow within 6 days after the end of one cycle of medication, pill-taking
must be resumed by the 10th day at the latest, or ovulation is very likely soon
to occur. The incidence of this interesting and physiologically instructive
phenomenon is suggested in Table 12. It happens, in fact, on the average in
less than 2% of all cycles (30).

Inhibition of Ovulation in the Human 235

B. Effects on the Endometrium

The effect of Enovid on the endometrium shows other very interesting and
striking aspects. After only 3 or 4 days of medication, we observe the glandu-
lar changes which are found 3 or 4 days after ovulation in a normal, untreated
cycle.

Typical are mobilization of the nuclei toward the luminal border of the
cells and beginning edema of the stroma. If the medication, started on cycle-
day 5, is continued for 8 days, we get a postovulatory 8-day tissue, with

"day" QUALITY OF ENDOMETRIAL GLANDS

5 Day

12 Day

18 Day

19 Day

21 Day

25 Day 27 Doy

NORMAL

OVULATORY

CYCLE

OVUL

ATION

\ (

STEROID
TREATED
CYCLE

CYCLE DAY
OF BIOPSY

9 Day

16 Day

19 Ooy

24Doy

27 Day

NO OF DAYS
TREATED

4 Days

II Days

14 Days

19 Days

22 Days

H R GUARD M.D.

Fig. 2. Time diflferential in development of endometrial glandular epithelium in steroid-
treated vs. untreated women. (Reproduced by permission from Pincus, G., J. Rock,
C.-R. Garcia, E. Rice-Wray, M. Paniagua and I. Rodriguez, Fertility Control with
Oral Medication. Am. J. Obst. & Gynec. 75, 1333-1346, 1958.)

decrease of secretion by the cells. We used to think that the presence of
secreted material in the dilated glands, characteristic of this phase, indicated
continued secretory activity. We are now taught by Bartelmez (42) that this
material is not being actively secreted but is merely the accumulation in the
glands of previously secreted material unable to pass out because progesterone
has inactivated the formerly contractile myometrium. This phase, then, as
pointed out by Bartelmez, is properly designated "progestational", not
"secretory".

Dr. H. R. Guard of Bombay, who was working here as a Research Fellow
with us, as well as with Dr. Pincus, made a schematic drawing (Fig. 2) from
some of our slides to illustrate the characteristic sequence of changes in the
glands during the normal ovulatory cycle. These changes, worked out by a
number of investigators, including our own group (43^5), are compared in
the schema with changes during medication with Enovid. This comparison
has been published previously (26, 27).

236 John Rock

1. The norma i untreated cycle. In the classical 28-ciay cycle, the pseudo-
cuboidal lining of the early proliferative gland (cf. Fig. 2, day 5) gradually
changes to pscudostratification as ovulation approaches (Fig. 2, day 12).
Next is depicted the 4-day postovulatory gland with mobilization of the
nuclei toward the lumen. Then the nuclei promptly recede toward the bases
of the cells at about 5 days after ovulation (Fig. 2, day 19). In the 21-day
gland, i.e. at about 7 days after ovulation, the secreted material begins to
accumulate so that the glands dilate and subsequently become ''saw-toothed"
on day 25 of the normal cycle. The succeeding premenstrual secretory
exhaustion, characteristic of day 27, is also depicted.

2. The treated cycle. Now let us consider what occurs during a treated
cycle. When medication is started on day 5, the entire process is accelerated.
Already on the 9th cycle-day, pills having been taken for 4 days, we find the
same sort of active gland that, in the normal, untreated cycle, is observed
not until 4 days after ovulation, i.e. on about day 18.

At this stage in the medicated cycle, the speed of epithelial change decreases.
On cycle-day 16, the 11th day of treatment, we get a gland which resembles
that typical of only the 5th day after ovulation (day 19). Even so, its secretory
progress is more advanced than would be the case with a 2-day-old corpus
luteum (day 16 of the normal, untreated cycle).

From then on, the glands regress faster and also further than they do in
the ordinary progestational phase of the normal cycle. Many of them become
very small, like the postmenstrual glands. We find numerous simple, hypo-
trophic glands in the thinned-out endometrium, accompanied by some glands
that are characteristic of secretory exhaustion. The reticular stroma of the
proliferative and early postovulatory phases also more rapidly and completely
progresses toward a predecidua.

At about the 21st day of the cycle, when the patient has had 16 days of
treatment, the pathologist who does not know this consisted of norethynodrel
may render a diagnosis: "consistent with beginning pregnancy". This is
excusable, for, commonly, the tissue closely resembles that in which pro-
gestational stromal mutation has been prolonged; and easily unnoticed is the
fact that some of the glands fail to show the regression which is so character-
istic of pregnancy dccidua.

It is noteworthy that this progestin may extend its influence in 15 days
to the stroma of the lower uterine area and even into the upper cervix where,
in the normal, untreated cycle, we ordinarily do not find the characteristic
signs of autogenous progesterone even just before menstruation (Fig. 3).

VI. EFFECTS OF LONG-TERM USE OF ENOVID
A. Ejfect on Ovulation in Postmedication Cycles

Since Enovid evokes endometrial changes reminiscent of pregnancy, it
seemed as though it might be of value in endometriosis for, during pregnancy.

tf'V ' < ,. K

Fk;. 3. Effect of Enovid on endometrial histology. Biopsy on 15th day of treatment.
Decidua-like stroma of cervix, probably at internal os. (Magnif. x400.) Reproduced by
permission of Rock, J., C.-R. Garcia and G. Pincus, Synthetic Progestins in the Normal
Human Menstrual Cycle. Recent Progress in Hormone Research, Volume XIII (Edited by
G. Pincus), pp. 323-346, Academic Press, New York, 1957.

Inhibition of Ovulation in the Human

231

ectopic endometrium not uncommonly regresses. Dr. Robert W. Kistner (37)
has already published extensively on his successful use of Enovid in endo-
metriosis. At the Reproductive Study Center, Dr. Garcia gave continuous
Enovid medication to patients in their twenties and thirties for time intervals
ranging from 2 to 9 months. This continuous administration afforded an
opportunity to evaluate the effects on ovulation after discontinuance of such
long-term therapy.

Table 13. Effect on Recurrence of Ovulation Following Cessation of Long-term
Enovid* Therapy for Endometriosis

No. of

patients

followed up

Postmedication
cycle
(No.)

Mean

cycle length

(days)

o/
/o

Ovulating

First
Second

70
100

* TTie regimen was as follows: lOmg/day for 2 weeks; 20 mg/day for the 3rd and 4th
weeks ; then 30 mg/day for 2 to 3 months.

As seen in Table 13, even after treatment with 10-20 mg per day for one
month and then 30 mg a day for 2-3 months, no permanent damage was
done to ovulation potential. In the first postmedication cycle, ovulation
occurred in 70% of 13 patients; and in the second postmedication cycle, all
of 7 patients tested were found to have ovulated. Fairly prompt recurrence of
ovulation is a constant finding after intermittent consumption of this material,
as has been pointed out previously (22).

B. Effect of Enovid or Norlutin on the Ovaries

The question arose: How about the effect of long-term use of these
substances on primordial follicles? Do these steroids, norethynodrel and
3-methyl-ether of ethynylestradiol (Enovid) or norethindrone (Norlutin),
cause atresia, not only of the ripe follicles or the second-grade ones, but do
they also cause destruction of the reserve ova ?

This was difficult to determine. Dr. Richard R. Thornton, then a medical
student, was kindly permitted to search through the pathological material
at the Massachusetts General Hospital and to collect all the normal ovaries
he could. These contributed largely to the untreated control material. For
comparison, some ovaries were obtained from our own patients treated with
Enovid before required oophorectomy. They were supplemented by ovarian
biopsies from the Puerto Rican study, most of which were supplied by
Dr. Pendleton.

As shown in Fig. 4, the treated and the control cases were divided into
age groups: 18-21 ; 22-25; 26-29 years of age, etc. Serial sections were made

238

John Rock

at 10 )u in thickness and every twentieth section was mounted and stained
for study. Most of the specimens suppHed from 10 to 25 such selected sections.
More were available in the control group than could be obtained from
biopsy material.

PRIMORDIAL FOLLICLE COUNTS IN OVARIES
UNTREATED AND TREATED WITH ENOVID
10 mgyd, D5-25/Cycle

SEPT 1958

I I UNTREATED

P=^ TREATEO

NO or

NO OF OVARIES

FOLLICLES mn CORTEX

Fig. 4. Effect of Enovid (and Norlutin) on the number of primordial ovarian follicles in
women of different age groups.

The stained slides were then projected on a screen for accurate measure-
ment of curvilinear distances along the ovarian cortex, and the number of
primordial follicles per millimeter of cortex was computed. The values for the
untreated and the treated specimens were then compared. Statistically, there
was no significant difference between untreated and treated ovaries in the
number of primordial follicles present. Even in one woman who had received
medication for 20 cycles, the number of normal primordial follicles was not
less than the control value.

Inhibition of Ovulation in the Human

239

Although not as many treated ovaries as we could wish have been
studied so far, the indication is that undeveloped ova are not damaged by
Enovid.

C. Effect of Enovid on Future Reproductive Potential

The innocuousness of Enovid to the ovaries is also evidenced by the
fertility of patients following cessation of medication. That Enovid does no
harm to the reproductive potential is shown by a follow-up study of women
in San Juan who, after treatment for even as long as 34 cycles, manifested,

Table 14. Fertility Control with Enovid: Pregnancy Rates of 84 Women Using No

Contraceptives Following Withdrawal from San Juan Project

(Medication for 1-34 Cycles)

No. of patients
followed up

No. of medication
cycles

Pregnancy rates
per 100 woman-years

36
16
11
13

1-5

6-10

11-15

16-25

26-34

181
159

258
200

189

—

Mean: 186

after cessation of therapy, a fertility rate that differed only slightly from their
premedication performance (Table 14). Moreover, even among those using
contraceptives of some other sort after discontinuance of Enovid, we find that
many pregnancies occurred.

Hence we believe that ovulation potential is not diminished by long use of
these steroids that prevent its expression.

D. Other Effects of Enovid

Appropriate studies revealed no evidence of liver damage in patients
participating in the field projects who had used the material cyclically without
interruption for as long as 2| years (30-32). In our own local cases, 10 indi-
viduals, who had been on Enovid therapy for more than a year, also failed to
show any sign of liver dysfunction. Furthermore, no deleterious effects on
the blood (26) or on general health and well-being (31, 32) could be detected.

COMMENT

I have reported that 10 mg a day was selected as the standard dosage of
Enovid. The material is expensive; the present retail price in this country
is about 55 cents per 10-mg tablet; and so we have tried 5 mg and even as
little as 2.5 mg per day. While, with lower dosage, there is a slightly higher

240 John Rock

incidence of breakthrough bleeding, the % of untoward reactions, such as
transient nausea, which at 10 mg per day is experienced by about 10% of
patients, is definitely decreased. Moreover, ovulation is equally well inhibited
at lower dosages.

In conclusion, it may be stated that in norethynodrel we have a substance
that suppresses ovulation and seems to be quite harmless. I believe that, with
availability of material and with the proper motivation, large numbers of
fairly illiterate people can be encouraged to use it. There is good reason
to conclude that Enovid will do no damage either to the woman herself or
to her future reproductive potential.

REFERENCES

1. Garcia, C.-R. and J. Rock, Ovulation. Chapter II in Essentials of Human Reproduction.

Clinical Aspects, Normal and Abnormal (Edited by J. T. Velardo), pp. 22-54, Oxford
University Press, New York, 1958.

2. SOMMERS, S. C, The Pituitary and Hypothalamus. Chapter V in The Endocrinology

of Reproduction (Edited by J. T. Velardo), pp. 59-97, Oxford University Press, New
York, 1958.

3. Rock, J., M. K. Bartlett and D. D. Matson, Am. J. Obst. & Gynec. 31, 3-12, 1939.

4. Sturgis, S. H., III. Functional Disorders. 1. Amenorrhea: Classification and Treatment.

In Progress in Gynecology, Volume II (Edited by J. V. Meigs and S. H. Sturgis),
pp. 163-175, Grune & Stratton, New York, 1950.

5. Sturgis, S. H. and F. Albright, Endocrinology 26, 68-72, 1940.

6. Henshaw, p. S., Science 111, 572-582, 1953.

7. Gordon, J. E., J. B. Wyon and T. H. Ingalls, Am. J. Med. Sci. 221, 326-357, 1954.

8. Hoagland, H., Population Problems and the Control of Fertility. Daedalus {Journal

of the American Academy of Arts and Sciences), pp. 425-443, Summer, 1959. (Issued
as Vol. 88, No. 3, of the Proceedings of the American Academy of Arts and Sciences.)

9. Jackson, H., Pharmac. Revs. 11, 135-172, 1959.

10. Noble, R. L., Chapter VI. Plenary Session: Oral Methods of Fertility Control. Anti-

gonadotrophins in Plants. Report of the Proceedings of the Sixth International
Conference on Planned Parenthood, 14-21 February, 1959, pp. 243-250, New Delhi,
India. The International Planned Parenthood Federation, London, 1959.

11. Sanyal, S. N., Chapter VI. Plenary Session: Oral Methods of Fertility Control. Oral

Contraceptive for Use by Both Males and Females. Report of the Proceedings of
the Sixth International Conference on Planned Parenthood, 14-21 Februai^y, 1959,
pp. 254-257, New Delhi, India. The International Planned Parenthood Federation,
London, 1959.

12. PiNCUS, G. and M. C. Chang, Acta Physiol. Latinoamericana 3, 177-183, 1953.

13. Slechta, R. F., M. C. Chang and G. Pincus, Fertd. & Steril. 5, 282-293, 1954.

14. PiNCUS, G., Acta Endocrinol. 23 (Supplement XXVIII), 18-36, 1956.

15. Beard, J., The Span of Gestation and the Cause of Birth, Jena, 1897. (Cited by Asdell,

S. A., Physiol. Revs. 8, 313-345, 1928. Citation is on page 325.)

16. Macht, D. I., Surg., Gynec. & Obst. 66, 732-747, 1938.

17. PiNCUS, G., M. C. Chang, E, S. E. Hafez, M. X. Zarrow and A. Merrill, Science

124, 890-891, 1956.

18. Pencus, G., M. C. Chang, M. X. Zarrow, E. S. E. Hafez and A. Merrill, Endo-

crinology 59, 695-707, 1956.

19. Rock, J., G. Pincus and C.-R. GarcIa, Science 124, 891-893, 1956.

20. Rock, J., C.-R. Garcia and G. Pincus, Synthetic Progestins in the Normal Human

Menstrual Cycle. Recent Progress in Hormone Research, Volume XIII (Edited by
G. Pincus), pp. 323-346, Academic Press, New York, 1957.

Inhibition of Ovulation in the Human TAX

21. Rock, J. and C.-R. Garcia, Observed Effects of 19-Nor Steroids on Ovulation and

Menstruation. Proceedings of a Symposium on \9-Nor Progestational Steroids,
pp. 14-25, Searie Research Laboratories, Chicago, 1957.

22. Garcia, C.-R., G. Pincus and J. Rock, Am. J. Ohst. & Gynec. 75, 82-97, 1958.

23. Rock, J., C.-R. Garcia and G. Pincus, Chapter VI. Plenary Session: Oral Methods

of Fertility Control. Clinical Studies with Potential Oral Contraceptives. Report of
the Proceedings of the Sixth International Conference on Planned Parenthood, 14-21
February, 1959, pp. 212-214, New Delhi, India. The International Planned Parenthood
Federation, London, 1959.

24. Rice-Wray, E., Field Study with Enovid as a Contraceptive Agent. Proceedings of a

Symposium on 1 9-Nor Progestational Steroids, pp. 78-85, Searie Research Laboratories,
Chicago, 1957.

25. Pincus, G., Long Term Administration of Enovid to Human Subjects. Proceedings of

a Symposium on \9-Nor Progestational Steroids, pp. 105-118, Searie Research
Laboratories, Chicago, 1957.

26. Pincus, G., J. Rock, C.-R. Garcia, E. Rice-Wray, M. Paniagua and I. Rodriguez,

Am. J. Obst. & Gynec. 75, 1333-1346, 1958.

27. Pincus, G., J. Rock and C.-R. Garcia, Effects of Certain 19-Nor Steroids Upon

Reproductive Processes. New Steroid Compounds with Progestational Activity. Ann.
N.Y. Acad. Sci. 71, Art. 5, 677-690, 1958.

28. Pincus, G., Postgrad. Med. 24, 654-660, 1958.

29. Pincus, G., Studies on Fertility 10, 3-26, 1959.

30. Pincus, G., J. Rock and C.-R. Garcia, Chapter VI. Plenary Session: Oral Methods

of Fertility Control. Field Trials with Norethynodrel as an Oral Contraceptive.
Report of the Proceedings of the Sixth International Conference on Planned Parenthood,
14-21 February, 1959, pp. 216-230, New Delhi, India. The International Planned
Parenthood Federation, London, 1959.

31. Pincus, G., C.-R. Garcia, J. Rock, M. Paniagua, A. Pendleton, F. Laraque,

R. Nicolas, R. Borno and V. Pean, Science 130, 81-83, 1959.

32. Pincus, G., J. Rock, M. C. Chang and C.-R. Garcia, Fed. Proc. 18, 1051-1055, 1959.

33. Pincus, G., Progestational Agents and the Control of Fertility. Vitamins and Hormones,

Volume XVII, pp. 307-324. Academic Press, New York and London, 1959.

34. Crosson, J. W., Fertil. & Steril. 10, 361-373, 1959.

35. Rock, J., C.-R. Garcia and G. Pincus, Am. J. Obst. & Gynec. 79, 758-767, 1960.

36. Drill, V. A., Fed. Proc. 18, 1040-1048, 1959.

37. Kistner, R. W., Clin. Obst. & Gynec. 2, 877-889, 1959.

38. Saunders, F. J. and V. A. Drill, Part I. Biological Activity in Animals. Some Biological

Activities of 17-Ethynyl and 17-Alkyl Derivatives of 17-Hydroxyestrenones. New
Steroid Compounds with Progestational Activity. Ann. N. Y. Acad. Sci. 71, Art. 5,
516-531, 1958.

39. Epstein, J. A., H. S. Kupperman and A. Cutler, Part III. Biological Activity in Man.

Comparative Pharmacological and Clinical Activity of 19-Nortestosterone and
1 7-Hydroxyprogesterone Derivatives in Man. New Steroid Compounds with Pro-
gestational Activity. Ann. N.Y. Acad. Sci. 71, Art. 5, 560-571, 1958.

40. Garcia, C.-R. and J. Rock, Unpublished data.

41. Matsumoto, S., Cited by Pincus (33).

42. Bartelmez, G. W., Am. J. Obst. & Gvnec. 74, 931-955, 1957.

43. Rock, J. and M. K. Bartlett, /. Am. Med. Assoc. 108, 2022-2028, 1937.

44. Rock, J., Am. J. Surg. 48 (New Series), 228-237, 1940,

45. Noyes, R. W., a. T. Hertig and J. Rock, Fertil. & Steril. 1, 3-25, 1950.

DISCUSSIONS

Dr. Frederick Hisaw: I notice that we have only a few minutes before closing time so
I shall be as brief as possible.

First, I should like to call Dr. Sturgis' attention to two papers, if he is not already
acquainted with them. One is by Dr. I. G. Schmidt (Am. J. Anat. 71, 245, 1942), who
made a thorough study of follicular development during the estrous cycle of the
guinea pig, and the other is a similar study of the rat by Dr. Charles E. Lane and
F. R. Davis {Anat. Rec. 73, 429, 1939).

In connection with Dr. Rock's discussion I should like to mention some unpublished
observations by F. L. Hisaw, Jr. on the effects of progesterone on the menstrual cycle
and ovulations in monkeys. We have several adult monkeys {Macaca mulalta) whose
menstrual cycles have been carefully recorded for several years, and these were used
in the experiments. The object was to find the minimal subcutaneous dose of
progesterone which, when given daily, would not disturb the length of a normal
cycle, and to determine the effect of such treatment on ovulaton. Briefly, it was found
that 0.25 or 0.5 mg progesterone daily, starting soon after conclusion of a menstrual
period, did not influence the time of appearance of the next expected menses, nor was
there an effect on subsequent normal cycles. However, 0.75 mg daily seemed to
produce an increase in length of the cycle. Laparotomies performed at a time corre-
sponding to the middle of the luteal phase of a normal cycle showed that one animal
out of six given 0.25 mg progesterone ovulated, and ovulation did not occur in eight
animals given 0.5 mg. This seems to suggest that it might be possible to give progesta-
tional compounds to women in amounts sufficient to inhibit ovulation and not modify
the length of the normal menstrual cycle.

Dr. Rock and Dr. Pincus have mentioned that in their experiments better results
were obtained when estrogen was given concurrently with their progestational
compounds. By this they mean, as I understand, that breakthrough bleeding during
a treatment is less likely to occur under these conditions. This probably is due to
two different effects, depending of course on dosage. It is well known that small doses
of estrogen greatly facilitate the action of progesterone on the endometrium, and also
these two hormones, when given concurrently, more effectively inhibit secretion of
pituitary gonadotropins than either alone. Castrated monkeys on 10 /ig of estradiol
daily rarely show breakthrough bleeding even though the treatment is continued for
a period of months, and the daily dose of progesterone is approximately 1 .5 to 2.0 mg.
Such treatments do not prevent the appearance of "castration cells" in the pituitary,
and gonadotropin content is correspondingly high. However, at the conclusion of
such treatments, if both hormones are given at the same dosage for an additional
twenty days, the gonad-stimulating capacity of the pituitary is almost depleted.
(Salhanick, H. a., F. L. Hisaw and M. X. Zarrow, J. Clin. Endocrinol. & Metab.
12, 310-320, 1952.)

Dr. Warren O. Nelson: In these closing minutes I should like to devote discussion
primarily to Dr. Rock's presentation. There are, however, two other points that I
should like to make in connection with the earlier papers.

During this meeting, we have considered occasionally, but only occasionally, the
important question of the relationship between the gonadotropic hormones and
estrogen production. This point arose this morning in connection with Dr. Gemzell's
presentation and it was evident, I believe, that the question as to whether FSH or LH
or a combination of the two is involved in the secretion of estrogen by the ovary
remains unresolved.

I think this relationship is much clearer in the case of the testes, where there seems
to be little doubt that LH is the factor important in the production of the steroid
hormones. There should no longer be serious doubt that steroid hormone production

242

Discussions 243

in the testes occurs in the Leydig cells. These are influenced by LH (or ICSH) and
by the same token, then, LH would be expected to be the factor that stimulates the
production of estrogen, and also of androgen in the ovary as well as the testis. Since
recent evidence indicates the source of estrogen production probably occurs by way
of an androgenic precursor, it follows that LH is the probable factor of importance.

I believe all of us should have liked to have heard more from Dr. Gemzell about
the direct effect of steroids on ovarian function. The evidence that he did present
suggests that there may be a direct inhibitory effect of progesterone on ovarian response
to FSH, but perhaps it might also be interpreted on the basis of progesterone inhibition
of endogenous gonadotropin. It must be remembered that the subjects had pituitaries
and that their pituitaries contributed to the total response or lack of response.

Finally I should like to comment on some of the interesting compounds discussed
by Drs. Rock and Pincus. We have had reason to be concerned with them because
of our interest in procedures that interfere with fertility, and in one way or another we
have examined all of these compounds.

A consideration that has commanded our interest has been their gonadotropin
inhibiting properties. Our evaluation of this activity has involved a procedure that we
believe gives a fairly good idea about the relative inhibition of FSH and LH. We have
used the 30-day-old male rat, treated 30 days. The 30-day-old male rat is immediately
pre-pubertal and during the next 30 days would normally become an adult male.
However, by suitable treatment with an effective inhibiting compound, he can be kept
in the immature state, so far as reproduction is concerned, for 30 days or as long as
might be desired.

As I have said, we can obtain a good index of the relative suppression of the two
gonadotropins. The weight of the testes provides excellent evidence of the effect, or
lack of effect, of FSH. The accessory organs, such as the prostate, seminal vesicles,
and epididymis, reflect the presence or absence of adequate amounts of LH.

In general, we have found that effective gonadotropin inhibiting compounds require
about twice the dose for FSH inhibition that they do for LH suppression. This has
been a consistent finding.

The one point that I should like, finally, to make with regard to the gonadotropin
inhibiting effects of these compounds is that the important point in the inhibition of
ovulation may not be so much a matter of relatively complete inhibition of total
gonadotropin production as it is the relative inhibition of FSH or LH. Since LH
appears to be inhibited more readily by the steroids in question, it would seem likely
that ovulation might be interfered with by reduction in LH without detectable reduction
in total gonadotropins.

This consideration recalls the studies that Dr. Rock and Dr. Pincus made with
progesterone in the inhibition of ovulation. In the women so treated, about 80 % of
the cycles were believed to be anovulatory. Where highly effective gonadotropin
inhibitors, such as Enovid and Norlutin, are concerned, gonadotropin inhibition may
be so complete that the question of relative inhibition is of little importance. In the
case of progesterone inhibition, I daresay that total inhibition was not obtained and
that the question of relative inhibition assumes importance. In all likelihood the
partial reduction of LH secretion was sufficient to prevent ovulation in some cases.

Chairman Astwood : Our time schedule has now run out, and I am afraid I shall have to
turn the meeting back to Dr. Villee, who wants to make a few remarks. Before so
doing, I want to voice the opinion of those preseiit that Dr. Villee has done a marvellous
job in arranging the Conference, and we are all sufficiently grateful to him to acclaim
this event. (Applause.)

Dr. Claude Villee: Thank you very much. Dr. Astwood, for your very kind remarks.
I want to express on your behalf our deep appreciation to the Association for the
Aid of Crippled Children and to Mrs. William FitzGerald, who is here, for making
this Conference possible. Many of you have told me how much this Conference has
meant to you, and I hope that Mrs. FitzGerald will take back to her Board the
consensus of opinion that it was a most worthwhile way to spend a pleasant week-end.

SUBJECT INDEX

Adenohypophysis, 59, 68, 98

— activation of, 115, 116

— activity of, 57, 67

— avian, 143

— control of, 66

— functions of, 101, 113

— infusions, 67

— stimulation of, 82, 109
Adrenergic agents, effects of, 67, 146
Adrenolytic blocking agent SKF-501, effect

of, 146
Adrenocorticotropin (ACTH) (see also
Hormones)

— effects of (in animals), 8, 20, 52, 84, 182,

220

— secretion of, 67, 113, 189
Adynamia, 84

Amygdaloid complex (see also Glands)

— lesions, effect of, 60, 61, 76, 77, 82, 115,

183

— pathways, 81

— role of, 75, 78, 115

— stimulation of, 82, 101
Androgenicity in women, 222
Androgens, effect of, 113, 115-117, 120,

121,243

— potency of, 39

— secretion of, in hens, 147
Antifertility agents, effect, in rabbits, 94, 95

in women, 229-234, 239

Atropine, effect of, in hens, 146

in rabbits, 124

in rats, 102, 104, 107-111

in ruminants, 99

Barbiturates, effect of, 113, 145, 146

Chlorpromazine, effect of, 50

Cholinergic blocking agents, effect of, in
hens, 146

Chorionic gonadotropin (HCG) [see also
Hormones, Gonadotropins and Preg-
nant Mare Serum (PMS)]

— effect of, in monkeys, 1, 19, 20, 22, 52
in rabbits, 84, 92

in rats, 16-20, 25-29, 185, 216, 219

in women, 192, 194, 197-208, 210,

211

Conception, rate of, in ruminants, 172, 173,

174
Corpus luteum (see also Ovaries, Ovulation)

— ascorbic acid content of, 216-219, 221

— cysts, 99, 223

— formation of, in rabbits, 29, 170
in rats, 3-5, 26, 46, 47, 76, 113, 116,

218

in ruminants, 98, 99, 177

in women, 193, 216-218

■ — function of, 217

— maturity of, in rats, 5

— occurrence of, in rats, 76, 77

— regression of, in ruminants, 164, 165,

177

— removal of, in ruminants, 169, 170,

173

— resorption of, in rats, 47
Corticoids (see also Steroids)

— effect of, 120
Cortisone (see also Steroids)

— effect of, 25, 50

Delalutin (see Progesterone derivatives)
Diencephalon, centre, 178

— lesions, effect of, 151, 178
Dysthyroidism, effect of, in women, 223

EEG patterns and characteristics, in
rabbits, 82-86, 88, 91, 93-95, 98

— reactions, in rabbits, 85-93, 95, 98,

100
Endometrium, activity of, in ruminants, 99
in women, 195, 197, 208, 209

— atrophy of, 196-198, 209

— development of, 235

— extracts, effect of, in ruminants, 99

— reactions of, 202, 204

Enovid (see also Norethynodrel), as fertility
control agent, 229-234, 239

— effect of, on "break-through" bleeding,

233, 234

on control of amenorrhea, 234

on endometrium, 235

on future reproductive potential,

239
on liver disfunction and blood, 239

245

246

SUBJECT INDEX

Enovid, effect of, on ovaries, 237, 238
as ovulation inhibitor, in rabbits,

93
in women, 50, 226, 227, 240,

243
ovulation suppressant, in women,

228
in post-medication cycles, 236,

237
on preganediol excretion, 228

— preparation of, 226
Estradiol, assay, 195

— effect of, in monkeys, 242
in rabbits, 90

in rats, 187

— occurrence, 53
Estriol, assay, 195
Estrogens, assay, clinical, 195

— effect of, in monkeys, 216, 218

as ovulation inhibitor, in hens, 132,

154, 159

in rabbits, 37, 81, 82, 89-95

in rats, 46, 48, 50, 110, 120

in ruminants, 118, 163, 164, 166, 169,

173, 174, 179

in vitro, 51

in women, 216, 218, 242, 243

— excretion, in women, 195-205, 207, 211,

212

— implants, 51

— in invertebrates, 49

— levels, 154, 155, 158, 190

— production of, 48, 51, 207, 208, 215, 242

— release of, in women, 208, 209, 215, 219,

242

— secretion of, in animals (misc.), 56, 79,

119, 178

in hens, 147, 158, 159

in monkeys, 52

in rats, 52, 113,219

— stimulation, in hens, 154
Estrogenicity, in women, 223
Estrone, assay of, 195

Excitation hormone (progestagen?) {see
also Hormones)

— concentration of, in hens, 153, 154

— effect of, in hens, 155

— occurrence of, in hens, 1 56

Fetus, development of, in rats, 190

in women, 207

Follicles, activation of, 70

— aggregates of, in hens, 1 59

— atresia, 24, 29, 30, 184, 186

in hens, 125, 126, 128-130, 132, 142,

147. 160,214,217,218

Follicles, atresia, in monkeys, 214, 215,

217

in rats, 50, 215

in women, 193, 207, 213, 215, 216,

237

— atrophy of, 65, 213

— ceil wall of, 35, 48, 51, 124, 129, 132

— cysts, 167, 216

— degeneration of, in rats, 26, 27, 33

— development of, general, 1, 52-54, 56,

59, 61,221,242
in hens, 123, 128, 130, 133, 134, 153,

158, 185
in rats, 2, 3, 6, 8, 9, 13-15, 17-19, 20,

24-27, 30-35, 49-50, 1 13, 242
in ruminants, 98, 164, 169, 170, 173,

186
in women, 192, 207, 217

— enlargement of, 26, 33, 56, 207

— ischemia of, 129, 132, 184, 186

— maturation of, general, 27, 35, 134, 170,

210,214,215,217
in hens, 133, 134, 137-143, 151, 153,

156, 160, 161

in rats, 26, 27, 30, 33

in women, 204, 207, 213

— meiosis of, 24, 26, 30

— overgrowth, in hens, 147

— resorption of, in hens, 156

— release of, in hens, 153

— rupture of, 56, 63, 122-124, 186
in hens, 124, 130, 141, 146, 147,

156

in rabbits, 53, 70

in women, 207

— sensitizing substances, 123

Follicle stimulating hormone (FSH) {see
also Hormones)

— assay, 6, 139, 227

— effect of, in animals (misc.), 123
in hens, 127-130, 132, 138, 143, 153,

154, 158, 185
in monkeys, 1, 19, 20, 22, 23, 52,

192

in rabbits, 84

in rats, 2, 4, 5, 7-12, 14-20, 49, 54,

190, 220
in ruminants, 163, 165, 168, 169, 171,

173, 180
in women, 193-195, 197-208, 210-

212, 220, 242

— estrogen excretion effect, 36

— inhibition of effect, 184, 185, 187,

243

— occurrence of, 35, 53

— potency of, 6-9, 19, 20, 193, 194

— preparation of, 6, 7, 138, 194

SUBJECT INDEX

247

Follicle stimulating hormone (FSH), puri-
fication of, 6, 7, 20, 194

— secretion in animals, misc., 59, 61, 63,

65, 66
in hens, 1 56, 1 77

Gestagen, effect of, in hens, 1 56
Gestation in rats, 190

— in women, 192, 205, 206

Glands (see also Amygdaloid complex.
Gonads, Optic glands. Pituitary)

— activity of, 57, 59

— endocrine, maturing of, 56

Gonadotropins [see also Hormones, Chori-
onic gonadotropin (HCG), Pregnant
Mare Serum (PMS)]

— assay, 19, 120, 121, 181, 210, 211

— effect of, in animals, misc., 79, 124, 216
in hens, 124, 128, 130, 139, 140, 144,

154, 155, 158

in monkeys, 2, 52

in rabbits, 70, 91, 95, 185, 221

in rats, 2, 14, 19, 24-28, 33, 50, 57,

58, 111, 221
in ruminants, 98, 163, 165, 168, 169,

179
in women, 192, 193, 211, 216, 224

— excretion, in women, 198, 211

— inactivation of, 224

— levels, 27, 33, 211

— occurrence of, 56, 57, 180

— production of, 2, 3

— release blocking, in ruminants, 167

— release of, 79

— secretion of, in hens, 143, 144, 151, 152,

153, 156-158, 160

in rabbits, 84, 95, 98, 99

inrats, 57, 58, 61,63, 75, 78, 113,115,

116, 119-121, 184

in ruminants, 118, 173, 178

suppression of, 157

— specificity, 192

— stimulation, in monkeys, 182, 214
in women, 216

Gonads (see also Glands)

— activity of, 57, 58

— atrophy of, 62

— effect of environment on, 59
light, in birds, 144

— enlargement of, 58

— function, 133, 144

— stimulation of, 59

Growth hormone (see Somatotropin,
Hormones)

Hamartomata, effect of, 58
Heats, in rabbits, 87, 89, 90

— in ruminants, 165-171, 174, 177

Hormones [see also Adrenocorticotropin
(ACTH), Chorionic Gonadotropin
(HCG), Excitation Hormone (Pro-
gestagen), Follicle Stimulating Hor-
mone (FSH), Growth Hormone
(Somatotropin), Human Menopausal
Hormone (HMG), Interstitial Cell
Hormone (ICSH), Luteotropin (LH),
Melanophore Stimulating Hormone
(MSH), Neurohypophysis Hormone,
Ovulation Inducing Hormone (OIH),
Oxytocin, Posterior Lobe Hormone,
Pregnant Mare Serum (PMS), Sex
Hormone]

— balance, in hens, 158

— disturbance, 223

— effect of, 123, 184, 188

in hens, 132, 152

in monkeys, 22

on ovulation, 79

— — on rats, 3, 4

— endogenous, elimination of, 3, 95

■ production of, in ruminants. 1 63

— exogenous, effect of, 95, 125, 128

— as fertility control agents, in ruminants,

163

— interaction with other hormones, 52
Human menopausal hormone (HMG) (see

also Hormones)

— effect of, in women, 194

Human pregnancy urine (PU), effect of, in
ruminants, 163, 165, 168-170, 188

in women, 192

1 7-Hydroxycorticoids (see also Steroids)

— excretion of, in women, 196, 197, 199,

200-203, 205

— levels of, in ruminants, 179
Hypophysectomy, effect of, in hens, 125,

126, 129, 130, 144, 149, 186

inrats, 3, 110, 184,219

Hypophysis, activation of, 84, 91

— blocking action, 1 10

— effect of lesions, in hens, 151

— portal veins of. 66, 101

— role of, 79

— transplants, 79
Hypoplasia in women, 222
Hypothalamus, activation of, 67, 113, 115,

151

— assay of, 69

— centres of, 94, 95, 146, 179

— effect of lesions, in animals (misc.),

61-63, 181, 187, 188

in hens, 146-149, 177

in rats, 57, 58, 75, 76, 117, 182-

184
in ruminants, 174, 178-180

248

SUBJECT INDEX

Hypothalamus, effect of lesions, on FSH

secretion, 62
implants, 187

— extracts, effect of, 68, 69, 100

— function of, 56, 65-67, 82, 98, 109, 222

— preoptic region, activity of, 149
effect on ovulation stimulation, 59,

64, 101, 102, 104-106, 108, 109, 111,
115

lesions, effect of, in hens, 147-149,

151

— sex centres, 101, 118

— stimulation of, 64, 81, 98, 101, 103, 104,

113, 115, 117

— supra-optic region, avian, 151, 152, 189
function of, in hens, 1 52

Insemination, artificial, effect of (rumi-
nants), 165, 167, 168, 171, 184
Interstitial cell, ascorbic acid content, 216

— atrophy of, 187

— evolution of, 187

— repair of (rats), 3, 4, 6, 8, 9, 190

— stimulation of, 13, 36

Interstitial cell hormone (ICSH) {see also
Hormones, Gonadotropins)

— assay and purification of, 8, 9

— effect of, in frogs, 123

in rats, 2, 3, 5-8, 12, 14-20, 49

— occurrence, 181, 243

— secretion of, in rats, 113

Ketosteroids (see also Steroids)

— excretion of (animals), 118

(women), 196, 197, 199-203, 205

Lithosperm, effect of, in hens, 185

in women, 224

Luteotropin (LH) {see also Hormones,
Prolactin)

— activity levels, in hens, 141, 154, 160
in monkeys, 215

in ruminants, 180

— assay of, 156,216,221

— content in pituitary, in rats, 120, 121

— effect of, in hens, 122, 123-130, 132, 138,

139, 147, 154, 157, 185, 186

in monkeys, 49, 52, 53

in rabbits, 84

in rats, 56, 177, 190, 216, 218-221,

243

in ruminants, 163, 168, 173, 174, 179

in women, 193, 194, 209, 211, 228,

242, 243

— excretion of, in women, 217

— mechanism, in the rat, 111, 157

— preparation of, 138

Luteotropin (LH), secretion of, in hens, 124,
125, 132, 138, 145-147, 156, 157,
160

in rabbits, 64-67, 69, 122

in rats, 71, 113, 122

in ruminants, 98, 99, 174

Median eminence (.v^^' also Tuber cinereum)

— avian, 143, 144, 147, 149

— lesions, effect of, 61

— stimulation of, 65, 101, 104, 110, 111,

113, 115

— structure of, 66-69, 189

— tissue extracts, 67-72, 119
Melanophore stimulating hormone (MSH)

{see also Hormones)

— effect of, 52
Myometrium, development of, 132

Neurohypophysectomy, effect of, in hens,

144
Neurohypophysis, avian, 143, 152

— innervation of, 189

— structure of, 68, 189
Neurohypophysis hormone {see also Hor-
mones)

— effect of, in ruminants, 98
Nilevar {see Nortestosterones)
Norethindrone (Norlutin), effect of, as

ovulation inhibitors, in rabbits, 93-95

in rats, 46, 48

in women, 224, 237, 238, 243

ovulation suppressant, in women,

228

— preparation of, 225
Norethynodrel {see also Enovid), effect

of, as ovulation inhibitor, in rabbits,

in rats, 46-48

in women, 225, 227, 228, 237

— — ovulation suppressant, 240
Norgestagens, effect of, 93-95
Norlutin {see Norethindrone)
Norsteroids {see also Steroids)

— derivatives: 17a-(l-methallyl)-19-nortest-

osterone (SC 8117), 229, 230
methylpregnone, 229

— effect of, as ovulation inhibitors, in

women, 44, 48, 224

— properties of, 225
Nortestosterones (incl. Nilevar)

— derivatives, 41, 44

as ovulation inhibitors, in rabbits,

41,44,93
in women, 224

SUBJECT INDEX

249

Optic gland (see also Glands)

— enlargement of, 59

— lesions, effect of, 57
Ovaries, activation of, 104, 130

— atresia, in monkeys, 214

— atrophy of, 56, 61, 65, 81, 125, 178

— avian, 124

development of, 133

— development of, 57, 58

— enlargement of, in animals, 58, 188
polycystic, in women, 188, 192, 195,

197, 198, 200, 204, 206, 208, 216, 218

— function of, 134, 193

— hypoplastic, in women, 198

— implants in, in rats, 50

— insufficiency (hypoplasia), 222

— ovum content in, 213

— regression of, 151, 170

— removal of, in ruminants, 171

— rupture points, 71

— stimulation of, 207

— superovulation, in rats, 30, 192

— transplants, 24-28, 30, 33, 56, 79
regression of, 26

relation to iris and cornea, 26

vascularization of, 25, 26, 33, 56,

viability of, 26

Oviducts, regression of, in hens, 151
Ovulation, general: blocking agents, 84,

98-100, 102, 104, 107-111, 113, 124,

130

— cycle, diestrous, 102, 104-106, 109-111,

115, 116

effect of environment, 59-61, 98,

109

effect of operations, 60, 61

cycle, effect of pharmaceutical com-
pounds, 87, 115, 116, 119

induction of, 118

proestrous, 102-107, 111, 115,

116

— effects of hormones on, 79
pre-optic region, 101, 109

— induction of, 81

— non-spontaneous, 63

— reflex, 79

— spontaneous, 25, 63
Ovulation in hens: accelerators, 124

— blocking agents, 146

— cycle, 134, 137-139, 152, 154

induction of, 177

mechanism, 156

threshold response, 153, 154

— frequency, 134, 135, 137-139, 153

— induction of, 128-133, 139, 140, 143,

145, 148, 149, 151, 157

Ovulation in hens: inhibition, 145, 146, 185

— inhibitors, 142, 159

— interruption of, 147, 148, 151, 158

— lag, 134-139, 152-155, 158-160

— lapse, 141-143, 145, 147, 152-154, 157,

159

effect of barbiturates, 146

effect of photoperiod, 144, 145, 154,

155, 157, 158, 160, 161

— mechanism, 122, 124, 128, 129, 132,

134

— multiple, 130, 186

— premature, 141, 145, 146

— resumption of, 143, 144, 151

— sequence, 134-143, 153, 154, 157-

159

— stimulation, 140, 152, 159

— super-, 130

— suppression of, 147, 148
Ovulation in monkeys: control, 242

— mechanism, 213, 217

Ovulation in rabbits: control, 37,
48

— induction of, 81, 82 101

— "reflex", 101

— spontaneous, 70, 71, 90

— super-, 185

Ovulation in rats: control of, 37, 113, 115,
117

— inhibitors, 1 13

— mechanism, 215

— spontaneous, 71, 101, 104, 105, 113,

121

— super-, 2, 5, 25, 190

Ovulation in ruminants: "asynchronous",
160

— blocking agents, 167

— cycle, control of, 163

effect of lesions, 1 77

effect of photoperiod, 1 64

effect of transplants, 119

follicular phase, 164

induction of, 1 66

length, 164, 168, 171-174

luteal phase, 164, 167, 168,

175

— interference, 166

— mid-cycle, 168, 169

— multiple, 99, 164-166, 168, 169, 171, 172,

173, 175

— rate of, 166, 167, 169-171, 173-

175

— "shock", 168, 169

— "synchronous", 165

Ovulation in women: anovulation, 218, 222,
223

— control of, 214

250

SUBJECT INDEX

Ovulation in women: criteria, 195

— cycle, factors, 213

length of, 228

luteal phase, 207

prolongation of, 21 1

— failure, 222

— indices, 228

— induction of, 192-194, 198, 204-206,

210

— inhibition of, 222, 223, 225, 243

— mechanism, 193, 208, 222

— mid-cycle, 217

— multiple, 21 1

— oligo-ovulation, 222

Ovulation inducing hormone (OIH) (see
also Hormones)

— effect of, in animals, misc., 19, 32, 62,

122
in hens, 144, 154, 155, 159,

161
in rats, 19, 105, 107, 109,

220

— occurrence of, 19

— release of, in hens, 138-147, 149-155,

157-159, 161
effect of light on, in rats and rabbits,

146
pharmacological agents on, in

hens, 146

in rats and rabbits, 145

interruption, in hens, 151

— release, in rabbits, 84

— release-mechanism, in hens, 153, 154,

157, 158, 161

stimulus, in hens, 152, 159

-suppression, in hens, 147, 158

— secretion of, in rabbits, 79, 80
Ovum, atresia, 25

— degeneration, 25, 26, 170, 214

— fertility of, of rats, 31, 33

— fertilization of, in rats, 25, 31, 54
in ruminants, 165, 167, 169, 171,

172
in women, 207

— implants, in ruminants, 164, 168

— maturation of, 24-26, 30, 33, 35, 50, 54
in women, 192, 213

— meiosis, 26, 30, 33, 36, 54

— recovery of, 31, 168, 171, 191

— release of, in animals, misc., 50, 56, 123
in hens, 125, 129, 132

inrats, 2, 4, 9-11, 15, 19, 105

in ruminants, 168, 169

— survival of, 31, 171

— transplants, 31-33

— transport of, in rats, 190
in ruminants, 168, 170, 172

Oxytocin (see also Hormones)

— effect of, 67, 98, 99, 1 18, 1 19, 124

— secretion of, 118

Pituitary {see also Glands)

— activation of, general, 63

in hens, 146, 147, 154

in rabbits, 82, 87, 89, 95, 98

— activity of, 66, 68, 98, 143, 149,

209

— development of, 57

effect of, in hens, 142, 143

— extracts, infusions, effect of, 68, 69, 71,

119,210,219

— function of, 66, 67, 143, 144, 152

— general systemic circulation, 65

— hypophyseal portal circulation, 65

— implants, 187

— nerve-supply of, 65

— removal of, 147, 149

— secretion, effect in ruminants, 166,

179
effect of, 56, 58

— stalk, hypophyseal portal vessels, 59, 61,

63, 66, 67-69, 79, 179

stimulation of, 65

transplantation, effect of, 65, 119,

123
Pituitary hormones (see also Hormones)

— effect of, in monkeys, 2, 19, 49, 51,

in rabbits, 80, 84, 95, 189

in rats, 2, 13, 14, 49, 51

in ruminants, 168, 173

— release, 67, 80, 82, 95, 98, 100, 122, 123,

167,209
Polydypsia, in hens, 151
Posterior lobe hormone (see also Hormones)

— effect of, 19
Pregnanediol, assay, clinical, 195

— excretion of, 196, 198-205, 207, 211,

228, 229

— levels, 202

Pregnant Mare Serum (PMS) (see also
Hormones, Gonadotropins)

— effect of, in hens, 128, 158
in rabbits, 84

in rats, 25, 27-29, 33, 52, 190

in ruminants, 163, 165, 166-174, 185,

186

in women, 192, 219

Pregnenolone, effect of, 50
Progestagen, effect of, in hens, 1 55

— occurrence of, in hens, 156
Progesterone (see also Steroids)

— assay, 53, 155, 156

SUBJECT INDEX

251

Progesterone, derivatives of:

17a-hydroxyprogesterone(Delalutin),
41,45,93

17-acetoxyprogesterone and deriva-
tives, 41, 42, 45

— eflfects of, general, 53, 79, 217, 243
in frogs, 51, 123

in hens, 94, 126, 132, 140, 142, 143-

149, 151, 155, 156, 186

in invertebrates, 49

in mice, 50

in monkeys, 52, 242

in rabbits, 87-90, 93, 109

in rats, 102, 104, 109, 110, 115-117,

120, 220
in ruminants, 100, 118, 166, 169, 172,

173, 174, 179
in women, 39, 41-46, 51, 224, 228,

243

— levels, in rats, 190

— precursors, 217, 218

— secretion of, 79
Progestinicity, 223
"Progestins", effect of, 228

Prolactin (LTH) (Lactogenic hormone) [see
also Hormones, Luteotropin (LH)]

— activity levels, 215

— effect of, in frogs, 156

in hens, 123

in rabbits, 84

in rats, 5, 8, 20, 91, 119, 220

— function of, 118, 119

— secretion of, 118, 119

Protein hormones (see also Hormones)

— effect of, in hens, 186

Pubertas praecox, in humans, 182-184,

187
Puberty, onset of, in animals, 56-59, 62, 76

in humans, 58

Pyometra, in ruminants, 168

Reproductive patterns, in ruminants, 163
Reserpine, effect of, 50, 99, 119

Sex hormones, imbalance, 222

— secretion of, 57

Somatotropin (Growth Hormone (GH)) (see
also Hormones)

— effect of, in animals, 22, 23, 84, 192, 220

— properties of, 192
Sperms, transportation of, 184

Steroids, as ovulation inhibitor, 37, 45^7,

49, 50, 53, 80, 228, 234, 243
stimulants, 48-50

— effect of, in hens, 146

in rats, 120

in ruminants, 173

— excretion of, in women, 211

— production, in vivo, 215, 218

— secretion of, 79, 219, 228

• — urinary assay, clinical, 195
Stilbestrol, effect of, 50, 51, 109, 187
Stimulation, electrical, 79, 99, 101, 189
in rabbits, 64, 66, 67, 80, 81, 85-87,

89,91
in rats, 100, 103-106, 110, 111, 113,

115, 117, 120
parameters, 105-108, 111, 113

— sensory, 63
Stimulation-lesion experiments, 80

Testicles, atrophy of, in animals, 152, 180,

187
Testosterone, effect of, in rabbits, 90, 91, 95

in rats, 62, 113

in ruminants, 166, 167

in women, 224

Thalamus, effect of lesions in, 58, 60, 61, 76,

77, 151

— function, disturbance of, in women, 223
Thyrotropin (TSH) (see also Hormones)

— effect of, 8, 20, 84, 182

— secretion of, 67, 69

Tuber cinereum ( see also Median Eminence)

— effect of lesions, 58

— stimulation of, 64

Uterus, atrophy of, in rats, 187, 215

Sex hormones (see also Hormones)
— concentration of, 223

Vasopressin, effect of, 84
— infusions, effect of, 119

Internet Archive Audio

Featured

Top

Images

Featured

Top

Software

Featured

Top

Books

Featured

Top

Video

Featured

Top

Mobile Apps

Browser Extensions

Archive-It Subscription

Save Page Now

Full text of "Control of ovulation; proceedings of the conference held at Endicott House, Dedham, Massachusetts, 1960"

See other formats